<<<<<<< HEAD
"Covidence #","Study ID","Title","Reviewer Name","Peer-reviewed or Preprint","Journal","Database/Study ID","Date of Publication (Month and Year)","Title of paper","First Author (Last name and Initials)","Retrospective/Prospective","Study Design","Does the study primarily compare cancer vs. non-cancer cohorts?","Does the study include inpatients/ outpatients/both/ or non-specific?","Study Country/Countries","Study Regions/Cities","Hospital(s)","Study Start Date","Study End Date","Total study size (number of patients)","Primary Outcomes of Study","Secondary outcomes of study","outcomes described","Explicitly included vaccinated patients","Definition of Cancer patient","Comparison group","Comparator group matching strategy","Baseline characteristics:","Cancer Age (measure of centre) e.g. mean/median","Cancer Age (centre)","Cancer Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance","Cancer Age (spread)","Cancer Sex (% male)","Cancer Total number","Control (non-cancer) Age (measure of centre) e.g. mean/median","Control (non-cancer) Age (centre)","Control (non-cancer) Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance","Control (non-cancer) Age (spread)","Control (non-cancer) Sex (% male)","Control (non-cancer) Total number","Which COVID-19 variant does the study identify?","Co-morbidities:","Smoking Number (cancer)","Smoking Percentage (cancer)","Smoking Number (control)","Smoking Percentage (control)","Smoking Measure of Association","Smoking OR/RR value","Smoking 95% Confidence Interval","Smoking p-value","Hypertension Number (cancer)","Hypertension Percentage (cancer)","Hypertension Number (control)","Hypertension Percentage (control)","Hypertension Measure of Association","Hypertension OR/RR value","Hypertension 95% Confidence Interval","Hypertension p-value","Diabetes Mellitus (DM) Number (cancer)","Diabetes Mellitus (DM) Percentage (cancer)","Diabetes Mellitus (DM) Number (control)","Diabetes Mellitus (DM) Percentage (control)","Diabetes Mellitus (DM) Measure of Association","Diabetes Mellitus (DM) OR/RR value","Diabetes Mellitus (DM) 95% Confidence Interval","Diabetes Mellitus (DM) p-value","Cardiovascular Disease (CVD) Number (cancer)","Cardiovascular Disease (CVD) Percentage (cancer)","Cardiovascular Disease (CVD) Number (control)","Cardiovascular Disease (CVD) Percentage (control)","Cardiovascular Disease (CVD) Measure of Association","Cardiovascular Disease (CVD) OR/RR value","Cardiovascular Disease (CVD) 95% Confidence Interval","Cardiovascular Disease (CVD) p-value","Cerebrovascular Disease Number (cancer)","Cerebrovascular Disease Percentage (cancer)","Cerebrovascular Disease Number (control)","Cerebrovascular Disease Percentage (control)","Cerebrovascular Disease Measure of Association","Cerebrovascular Disease OR/RR value","Cerebrovascular Disease 95% Confidence Interval","Cerebrovascular Disease p-value","Chronic Liver Disease Number (cancer)","Chronic Liver Disease Percentage (cancer)","Chronic Liver Disease Number (control)","Chronic Liver Disease Percentage (control)","Chronic Liver Disease Measure of Association","Chronic Liver Disease OR/RR value","Chronic Liver Disease 95% Confidence Interval","Chronic Liver Disease p-value","Chronic Kidney Disease Number (cancer)","Chronic Kidney Disease Percentage (cancer)","Chronic Kidney Disease Number (control)","Chronic Kidney Disease Percentage (control)","Chronic Kidney Disease Measure of Association","Chronic Kidney Disease OR/RR value","Chronic Kidney Disease 95% Confidence Interval","Chronic Kidney Disease p-value","Chronic Lung Disease Number (cancer)","Chronic Lung Disease Percentage (cancer)","Chronic Lung Disease Number (control)","Chronic Lung Disease Percentage (control)","Chronic Lung Disease Measure of Association","Chronic Lung Disease OR/RR value","Chronic Lung Disease 95% Confidence Interval","Chronic Lung Disease p-value","Immunodeficiency/ Immunosuppression Number (cancer)","Immunodeficiency/ Immunosuppression Percentage (cancer)","Immunodeficiency/ Immunosuppression Number (control)","Immunodeficiency/ Immunosuppression Percentage (control)","Immunodeficiency/ Immunosuppression Measure of Association","Immunodeficiency/ Immunosuppression OR/RR value","Immunodeficiency/ Immunosuppression 95% Confidence Interval","Immunodeficiency/ Immunosuppression p-value","Autoimmune Disease Number (cancer)","Autoimmune Disease Percentage (cancer)","Autoimmune Disease Number (control)","Autoimmune Disease Percentage (control)","Autoimmune Disease Measure of Association","Autoimmune Disease OR/RR value","Autoimmune Disease 95% Confidence Interval","Autoimmune Disease p-value","Others: Please Specify Number (cancer)","Others: Please Specify Percentage (cancer)","Others: Please Specify Number (control)","Others: Please Specify Percentage (control)","Others: Please Specify Measure of Association","Others: Please Specify OR/RR value","Others: Please Specify 95% Confidence Interval","Others: Please Specify p-value","Notes Number (cancer)","Notes Percentage (cancer)","Notes Number (control)","Notes Percentage (control)","Notes Measure of Association","Notes OR/RR value","Notes 95% Confidence Interval","Notes p-value","Definition of severity","Definition of ICU admission/Critical","Definition of mortality","Definition of severe disease","Univariate or multivariate analysis?","Multivariate analysis is adjusted by","Primary Cancer Site:","Thoracic (lung, mesothelioma) Total Number of Patients","Thoracic (lung, mesothelioma) Measure of Association [mortality]","Thoracic (lung, mesothelioma) value [mortality]","Thoracic (lung, mesothelioma) 95% CI [mortality]","Thoracic (lung, mesothelioma) p-value [mortality]","Thoracic (lung, mesothelioma) cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Measure of Association [ICU]","Thoracic (lung, mesothelioma) value [ICU]","Thoracic (lung, mesothelioma) 95% CI [ICU]","Thoracic (lung, mesothelioma) p-value [ICU]","Thoracic (lung, mesothelioma) cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Measure of Association [severe disease]","Thoracic (lung, mesothelioma) value [severe disease]","Thoracic (lung, mesothelioma) 95% CI [severe disease]","Thoracic (lung, mesothelioma) p-value [severe disease]","Thoracic (lung, mesothelioma) cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Comment","Thoracic (lung, mesothelioma) Measure of Association [hospitalisation]","Thoracic (lung, mesothelioma) value [hospitalisation]","Thoracic (lung, mesothelioma) 95% CI [hospitalisation]","Thoracic (lung, mesothelioma) p-value [hospitalisation]","Thoracic (lung, mesothelioma) cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Comment.1","Breast Total Number of Patients","Breast Measure of Association [mortality]","Breast value [mortality]","Breast 95% CI [mortality]","Breast p-value [mortality]","Breast cancer: Event/Total [mortality]","Breast Non-cancer: Event/Total [mortality]","Breast Measure of Association [ICU]","Breast value [ICU]","Breast 95% CI [ICU]","Breast p-value [ICU]","Breast cancer: Event/Total [ICU]","Breast Non-cancer: Event/Total [ICU]","Breast Measure of Association [severe disease]","Breast value [severe disease]","Breast 95% CI [severe disease]","Breast p-value [severe disease]","Breast cancer: Event/Total [severe disease]","Breast Non-cancer: Event/Total [severe disease]","Breast Comment","Breast Measure of Association [hospitalisation]","Breast value [hospitalisation]","Breast 95% CI [hospitalisation]","Breast p-value [hospitalisation]","Breast cancer: Event/Total [hospitalisation]","Breast Non-cancer: Event/Total [hospitalisation]","Breast Comment.1","Upper GI (gastric, oesophageal) Total Number of Patients","Upper GI (gastric, oesophageal) Measure of Association [mortality]","Upper GI (gastric, oesophageal) value [mortality]","Upper GI (gastric, oesophageal) 95% CI [mortality]","Upper GI (gastric, oesophageal) p-value [mortality]","Upper GI (gastric, oesophageal) cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Measure of Association [ICU]","Upper GI (gastric, oesophageal) value [ICU]","Upper GI (gastric, oesophageal) 95% CI [ICU]","Upper GI (gastric, oesophageal) p-value [ICU]","Upper GI (gastric, oesophageal) cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Measure of Association [severe disease]","Upper GI (gastric, oesophageal) value [severe disease]","Upper GI (gastric, oesophageal) 95% CI [severe disease]","Upper GI (gastric, oesophageal) p-value [severe disease]","Upper GI (gastric, oesophageal) cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Comment","Upper GI (gastric, oesophageal) Measure of Association [hospitalisation]","Upper GI (gastric, oesophageal) value [hospitalisation]","Upper GI (gastric, oesophageal) 95% CI [hospitalisation]","Upper GI (gastric, oesophageal) p-value [hospitalisation]","Upper GI (gastric, oesophageal) cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Comment.1","Lower GI (colorectal, small bowel) Total Number of Patients","Lower GI (colorectal, small bowel) Measure of Association [mortality]","Lower GI (colorectal, small bowel) value [mortality]","Lower GI (colorectal, small bowel) 95% CI [mortality]","Lower GI (colorectal, small bowel) p-value [mortality]","Lower GI (colorectal, small bowel) cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Measure of Association [ICU]","Lower GI (colorectal, small bowel) value [ICU]","Lower GI (colorectal, small bowel) 95% CI [ICU]","Lower GI (colorectal, small bowel) p-value [ICU]","Lower GI (colorectal, small bowel) cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Measure of Association [severe disease]","Lower GI (colorectal, small bowel) value [severe disease]","Lower GI (colorectal, small bowel) 95% CI [severe disease]","Lower GI (colorectal, small bowel) p-value [severe disease]","Lower GI (colorectal, small bowel) cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Comment","Lower GI (colorectal, small bowel) Measure of Association [hospitalisation]","Lower GI (colorectal, small bowel) value [hospitalisation]","Lower GI (colorectal, small bowel) 95% CI [hospitalisation]","Lower GI (colorectal, small bowel) p-value [hospitalisation]","Lower GI (colorectal, small bowel) cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Comment.1","Hepatobiliary (liver, pancreas, gall bladder) Total Number of Patients","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [mortality]","Hepatobiliary (liver, pancreas, gall bladder) value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [mortality]","Hepatobiliary (liver, pancreas, gall bladder) p-value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [ICU]","Hepatobiliary (liver, pancreas, gall bladder) value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [ICU]","Hepatobiliary (liver, pancreas, gall bladder) p-value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) p-value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Comment","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) p-value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Comment.1","Renal Total Number of Patients","Renal Measure of Association [mortality]","Renal value [mortality]","Renal 95% CI [mortality]","Renal p-value [mortality]","Renal cancer: Event/Total [mortality]","Renal Non-cancer: Event/Total [mortality]","Renal Measure of Association [ICU]","Renal value [ICU]","Renal 95% CI [ICU]","Renal p-value [ICU]","Renal cancer: Event/Total [ICU]","Renal Non-cancer: Event/Total [ICU]","Renal Measure of Association [severe disease]","Renal value [severe disease]","Renal 95% CI [severe disease]","Renal p-value [severe disease]","Renal cancer: Event/Total [severe disease]","Renal Non-cancer: Event/Total [severe disease]","Renal Comment","Renal Measure of Association [hospitalisation]","Renal value [hospitalisation]","Renal 95% CI [hospitalisation]","Renal p-value [hospitalisation]","Renal cancer: Event/Total [hospitalisation]","Renal Non-cancer: Event/Total [hospitalisation]","Renal Comment.1","Urology (ureter, bladder, prostate) Total Number of Patients","Urology (ureter, bladder, prostate) Measure of Association [mortality]","Urology (ureter, bladder, prostate) value [mortality]","Urology (ureter, bladder, prostate) 95% CI [mortality]","Urology (ureter, bladder, prostate) p-value [mortality]","Urology (ureter, bladder, prostate) cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Measure of Association [ICU]","Urology (ureter, bladder, prostate) value [ICU]","Urology (ureter, bladder, prostate) 95% CI [ICU]","Urology (ureter, bladder, prostate) p-value [ICU]","Urology (ureter, bladder, prostate) cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Measure of Association [severe disease]","Urology (ureter, bladder, prostate) value [severe disease]","Urology (ureter, bladder, prostate) 95% CI [severe disease]","Urology (ureter, bladder, prostate) p-value [severe disease]","Urology (ureter, bladder, prostate) cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Comment","Urology (ureter, bladder, prostate) Measure of Association [hospitalisation]","Urology (ureter, bladder, prostate) value [hospitalisation]","Urology (ureter, bladder, prostate) 95% CI [hospitalisation]","Urology (ureter, bladder, prostate) p-value [hospitalisation]","Urology (ureter, bladder, prostate) cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Comment.1","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Total Number of Patients","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment.1","CNS Total Number of Patients","CNS Measure of Association [mortality]","CNS value [mortality]","CNS 95% CI [mortality]","CNS p-value [mortality]","CNS cancer: Event/Total [mortality]","CNS Non-cancer: Event/Total [mortality]","CNS Measure of Association [ICU]","CNS value [ICU]","CNS 95% CI [ICU]","CNS p-value [ICU]","CNS cancer: Event/Total [ICU]","CNS Non-cancer: Event/Total [ICU]","CNS Measure of Association [severe disease]","CNS value [severe disease]","CNS 95% CI [severe disease]","CNS p-value [severe disease]","CNS cancer: Event/Total [severe disease]","CNS Non-cancer: Event/Total [severe disease]","CNS Comment","CNS Measure of Association [hospitalisation]","CNS value [hospitalisation]","CNS 95% CI [hospitalisation]","CNS p-value [hospitalisation]","CNS cancer: Event/Total [hospitalisation]","CNS Non-cancer: Event/Total [hospitalisation]","CNS Comment.1","Head and neck Total Number of Patients","Head and neck Measure of Association [mortality]","Head and neck value [mortality]","Head and neck 95% CI [mortality]","Head and neck p-value [mortality]","Head and neck cancer: Event/Total [mortality]","Head and neck Non-cancer: Event/Total [mortality]","Head and neck Measure of Association [ICU]","Head and neck value [ICU]","Head and neck 95% CI [ICU]","Head and neck p-value [ICU]","Head and neck cancer: Event/Total [ICU]","Head and neck Non-cancer: Event/Total [ICU]","Head and neck Measure of Association [severe disease]","Head and neck value [severe disease]","Head and neck 95% CI [severe disease]","Head and neck p-value [severe disease]","Head and neck cancer: Event/Total [severe disease]","Head and neck Non-cancer: Event/Total [severe disease]","Head and neck Comment","Head and neck Measure of Association [hospitalisation]","Head and neck value [hospitalisation]","Head and neck 95% CI [hospitalisation]","Head and neck p-value [hospitalisation]","Head and neck cancer: Event/Total [hospitalisation]","Head and neck Non-cancer: Event/Total [hospitalisation]","Head and neck Comment.1","Skin (including melanoma) Total Number of Patients","Skin (including melanoma) Measure of Association [mortality]","Skin (including melanoma) value [mortality]","Skin (including melanoma) 95% CI [mortality]","Skin (including melanoma) p-value [mortality]","Skin (including melanoma) cancer: Event/Total [mortality]","Skin (including melanoma) Non-cancer: Event/Total [mortality]","Skin (including melanoma) Measure of Association [ICU]","Skin (including melanoma) value [ICU]","Skin (including melanoma) 95% CI [ICU]","Skin (including melanoma) p-value [ICU]","Skin (including melanoma) cancer: Event/Total [ICU]","Skin (including melanoma) Non-cancer: Event/Total [ICU]","Skin (including melanoma) Measure of Association [severe disease]","Skin (including melanoma) value [severe disease]","Skin (including melanoma) 95% CI [severe disease]","Skin (including melanoma) p-value [severe disease]","Skin (including melanoma) cancer: Event/Total [severe disease]","Skin (including melanoma) Non-cancer: Event/Total [severe disease]","Skin (including melanoma) Comment","Skin (including melanoma) Measure of Association [hospitalisation]","Skin (including melanoma) value [hospitalisation]","Skin (including melanoma) 95% CI [hospitalisation]","Skin (including melanoma) p-value [hospitalisation]","Skin (including melanoma) cancer: Event/Total [hospitalisation]","Skin (including melanoma) Non-cancer: Event/Total [hospitalisation]","Skin (including melanoma) Comment.1","Sarcoma (including Musculo skeletal) Total Number of Patients","Sarcoma (including Musculo skeletal) Measure of Association [mortality]","Sarcoma (including Musculo skeletal) value [mortality]","Sarcoma (including Musculo skeletal) 95% CI [mortality]","Sarcoma (including Musculo skeletal) p-value [mortality]","Sarcoma (including Musculo skeletal) cancer: Event/Total [mortality]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [mortality]","Sarcoma (including Musculo skeletal) Measure of Association [ICU]","Sarcoma (including Musculo skeletal) value [ICU]","Sarcoma (including Musculo skeletal) 95% CI [ICU]","Sarcoma (including Musculo skeletal) p-value [ICU]","Sarcoma (including Musculo skeletal) cancer: Event/Total [ICU]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [ICU]","Sarcoma (including Musculo skeletal) Measure of Association [severe disease]","Sarcoma (including Musculo skeletal) value [severe disease]","Sarcoma (including Musculo skeletal) 95% CI [severe disease]","Sarcoma (including Musculo skeletal) p-value [severe disease]","Sarcoma (including Musculo skeletal) cancer: Event/Total [severe disease]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [severe disease]","Sarcoma (including Musculo skeletal) Comment","Sarcoma (including Musculo skeletal) Measure of Association [hospitalisation]","Sarcoma (including Musculo skeletal) value [hospitalisation]","Sarcoma (including Musculo skeletal) 95% CI [hospitalisation]","Sarcoma (including Musculo skeletal) p-value [hospitalisation]","Sarcoma (including Musculo skeletal) cancer: Event/Total [hospitalisation]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [hospitalisation]","Sarcoma (including Musculo skeletal) Comment.1","SOLID AGGREGATED [add all solid values] Total Number of Patients","SOLID AGGREGATED [add all solid values] Measure of Association [mortality]","SOLID AGGREGATED [add all solid values] value [mortality]","SOLID AGGREGATED [add all solid values] 95% CI [mortality]","SOLID AGGREGATED [add all solid values] p-value [mortality]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [mortality]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [mortality]","SOLID AGGREGATED [add all solid values] Measure of Association [ICU]","SOLID AGGREGATED [add all solid values] value [ICU]","SOLID AGGREGATED [add all solid values] 95% CI [ICU]","SOLID AGGREGATED [add all solid values] p-value [ICU]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [ICU]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [ICU]","SOLID AGGREGATED [add all solid values] Measure of Association [severe disease]","SOLID AGGREGATED [add all solid values] value [severe disease]","SOLID AGGREGATED [add all solid values] 95% CI [severe disease]","SOLID AGGREGATED [add all solid values] p-value [severe disease]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [severe disease]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [severe disease]","SOLID AGGREGATED [add all solid values] Comment","SOLID AGGREGATED [add all solid values] Measure of Association [hospitalisation]","SOLID AGGREGATED [add all solid values] value [hospitalisation]","SOLID AGGREGATED [add all solid values] 95% CI [hospitalisation]","SOLID AGGREGATED [add all solid values] p-value [hospitalisation]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [hospitalisation]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [hospitalisation]","SOLID AGGREGATED [add all solid values] Comment.1","Haematological Total Number of Patients","Haematological Measure of Association [mortality]","Haematological value [mortality]","Haematological 95% CI [mortality]","Haematological p-value [mortality]","Haematological cancer: Event/Total [mortality]","Haematological Non-cancer: Event/Total [mortality]","Haematological Measure of Association [ICU]","Haematological value [ICU]","Haematological 95% CI [ICU]","Haematological p-value [ICU]","Haematological cancer: Event/Total [ICU]","Haematological Non-cancer: Event/Total [ICU]","Haematological Measure of Association [severe disease]","Haematological value [severe disease]","Haematological 95% CI [severe disease]","Haematological p-value [severe disease]","Haematological cancer: Event/Total [severe disease]","Haematological Non-cancer: Event/Total [severe disease]","Haematological Comment","Haematological Measure of Association [hospitalisation]","Haematological value [hospitalisation]","Haematological 95% CI [hospitalisation]","Haematological p-value [hospitalisation]","Haematological cancer: Event/Total [hospitalisation]","Haematological Non-cancer: Event/Total [hospitalisation]","Haematological Comment.1","Other Total Number of Patients","Other Measure of Association [mortality]","Other value [mortality]","Other 95% CI [mortality]","Other p-value [mortality]","Other cancer: Event/Total [mortality]","Other Non-cancer: Event/Total [mortality]","Other Measure of Association [ICU]","Other value [ICU]","Other 95% CI [ICU]","Other p-value [ICU]","Other cancer: Event/Total [ICU]","Other Non-cancer: Event/Total [ICU]","Other Measure of Association [severe disease]","Other value [severe disease]","Other 95% CI [severe disease]","Other p-value [severe disease]","Other cancer: Event/Total [severe disease]","Other Non-cancer: Event/Total [severe disease]","Other Comment","Other Measure of Association [hospitalisation]","Other value [hospitalisation]","Other 95% CI [hospitalisation]","Other p-value [hospitalisation]","Other cancer: Event/Total [hospitalisation]","Other Non-cancer: Event/Total [hospitalisation]","Other Comment.1","Unspecified Total Number of Patients","Unspecified Measure of Association [mortality]","Unspecified value [mortality]","Unspecified 95% CI [mortality]","Unspecified p-value [mortality]","Unspecified cancer: Event/Total [mortality]","Unspecified Non-cancer: Event/Total [mortality]","Unspecified Measure of Association [ICU]","Unspecified value [ICU]","Unspecified 95% CI [ICU]","Unspecified p-value [ICU]","Unspecified cancer: Event/Total [ICU]","Unspecified Non-cancer: Event/Total [ICU]","Unspecified Measure of Association [severe disease]","Unspecified value [severe disease]","Unspecified 95% CI [severe disease]","Unspecified p-value [severe disease]","Unspecified cancer: Event/Total [severe disease]","Unspecified Non-cancer: Event/Total [severe disease]","Unspecified Comment","Unspecified Measure of Association [hospitalisation]","Unspecified value [hospitalisation]","Unspecified 95% CI [hospitalisation]","Unspecified p-value [hospitalisation]","Unspecified cancer: Event/Total [hospitalisation]","Unspecified Non-cancer: Event/Total [hospitalisation]","Unspecified Comment.1","Total (OF ALL CANCERS) Total Number of Patients","Total (OF ALL CANCERS) Measure of Association [mortality]","Total (OF ALL CANCERS) value [mortality]","Total (OF ALL CANCERS) 95% CI [mortality]","Total (OF ALL CANCERS) p-value [mortality]","Total (OF ALL CANCERS) cancer: Event/Total [mortality]","Total (OF ALL CANCERS) Non-cancer: Event/Total [mortality]","Total (OF ALL CANCERS) Measure of Association [ICU]","Total (OF ALL CANCERS) value [ICU]","Total (OF ALL CANCERS) 95% CI [ICU]","Total (OF ALL CANCERS) p-value [ICU]","Total (OF ALL CANCERS) cancer: Event/Total [ICU]","Total (OF ALL CANCERS) Non-cancer: Event/Total [ICU]","Total (OF ALL CANCERS) Measure of Association [severe disease]","Total (OF ALL CANCERS) value [severe disease]","Total (OF ALL CANCERS) 95% CI [severe disease]","Total (OF ALL CANCERS) p-value [severe disease]","Total (OF ALL CANCERS) cancer: Event/Total [severe disease]","Total (OF ALL CANCERS) Non-cancer: Event/Total [severe disease]","Total (OF ALL CANCERS) Comment","Total (OF ALL CANCERS) Measure of Association [hospitalisation]","Total (OF ALL CANCERS) value [hospitalisation]","Total (OF ALL CANCERS) 95% CI [hospitalisation]","Total (OF ALL CANCERS) p-value [hospitalisation]","Total (OF ALL CANCERS) cancer: Event/Total [hospitalisation]","Total (OF ALL CANCERS) Non-cancer: Event/Total [hospitalisation]","Total (OF ALL CANCERS) Comment.1","Metastasis status:","M0/Stage I-III: No metastasis Total number of Patients","M0/Stage I-III: No metastasis Measure of Association [mortality]","M0/Stage I-III: No metastasis value [mortality]","M0/Stage I-III: No metastasis 95% CI [mortality]","M0/Stage I-III: No metastasis p-value [mortality]","M0/Stage I-III: No metastasis cancer: Event/Total [mortality]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [mortality]","M0/Stage I-III: No metastasis Measure of Association [ICU]","M0/Stage I-III: No metastasis value [ICU]","M0/Stage I-III: No metastasis 95% CI [ICU]","M0/Stage I-III: No metastasis p-value [ICU]","M0/Stage I-III: No metastasis cancer: Event/Total [ICU]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [ICU]","M0/Stage I-III: No metastasis Measure of Association [severe]","M0/Stage I-III: No metastasis value [severe]","M0/Stage I-III: No metastasis 95% CI [severe]","M0/Stage I-III: No metastasis p-value [severe]","M0/Stage I-III: No metastasis cancer: Event/Total [severe]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [severe]","M0/Stage I-III: No metastasis Comment","M0/Stage I-III: No metastasis Measure of Association [hospitalisation]","M0/Stage I-III: No metastasis value [hospitalisation]","M0/Stage I-III: No metastasis 95% CI [hospitalisation]","M0/Stage I-III: No metastasis p-value [hospitalisation]","M0/Stage I-III: No metastasis cancer: Event/Total [hospitalisation]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [hospitalisation]","M0/Stage I-III: No metastasis Comment.1","M1/Stage IV: metastatic disease Total number of Patients","M1/Stage IV: metastatic disease Measure of Association [mortality]","M1/Stage IV: metastatic disease value [mortality]","M1/Stage IV: metastatic disease 95% CI [mortality]","M1/Stage IV: metastatic disease p-value [mortality]","M1/Stage IV: metastatic disease cancer: Event/Total [mortality]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [mortality]","M1/Stage IV: metastatic disease Measure of Association [ICU]","M1/Stage IV: metastatic disease value [ICU]","M1/Stage IV: metastatic disease 95% CI [ICU]","M1/Stage IV: metastatic disease p-value [ICU]","M1/Stage IV: metastatic disease cancer: Event/Total [ICU]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [ICU]","M1/Stage IV: metastatic disease Measure of Association [severe]","M1/Stage IV: metastatic disease value [severe]","M1/Stage IV: metastatic disease 95% CI [severe]","M1/Stage IV: metastatic disease p-value [severe]","M1/Stage IV: metastatic disease cancer: Event/Total [severe]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [severe]","M1/Stage IV: metastatic disease Comment","M1/Stage IV: metastatic disease Measure of Association [hospitalisation]","M1/Stage IV: metastatic disease value [hospitalisation]","M1/Stage IV: metastatic disease 95% CI [hospitalisation]","M1/Stage IV: metastatic disease p-value [hospitalisation]","M1/Stage IV: metastatic disease cancer: Event/Total [hospitalisation]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [hospitalisation]","M1/Stage IV: metastatic disease Comment.1","Unknown Total number of Patients","Unknown Measure of Association [mortality]","Unknown value [mortality]","Unknown 95% CI [mortality]","Unknown p-value [mortality]","Unknown cancer: Event/Total [mortality]","Unknown Non-cancer: Event/Total [mortality]","Unknown Measure of Association [ICU]","Unknown value [ICU]","Unknown 95% CI [ICU]","Unknown p-value [ICU]","Unknown cancer: Event/Total [ICU]","Unknown Non-cancer: Event/Total [ICU]","Unknown Measure of Association [severe]","Unknown value [severe]","Unknown 95% CI [severe]","Unknown p-value [severe]","Unknown cancer: Event/Total [severe]","Unknown Non-cancer: Event/Total [severe]","Unknown Comment","Unknown Measure of Association [hospitalisation]","Unknown value [hospitalisation]","Unknown 95% CI [hospitalisation]","Unknown p-value [hospitalisation]","Unknown cancer: Event/Total [hospitalisation]","Unknown Non-cancer: Event/Total [hospitalisation]","Unknown Comment.1","Treatment type:","Chemotherapy Total number of patients","Chemotherapy percentage","Chemotherapy Measure of Association [mortality]","Chemotherapy value [mortality]","Chemotherapy 95% CI [mortality]","Chemotherapy p-value [mortality]","Chemotherapy cancer: Event/Total [mortality]","Chemotherapy Non-cancer: Event/Total [mortality]","Chemotherapy Measure of Association [ICU]","Chemotherapy value [ICU]","Chemotherapy 95% CI [ICU]","Chemotherapy p-value [ICU]","Chemotherapy cancer: Event/Total [ICU]","Chemotherapy Non-cancer: Event/Total [ICU]","Chemotherapy Measure of Association [severe]","Chemotherapy value [severe]","Chemotherapy 95% CI [severe]","Chemotherapy p-value [severe]","Chemotherapy cancer: Event/Total [severe]","Chemotherapy Non-cancer: Event/Total [severe]","Chemotherapy Comment [incl. name of targeted/immunotherapy]","Chemotherapy Measure of Association [hospitalisation]","Chemotherapy value [hospitalisation]","Chemotherapy 95% CI [hospitalisation]","Chemotherapy p-value [hospitalisation]","Chemotherapy cancer: Event/Total [hospitalisation]","Chemotherapy Non-cancer: Event/Total [hospitalisation]","Chemotherapy Comment","Hormonal therapy Total number of patients","Hormonal therapy percentage","Hormonal therapy Measure of Association [mortality]","Hormonal therapy value [mortality]","Hormonal therapy 95% CI [mortality]","Hormonal therapy p-value [mortality]","Hormonal therapy cancer: Event/Total [mortality]","Hormonal therapy Non-cancer: Event/Total [mortality]","Hormonal therapy Measure of Association [ICU]","Hormonal therapy value [ICU]","Hormonal therapy 95% CI [ICU]","Hormonal therapy p-value [ICU]","Hormonal therapy cancer: Event/Total [ICU]","Hormonal therapy Non-cancer: Event/Total [ICU]","Hormonal therapy Measure of Association [severe]","Hormonal therapy value [severe]","Hormonal therapy 95% CI [severe]","Hormonal therapy p-value [severe]","Hormonal therapy cancer: Event/Total [severe]","Hormonal therapy Non-cancer: Event/Total [severe]","Hormonal therapy Comment [incl. name of targeted/immunotherapy]","Hormonal therapy Measure of Association [hospitalisation]","Hormonal therapy value [hospitalisation]","Hormonal therapy 95% CI [hospitalisation]","Hormonal therapy p-value [hospitalisation]","Hormonal therapy cancer: Event/Total [hospitalisation]","Hormonal therapy Non-cancer: Event/Total [hospitalisation]","Hormonal therapy Comment","Targeted therapy (RTK inhibitor/mAb against receptors) Total number of patients","Targeted therapy (RTK inhibitor/mAb against receptors) percentage","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) value [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) value [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) value [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) Comment [incl. name of targeted/immunotherapy]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) value [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) Comment","radiotherapy Total number of patients","radiotherapy percentage","radiotherapy Measure of Association [mortality]","radiotherapy value [mortality]","radiotherapy 95% CI [mortality]","radiotherapy p-value [mortality]","radiotherapy cancer: Event/Total [mortality]","radiotherapy Non-cancer: Event/Total [mortality]","radiotherapy Measure of Association [ICU]","radiotherapy value [ICU]","radiotherapy 95% CI [ICU]","radiotherapy p-value [ICU]","radiotherapy cancer: Event/Total [ICU]","radiotherapy Non-cancer: Event/Total [ICU]","radiotherapy Measure of Association [severe]","radiotherapy value [severe]","radiotherapy 95% CI [severe]","radiotherapy p-value [severe]","radiotherapy cancer: Event/Total [severe]","radiotherapy Non-cancer: Event/Total [severe]","radiotherapy Comment [incl. name of targeted/immunotherapy]","radiotherapy Measure of Association [hospitalisation]","radiotherapy value [hospitalisation]","radiotherapy 95% CI [hospitalisation]","radiotherapy p-value [hospitalisation]","radiotherapy cancer: Event/Total [hospitalisation]","radiotherapy Non-cancer: Event/Total [hospitalisation]","radiotherapy Comment","immunotherapy (immune checkpoint inhibitors/CAR-T) Total number of patients","immunotherapy (immune checkpoint inhibitors/CAR-T) percentage","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) Comment [incl. name of targeted/immunotherapy]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) Comment","surgery Total number of patients","surgery percentage","surgery Measure of Association [mortality]","surgery value [mortality]","surgery 95% CI [mortality]","surgery p-value [mortality]","surgery cancer: Event/Total [mortality]","surgery Non-cancer: Event/Total [mortality]","surgery Measure of Association [ICU]","surgery value [ICU]","surgery 95% CI [ICU]","surgery p-value [ICU]","surgery cancer: Event/Total [ICU]","surgery Non-cancer: Event/Total [ICU]","surgery Measure of Association [severe]","surgery value [severe]","surgery 95% CI [severe]","surgery p-value [severe]","surgery cancer: Event/Total [severe]","surgery Non-cancer: Event/Total [severe]","surgery Comment [incl. name of targeted/immunotherapy]","surgery Measure of Association [hospitalisation]","surgery value [hospitalisation]","surgery 95% CI [hospitalisation]","surgery p-value [hospitalisation]","surgery cancer: Event/Total [hospitalisation]","surgery Non-cancer: Event/Total [hospitalisation]","surgery Comment","COVID variants:","WT/Wu-1 Total Number of patients","WT/Wu-1 Percentage","WT/Wu-1 Measure of Association [mortality]","WT/Wu-1 value [mortality]","WT/Wu-1 95% CI [mortality]","WT/Wu-1 p-value [mortality]","WT/Wu-1 cancer: Event/Total [mortality]","WT/Wu-1 Non-cancer: Event/Total [mortality]","WT/Wu-1 Measure of Association [ICU]","WT/Wu-1 value [ICU]","WT/Wu-1 95% CI [ICU]","WT/Wu-1 p-value [ICU]","WT/Wu-1 cancer: Event/Total [ICU]","WT/Wu-1 Non-cancer: Event/Total [ICU]","WT/Wu-1 Measure of Association [severe]","WT/Wu-1 value [severe]","WT/Wu-1 95% CI [severe]","WT/Wu-1 p-value [severe]","WT/Wu-1 cancer: Event/Total [severe]","WT/Wu-1 Non-cancer: Event/Total [severe]","WT/Wu-1 Comment","WT/Wu-1 Measure of Association [hospitalisation]","WT/Wu-1 value [hospitalisation]","WT/Wu-1 95% CI [hospitalisation]","WT/Wu-1 p-value [hospitalisation]","WT/Wu-1 cancer: Event/Total [hospitalisation]","WT/Wu-1 Non-cancer: Event/Total [hospitalisation]","WT/Wu-1 Comment.1","Beta Total Number of patients","Beta Percentage","Beta Measure of Association [mortality]","Beta value [mortality]","Beta 95% CI [mortality]","Beta p-value [mortality]","Beta cancer: Event/Total [mortality]","Beta Non-cancer: Event/Total [mortality]","Beta Measure of Association [ICU]","Beta value [ICU]","Beta 95% CI [ICU]","Beta p-value [ICU]","Beta cancer: Event/Total [ICU]","Beta Non-cancer: Event/Total [ICU]","Beta Measure of Association [severe]","Beta value [severe]","Beta 95% CI [severe]","Beta p-value [severe]","Beta cancer: Event/Total [severe]","Beta Non-cancer: Event/Total [severe]","Beta Comment","Beta Measure of Association [hospitalisation]","Beta value [hospitalisation]","Beta 95% CI [hospitalisation]","Beta p-value [hospitalisation]","Beta cancer: Event/Total [hospitalisation]","Beta Non-cancer: Event/Total [hospitalisation]","Beta Comment.1","Gamma Total Number of patients","Gamma Percentage","Gamma Measure of Association [mortality]","Gamma value [mortality]","Gamma 95% CI [mortality]","Gamma p-value [mortality]","Gamma cancer: Event/Total [mortality]","Gamma Non-cancer: Event/Total [mortality]","Gamma Measure of Association [ICU]","Gamma value [ICU]","Gamma 95% CI [ICU]","Gamma p-value [ICU]","Gamma cancer: Event/Total [ICU]","Gamma Non-cancer: Event/Total [ICU]","Gamma Measure of Association [severe]","Gamma value [severe]","Gamma 95% CI [severe]","Gamma p-value [severe]","Gamma cancer: Event/Total [severe]","Gamma Non-cancer: Event/Total [severe]","Gamma Comment","Gamma Measure of Association [hospitalisation]","Gamma value [hospitalisation]","Gamma 95% CI [hospitalisation]","Gamma p-value [hospitalisation]","Gamma cancer: Event/Total [hospitalisation]","Gamma Non-cancer: Event/Total [hospitalisation]","Gamma Comment.1","Delta Total Number of patients","Delta Percentage","Delta Measure of Association [mortality]","Delta value [mortality]","Delta 95% CI [mortality]","Delta p-value [mortality]","Delta cancer: Event/Total [mortality]","Delta Non-cancer: Event/Total [mortality]","Delta Measure of Association [ICU]","Delta value [ICU]","Delta 95% CI [ICU]","Delta p-value [ICU]","Delta cancer: Event/Total [ICU]","Delta Non-cancer: Event/Total [ICU]","Delta Measure of Association [severe]","Delta value [severe]","Delta 95% CI [severe]","Delta p-value [severe]","Delta cancer: Event/Total [severe]","Delta Non-cancer: Event/Total [severe]","Delta Comment","Delta Measure of Association [hospitalisation]","Delta value [hospitalisation]","Delta 95% CI [hospitalisation]","Delta p-value [hospitalisation]","Delta cancer: Event/Total [hospitalisation]","Delta Non-cancer: Event/Total [hospitalisation]","Delta Comment.1","Omicron Total Number of patients","Omicron Percentage","Omicron Measure of Association [mortality]","Omicron value [mortality]","Omicron 95% CI [mortality]","Omicron p-value [mortality]","Omicron cancer: Event/Total [mortality]","Omicron Non-cancer: Event/Total [mortality]","Omicron Measure of Association [ICU]","Omicron value [ICU]","Omicron 95% CI [ICU]","Omicron p-value [ICU]","Omicron cancer: Event/Total [ICU]","Omicron Non-cancer: Event/Total [ICU]","Omicron Measure of Association [severe]","Omicron value [severe]","Omicron 95% CI [severe]","Omicron p-value [severe]","Omicron cancer: Event/Total [severe]","Omicron Non-cancer: Event/Total [severe]","Omicron Comment","Omicron Measure of Association [hospitalisation]","Omicron value [hospitalisation]","Omicron 95% CI [hospitalisation]","Omicron p-value [hospitalisation]","Omicron cancer: Event/Total [hospitalisation]","Omicron Non-cancer: Event/Total [hospitalisation]","Omicron Comment.1","Unspecified/Total Total Number of patients","Unspecified/Total Percentage","Unspecified/Total Measure of Association [mortality]","Unspecified/Total value [mortality]","Unspecified/Total 95% CI [mortality]","Unspecified/Total p-value [mortality]","Unspecified/Total cancer: Event/Total [mortality]","Unspecified/Total Non-cancer: Event/Total [mortality]","Unspecified/Total Measure of Association [ICU]","Unspecified/Total value [ICU]","Unspecified/Total 95% CI [ICU]","Unspecified/Total p-value [ICU]","Unspecified/Total cancer: Event/Total [ICU]","Unspecified/Total Non-cancer: Event/Total [ICU]","Unspecified/Total Measure of Association [severe]","Unspecified/Total value [severe]","Unspecified/Total 95% CI [severe]","Unspecified/Total p-value [severe]","Unspecified/Total cancer: Event/Total [severe]","Unspecified/Total Non-cancer: Event/Total [severe]","Unspecified/Total Comment","Unspecified/Total Measure of Association [hospitalisation]","Unspecified/Total value [hospitalisation]","Unspecified/Total 95% CI [hospitalisation]","Unspecified/Total p-value [hospitalisation]","Unspecified/Total cancer: Event/Total [hospitalisation]","Unspecified/Total Non-cancer: Event/Total [hospitalisation]","Unspecified/Total Comment.1","Other Total Number of patients","Other Percentage","Other Measure of Association [mortality].1","Other value [mortality].1","Other 95% CI [mortality].1","Other p-value [mortality].1","Other cancer: Event/Total [mortality].1","Other Non-cancer: Event/Total [mortality].1","Other Measure of Association [ICU].1","Other value [ICU].1","Other 95% CI [ICU].1","Other p-value [ICU].1","Other cancer: Event/Total [ICU].1","Other Non-cancer: Event/Total [ICU].1","Other Measure of Association [severe]","Other value [severe]","Other 95% CI [severe]","Other p-value [severe]","Other cancer: Event/Total [severe]","Other Non-cancer: Event/Total [severe]","Other Comment.2","Other Measure of Association [hospitalisation].1","Other value [hospitalisation].1","Other 95% CI [hospitalisation].1","Other p-value [hospitalisation].1","Other cancer: Event/Total [hospitalisation].1","Other Non-cancer: Event/Total [hospitalisation].1","Other Comment.3","COVID vaccination status:","vaccinated Total number of patients","vaccinated Percentage","vaccinated Measure of Association [mortality]","vaccinated value [mortality]","vaccinated 95% CI [mortality]","vaccinated p-value [mortality]","vaccinated cancer: Event/Total [mortality]","vaccinated Non-cancer: Event/Total [mortality]","vaccinated Measure of Association [ICU]","vaccinated value [ICU]","vaccinated 95% CI [ICU]","vaccinated p-value [ICU]","vaccinated cancer: Event/Total [ICU]","vaccinated Non-cancer: Event/Total [ICU]","vaccinated Measure of Association [severe]","vaccinated value [severe]","vaccinated 95% CI [severe]","vaccinated p-value [severe]","vaccinated cancer: Event/Total [severe]","vaccinated Non-cancer: Event/Total [severe]","vaccinated Measure of Association [hospitalisation]","vaccinated value [hospitalisation]","vaccinated 95% CI [hospitalisation]","vaccinated p-value [hospitalisation]","vaccinated cancer: Event/Total [hospitalisation]","vaccinated Non-cancer: Event/Total [hospitalisation]","vaccinated Comment","unvaccinated Total number of patients","unvaccinated Percentage","unvaccinated Measure of Association [mortality]","unvaccinated value [mortality]","unvaccinated 95% CI [mortality]","unvaccinated p-value [mortality]","unvaccinated cancer: Event/Total [mortality]","unvaccinated Non-cancer: Event/Total [mortality]","unvaccinated Measure of Association [ICU]","unvaccinated value [ICU]","unvaccinated 95% CI [ICU]","unvaccinated p-value [ICU]","unvaccinated cancer: Event/Total [ICU]","unvaccinated Non-cancer: Event/Total [ICU]","unvaccinated Measure of Association [severe]","unvaccinated value [severe]","unvaccinated 95% CI [severe]","unvaccinated p-value [severe]","unvaccinated cancer: Event/Total [severe]","unvaccinated Non-cancer: Event/Total [severe]","unvaccinated Measure of Association [hospitalisation]","unvaccinated value [hospitalisation]","unvaccinated 95% CI [hospitalisation]","unvaccinated p-value [hospitalisation]","unvaccinated cancer: Event/Total [hospitalisation]","unvaccinated Non-cancer: Event/Total [hospitalisation]","unvaccinated Comment","Is individual patient data available?"
<<<<<<< HEAD:data/backup/review_241469_20240121210853_DE_knownDx_peerReviewed_James_version.csv
"137597","Yienolu 2020","The outcome of COVID-19 in patients with hematological malignancy.","Consensus","Peer-reviewed","Journal of Medical Virology","Republic of Turkey, Ministry of Health Database","2020-08","The outcome of COVID19 in patients with hematological malignancy","Tugce N","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Republic of Turkey","N/A","","2020-03-11","2020-06-22","1480","Comparison of COVID-19 severity and mortality between cancer patient and control ","","Severity; Hospitalisation; ICU admission; Mortality","no"," All COVID19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbiditymatched COVID19 patients without cancer (n = 740) at 1:1 ratio was used for comparison.","All COVID19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbidity-matched COVID19 patients without cancer (n = 740) at 1:1 ratio was used for comparison","All COVID19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbidity-matched COVID19 patients without cancer (n = 740) at 1:1 ratio was used for comparison",NA,"median","56","range","18-94","53.6","740","median","56","range","18-87","54.1","740","Not mentioned",NA,"","","","","",NA,"","","379","51.2","378","51.1","",NA,"","1","198","26.8","198","26.8","",NA,"","1","156","21.1","135","18.2","","","","0.2","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","175","23.6","164","22.2","","","","0.5","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Severe COVID-19 was defined as the existence of dyspnea, blood oxygen saturation less than or equal to 93% PaO2/FiO2 <300 greater than 50% in lung infiltration within 24 hours to 48hours. Critical COVID-19 was described as the existence of respiratory failure septic shock and/or multiple organ failure. ","physical admission to ICU","case-fatality rate: follow up not specified","Combined Severe + Criticial cohorts: Severe COVID19 was defined as the existence of dyspnea, blood oxygen saturation less than or equal to 93%, PaO2/FiO2 < 300 and greater than 50% progression in lung infiltrates within 24 to 48 hours. Critical COVID19 was defined as the existence of respiratory failure, septic shock, and/or multiple organ dysfunctions.","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","740","uOR","0.45","0.32-0.65","8.48E-06","0.138 (102/740)","0.0676 (50/740)","uOR","1.8","1.34-2.41","6.84E-05","0.189 (140/740)","0.115 (85/740)","uOR","1.66","1.30-2.11","3.67E-05","0.288 (213/740)","0.196 (145/740)","uOR","","","","","0.611 (452/740)","0.553 (409/740)","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"740","uOR","0.45","0.32-0.65","8.48E-06","0.138 (102/740)","0.0676 (50/740)","uOR","1.8","1.34-2.41","6.84E-05","0.189 (140/740)","0.115 (85/740)","uOR","1.66","1.30-2.11","3.67E-05","0.288 (213/740)","0.196 (145/740)","uOR","","","","","0.611 (452/740)","0.553 (409/740)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"1480","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"131660","Muge 2021","Comparison of Systemic Immune-Inflammation Index (SII), Early Warning Score (ANDC) and Prognostic Nutritional Index (PNI) in Hospitalized Patients with Malignancy, and Their Influence on Mortality from COVID-19 (preprint)","Consensus","Other: Peer-reviewed","Infectious Agents and Cancer","","15/09/2021","Comparison of Systemic Immune-Inflammation Index (SII), Early Warning Score (ANDC) and Prognostic Nutritional Index (PNI) in Hospitalized Patients with Malignancy, and Their Influence on Mortality from COVID-19","Bilge M","Retrospective","Cohort","Yes","Other: Inpatient","Turkey","Istanbul","Prof. Dr. Murat Dilmener Emergency Hospital","2020-09-01","2020-12-31","186","Mortaility","ICU admission","Severity; ICU admission; Mortality","Other: No","No limits on type of malignancy, simple stated as ""various malignancies""","No malignancy","75:111; age matched; comorbidity matched",NA,"Mean","64.69","Variance","12.98","62.7","75","Mean","64.81","Variance","6.35","63","111","Not mentioned",NA,"","","","","",NA,"","","33","44%","50","45%","",NA,"","Not significant","20","26.70%","21","18.90%","",NA,"","Not significant","8","10.70%","24","21.60%","","","","Not significant","","","","","",NA,"",NA,"","","","","",NA,"","","4","5.30%","6","5.40%","",NA,"","Not significant","7","9.30%","5","4.50%","","","","Not significant","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","","Not specified; simply categorised into moderate and severe categories","univariate","Age; Sex; Comorbidities",NA,"15","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"7","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"14","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","","","","","","","","","","","","","","","14","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"75","uOR","2.39","1.803.16","","17.30%","2.70%","cRR","0","","","0/75=0.00%","0/111=0.00%","cRR for moderate disease; cRR for severe disease","Moderate: 41.3/51.4=0.804; Severe: 58.7/48.6=1.21","","Not significant; not significant","41.3%; 58.7%","51.4%; 48.6%","No p-value stated; simply reported ""not significant"" for disease status between cancer and non-cancer groups","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"128789","Joaquin 2020","Multiple Myeloma and SARS-CoV-2 Infection: Clinical Characteristics and Prognostic Factors of Inpatient Mortality (preprint)","Consensus","Peer-reviewed","Blood Cancer Journal ","This retrospective case series investigated 167 patients reported from 73 hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes were compared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admitted at six participating hospitals. A modified version of a questionnaire proposed by the International Myeloma Society was used for data extraction. A common set of demographic, clinical, laboratory, treatment, and outcome variables were collected for the MM and noncancer cohorts of hospitalized COVID-19 patients. Specific disease status and treatment data were obtained for MM patients. Data extraction was performed locally by hematology departments in participating hospitals and centrally processed by the PETHEMA/GEM data-monitoring unit","2020-10","Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality","Martnez-Lpez J","Retrospective","Cohort","Yes","inpatient","Spain","N/A","","2020-03-01","2020-04-30","210","mortality, severity ","","Severity; Mortality","no","patients diagnosed with multiple myeloma  active cancer n=43  *active cancer*","167 MM patients reported from 73 hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes were compared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admitted at six participating hospitals.  matched for age and sex 1:1","ratio of cancer to non-cancer = 1:1 age and sex matched = 1:1",NA,"median","71","IQR","62 - 78","57","167","median","71","IQR","63 - 78","57","167","Not mentioned",NA,"","","","","",NA,"","","67","40","79","47","",NA,"","","28","17","36","22","",NA,"","","35","21","32","19","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","32","19","13","8","",NA,"","","23","14","34","20","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","inpatient mortality ","","Other: crude OR/CI/p-values calculated as univariate/multivariate analysis not provided for outcomes of interest","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","43 (Multiple Myeloma)","cOR (Multiple Myeloma)","3.24 (Multiple Myeloma)","1.61 - 6.52 (Multiple Myeloma)","0.00103 (Multiple Myeloma)","0.488 (21/43) (Multiple Myeloma)","0.228 (38/167) (Multiple Myeloma)","","","","","","","","","","","","","I calculated crude OR, CI and p-value for mortality and active MM (n=43) vs. non-cancer (n=167). Raw mortality data taken from table 1 and 2","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"124497","Brijesh 2023","Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2 (preprint)","Consensus","Peer-reviewed","Cardio-Oncology","National COVID Cohort Collaborative (N3C) supported by NIH","2023-10","Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2","Brijesh Patel","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","United States","N/A","N/A","2020-01-01","2022-07-22","418306","1) Major adverse cardiac events: acute heart failure, stroke, myocardial infarction, death as all-cause mortality   2) Death all-cause mortality ","Survival probability for COVID-19 strains ","Severity; Mortality","no","Cancer cohort: Active oncologic condition - received chemotherapy within 30 days before or after index admission + Cardiovascular disease + Covid positive   Cancers that were excluded included non-melanoma skin cancers, benign tumors, or unknown types: to avoid uncertainties related to unknown cancer types, and to prevent the incorporation of relatively benign cancers that may not reflect the serious implications typically associated with malignancies. ","Non-cancer cohort: Cardiovascular disease + NO cancer + Covid positive, drawn from patients from the same N3C database from hospitals across the US  Cancer (cardioonc +): control (CVD +) = 1414: 41985","All patients had cardiovascular disease  Cancer (cardioonc +): control (CVD +) = 1414: 41985 Not matched ",NA,"% of those >65 = 63.3%","","","","50.7","1414","% of those >65 = 62.9%","","","","56.6","41985","Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"","","","","",NA,"","","1190","84.2","31978","76.2","",NA,"","","649","45.9","22283","53.1","",NA,"","","All patients have but specific ones - Atrial fibrillation/flutter; chronic heart failure; chronic ischaemic heart disease; history of CABG; pacemaker ICD; peripheral vascular disease; prior heart transplant; prior heart valve; valvular heart disease: 488; 623; 853; 40; 24; 945; 24; 62; 797","34.5; 44.1; 60.3; 20.8; 1.7; 66.8; 1.7; 4.4; 56.4","14086; 19785; 28195; 1319; 409; 29209; 350; 1940; 16802","33.6; 47.1; 67.2; 3.1; 1; 69.6; 0.8; 4.6; 40","","","","","245","17.3","6852","16.3","",NA,"",NA,"","","","","",NA,"","","650","46","17063","40.6","",NA,"","","COPD  204","14.4","3506","8.4","","","","","Prior heart transplant 24","1.7","350","0.8","","","","",NA,NA,NA,NA,"",NA,"",NA,"Alcohol abuse; asthma; dyslipidemia: 103; 81; 998 ","7.3; 5.7; 70.6","2815; 1636; 28779","6.7; 3.9; 68.5","","","","","","","","",NA,"","","","MACE (major adverse cardiac events) = acute heart failure, stroke, myocardial infarction, death as all-cause mortality ","","All-cause mortality ","MACE (major adverse cardiac events) = acute heart failure, stroke, myocardial infarction, death as all-cause mortality between January 1, 2020 and July 21, 2022  But MACE was adjusted: the cumulative incidences from each component in MACE including stroke, acute heart failure and MI were estimated and compared between different disease groups using competing risk analysis adjusting for the death  the terminal event.","multivariate","Age; Sex; Comorbidities; Other: BMI and other available patient characteristics  the cumulative incidences from each component in MACE including stroke, acute heart failure and MI were estimated and compared between different disease groups using competing risk analysis adjusting for the death  the terminal event.",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1391","cOR","1.8620 ","1.6599-2.0887","P < 0.0001 ","0.324 (450/1391)","0.204 (8310/40666)","","","","","","","cOR","1.3037 ","1.1715-1.4508","P < 0.0001 ","0.498 (693/1391)","0.432 (17581/40666)","CardioOnc+WRTCardioOnc-_CalculatedRatio: Cardio onc + / CVD+","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","1391","cOR","1.862","1.6599-2.0887","P < 0.0001","0.324 (450/1391)","0.204 (8310/40666)","",NA,"","","","","cOR","1.3037","1.1715-1.4508","P < 0.0001","0.498 (693/1391)","0.432 (17581/40666)","","",NA,"","","","",NA,NA,"791","55.9","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","537","38","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"382","27","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","297","21","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"737","52.1% of all cancer covid patients ","cOR","2.0391","1.7509-2.3746","P < 0.0001","0.376 (277/737)","0.228 (5047/22137)","",NA,"",NA,"","","cOR","1.3806","1.1914-1.5998","P < 0.0001","0.545 (402/737)","0.465 (10294/22137)","","",NA,"",NA,"","","Early strain",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"262","18.5% of all cancer covid patients","cOR","1.1457","0.8569-1.5318","P = 0.3586","0.225 (59/262)","0.167 (1075/6440) ",NA,NA,NA,NA,NA,NA,"cOR","1.1753","0.9139-1.5113","P = 0.2082","0.408 (107/262)","0.370 (2383/6440)","",NA,NA,NA,NA,NA,NA,NA,"68","4.81% of all cancer covid patients","cOR","1.5941","0.8746-2.9052","P = 0.1279","0.206 (14/68)","0.140 (303/2166)",NA,NA,NA,NA,NA,NA,"cOR","1.0173","0.6139-1.6859","P = 0.9469","0.353 (24/68)","0.349 (756/2166)","",NA,NA,NA,NA,NA,NA,NA,"1391","100%","cOR","1.862","1.6599-2.0887","P < 0.0001","0.324 (450/1391)","0.204 (8310/40666)","","","","","","","cOR","1.3037","1.1715-1.4508","P < 0.0001","0.498 (693/1391)","0.432 (17581/40666)","","","","","","","","1391 is not the same as the total number of cardioonc patients (1414) reported in table 1","324 Alpha","22.9% of all cancer covid patients","cOR","1.9037","1.4960-2.4224","P < 0.0001","0.309 (100/324)","0.190 (1885/9923)","",NA,"",NA,"","","cOR","1.3583","1.0885 to 1.6949","P = 0.0067","0.494 (160/324)","0.418 (4148/9923)","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"122739","Adrian 2021","Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): A Sub-Study of the Philippine CORONA Study (preprint)","Consensus","Peer-reviewed","Frontiers in Oncology","Database from previous clinical trial, The Philippine CORONA study (NCT04386083)","2022-04","Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): Findings from The Philippine CORONA Study","Espiritu A. I.","Retrospective","Cohort","Yes","not specified","The Philippines","Nationwide","Asian Hospital and Medical Center, Muntinlupa City; Baguio General Hospital and Medical Center, Baguio City; Cagayan Valley Medical Center, Tuguegarao City; Capitol Medical Center, Quezon City; Cardinal Santos Medical Center, San Juan City; Chong Hua Hospital, Cebu City; De La Salle University Medical and Health Sciences Institute, Dasmarias City; East Avenue Medical Center, Quezon City; Jose B. Lingad Memorial Regional Hospital, City of San Fernando, Pampanga; Dr. Jose N. Rodriguez Memorial and Sanitarium Hospital, Caloocan City; Jose R. Reyes Memorial Medical Center, Manila; Lung Center of the Philippines, Quezon City; Manila Doctors Hospital, Manila; Medical Center Manila, Manila; Makati Medical Center, Makati City; New Era General Hospital, Quezon City; Northern Mindanao Medical Center, Cagayan de Oro City; Quirino Memorial Medical Center, Quezon City; Ospital ng Makati, Makati City; Perpetual Succour Hospital, Cebu City; Dr. Pablo O. Torre Memorial Hospital (Riverside Medical Center, Inc.), Bacolod City; University of the PhilippinesPhilippine General Hospital, Manila; Philippine Heart Center, Quezon City; Research Institute for Tropical Medicine, Muntinlupa City; San Lazaro Hospital, Manila; San Juan De Dios Educational Foundation Inc.Hospital, Pasay City; Southern Isabela Medical Center, Santiago City; St. Lukes Medical Center, Quezon City; St. Lukes Medical Center, Bonifacio Global City, Taguig City; Southern Philippines Medical Center, Davao City; The Medical City, Pasig City; University of the East Ramon Magsaysay Memorial Medical Center, Inc., Quezon City; University of Santo Tomas Hospital, Manila; Veterans Memorial Medical Center, Quezon City; Vicente Sotto Memorial Medical Center, Cebu City; Western Visayas Medical Center, Iloilo City; Zamboanga City Medical Center, Zamboanga City","2020-02","2020-12","10881","Mortality, respiratory failures, duration of ventilator dependence, intensive care unit (ICU) admission, length of ICU and hospital stay","","Severity; Hospitalisation; ICU admission; Mortality","no"," 19 years old with cancer in hospital record (ambiguous timecourse)","Controls from the same 37 hospitals","Ratio of cancer:non-cancer: 244:10637 Cancer cohort significantly more likely to be female and  60 years old (James chi2)",NA,"","","","","48.90%","244","","","","","53.50%","10637","Not mentioned",NA,"31","12.70%","995","9.40%","",NA,"","<0.001","113","46.30%","3534","33.20%","",NA,"","<0.001","64","26.20%","2127","20.00%","",NA,"","0.016","20","8.20%","492","4.60%","","","","0.009","14","5.70%","307","2.90%","",NA,"","0.009","1","0.40%","59","0.60%","",NA,"","1","24","9.80%","587","5.50%","",NA,"","0.004","12","4.90%","604","5.70%","","","","0.611","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Did not specify","ICU admission evidenced on EPIC","in hospital mortality (before discharge/ transfer)","COVID-19 severity at nadir: mild/moderate, severe/critical","univariate; multivariate","Age; Sex; Comorbidities; Other: y adjusted for age group, sex, smoking history, hypertension, diabetes, chronic cardiac disease, chronic kidney disease, chronic respiratory disease, and chronic neurologic disease",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"244","uOR; uHR; mHR","2.71; 2.07; 1.72","2.06-3.56; 1.65-2.59; 1.37-2.16","8.87E-14; nr; nr","0.328 (80/244); 0.328 (80/244); 0.328 (80/244)","0.152 (1622/10637); 0.152 (1622/10637); 0.152 (1622/10637)","uOR; uHR; mHR","2.54; 2.25; 1.57","1.93-3.34; 1.79-2.83; 1.24-1.97","5.73E-12; nr; nr","0.320 (78/244); 0.320 (78/244); 0.320 (78/244)","0.156 (1662/10637); 0.156 (1662/10637); 0.156 (1662/10637)","uOR; aOR","1.79; 1.75","1.39-2.31; 1.32-2.33","5.55E-06; nr","0.521 (125/244); 0.521 (125/244)","0.374 (3936/10637); 0.374 (3936/10637)","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"10881","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"81620","Johannesen 2021","COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway.","Consensus","Peer-reviewed","Frontiers in Oncology"," Norwegian Surveillance System for Communicable Diseases  Data on cancer and treatment was available from the Cancer Registry of Norway, the Norwegian Patient Registry and the Norwegian Prescription Database","2021-03","COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway","Johannesen T.B","Retrospective","Cohort study","Yes","inpatient and outpatient (no breakdown)","Norway","N/A","N/A","2020-01-01","2020-05-31","8410","Death due to Covid-19 ","Combined outcome: Death and/or admitted to hospital due to COVID-19","Hospitalisation; Mortality; Other: Combined outcome: Death and/or admitted to hospital due to COVID-19","no","Any cancer diagnosis before the confirmed diagnosis of Covid-19. Cancer group split by treatment recency <1 year, 1-5 years, >5 years since cancer diagnosis. Only data on <1 year since cancer diagnosis included below. ","Same cohort without history of cancer","No matching",NA,"","","","","","53","","","","","","7841","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Death and/or admission to hospital due to Covid19","","Norwegian Cause of Death Registry all deaths up to May 31, 2020 were included. The registry follows the WHO guidelines for certifying COVID-19 as a cause of death and the ICD-10 code U07.1 was used for defining COVID-19 as the underlying cause of death. The definition of the causal sequence leading to death due to COVID-19 was followed and 19 patients with COVID-19 as contributing but not underlying cause of death were excluded","Death and/or admission to hospital due to Covid19","univariate; multivariate","Age; Sex; Other: Multivariate model adjusted for age and gender.  Unclear about any other additional variables - potentially all variables in table 5  (all cancer, solid tumour, non solid tumour, localised/ regional disease, distant disease, unknown stage, chemo therapy, immunotherapy, steroids, radiotherapy, surgery).",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"53","","","","","","","","","","","","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53); 0.400 (21/53)","0.110 (854/7841); 0.110 (854/7841)","table5: Rates of death due to COVID-19 and/or admission to hospital due to COVID-19","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53;53","","","","","","","",NA,"","","","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.396 (21/53);0.396 (21/53)","0.110 (854/7841);0.110 (854/7841)","Non cancer mortality and /or hospitalisation due covid not given but stated as comparison group ","",NA,"","","","",NA,NA,"71","0.130 (71/547)","","","","","","","","","","","","","uOR; mOR","5.33; 1.80","3.29-8.62; 1.07-3.01",NA,"0.394 (28/71); 0.394 (28/71)",NA,"Chemotherapy including targeted therapy and immunotherapy last 3 months","","","","","","","","45","0.0823 (45/547)","","","","","","","","","","",NA,NA,"uOR; mOR","5.89; 1.70","3.30-10.85; 0.91-3.20",NA,"0.422 (19/45); 0.422 (19/45)",NA,NA,"","","","",NA,NA,NA,NA,NA,"","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,"","","","","","","","","7","0.0128 (7/547)","","","","","","","","","","","","","uOR; mOR","6.14; 2.67","1.37-27.46; 0.54-13.14",NA,"0.423 (3/7); 0.423 (3/7)","","","","","","","","","","15","0.0274 (15/547)","","","","","","","","","","","","","uOR; mOR","5.45; 1.63","1.94-15.36; 0.55-4.81",NA,"0.400 (6/15); 0.400 (6/15)",NA,NA,"","","","","","","","90","0.165 (90/547)","",NA,"","","","",NA,NA,NA,NA,NA,NA,"uOR; mOR","7.16; 2.19","4.70-10.90; 1.40-3.44",NA,"0.467 (42/90); 0.467 (42/90)",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","53","","",NA,"","","","","",NA,"",NA,"","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53)","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"81415","Mohamed 2021","COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes.","Consensus","Peer-reviewed","Journal of Cancer Biology","Mount Sinai Health System EHRs (NYC)","2021-03","COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes","Mohamed NE","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","USA","New York, USA","8 Hospitals comprising the Mount Sinai Health System (Mount Sinai Beth Israel, Mount Sinai Brooklyn, Mount Sinai Hospital, Mount Sinai Queens, Mount Sinai Morningside, Mount Sinai West, New York Eye and Ear Infirmary of Mount Sinai, Mount Sinai South Nassau).","2020-03-28","2020-04-26","4641","Mortality","Hospitalisation","Hospitalisation; Mortality","no","""cancer status (yes, no).""","All patients who tested positive for covid-19 across the same hospital group over the same period whom were not included in the cancer cohort","Table 1 shows gender matched but mismatch in terms of age and ethnicity.",NA,"Median","69","IQR","61-78","55.35","236","Median","57","IQR","40-70","55.2","4405","Not mentioned",NA,"94","39.8","797","18.1","OR (univariate)","1.55","1.20 - 1.56",">.1","118","50","929","21.1","aOR","1.32","1.00 - 1.74",".1","73","30.9","672","15.3","aOR","1.27","0.95 - 1.70",".1","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","32","13.6","256","5.81","","","","","11","4.6","60","1.4","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Not assessed","/","Does not specify beyond "" during the observation period"" - unclear if this has the same cut-off dates as the inclusion period","Not given","univariate; multivariate","Age; Sex; Comorbidities; Other: Age, sex, smoking status, COPD, HTN, DM, Obesity, Cancer",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"236","aOR;uOR(unadjusted)","1.58;0.85","1.05-2.36;0.56-1.29","NA;NA","0.123;0.123","0.081;0.081","","","","","","","","","","","","","p value not given for MV - included in MV regression so had to have a significance of p0.1 on univariate to be included.","Crude OR","1.07","0.67-1.71","0.779","0.915","0.91","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","236","","","","","0.123","0.081","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"4641","100","","","","","0.123","0.081","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"79599","Noh 2023","Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.","Consensus","Peer-reviewed","Cancer Medicine","Cancer pts: The University of Texas MD Anderson Cancer Center Controls: The University of Texas Health Science Center at Houston, UTH","2023-07","Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study","Noh S","Prospective","Cohort","Yes","inpatient","USA","Texas USA","The University of Texas MD Anderson Cancer Center and The University of Texas Health Science Center at Houston, UTH.","2020-03","2021-06","139","WHO Clinical Progression Scale","Radiographic data","Severity; ICU admission","no","Patients recruited from a cancer centre (University of Texas MD Anderson Cancer Centre MDACC)","Patients without cancer at a tertiary referral centre (University of Texas Health Science Center at Houston UTH) both in the same city.","Not formally controlled. Chi2 confirms matched for sex.",NA,"Mean","60","Range","50-69","53","94","Mean","54","Range","45-65","49","45","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","WHO scale 6, 7, 8 or 9","World Health Organization (WHO) clinical progression scale of 7, 8 or 9","not reported","WHO scale 6, 7, 8, 9","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"94","","","","","","","uOR","0.46","0.11 - 1.91","0.27","0.0426","0.0889","uOR","0.58","0.28 - 1.21","0.15","0.298","0.422","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","94","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"94","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"78588","Dai 2020","Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China","Consensus","Peer-reviewed","Cancer Control","","2020-09","Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China","Dai MY","Retrospective","Cohort","Yes","inpatient","China","Wuhan","6 hospitals in Wuhan, China: Zhongnan  Hospital  of  Wuhan  University,  The  Leishenshan  Hospital,  Hubei  Cancer  Hospital,  Union Hospital affiliated to Tongji Medical College, The Central Hospital of Wuhan, Wuhan Seventh hospital","2020-01-01","2020-03-01","217","Severe event, ICU, IMV, Death","Restricted mean survival time for each of the primary outcomes","Severity; ICU admission; Mortality","no","*Pre-existing diagnostic code of lung cancer* active rx within last 3 months presented for MV regression giving aOR of death for several different chemotherapy methods in table s3.","A matched cohort of inpatients from the same six hospitals whom did not have a pre-existing diagnostic code for cancer","Matched for age, sex, region and time period with 1:6 cancer: control",NA,"Mean","67.26","SD","8.4","80.6","31","","","","","","186","Not mentioned",NA,"15","48.39","","","",NA,"","","9","29.03","","","",NA,"","","4","12.9","","","",NA,"","","4","12.9","","","","","","","2","6.45","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","3","9.68","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Severe symptoms according to the 5th edition of 2019 novel coronavirus disease diagnostic criteria published by the national health commission in China. Definition is as follows. Adults who meet any one of the following:1.Shortness of breath, RR>30 breaths/minute; 2.Oxygen saturation<93% at rest;3.Arterial oxygen partial pressure (PaO2)/ fraction of inspired oxygen (FiO2)<300mmHg(1mmHg=0.133kPa);4.The patient should be managed as a severe case if lung imaging shows a substantial progression of lesions (greater than 50%) within 24-48 hours.","Physical ICU admission (not just IMV)","Death before end date of the study","Severe symptoms according to the 5th edition of 2019 novel coronavirus disease diagnostic criteria published by the national health commission in China. Definition is as follows. Adults who meet any one of the following:1.Shortness of breath, RR>30 breaths/minute; 2.Oxygen saturation<93% at rest;3.Arterial oxygen partial pressure (PaO2)/ fraction of inspired oxygen (FiO2)<300mmHg(1mmHg=0.133kPa);4.The patient should be managed as a severe case if lung imaging shows a substantial progression of lesions (greater than 50%) within 24-48 hours.","multivariate","Age; Sex; Other: Smoking hx, smoking, surgey,   Radiotherapy, Chemotherapy, Targeted therapy, Immunotherapy), IL-6 (not cancer vs no controls)",NA,"31","mHR","3.87","1.02 - 14.71","0.047","0.258 (8/31)","","mHR","4.72","1.19 - 18.72","0.027","0.322 (10/31)","","mHR","4.28","1.44 - 12.71","0.009","0.548 (17/31)","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"31","mHR","3.87","1.02 - 14.71","0.047","0.258 (8/31)","","mHR","4.72","1.19 - 18.72","0.027","0.322 (10/31)","","mHR","4.28","1.44 - 12.71","0.009","0.548 (17/31)","","","","","","","","","",NA,"15","","","","","0.267 (4/15)","","","","","","0.267 (4/15)","",NA,NA,NA,NA,"0.467 (7/15)",NA,"","","","","","",NA,NA,"12","","","","","0.250 (3/12)","","","","","","0.333 (4/12)","","",NA,"",NA,"0.583 (7/12)","","","","","","","","","","4","","","","","0.250 (1/12)","","",NA,"","","0.500 (2/4)","","","","","","0.500 (2/4)","","","",NA,"","","","",NA,NA,"10","32.3","aOR (MV reg)","0.19","0.014 - 2.537","0.209","","","","","","","","","aOR (MV reg)","0.295","0.033 - 2.635","0.275","",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"3","9.68","aOR (MV reg)",NA,NA,NA,"","","","","","","","","aOR (MV reg)",NA,NA,NA,"",NA,"","","","","","","","","8","25.8","aOR (MV reg)","5.15","0.332 - 79.969","0.241","","","","","","","","","aOR (MV reg)","1.555","0.137 - 17.705","0.722","","","","","","","","","","","4","12.9","aOR (MV reg)","0.983","0.047 - 20.494","0.991","","","","","","","","","aOR (MV reg)","0.368","0.025 - 5.415","0.466","",NA,NA,"","","","","","","","7","22.6","aOR (MV reg)","1.255","1.019 - 4.287","0.03","","",NA,NA,NA,NA,NA,NA,"aOR (MV reg)","1.342","0.049 - 2.366","0.027","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"31","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"75567","Bazgir 2022","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Consensus","Peer-reviewed","International Journal of Cancer Management","all patients with COVID-19 who were admitted to the hospital were eligible for enrolment into the Ilam COVID-19 monitoring and evaluation project (Ilam-CEMP). The Ilam-CEMP is one of the first registries in the country (Iran) that enables near real-time monitoring of essential data and trends about the effect of COVID-19 on patients","2022-10","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Bazgir N","Retrospective","Cohort","Yes","inpatient","Iran","Ilam","urban primary and secondary academic hospital in Ilam.","2020-03-05","2021-03-21","2350","This studys primary outcome was in-hospital mortality or discharge from the hospital.","","ICU admission; Mortality; Other: Survival probability","no","Patients with active cancer were defined as those receiving treatments for cancer such as adjuvant, radical, cura-tve, neo-adjuvant settings, or chemotherapy within the past two months. ","At the same time, 256 controls matched cases by age, gender, and without a history of cancer were randomly selected from the same registry dataset.","64:256 Age and gender matched Multivariate analysis adjusted for comorbidities. 256 without cancer at Irans urban academic hospital.",NA,"Mean","63.9","SD","2.5","53.1","64","Mean","62.1","SD","0.8","52.7","256","Not mentioned",NA,"0","0","7","2.7","",NA,"","","21","32.8","97","37.9","",NA,"","0.45","11","17.2","64","25","",NA,"","0.19","14","21.9","76","29.7","","","","0.21","8","3.1","2","3.1","",NA,"","1","","","","","",NA,"","","14","5.5","5","7.8","",NA,"","0.48","20","7.8","5","7.8","","","","1","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","","","univariate; multivariate","Age; Sex",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"64","uHR; mHR","2.79; 2.27","1.70-4.59; 1.25-4.13","<0.001; 0.007","0.453 (29/64); 0.453 (29/64)","0.137 (35/256); 0.137 (35/256)","uHR; mHR","10.8; 6.68","5.11-22.72; 2.97-15.01","<0.001; <0.001","0.563 (36/64); 0.563 (36/64)","0.266 (68/256); 0.266 (68/256)","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"28","44","uHR; mHR","3.14; 1.65","1.77-5.57; 0.60-4.56","<0.001; 0.33","0.571 (16/27); 0.571 (16/27)","0.137 (35/256); 0.137 (35/256)","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"75065","Zhou 2023","Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study","Consensus","Peer-reviewed","Cancer Medicine","population based study on patients who presented to Hong Kong public hospitals and outpatient clinics using CDARS, a territory-wide database that centralizes patient information from 43 local hospitals and their associated ambulatory and outpatient facilities","2022-01","Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study","Zhou J","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","China","Hong Kong","43 local hospitals and their associated ambulatory and outpatient facilities","2020-01-01","2020-12-08","6089","composite endpoint of requirement for intubation, ICU admission and 30-day mortality. Details regarding the individual components that constitute this composite endpoint were extracted from CDARS","","Severity; ICU admission; Mortality","no","The inclusion criteria for this study were as follows: patients who had a positive RT-PCR for COVID-19, had pre-existing active malignancy diagnosed by clinical, radiological and pathological investigations and were admitted to the public hospital within the stated time period. The exclusion criteria included malignancy diagnosed after COVID-19 infection and patients in complete remission from cancer.","Same hospitals   The following study consisted of 6089 COVID-19 patients (median age: 45.9 [27.8.162.7] years; 50% male), of which 142 were cancer subjects","ratio of cancer to non-cancer = 142:5947  no matching mentioned or evident ",NA,"Median","63.82","IQR","51.0178.62","45.07","142","Median","45.22","IQR","27.6262.33","49.87","5947","Not mentioned",NA,"","","","","",NA,"","","54","38.02","845","14.2","cOR","3.71","2.62 - 5.24","0","11","7.74","132","2.21","cOR","3.7","1.95 - 7.01","0.00007","","","","","","","","","9","6.33","112","1.88","cOR","3.53","1.75 - 7.10","5e-04","3","2.11","29","0.48","cOR","4.4","1.33 - 14.63","0.0154","1","0.7","15","0.25","cOR","2.8","0.37 - 21.38","0.3245","6","4.22","75","1.26","cOR","3.45","1.48 - 8.07","0.0042","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"systemic embolism 1, gastrointestinal bleeding 12, obesity 1, dementia and alzheimer's 3, heart failure 1, atrial fibrillation 5, ventricular tachycardia/fibrillation 3, acute MI 6, ischaemic heart disease 16, peripheral vascular disease 2","systemic embolism 0.7, gastrointestinal bleeding 8.45, obesity 0.7, dementia and alzheimer's 2,11, heart failure 0.70, atrial fibrillation 3.52, ventricular tachycardia/fibrillation 2.11, acute MI 4.22, ischaemic heart disease 11.26, peripheral vascular disease 1.4","systemic embolism 16, gastrointestinal bleeding 103, obesity 23, dementia and alzheimer's 22, heart failure 31, atrial fibrillation 84, ventricular tachycardia/fibrillation 28, acute MI 68, ischaemic heart disease 180, peripheral vascular disease 25","systemic embolism 0.26, gastrointestinal bleeding 1.73, obesity 0.38, dementia and alzheimer's 0.36, heart failure 0.52, atrial fibrillation 1.41, ventricular tachycardia/fibrillation 0.47, acute MI 1.14, ischaemic heart disease 3.02, peripheral vascular disease 0.42","","","","","CVD has been separated out in ""others""  Chronic lung disease = COPD  Cerebrovascular disease = stroke/TIA","","","",NA,"Self-calculated","Self-calculated","Self-calculated","","The primary outcome was a composite endpoint  of patients who required intubation, required intensive care unit (ICU) admission and/or suffered 30-day mortality.","30 day mortality ","""patients with malignancy more frequently progress to severe complications, ranging from liver injury  and acute respiratory distress syndrome"". In this paper they present outcomes as severe COVID-19 composite outcome. The primary outcome was a composite endpoint of requirement for intubation, ICU admission and 30-day mortality","univariate; multivariate","Age; Sex; Comorbidities; Other: multivariate analysis is also adjusted for medication treatments ",NA,"lung 9","","","","","","","","","","","","","aHR","3.19","0.88 - 11.54","0.0766","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","27","","","","","","","","","","","","","aHR","2.73","0.76 - 9.79","0.1222","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","gastrointestinal 14","","","","","","","","","","",NA,NA,"aHR","3.79","1.12 - 12.88","0.0325","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","",NA,NA,"colorectal 11","","","","","","","","","","","","","aHR","5.07","1.5 - 17.17 ","0.0091","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"genitourinary 8","","","","","","","","","","","","","aHR","2.63","0.67 - 10.31","0.1659","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","85","","","","","","","","","","","","","aHR","1.34","0.58 - 3.11","0.4897",NA,NA,"outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"154","","","","","","","","","","","","","aHR","3.77","1.63 - 8.72 ","0.0019","","","outcome = severe COVID-19 composite outcome in hospitalized patients; Composite outcome of intubation ICU admission and/or 30-day mortality","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"74954","Kodde 2023","Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network","Consensus","Peer-reviewed","Infection","QlikView","03/06/2022","Mortality in cancer patients with SARSCoV2 or seasonal influenza:  an observational cohort study from a Germanwide hospital network","Kodde C","Retrospective","Cohort","Yes","inpatient","Germany","","Helios group hospitals (85)","2020-01","2021-08","36726","Mortality, mechanical ventilation","","Severity; Mortality","no","The cancer cohort was defined by the presence of any of the three related Elixhauser comorbidities (lymphoma, meta- static cancer, solid tumor).","Same hospital group","1625:27659",NA,"Mean","72.2","SD","11.8","58.2","1625","Mean","68","SD","17.6","52.1","27659","Not mentioned",NA,"","","","","",NA,"","","Uncomplicated: 733 Complicated: 219","Uncomplicated: 45.1% Complicated: 13.5%","","","",NA,"","","Uncomplicated: 301 Complicated: 186","Uncomplicated: 18.5% Complicated: 11.4%","","","",NA,"","","CHF: 402","CHF: 24.7%","","","","","","","","","","","",NA,"",NA,"116","7.10%","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Need for mechanical ventilation","Not specified","In-hospital mortality","","univariate; multivariate","Age; Sex; Comorbidities; Other: comorbidities: Elixhauser index",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1625","mOR","2.1","1.88-2.35","<0.01","0.349 (530/1519)","0.203 (5483/27015)","","","","","0.294 (477/1625)","0.276 (8076/29284)","mOR","0.82","0.72-0.94","<0.01","","","","","","","","","","",NA,"1391","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"629","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73804","Starkey 2023","A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","Consensus","Peer-reviewed","Nature Scientific Reports","National Cancer Registry UK and National Immunisation Management Service (NIMS)","2023-07","A populationscale temporal casecontrol evaluation of COVID19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","Thomas Starkey","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","England","Population Scale (England)","Population Scale (England)","2020-11-01","2022-08-31","15928326","Hospitalisation, ICU, COVID-19 mortality","Hospital assessment","Hospitalisation; ICU admission; Mortality","yes","On the National Cancer Registry UK","Same National Cohort (National Immunisation Management Service (NIMS) of the UK)","No matching specified. Have assessed manually and cohorts match neither in terms of sex nor in terms of age. Approx 1:124.1 cancer: control.Multivariate aORs are adjusted for age, sex, ethnicity and deprivation however.",NA,"","","","","50.48","127322","","","","","43.05","15801004","Other: ORs and base rates are given for each of the four outcomes for each two month period so could be used to generate these figures",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Any of: hospital assessment, inpatient hospitalisation, intensive care  admission, COVID-19 mortality","physical ICU admission (not just IMV)","""Case-mortality rate"" unclear follow up"," Any of: hospital assessment, inpatient hospitalisation, intensive care  admission, COVID-19 mortality","multivariate","Age; Sex; Other: age, sex, ethnicity and deprivation.",NA,"","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","12.13;4.43;18.55;4.97","8.62-17.08;3.04-6.44;16.75-20.55;4.45-5.56","<0.00001;<0.00001;<0.00001;<0.00001","","","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","13.5;6.47;5.58;2.53","6.40-28.45;2.88-14.51;3.70-8.42;1.64-3.89","<0.00001;<0.00001;<0.00001;0.00003","","","",NA,"",NA,"","","","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","9.55;3.60;7.28;3.39","8.83-10.33;3.32-3.92;5.71-9.28;2.60-4.41","<0.00001;<0.00001;<0.00001;<0.00001","","","","","uOR;mOR","2.53;1.66","2.23-2.88;1.45-1.91","<0.00001;<0.00001","","","uOR;mOR","0.56;0.58","0.29-1.07;0.29-1.16","0.07973;0.12508","","","",NA,"",NA,"","","","uOR;mOR","1.78;1.14","1.64-1.93;1.05-1.24","<0.00001;0.00308","","","","","uOR;mOR (includes small bowel and hepatobiliary)","17.34;5.85","15.22-19.76;5.08-6.74","<0.00001;<0.00001","","","uOR;mOR (includes small bowel and hepatobiliary)","1.51;0.78","0.56-4.02;0.29-2.09","0.41298;0.62780",NA,NA,"",NA,"",NA,"","","","uOR;mOR (including small bowel and hepatobiliary)","7.48;3.17","6.72-8.33;2.83-3.55","<0.00001;<0.00001","",NA,NA,"","uOR;mOR (colorectal only)","8.11;2.36","7.31-9.00;2.10-2.64","<0.00001;<0.00001","","","uOR;mOR (colorectal only)","4.91;2.76","3.60-6.71;2.01-3.79","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR (colorectal only)","4.49;2.01","4.17-4.84;1.86-2.18","<0.00001;<0.00001","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract","2.19;2.76;4.76;1.08; 8.99;1.86","1.27-3.78;1.54-4.95;4.30-5.28;0.97-1.20;7.89-10.23;1.62-2.15","0.00502;0.00069;<0.00001;0.18331;<0.00001;<0.00001","","","uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract","1.95;2.13;2.38;0.89;4.18;1.80","0.49-7.80;0.53-8.53;1.69-3.36;0.61-1.28;2.69-6.49;1.13-2.86","0.34593;0.28740;<0.00001;0.52082;<0.00001;0.01341","","","",NA,"",NA,"","","","uOR;mOR of male urological;uOR;mOR of prostate; uOR;mOR of urinary tract","1.65;2.04;3.19;1.25;4.93;1.78","1.19-2.29;1.43-2.90;2.98-3.41;1.16-1.34;4.49-5.41;1.61-1.97","0.00271;0.00007;<0.00001;<0.00001;<0.00001;<0.00001","","","","","uOR;mOR","4.32;2.80","3.61-5.18;2.30-3.41","<0.00001;<0.00001","","","uOR;mOR","2.06;1.78","1.11-3.84;0.96-3.31","0.02220;0.06927","","","",NA,"",NA,"","","","uOR;mOR","2.64;1.77","2.34-2.98;1.56-2.02","<0.00001;<0.00001","","",NA,"","uOR;mOR","9.94;11.35","7.26-13.61;7.93-16.23","<0.00001;<0.00001","","","uOR;mOR","4.05;4.37","1.30-12.60;1.40-13.60","0.01554;0.01098",NA,NA,NA,NA,NA,NA,NA,NA,NA,"uOR;mOR","4.64;4.02","3.64-5.92;3.07-5.28","<0.00001;<0.00001","",NA,NA,"","uOR;mOR","5.32;2.79","4.03-7.03;2.08-3.74","<0.00001;<0.00001","","","uOR;mOR","7.77;5.24","4.50-13.41;3.03-9.06","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","3.86;2.24","3.24-4.60;1.86-2.70","<0.00001;<0.00001","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","uOR;mOR","10.43;4.08","8.08-13.47;3.09-5.39","<0.00001;<0.00001","","","uOR;mOR","2.80;1.78","0.90-8.71;0.57-5.52","0.07451;0.32148",NA,NA,NA,NA,NA,NA,NA,NA,NA,"uOR;mOR","5.02;2.51","4.12-6.11;2.03-3.11","<0.00001;<0.00001",NA,NA,NA,"","uOR;mOR","6.42;2.27","6.15-6.71;2.17-2.38","<0.00001;<0.00001","","","uOR;mOR","2.77;1.64","2.38-3.23;1.39-1.92","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","3.67;1.80","3.56-3.78;1.74-1.86","<0.00001;<0.00001","","","","","uOR;mOR","11.46;4.27","10.57-12.42;3.91-4.66","<0.00001;<0.00001","","","uOR;mOR","13.05;7.70","10.96-15.54;6.43-9.22","<0.00001;<0.00001","","","","","","","","","","uOR;mOR","7.82;4.12","7.41-8.25;3.89-4.37","<0.00001;<0.00001","","","","","uOR;mOR of endocrine glands","1.92;2.29","1.15-3.19;1.30-4.04","","","","uOR;mOR of endocrine glands","1.48;0.00","0.37-5.93;0.00-5.11E+46","0.57912;0.87726","","","",NA,"",NA,NA,NA,"","uOR;mOR of endocrine glands","1.91;2.00","1.46-2.49;1.50-2.66","<0.00001;<0.00001","","","","","uOR;mOR",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"127322","uOR;mOR","7.12;2.54","6.85-7.40;2.44-2.65","<0.00001;<0.00001","0.0752; 0.0752","0.00715; 0.00715","uOR;mOR","4.22;2.53","3.76-4.74;2.24 - 2.86","<0.00001;<0.00001","0.00892;0.00892","0.00229;0.00229","","","","","","","","uOR;mOR","4.22;2.10","4.11-4.33;2.04 - 2.16","<0.00001;<0.00001","0.128;0.128","0.0261;0.0261","",NA,"","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","3.68;1.38;4.55;1.75;8.22;2.66","3.31-4.09;1.23-1.54;4.03-5.14;1.54-1.99;7.44-9.08;2.39-2.95","<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001","","","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","1.89;1.12;3.32;2.11;1.70;0.86","1.33-2.69;0.77-1.63;2.37-4.65;1.48-3.01;1.02-2.82;0.51-1.46","0.00042;0.53783;<0.00001;0.00004;0.04105;0.58374","","",NA,NA,NA,NA,"",NA,"","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","2.62;1.29;3.12;1.57;4.46;2.01","2.46-2.80;1.21-1.39;2.88-3.37;1.44-1.70;4.15-4.79;1.86-2.16","<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001","",NA,NA,"","uOR;mOR","19.71;6.66","17.69-21.97;5.90-7.52","<0.00001;<0.00001","","","uOR;mOR","8.36;3.98","5.79-12.05;2.70-5.87","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR ","7.66;3.57","6.98-8.40;3.24-3.94","<0.00001;<0.00001","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","uOR;mOR","11.58;7.69","10.81-12.40;7.13-8.29","<0.00001;<0.00001","","","uOR;mOR","7.53;5.51","6.20-9.15;4.50-6.74","<0.00001;<0.00001","","","","","",NA,"",NA,"","uOR;mOR","6.29;4.14","5.98-6.61;3.92-4.36","<0.00001;<0.00001","","","","","","uOR;mOR","11.32;3.17","7.36-17.40;2.03-4.95","<0.00001;<0.00001","","","uOR;mOR","2.85;1.21","0.40-20.25;0.17-8.63","0.29636;0.84867",NA,NA,"","","",NA,"",NA,NA,"uOR;mOR","9.18;4.07","6.86-12.27;3.00-5.53","<0.00001;<0.00001",NA,NA,NA,"","","uOR;mOR","20.61;14.12","16.38-25.93;10.93-18.25","<0.00001;<0.00001","","","uOR;mOR","28.91;21.97","18.73-44.62;14.17-34.05","<0.00001;<0.00001","","","",NA,NA,NA,"",NA,"B/T-cell antibody therapy","uOR;mOR","13.03;9.38","11.02-15.41;7.83-11.24","<0.00001;<0.00001","","","","","","uOR;mOR","8.12;4.29","7.38-8.93;3.88-4.76","<0.00001;<0.00001","","","uOR;mOR","3.68;2.53","2.65-5.10;1.81-3.56","<0.00001;<0.00001","","","","","",NA,"","","","uOR;mOR","4.17;2.39","3.88-4.47;2.21-2.57","<0.00001;<0.00001","","","","","","uOR;mOR","11.10;3.76","6.99-17.63;2.32-6.10","<0.00001;<0.00001","","","uOR;mOR","0.00;0.00","0.00-1.95E+37;0.00-1.37E+36","0.87403;0.86020","","","","","",NA,"",NA,NA,"uOR;mOR","7.56;3.06","5.64-10.12;2.26-4.15","<0.00001;<0.00001","","","","","","",NA,"","<0.00001;<0.00001","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"15928326","100","uOR;mOR","7.12;2.54","6.85-7.40;2.44-2.65","<0.00001;<0.00001","","","uOR;mOR","4.22;2.53","3.76-4.74;2.24-2.86","<0.00001;<0.00001","","","","","","","","","","uOR;mOR","4.22;2.53","3.76-4.74;2.24-2.86","<0.00001;<0.00001","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73512","Johansson 2023","Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era","Consensus","Peer-reviewed","The Lancet","National health registry data from Norway, Denmark, and Iceland","2023-07","Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era","Johansson A. L. V","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Norway, Denmark, Iceland","N/A","N/A","2020-03-01","2020-12-31","9,222,321","COVID-19 hospitalisation COVID-19 ICU admission COVID-19 ICU mechanical ventilation COVID-19 death","","Hospitalisation; ICU admission; Mortality; Other: ICU mechanical ventilation","no","*Cancer diagnosed <1 year before testing positive for SARS-CoV-2* Cancer diagnosed <5 years before testing positive for SARS-CoV-2","Same country, general population","Cancer diagnosed <1yr : general population = 949:9222321 No matching",NA,"Median (Norway); Median (Denmark); Median (Iceland)","60-64; 65-69; 18-69","25th centile (Norway); 75th centile (Norway); 25th centile (Denmark); 75th centile (Denmark); 25th centile (Iceland); 75th centile (Iceland)","50-54; 75-79; 50-54; 75-79; 18-69; >70","52.1","495","","","","","","","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Severe COVID-19 outcomes: COVID-19 hospitalisation, COVID-19 ICU admission, COVID-19 ICU mechanical ventilation, COVID-19 death","""Intensive care admission due to COVID-19 was defined as admission to an ICU with a primary discharge diagnosis of COVID-19""","""Death related to COVID-19 was defined as a) death with COVID-19 as underlying cause of death, or b) death within 30 days after admission to hospital with COVID-19 as primary discharge diagnosis.""","Severe COVID-19 outcomes: COVID-19 hospitalisation, COVID-19 ICU admission, COVID-19 ICU mechanical ventilation, COVID-19 death","","Age; Comorbidities",NA,"11; 63","SIR (Norway lung); SIR (Denmark lung)","4.07; 5.42","0.84-11.90; 2.71-9.70","NR; NR","(<5/11); (11/63)","(407/41468); (1019/166522)","SIR (Norway lung); SIR (Denmark lung)","0; 1.29","N/A; 0.16-4.65","NR; NR","(0/11); (<5/63)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR (Norway lung); SIR (Denmark lung)","1.94; 2.25","0.63-4.53; 1.47-3.30","NR; NR","(5/11); (26/63)","(2361/41468); (8230/166522)","Norway (lung); Denmark (lung)","28; 100","SIR (Norway); SIR (Denmark)","3.29; 0.62","0.40-11.87; 0.02-3.44","NR; NR","(<5/28); (<5/100)","(407/41468); (1019/166522)","SIR (Norway); SIR (Denmark)","0; 2.12","N/A; 0.26-7.66","NR; NR","(0/28); (<5/100)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR (Norway); SIR (Denmark)","2.49; 1.46","0.91-5.41; 0.84-2.38","NR; NR","(6/28); (16/100)","(2361/41468); (8230/166522)","Norway; Denmark","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"24; 92","SIR (Norway colorectal); SIR (Denmark colorectal)","0.64; 1.30","0.02-3.58; 0.35-3.33","NR; NR","(<5/24); (<5/92)","(407/41468); (1019/166522)","SIR (Norway colorectal); SIR (Denmark colorectal)","4.03; 3.87","0.83-11.79; 1.55-7.97","NR; NR","(<5/24); (7/92)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR (Norway colorectal); SIR (Denmark colorectal)","1.93; 2.13","0.83-3.80; 1.45-3.00","NR; NR","(8/24); (32/92)","(2361/41468); (8230/166522)","Norway (colorectal); Denmark (colorectal)","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"35; 76","SIR (Norway prostate); SIR (Denmark prostate)","0.69; 1.19","0.02-3.87; 0.33-3.06","NR; NR","(<5/35); (<5/76)","(407/41468); (1019/166522)","SIR (Norway prostate); SIR (Denmark prostate)","2.18; 0.35","0.45-6.37; 0.01-1.94","NR; NR","(<5/35); (<5/76)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR (Norway prostate); SIR (Denmark prostate)","2.16; 1.18","1.11-3.77; 0.73-1.81","NR; NR","(12/35); (21/76)","(2361/41468); (8230/166522)","Norway (prostate); Denmark (prostate)","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"21; 59","SIR (Norway melanoma); SIR (Denmark melanoma)","N/A; 0.79","N/A; 0.02-4.42","NR; NR","(0/21); (<5/59)","(407/41468); (1019/166522)","SIR (Norway melanoma); SIR (Denmark melanoma)","N/A; 3.33","N/A; 0.69-9.74","NR; NR","(0/21); (<5/59)","(379/41468); (911/166522)","",NA,"",NA,"","",NA,"SIR (Norway melanoma); SIR (Denmark melanoma)","1.73; 1.35","0.47-4.44; 0.65-2.49","NR; NR","(4/21); (10/59)","(2361/41468); (8230/166522)","Norway (melanoma); Denmark (melanoma)","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","28; 123","SIR (Norway); SIR (Denmark)","5.64; 4.15","1.83-13.16; 2.32-6.85","NR; NR","(5/28); (15/123)","(407/41468); (1019/166522)","SIR (Norway); SIR (Denmark)","7.64; 5.93","2.08-19.56; 3.24-9.94","NR; NR","(<5/28); (14/123)","(379/41468); (911/166522)","","","","","","","","SIR (Norway); SIR (Denmark)","4.37; 3.96","2.26-7.63; 3.10-4.98","NR; NR","(12/28); (73/123)","(2361/41468); (8230/166522)","Norway; Denmark","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"203; 727; 19","SIR (Norway); SIR (Denmark); SIR (Iceland)","2.18; 2.29; NR","1.29-3.45; 1.66-3.07; NR","NR; NR; NR","(18/203); (44/727); NR","(407/41468); (1019/166522); NR","SIR (Norway); SIR (Denmark); SIR (Iceland)","3.19; 2.52; NR","1.86-5.11; 1.75-3.50; NR","NR; NR; NR","(17/203); (35/727); NR","(379/41468); (911/166522); NR","","","","","","","","SIR (Norway); SIR (Denmark); SIR (Iceland)","2.43; 2.23; NR","1.89-3.09; 1.96-2.54; NR","NR; NR; NR","(67/203); (241/727); NR","(2361/41468); (8230/166522); NR","Norway; Denmark; Iceland",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"56; 35; 176; 167","27.6; 17.2; 24.2; 23.0","SIR; SIR; SIR; SIR","2.74; 2.49; 6.30; 6.61","0.56-8.00; 0.30-9.01; 3.73-9.96; 3.92-10.44","","(<5/56); (<5/35); (18/176); (18/167)","(407/41468); (407/41468); (1019/166522); (1019/166522)","SIR; SIR; SIR; SIR","5.35; 6.61; 7.27; 6.94","1.96-11.64; 2.15-15.42; 4.44-11.24; 4.11-10.97","","(6/56); (5/35); (20/176);  (18/167)","(379/41468); (379/41468);(911/166522); (911/166522)","","","",NA,"",NA,"","SIR; SIR; SIR; SIR","4.10; 4.75; 4.92; 4.89","2.60-6.15; 2.81-7.50; 3.99-5.99; 3.94-5.99","","(23/56); (18/35); (98/176); (92/167)","(2361/41468); (2361/41468); (8230/166522); (8230/166522)","Norway ""CT any""; Norway ""CT only""; Denmark ""CT any"";  Denmark ""CT only""  (For non-cancer column, just Norway; Denmark)","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"79","10.9","SIR","5.73","2.47-11.29","","(8/79)","(1019/166522)","SIR","9.55","4.77-17.08","","(11/79)","(911/166522)","",NA,NA,NA,"",NA,"","SIR","5.7","4.23-7.52","","(50/79)","(8230/166522)","Denmark","24; 77","11.8; 10.6%","SIR; SIR","1.50; 5.95","0.04-8.38; 2.72-11.30","","(<5/24); (9/77)","(407/41468); (1019/166522)","SIR; SIR","1.86; 2.26","0.05-10.36; 0.47-6.60","","(<5/24); (<5/77)","(379/41468); (911/166522)","","","",NA,"","","","SIR; SIR","3.27; 2.97","1.49-6.21; 1.99-4.26","","(9/24); (29/77)","(2361/41468); (8230/166522)","Norway ""RT any"";  Denmark ""RT any""  (For non-cancer column, just Norway; Denmark)","51","7","SIR","8.26","3.32-17.03","","(7/51)","(1019/166522)","SIR","5.79","1.58-14.82","","(<5/51)","(911/166522)","","","",NA,"",NA,NA,"SIR","4.59","2.97-6.78","","(25/51)","(8230/166522)","Denmark","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73383","Hosseini-Moghaddam 2023","SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer","Consensus","Peer-reviewed","JAMA Network Open","COVID-19 Integrated Testing Database; Ontario Registered Persons Database; Canadian Institute for Health Information's Discharge Abstract Database.","2023-08","SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer","Hosseini-Moghaddam, S M","Retrospective","Cohort","Yes","outpatient","Canada","Ontario","","2020-01-01","2021-12-31","464574","COVID-19 infection positivity.","Hospitalisation, ICU admission and mortality.","Hospitalisation; ICU admission; Mortality","yes","Not specified.","Drawn from same national cohort. ","Age, gender and co-morbidities were not matched.  Cancer : control =8378 : 456196",NA,"Mean","59.61","SD","18.05","40.6","8378","Mean","45.95","SD","18.24","48.96","456196","Not mentioned",NA,"","","","","",NA,"","","4219","50.4","108968","23.9","cOR","3.23","3.10-3.38 ","","2475","29.5","69480","15.2","cOR","2.33","2.23-2.45","","1499","17.9","26250","5.8","cOR","3.57","3.37-3.78","","207","2.5","4248","0.9","cOR","2.7","2.34-3.10",NA,"124","1.5","1102","0.2","cOR","6.2","5.15-7.48","","779","9.3","11959","2.6","cOR","3.81","3.53-4.11","","2035","24.3","83958","18.4","cOR","1.42","1.35-1.50","","128","1.5","1715","0.4","cOR","","","",NA,NA,NA,NA,"",NA,"",NA,"88; 647","1.1; 7.7","2797; 16094","0.6; 3.5","cOR","1.72; 2.29","1.39-2.13; 2.11-2.48","","IBD; Dementia  taken from eTable4 in supps","IBD; Dementia   taken from eTable4 in supps","IBD; Dementia  data taken from eTable2 and cancer data from eTable4 has been subtracted to get non-cancer cohort data","IBD; Dementia",NA,"IBD; Dementia","IBD; Dementia","I calculated crude OR and CI and have left p-values for James as discussed","","21-day ICU admission","28-day mortality.","","multivariate","Age; Sex; Comorbidities; Other: Past healthcare utilisation, income, rurality, PHU region, Ontario Marginalisation Index, 2016 Canada census variables.",NA,"321","","","","","0.178 (57/321)","","","","","","","","",NA,"",NA,"","","","","","","","0.312 (100/321)","","","1272","","","","","0.061 (78/1272)","","","","","","","","",NA,"",NA,"","","","","","","","0.134 (171/1272)","","","132","","","","","0.106 (14/132)","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","0.257 (34/132)",NA,NA,"676","","","","","0.095 (64/676)","","","","","","","","",NA,"",NA,"","","","","","","","0.204 (138/676)","","","71","","","","","0.113 (8/71)","","","","","","","","","","","","","","","","","","","0.225 (16/71)","",NA,"271","","","","","0.077 (21/271)","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"0.155 (42/271)","",NA,"1336","","","","","0.099 (132/1336)","","","","","","","","",NA,"",NA,"","","","","","","","0.208 (278/1336)","","","1797","","","","","0.015 (27/1797)","","","","","","","","",NA,"",NA,"","","","","","","","0.0573 (103/1797)","",NA,"47","","","","","0.128 (6/47)","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","0.255 (12/47)",NA,NA,"698","","","","","0.016 (11/698)","","","","","","","","",NA,"",NA,"","","","","","","","0.113 (79/698)","",NA,"125","","","","","0.080 (10/125)","","","","","","","","",NA,"",NA,"","",NA,"","","","","0.096 (12/125)","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"7185","aHR","1.31","1.19-1.44","","0.066 (475/7185)","","aHR","0.93","0.82-1.05","","0.366 (388/1060)","","",NA,"",NA,"","","","aHR","1.11","1.05-1.18","","0.148 (1061/7185)","","adjusted HRs taken from eTable10 in supps","1193","aHR","2.04","1.74-2.38","","0.137 (163/1193)","","aHR","1.14","0.93-1.40","","0.405 (130/321)","","","","","","","","","aHR","1.75","1.57-1.96","","0.269 (321/1193)","","adjusted HRs taken from eTable10 in supps","439; 357","","","","","0.107 (47/439); 0.151 (54/357)","","","","","","","","",NA,"",NA,NA,NA,"","","","","","0.173 (76/439); 0.303 (108/357)","","other solid tumour; other haematological malignancy ","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"8378","","","","","","0.0466 (21267/456188)","","","","","","0.345 (10207/29582)","","","","","","","non-cancer EVENT/TOTAL taken from graphs in figure 1. We have subtracted number survived at end of period from number survived at start of period to get number who died.   cancer EVENT/TOTAL taken from eTable11 in supps","","","","","","0.094 (42886/456034)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,"43046","9.3","aHR (1 dose); aHR ( >2 dose)","0.57; 0.50","0.51-0.63; 0.45-0.57",NA,"","","aHR (1 dose); aHR ( >2 dose)","0.76; 0.74","0.68-0.85; 0.63-0.87",NA,"","",NA,NA,NA,NA,NA,NA,"aHR (1 dose); aHR ( >2 dose)","0.68; 0.42","0.64-0.71; 0.39-0.46",NA,NA,NA,"raw data taken from supps eTable2. Vaccinated is sum of dose 1, dose 2 and dose 3. Data taken for covid-19 positive cohort   HRs taken from eTable10 (1dose; >2 dose). Note: it is not comparing cancer to non-cancer but vaccinated to unvaccinated so data may not be relevant ","421528","90.7",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73036","Mirgh 2021","Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India(rerun)","Consensus","Peer-reviewed","Cancer Medicine","Records from Tata Memorial Centre","16/11/2021","Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India","Mirgh S. P.","Retrospective","Cohort","Yes","inpatient","India","Navi Mumbai","Tata Memorial Centre","2020-05-22","2020-12-01","202 - 2 excluded due to indeterminate PCR   200 included ","Overall mortality","Duration of hospitalisation  Factors affecting mortality  Baseline covid-19 severity","Severity; Mortality","no","*Patients with cancer (cancer cohort)*: Patients with both haematological and solid organ malignancies comprised the cancer cohort   *Active anti-cancer treatment cohort*: any chemotherapy or radiotherapy or major surgery within 4 weeks of SARS-CoV-2 positiv- ity  Remission of the malignant disease was defined as ab- sence of disease at last follow-up before contracting SARS- CoV-2 infection","Cancer:control = 109:91  Not matched ","Cancer:control = 109:91  Not matched ",NA,"Median","51","IQR","33-62","58.7","109","Median","38","IQR","32-49","68.1","91","Not mentioned",NA,"","","","","",NA,"","","19","17.1","21","23.6","",NA,"","","9","8.1","13","14.6","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Baseline COVID-19 severity ON ADMISSION was graded as per 7-point ordinal scale published by Goldman et al  Whether oxygen support was subsequently required during hospitalization ","","Overall mortality = calculated from first date of SARS-CoV-2 RT-PCR positivity until date of death during hospital stay","Baseline covid19 severity per ordinal scale by Goldman et al AT ADMISSION   Also whether COVID-19 infection required oxygen support during hospitalization","univariate; multivariate","Other: Unclear ",NA,"4 (lung)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","18","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8 (gastrointestinal)","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"11 (genitourinary)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"12","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","7 (bone, soft tissue)","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","48","","","","","","","","","","","","","","","","","","","","","","","","","","","Unknown primary 1","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"109","uOR","7.04","1.25-39.54","0.027","0.101 (11/109)","0.0110 (1/91)","","","","","","","","","","","0.110 (12/109); 0.312 (34/109)","0.0220 (2/91); 0.147 (16/109)","Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","109","uOR","7.04","1.25-39.54","0.027","0.101 (11/109)","0.0110 (1/91)","",NA,"","","","","","","","","0.110 (12/109); 0.312 (34/109)","0.0220 (2/91); 0.147 (16/109)","Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","",NA,"","","","",NA,NA,"82","75.2","uOR","11.1","1.37-89.62","","Sep-82","1/109","","","","","","","","","",NA,"",NA,"In preceding one month","","","","","","","They have a discrepancy btw in-text number of chemo patients (79) and the table 4 (82), we used table 4 value to calculated crude OR ","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"9","8.26","","","","","","","","","","","","","",NA,NA,NA,"",NA,"Rituximab within 6mo of infection ","","","","","","","","7","6.4","","","","","","","","","","","","","","","",NA,"","","In preceiding 1 month of coid infection ","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","9","8.2","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"In preceiding 1 month of coid infection ",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"109","100","uOR","7.04","1.25-39.54","0.027","0.101 (11/109)","0.0110 (1/91)","","","","","","","","","","","0.110 (12/109); 0.312 (34/109)","0.0220 (2/91); 0.147 (16/109)","Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72989","Li 2020","Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission(rerun)","Consensus","Peer-reviewed","Leukemia - Nature","","20/07/2020","Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission","Li Q","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Union Hospital, Wuhan Central Hospital, General Hospital of Central Theater Command, PLA, Wuhan Jinyintan Hospital","2020-01-20","2020-04-04","1859","Death COVID-19 severity","Time from illness onset to ICU admission Time from illness onset to repeated negative SARSCOV2 tests Time from illness onset to admission, progression, or outcome (discharged alive or died) Time from diagnosis to outcome (discharged alive or died) Time from admission to outcome (discharged alive or died)","Severity; ICU admission; Mortality","no","*Non-remission* Remission defined as complete remission for >= 1year","Not explicitly matched","Cancer:non-cancer = 18:1794 Not age, gender, or comorbidity matched",NA,"Median","54","IQR","27-66","61","11","Median","59","IQR","45-68","50","903","Not mentioned",NA,"3","17","105","6","",NA,"","","3","17","559","31","",NA,"","","0","0","250","14","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Severity of COVID-19 was graded as follows: (1) mild; mild clinical symptoms, no pneumonia on lung CT; (2) common: fever, cough and lung CT with pneumonia; (3) severe: respiratory distress (respiratory rate>30min1, oxygen saturation (O2Sat)93% at rest and/or ratio of arterial oxygen partial pressure to fractional inspired oxygen300mmHg (PaO2/FIO2); and (4) critical: aforementioned criteria of respiratory failure receiving mechanical ventilation, shock and/or organ failure other than lung and/or intensive care unit (ICU) hospitalisation.","Critical: aforementioned criteria of respiratory failure receiving mechanical ventilation; shock; and/or organ failure other than lung; and/or intensive care unit (ICU) hospitalisation.","not stated","Severe: respiratory distress (respiratory rate>30min1, oxygen saturation (O2Sat)93% at rest and/or ratio of arterial oxygen partial pressure to fractional inspired oxygen300mmHg (PaO2/FIO2)","multivariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"18","NR","NR","NR","NR","0.500 (9/18)","0.106 (191/1794)","NR","NR","NR","NR","0.056 (1/18)","NR ","NR","NR","NR","NR","0.444 (8/18)","NR","NB: 'critical' disease is also a category in this paper. Data pulled from suppl table 7 (limited data available).","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72919","Cook 2022","Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19(rerun)","Consensus","Peer-reviewed","Clinical Lymphoma, Myeloma and Leukemia","MedStar electronic health record at MedStar Georgetown University Hospital and/or Washington Hospital Center","2022-07","Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19","Cook MR","Retrospective","Cohort","Yes","inpatient","USA","Washington D.C.","MedStar Georgetown University Hospital and Washington Hospital Center","2020-03","2020-05","762","VTE and Cerebrovascular accident","VTE + CVA composite, ICU admission, COVID-related mortality","ICU admission; Mortality","no","Doesn't specify beyond: haematological malignancy and control cohorts extracted from the REDCap database","Non-haematological malignancy patients who had a positive COVID-19 test at ED or as an inpatient at the same hospital group.","Not matched for age",NA,"Mean","69.4","SD","14.8","52.4","124*","Mean","53.95","SD","16.81","48.8","709","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","none","physical ICU admission (which was presented as a different outcome to respiratory support)","heterogenous follow up: "" date of last clinical follow-up or date of death.""","none","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"0","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53","uOR","uOR == 4.37","2.38-8.03","3.20E-07","0.358","0.113","uOR","mOR ==1.32","0.68-2.59","0.414","0.226","0.181","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"53","uOR","uOR == 4.37","2.38-8.03","3.20E-07","0.358","0.113","uOR"," mOR == 1.32","0.68-2.59","0.414","0.226","0.181","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"762","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72884","Mohamed 2021","Cancer and COVID-19: Analysis of patient outcomes(rerun)","Consensus","Peer-reviewed","Future Oncology ","REDCap electronic data capture tools hosted at Tulane Medical Center","2021-07","Cancer and COVID-19: analysis of patient outcomes","Mohamed A","Retrospective","Cohort","Yes","inpatient","USA","Louisiana, New Orleans","Tulane Medical Center","2020-02-27","2020-04-27","214","in-hospital mortality ","risk of ICU admission, risk of endotracheal intubation, duration of mechanical ventilation and length of hospital stay ","Severity; ICU admission; Mortality","no","Cancer patients were divided into patients receiving treatment as active cancer and patients in remission with nonactive cancer   *active cancer*","same hospitals   This cohort of COVID-19 patients is representative of the patient population at two university hospitals in New Orleans, Louisiana","active cancer to non-cancer ratio = 11:203",NA,"mean","60.7","SD","9.3","54.5","11","mean","58.7","SD","14.6","45.5","203","Not mentioned",NA,"","","44","22.9","",NA,"","","9","81.8","152","74.9","uOR","1.51","0.32 - 7.22","0.603447","1","9.1","84","41.4","uOR","0.14","0.02 - 1.13","0.33","1","9.1","22","10.8","uOR","0.82","0.10 - 6.74","0.855459","","","25","12.3","",NA,"",NA,"","","","","",NA,"","","2","18.2","27","13.3","uOR","1.45","0.30 - 7.07","0.645025","","","48","23.6","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"4","36.4","125","63.8","uOR","0.36","0.10 - 1.26","0.096026","Other = obesity, Chronic lung disease = COPD + Asthma ","","","",NA,"","","","Two scoring systems were used for severity assessment: 1) the CURB-65 score and 2) the Quick Sequential Organ Failure Assessment (qSOFA) score  - unclear if severe was when either or both were positive or if all patients even had both","/","in hospital mortality. No mention of how long patients were followed up for","Two scoring systems were used for severity assessment: 1) the CURB-65 score and 2) the Quick Sequential Organ Failure Assessment (qSOFA) score ","univariate; Other: no relevant analysis provided so calculated crude OR, CI and p-values from the data","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"11","uOR","1.93","0.49 - 7.67","0.355","0.273 (3/11)","0.163 (33/203)","uOR","5","1.43 - 17.45","0.012","0.455 (5/11)","0.143 (29/203)","","","","","","","I calculated crude OR, CI and p-values for mortality and ICU admission using data in table 1 for non-cancer patients and table 3 for active cancer patients ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"214","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72854","Konermann 2023","High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.(rerun)","Consensus","Peer-reviewed","Oncology Research and Treatment","ClinicalTrials.gov, NCT04659187","2023-02","High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study","Konermann F M","Prospective","Cohort","Yes","inpatient","Germany","N/A","The hospital network Asklepios","2020-03-11 (WT to Delta); 2022-01-01 (Omicron)","2022-01-01 (WT to Delta); 2022-07-20 (Omicron)","27,490","""Survival status at discharge from hospital is the primary end-point of the investigation."" ","""Additionally, we differentiated patients with solid and hematological malignancies with regard to the primary endpoint.""","Mortality","no","*Active cancer*, history of cancer","Same country, but involved multiple centers across Germany","2,578:24,912",NA,"Active Cancer/ WT-D; Active Cancer/Omicron  Median","75; 74","IQR","65 - 82; 64 - 81","58; 62","777; 736","No Cancer/WT-D; No Cancer/Omicron  Median","70; 72","IQR","54 - 82; 53 - 83","52; 49","14,998; 9,914","Wild Type (Ancestral/Wu-1); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"","","","","",NA,"","","","","","","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  166; 138","21; 19","No Cancer/WT-D; No Cancer/Omicron  3,644; 1,890","24; 19","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  120; 103   CAD Active Cancer/ WT-D; Active Cancer/Omicron  119; 117","Heart Failure 15; 14   CAD 15; 16","Heart Failure No Cancer/WT-D; No Cancer/Omicron 1,962; 1,342  CAD No Cancer/WT-D; No Cancer/Omicron 2,020; 1339","Heart Failure 13; 14  CAD 13; 14","","","","","Active Cancer/ WT-D; Active Cancer/Omicron  45; 33","5.8; 4.5","No Cancer/WT-D; No Cancer/Omicron  997; 676","6.6; 6.8","",NA,"",NA,"Active Cancer/ WT-D; Active Cancer/Omicron  11;15","1.4; 2.0","No Cancer/WT-D; No Cancer/Omicron  94; 85","0.6; 0.9","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  136; 110  ","18; 15","No Cancer/WT-D; No Cancer/Omicron  2, 332; 1,334","16; 13","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  99; 73","13; 9.9","No Cancer/WT-D; No Cancer/Omicron  1,396; 842","9.3; 8.5","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Dyslipidemia Active Cancer/ WT-D; Active Cancer/Omicron  127; 95  Obesity Active Cancer/ WT-D; Active Cancer/Omicron 29; 19","Dyslipidemia 16; 13   Obesity 3.7; 2.6","Dyslipidemia No Cancer/WT-D; No Cancer/Omicron  2,334; 1,521  Obesity No Cancer/WT-D; No Cancer/Omicron  992; 382","Dyslipidemia 16; 15  Obesity 6.6; 3.9","","","","","","","","",NA,"","","","Mechanical ventilation (intubation)","","Survival status at discharge from hospital is the primary endpoint of the investigation.","","multivariate","Sex; Comorbidities",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"1172","cOR","NR","NR","NR","0.234 (274/1172)","0.220 (2000/9089)","","","","","","","",NA,"",NA,"","","","","","","","","","","341","cOR","NR","NR","NR","0.237 (81/341)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1513","mOR","1.685","1.686 - 2.064","NR","0.235 (355/1513)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"WT/D cancer patients 777","51.4 of cancer patients","mOR","1.94","1.646 - 2.285","NR","0.272 (211/777)","0.161 (2418/14998)","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"736 cancer patients","48.6 of cancer patients","mOR","2.864","2.354 - 3.486","NR","0.196 (144/736)","0.0783 (776/9914)",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"1513","100","cOR","","","","0.235 (355/1513)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72749","Passamonti 2020","Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(rerun)","Consensus","Peer-reviewed","Lancet Haematology","","2020-08","Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","Passamonti F","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Italy","","","2020-02-25","2020-06-22","536","Mortality among patients with haematological malignancies and COVID-19 and evaluation of potential predictive parameters of mortality including biochemical parameters, haematological malignancy characteristics (disease type, disease status, and therapy status), and COVID-19 severity.","Epidemiology of patients with haematological malignancies infected by SARS-CoV-2 (ie, type of haematological malignancy, ICU admission  rate, laboratory abnormalities, and haematological malignancy-specific treatments) Evolution of haematological malignancies Dynamics of viral load","Severity; ICU admission; Mortality","no","Haematological malignancies Median time since haematological malignancy diagnosis (years) is 2 (IQR: 0-6). Table 1.","general Italian population","no",NA,"Mean;Median","66.8;68","SD for mean;IQR for median","13.3;58-77","63","340","","","","","","","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","72","13","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"34","6","","","",NA,"","","42","8","","","",NA,"","","43","8","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"82 (Heart disease); 91 (Vascular disease); 13 (Connective tissue diseases)","15 (Heart disease); 17 (Vascular disease); 2 (Connective tissue diseases)","","","","","","","","","","",NA,"","","","Severe = dyspnoea, respiratory frequency 30 breaths per min, SpO2 93%, PaO2/FiO2 <300, or lung infiltrates >50%.","Critical = respiratory failure, septic shock, or multiple organ disfunction or failure.","not stated","Severe = dyspnoea, respiratory frequency 30 breaths per min, SpO2 93%, PaO2/FiO2 <300, or lung infiltrates >50%.","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","536","Standardised mortality ratio","2.04","1.77-2.34","","0.369","","","","","","0.153","","","","","","0.362","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"See haematological row","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72735","Altuntas 2021","COVID-19 in hematopoietic cell transplant recipients(rerun)","Consensus","Peer-reviewed","Bone Marrow Transplantation","","28/10/2020","COVID-19 in hematopoietic cell transplant recipients","Altuntas F","Retrospective","Cohort","Yes","inpatient","Turkey","N/A ","N/A ","2020-03-11","2020-05-29","994","Hospital stay duration  ICU stay duration  ICU admission  Mechanical ventilation  COVID-19 severity  Case fatality rate","","Severity; Hospitalisation; ICU admission; Mortality","no","*Haematological cancer + hematopoietic cell transplant*, *Haematological cancer*  No definition of timeline of diagnosis/treatment allowed ","Total cancer group (recipients of haematological cell transplant, or no transplant) : non-cancer = 32 or 465 : 497  Patients that were also diagnosed and included in the Republic of Turkey Ministry of Health database ","Total cancer group (recipients of haematological cell transplant, or no transplant) : non-cancer = 32 or 465 : 497  Age and comorbid disease matched ",NA,"Median (Haematological cell transplant recipients w cancer); Median (non-HCT recipients with cancer)","56.5; 57","Range (Haematological cell transplant recipients w cancer); Range (non-HCT recipients with cancer)","19-74; 18-93","78.1; 53.8","32; 465","Median","55","Range","19-87","54.1","497","Not mentioned",NA,"","","","","",NA,"","","18; 201","56.3; 43.2","200","40.2","",NA,"","0.2","7; 111","21.9; 23.9","114","22.9","",NA,"","0.9","5; 69","15.6; 14.8","63","12.7","","","","0.6","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","10; 86","31.3; 18.5","86","17.3","","","","0.1","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","Haematological cell transplant recipients w cancer; non-HCT recipients with cancer","Severity classified as ""severe"" or ""critical"" but how these were defined was not explained   Also whether or not mechanical ventilation was required","Rate of ICU admission","Case fatality rate, duration of follow up not defined. ","Severity classified as ""severe"" or ""critical"" but how these were defined was not explained  HENCE THIS WILL NOT BE INCLUDED IN DATA EXTRACTION ","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","32; 465","cOR (haematological cell transplant age and comorbid matched); cOR (non-haematological cell transplant age and comorbid matched)","3.10; 2.25","1.11-8.67; 1.40-3.61","0.0308; 0.0008","0.156 (5/32); 0.118 (55/465)","0.0563 (28/497); 0.0563 (28/497)","cOR (haematological cell transplant age and comorbid matched); cOR (non-haematological cell transplant age and comorbid matched)","2.21; 25.69","0.912-5.33; 15.25-43.27","0.0792; <0.0001","0.219 (7/32); 0.211 (98/465)","0.113 (56/497); 0.113 (56/497)","cOR (severe/critical in haematological cell transplant age and comorbid matched); cOR (severe/critical in non-haematological cell transplant age and comorbid matched); cOR (mechanical ventilation in haematological cell transplant age and comorbid matched); cOR (mechanical ventilation in non-haematological cell transplant age and comorbid matched)","2.13; 1.81; 2.37; 2.269","0.995-4.570; 1.345-2.431; 0.861-6.529; 1.485-3.467","0.0515; 0.0001; 0.0947; 0.0002","0.344 (11/32); 0.308 (143/465); 0.156 (5/32); 0.151 (70/465)","0.197 (98/497); 0.197 (98/497); 0.0724 (36/497); 0.0724 (36/497)","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72612","Mariniello 2021","Descriptive Comparative Analysis of Patients with Cancer Referring to the Emergency Department of an Italian University Hospital across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves(rerun)","Consensus","Peer-reviewed","JCO Oncology Practice","Electronic Database of the San Luigi Gonzaga University Hospital (Orbassano-Turin, Italy) in a 3-week time frame during the first and second COVID-19 waves. We considered ED admissions from March 9 to March 29, 2020, for the first wave. From October 24 to November 13, 2020, for the second wave.","2021-07","Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the SARS-CoV-2 Waves","Mariniello, AM","Retrospective","Cohort","Yes","not specified","Italy","Turin, Italy","San Luigi Gonzaga University Hospital","2020-03-09 (1st wave); 2020-10-24 (2nd wave) ","2020-03-29 (1st wave);  2020-11-13 (2nd wave)","739","Symptoms at ED - None, Fever, Respiratory, GI, Respiratory Failure","Whether patients were discharged, ICU, HDU or deceased ","Severity; Hospitalisation; ICU admission; Mortality","no","histologically confirmed active solid or hematologic mal ignancies, including all patients with cancer at advanced disease stage, and those at early stages who underwent treatment with radical intent up to 12 months before ED admission. Patients with cancer who were radically treated and disease-free for at least 12 months were excluded.","Yes","Number of cancer to non-cancer patients broken up into two distinct time periods -""first wave and second wave"".  First wave - 155 Non-cancer and 8 Oncological Patients Second wave - 537 Non-cancer and 39 Oncological patients. Age matched, gender matched. Comorbidity matched. ",NA,"Median","73(first wave), 68(2nd wave)","IQR","63-80(first wave); 45-75(2nd wave)","87% male(first wave);  56% male(2nd wave)","8 pts in first wave;  39 pts in second wave","Median","59(first wave); 63(2nd wave)","IQR","49-73(first wave); 45-75(second wave)","61% male(1st wave);  58% male(2nd wave)","155 pts in first wave;  537 pts in second wave","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","metabolic defined(includes obesity and diabetes) 3 in first wave;  7 in second wave","27.5% first wave;  17.9% in second wave","42 in first wave;  105 in second wave","27% first wave;  19.6% second wave","",NA,"","0.9 (overall); 0.9 (overall)","CCV - Cardiocerebrovascular defined as  5 in first wave;  25 in second wave","62.5% first wave;  64% in second wave","69 in first wave;  215 in second wave","44.5% in first wave;  40% in second wave","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","2(first wave);  6(second wave)","25%(first wave);  15.4%(second wave)","17(1st wave);  49(2nd wave)","11%(first wave);  9.1%(second wave)","","","","","2(1st wave) 4(2nd wave)","25%(1st wave);  10.3%(2nd wave)","6(1st wave);  16(2nd wave)","3.9%(1st wave);  3%(1st wave)","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Respiratory failure","Admitted to ICU ","Deceased at Emergency Department","Respiratory failure ","univariate","",NA,"4(1st wave);  7(2nd wave)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"3(1st wave);   6(2nd wave) ","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","1(1st wave);  13(2nd wave) ","","","","","","","","","","","","","","","","","","","","","","","","","","","NR; 6 (2nd wave) ","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"8 (1st wave);  39 (2nd wave)","NR; NR","NR; NR","NR; NR","NR; NR","0/ 8 (1st wave);   3/39(2nd wave) ","1/155(1st wave); 0/537 (2nd wave) ","NR; NR","NR; NR","No statistical significance (no further information given); No statistical significance (no further information given)","0.5 - No statistical significance in ICU admission between cohorts for 1st and 2nd wave together; overall value provided","3/8 (1st wave); 6/39 (2nd wave) ","33/155 (1st wave); 41/537 (2nd wave) ","NR; NR","NR; NR","NR; NR","0.049 (1st and 2nd wave) also says this but not sure what it means ""However, the higher frequency of respiratory fai lure in C19-CP was significant even when stratifying for pandemic wave (Mantel-Haenszel test P 5 .045); overall value provided","6/8 (1st wave); 23/39 (2nd wave) ","90/155 (1st wave);  231/537 (2nd wave) ","dates = start: 2020-03-09 (1st wave): 2020-10-24 (2nd wave);  end: 2020-11-13 (1st wave); 2020-11-13 ","NR; NR"," NR; NR","","0.0004 (overall across 1st and 2nd wave); 0.0004 (overall across 1st and 2nd wave)","7/8 (1st wave);  30/39 (2nd wave) ","118/155 (wave 1);  246/537 (wave 2)  ","dates = start: 2020-03-09 (1st wave): 2020-10-24 (2nd wave);  end: 2020-11-13 (1st wave); 2020-11-13 ",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"Stage 3 and 4 - Advanced disease 5/8 in first wave;  28/39 in second wave","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"1(1st wave); 18(2nd wave)","16%(1st wave);  66.7%(2nd wave)","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","1(1st wave);  4(2nd wave)","16%(1st wave);  14.8%(2nd wave)","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"TK Inhibitors 1(1st wave);  2(2nd wave)","TK Inhibitors 16%(1st);  7.4%(2nd wave)","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","2(1st wave);  2(2nd wave)","33%(1st);  7.4%(2nd)","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72593","Anantharaman 2021","SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California(rerun)","Consensus","Peer-reviewed","The Oncologist ","","2020-12","SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California","Anantharaman, A","Retrospective","Cohort Study","Yes","inpatient and outpatient (no breakdown)","USA","Northern California ","n/a","2020-02-25","2020-06-08","4627","Emergency department visit, inpatient hospitalisation, ICU stay, mechanical ventilation, non invasive ventilation and mortality between Covid-19 diagnosis and first 45 days of diagnosis or end of study","Distinct primary and secondary outcomes not stated","Hospitalisation; ICU admission; Mortality; Other: ED visit, non invasive ventilation ","no","*Active cancer: Patients having active treatment for cancer (including infusion or oral chemo or radiation) in 180 days prior to covid-19 diagnosis* History of cancer but no active treatment  - this group was not included below  ","Adults with positive lab test for Covid-19 with no cancer history. Adults with positive lab test for Covid-19 with history of cancer in Kaiser Permanente Northern California (KPNC) cancer registry but no active treatment cancer in 180 days prior to Covid-19 diagnosis and no history of cancer.   N.b.Adjusted ORs calculated adjusting for demographic and clinical characteristics (cancer history, age, sex, race/ethnicity, body mass index, charlson comorbidity index, hypertension, diabetes, smoking status, neighbourhood deprivation index) and week of Covid-19 diagnosis to account for changing testing and treatment guidelines. ","33 patients with active cancer treatment within 180 days,  4380 no active cancer treatment or history. No age/gender/comorbidity matching. Adjusted ORs calculated adjusting for demographic and clinical characteristics (cancer history, age, sex, race/ethnicity, body mass index, charlson comorbidity index, hypertension, diabetes, smoking status, neighbourhood deprivation index) and week of Covid-19 diagnosis to account for changing testing and treatment guidelines. ",NA,"","","Age groups","18-59: 39%; 60-69: 24%; 70+: 36%","45%","33","","","Age groups","18-59: 77%; 60-69: 13%; 70+: 10%","48%","4380","Not mentioned",NA,"","39","","25","",NA,"","","","42","","13","",NA,"","","","18","","13","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Invasive mechanical Ventilation ","","45 days (or end of study) ","Severe disease not explicitly stated but patients requiring invasive ventilation investigated and recorded below","multivariate","Age; Sex; Comorbidities; Other: cancer history, age, sex, race/ethnicity, body mass ass index, Charlson comorbidity index, hypertension, diabetes, smoking status, and neighborhood deprivation index and week of COVID-19 diagnosis",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"33","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.3","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","Severity = invasive ventilator ","mOR","1.55","0.67-3.59","NR","NR","NR","No p values or absolute numbers stated. Also have pooled outcomes, ED visit, non invasive ventilation cancer vs non cancer if relevant.",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","33","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.3","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","","mOR","1.55","0.67-3.59","NR","NR","NR",NA,NA,"12","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","11","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"14","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"4413","100","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.3","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","","mOR","1.55","0.67-3.59","NR","NR","NR","NR","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"71781","Martin 2023","SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation.","Consensus","Peer-reviewed","Oncology","Research Electronic Data Capture (REDCap) electronic data capture tools hosted at IRYCIS","2022-09","SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation","Martin M.","Retrospective","Cohort","Yes","inpatient","Spain","Madrid","Hospital Universitario Ramn y Cajal","2020-03","2020-09","2772","Mortality","","Mortality","no","Only patients with a diagnosis of SARS-CoV-2 infection confirmed by PCR in nasopharyngeal exudate and with available data for status, current oncological treatment, and follow-up of the oncological disease were included. ","81 (active cancer treatment) vs 164 (cancer survival) vs 2527 (control)","2527 (control) vs 81 (active cancer treatment) vs 164 (with history of cancer). Not matched.",NA,"Median","71","IQR","62-79","60.5","81","Median","69","IQR","55-81","58.8","2527","Not mentioned",NA,"","","","","",NA,"","","39","48.1","1093","43.3","",NA,"","0.01","21","25.9","466","18.5","",NA,"","0.04","14","17.3","458","18.1","","","","0.01","","","","","",NA,"",NA,"","","","","",NA,"","","4","4.9","197","7.8","",NA,"","0.01","10","12.3","282","11.2","","","","0.01","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","N/A","N/A","Not specified.","N/A","univariate; multivariate","Age; Comorbidities; Other: Active cancer treatment",NA,"10","uOR","9.6","2.4-37.3","N/A","0.7 (7/10)","0.4 (4/10)","","","","","","","",NA,"",NA,"","","","","","","","","","","19","uOR","0.7","0.2-2.6","N/A","0.158 (3/19)","0.125 (2/16)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2","uOR","N/A","","N/A","0.5 (1/2)","0 (0/3)","","","","","","","","","","","","","","","","","","","",NA,"3","uOR","N/A","","N/A","0","0.333 (4/12)","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"16","uOR","2.4","0.8-6.8","N/A","0.375 (6/16)","0.313 (10/32)","","","","","","","",NA,"",NA,"","","Bladder cancer has no death, and is classified in another group in the paper","","","","","","","","1","uOR","N/A","","N/A","0","0 (0/2)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1","uOR","N/A","","N/A","0","0/0","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"4","uOR","N/A","","N/A","0","0.6 (3/5)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1","uOR","N/A","","N/A","1 (1/1)","0.286 (4/14)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","2","uOR","N/A","","N/A","0.5 (1/2)","0.333 (1/3)","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8","uOR","2.4","0.5-10.3","N/A","0.375 (3/8)","0.286 (4/14)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"81","uOR","2.259","1.35-3.77","0.002","0.333 (27/81)","0.268 (44/164 )","","","","","","","","","","","","","multivariate analysis of risk of death in patients under active oncological treatment","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"30","37.0% (30/81)","OR","3.15 (univariate)  3.624","1.52-6.53  1.17-11.17","0.002  0.025","0.467 (14/30)","","","","","","","","","","",NA,"",NA,"","","","","","","","Chemotherapy treatment versus other treatment","25","","","","","","0.32 (8/25)","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"7","","","","","","0","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","11","","","","","","0.364 (4/11)","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","6","","",NA,"","","0.167 (1/6)","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"71633","Raad 2023","International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.","Consensus","Peer-reviewed","eLife","","2023-01","International multicenter study  comparing COVID-19 in patients with  cancer to patients without cancer: Impact  of risk factors and treatment modalities  on survivorship","Raad I. I.","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","USA, Australia, Brazil, France, Japan, Lebanon, Singapore, South Korea, Spain","","","2020-01-04","2020-11-15","3966","30 day mortality","Hospital readmissions within 30 days after  COVID-19 diagnosis, mechanical ventilation, progression to lower respiratory tract infection, co-infection","Hospitalisation; ICU admission; Mortality","Other: No","Cancer diagnosed or treated within a year  before the diagnosis of COVID-19","Same multinational cohort","1115:2851 = 1:2.56 country adjusted, age/gender/comorbidity matching not mentioned",NA,"Median","61","Range","18-100","45","1115","Median","50","Range","18-100","47","2851","Not mentioned",NA,"409","38","348","17","",NA,"","<0.0001","546","49","1020","36","",NA,"","<0.0001","299","27","6599","23","",NA,"","<0.0001","History of ischemic heart disease: 94; history of heart failure: 85","History of ischemic heart disease: 9; history of heart failure: 12","History of ischemic heart disease: 226; history of heart failure: 240","History of ischemic heart disease: 8; history of heart failure: 12","","","","History of ischemic heart disease: 0.57; history of heart failure: <0.001","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","COPD/bronchiolitis obliterans: 75; asthma: 106","COPD/bronchiolitis obliterans: 7; asthma: 10","COPD/bronchiolitis obliterans: 175; asthma: 178","COPD/bronchiolitis obliterans: 9; asthma: 6","","","","COPD/bronchiolitis obliterans: 0.07; asthma: <0.001","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","","","multivariate","Other: Country, tocilizumab treatment, convalescent plasma treatment",NA,"64","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"632","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","283","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1115","mOR (multiple imputations)","1.23","0.87-1.75","0.24","","","cRR","(141/1100)/(225/1846)=1.05","","0.62","141/1100","225/1846","","","","0.98","135/1096=12.3%","130/1052=12.4%","","cRR","(63/481)/(60/806)=1.76","","<0.0001","63/481=13.1%","60/806=7.44%","Hospitalisation referred to hospital re-admission within 30 days of COVID-19 diagnosis",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"71628","Turtle 2023","Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.","Consensus","Peer-reviewed","PLOS Medicine"," ISARIC WHO Clinical Characterisation Protocol UK prospective observational cohort study (ISARIC4C)","2023-01","Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study","Lance Turtle","Prospective","Cohort","Yes","inpatient","United Kingdom","N/A","N/A","2020-01-17","2022-02-28","156552","In-hospital mortality ","4C mortality score - illness severity at presentation until 28 days after admission   In-hospital interventions: Use of oxygen  Noninvasive ventilation  Invasive mechanical ventilation  Admission to critical care ","Severity; ICU admission; Mortality","yes","Cancer patients who are immunocompromised ","Drawn from the same multinational cohort  Includes patients with a 'history of malignant neoplasm'","Cancer immunocompromised to immunocompetent (assumed non-cancer) = 5116:134598  Not matched ",NA,"median","72","IQR","62.0-79.7","58.1","5116","median","69.5","IQR","53.4-82.0","55.3","134598","Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"1621","31.7","33798","25.1","",NA,"","","2049","40.1","57117","42.4","",NA,"","","1188","23.2","36322","27","",NA,"","","1318","25.8","35597","26.4","","","","","","","","","",NA,"",NA,"229","4.5","3800","2.8","",NA,"","","790","15.4","18901","14","",NA,"","","946","18.5","18495","13.7","","","","","5116","100","0","0","","","","",NA,NA,NA,NA,"",NA,"",NA,"Asthma;chronic neurological disorder;chronic haematologic disease;dementia;malnutrition;Rheumatologic disease 511;385;1132;160;559","10;7.5;22.1;5.6;3.1;10.9","17720;13957;3665;15328;2417;12901","13.2;10.4;2.7;11.4;1.8;9.6","","","","","","","","",NA,"","","","Invasive ventilation required   Note that paper states ""Disease severity as measured using 4C mortality score (respiratory rate (breaths per min), Glasgow Coma Scale, oxygen saturation (%), blood urea (mmol/L), blood C-reactive protein (CRP, mg/L)"" but this data is not avilable for individual immunocompromised subtypes (cancer) ","Critical care admission ","28 days","Noninvasive or Invasive ventilation required ","multivariate","Age; Sex; Comorbidities; Other: Ethnicity, deprivation index, vaccination, ",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"5116","mOR","2","1.87-2.15","<0.001","0.355 (1818/5116)","0.213 (28608/134598)","mOR","0.77","0.70-0.85","<0.001","0.867 (4437/5116)","0.154 (20710/134598)","mOR;mOR","0.93;0.65","0.86-1.01;0.56-0.76","0.095;<0.001","0.179 (918/5116);0.0461(236/5116)","0.182 (24445/134598);0.0644 (8665/134598)","Noninvasive;invasive","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5116","mOR","2","1.87-2.15","<0.01","0.365 (1818/5116)","0.219 (28608/134598)","mOR","0.77","0.70-0.85","<0.001","0.873 (4437/5116)","0.155 (20710/134598)","mOR;mOR","0.93;0.65","0.86-1.01;0.56-0.76","0.095;<0.001","0.182 (918/5116);0.047(236/5116)","0.185 (24445/134598);0.066 (8665/134598)","Noninvasive;invasive","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","mOR","1.28","1.20-1.36","<0.001","","","",NA,"",NA,"","","",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","mOR","0.83","0.76-0.91","<0.001","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,NA,NA,"","","mOR","0.66","0.54-0.80","<0.001","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","Alpha","","mOR","1.19","1.12-1.26","<0.001","","","",NA,"",NA,"","","","","","","","","Compared to immunocompetent wave 1 hence may not be useful","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"71512","Nolan 2023","Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.","Consensus","Peer-reviewed","CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION","COVID EHR Cohort","2023-01","Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin","Nolan, M. B.","Retrospective","Cohort","Yes","inpatient","US","","Duke University, Hackensack Meridian Health, Mayo Clinic (3 locations: Phoenix, AZ, Jacksonville, FL, Rochester, MN), Memorial Sloan Kettering Cancer Center, Mount Sinai, New York University, Northwestern University, University of California-Davis, University of California-San Francisco, University of Chicago, University of Illinois at Chicago, University of Kansas, University of Maryland, University of Michigan, University of North Carolina, University of Utah, University of Wisoconsin, Vanderbilt University, Virginia Commonweatlth University, Washington University, Yale University","2020-02-01","2021-09-30","104590","in-hospital mortality and ICU admission","","ICU admission; Mortality","yes","Current cancer (not extracted data on past history of cancer as timeline not specified) ","same databases","No matching of patients and controls.",NA,"","","","","55","7141","","","","","49.2","90700","Not mentioned",NA,"3616","50.6","33647","36.9","",NA,"","0.079","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","icu admission","in hospital mortality","","multivariate","Age; Sex; Comorbidities; Other: BMI",NA,"732","uOr; mOR","2.47; 1.93","2.04-2.99; 1.59-2.36","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","611","uOr; mOR","1.47; 1.57","1.14-1.88; 1.21-2.03","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"1062","uOr; mOR","1.70; 1.40","1.42-2.04; 1.17-1.69","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"628","uOr; mOR","1.88; 1.05","1.49-2.36; 0.83-1.33","<0.001; 0.66","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"2012 (metastatic); 2012 (metastatic); 4337 (solid tumour without metastasis);  4337 (solid tumour without metastasis)","uOR (metastatic); mOR (metastatic);  uOR (solid tumour without metastasis); mOR  (solid tumour without metastasis)","2.28 (metastatic); 1.94 (metastatic); 1.82 (solid tumour without metastasis); 1.48 (solid tumour without metastasis)","2.01-2.58 (metastatic); 1.71-2.21 (metastatic); 1.66-1.99 (solid tumour without metastasis); 1.35-1.62 (solid tumour without metastasis)","<0.001 (metastatic); <0.001 (metastatic); <0.001 (solid tumour without metastasis);  <0.001 (solid tumour without metastasis)","nr (metastatic); nr (metastatic); nr (solid tumour without metastasis); nr (solid tumour without metastasis)","0.092 (8384/90700) (metastatic); 0.092 (8384/90700) (metastatic); 0.092 (8384/90700) (solid tumour without metastasis); 0.092 (8384/90700) (solid tumour without metastasis)","","","","","","","",NA,"",NA,"","","","","","","","","","","2482","uOr; mOR","2.02; 1.71","1.80-2.26; 1.52-1.92","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"7141","uOr; mOR","1.91; 1.58","1.78-2.06; 1.46-1.70","<0.001; <0.001","0.146 (1040/7141); 0.146(1040/7141)","0.092 (8384/90700); 0.092 (8384/90700)","uOR; mOR","1.31; 1.24","1.24-1.39; 1.17-1.32","<0.001; <0.001","0.247 (1763/7141); 0.247(1763/7141)","0.199 (18063/90700); 0.199 (18063/90700)","","","","","","","","","","","","","","",NA,"4337","uOR; mOR","1.82; 1.48","1.66-1.99; 1.35-1.62","<0.001; <0.001","nr; nr","0.92 (8384/90700); 0.92 (8384/90700)","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"2012","uOR; mOR","2.28; 1.94","2.01-2.58; 1.71-2.21","<0.001; <0.001","nr; nr","0.92 (8384/90700); 0.92 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,"6344","11.5","","","",NA,"0.104 (76/733)","0.052 (252/4848)","","","",NA,"0.205 (150/733)","0.163 (790/4848)",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"","48639","88.5",NA,NA,NA,NA,"0.131 (403/3074)","0.076 (3237/42593)",NA,NA,NA,NA,"0.241 (741/3074)","0.182 (7752/42593)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"70896","Abuhelwa 2022","In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States.","Consensus","Peer-reviewed","Cancers","the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) 2020 database","2022-12"," In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States ","Abuhelwa Z","Retrospective","Cohort","Yes","inpatient","United States","N/A","N/A","2020-01-01","2020-12-31","1050045","All-cause in-hospital mortality","(i) morbidity as measured by the rates of septic shock, acute respiratory failure, acute respiratory distress syndrome, and mechanical ventilation (ii) resource utilization as measured by length of hospital stay and total hospitalization charges.","ICU admission; Mortality; Other: Morbidity (ARDS, Mechanical ventilation), resource utilization","no","Patients with a principal diagnosis of COVID-19 who have underlying cancer as secondary diagnosis were included in the analyses. The included cancers were lung, breast, colorectal, prostate, leukemia, lymphoma, and multiple myeloma. Patients were excluded if they were less than 18 years of age. The ICD-10-CM diagnosis codes were used to extract data (Supplementary Table S1).","Patient with a COVID-19 diagnosis without a cancer diagnosis","No matching - all non-cancer patients used in multivariable regression model.",NA,"mean","70.92","95% CI","70.52-71.32","56.57","27760","mean","64.57","95% CI","64.41-64.74","52.7","1022285","Not mentioned",NA,"10110","36.42","273260","26.73","",NA,"","<0.001","19380","69.81","692565","67.75","",NA,"","<0.001","9585","34.53","419910","41.08","",NA,"","","6175","22.24","186725","18.27","","","","<0.001","","","","","",NA,"",NA,"1320","4.76","44360","4.34","",NA,"","0.151","4790","17.26","150100","14.68","",NA,"","<0.001","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","No mention of CVD. I put in numbers of coronary artery disease.","","","",NA,"","","","N/A","Mechanical ventilation","all-cause in-hospital mortality","N/A","multivariate","Age; Sex; Comorbidities; Other: age, sex, race, admission type, admission day, hospital bed size, hospital teaching status, hospital region, insurance status, median annual income, and comorbidities.",NA,"4400","mOR","1.57","1.31-1.88","<0.001","0.209 (920/4400)","","","","","","","","",NA,"",NA,"","","lung","","","","","","","","3340","mOR","0.96","0.73-1.27","0.763","0.103 (345/3340)","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"1675","mOR","1.45","1.07-1.96","0.015","0.191 (320/1675)","","","","","","","","",NA,"",NA,"","","colorectal","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"4080","mOR","0.94","0.77-1.14","0.533","0.190 (775/4080)","","","","","","","","",NA,"",NA,"","","prostate","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"13495","","","","","0.175 (2360/13495)","","","","","","","","",NA,"",NA,"","","","","","","","","","","13550","mOR;mOR;mOR","1.22;1.30;1.20","1.02-1.45;1.05-1.61;0.94-1.52","0.028;0.016;0.137","0.224;0.156;0.108","","","","","","","","","","","","","","leukemia;lymphoma;multiple myeloma","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"27760","mOR","1.21","1.12-1.31","<0.001","0.176 (4880/27760)","0.120 (122451/1022285)","mOR(mechanical_ventilation)","0.98","0.88-1.09","0.767","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"70028","Sanchez-Pina 2020","Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies","Consensus","Peer-reviewed","European Journal of Haematology","","20/07/2020","Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies","Sanchez-Pina JM","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","Spain","Madrid","Universitario 12 de Octubre, Instituto de Investigacin Sanitaria Hospital ","2020-03-07","2020-04-07","92","Mortality","","Severity; Hospitalisation; ICU admission; Mortality","no","The objective of the present study was to describe infection in a consecutive series of patients with haematological malignancies who were diagnosed with COVID-19 in the greater Madrid area.","We also compared the outcome of this cohort of patients with a contemporaneous control population of patients with COVID-19 and similar characteristics but without haematological malignancies at our hospital","We selected a control group of 53 patients without haematological malignancies from the overall COVID-19 patients who were admitted or attended to in the emergency room at our hospital during the study period. These selected patients were similar to the haematological cases with respect to age and severity index values at admission, but they did not have any history of cancer.",NA,"Mean","64.7","Range","36-88","59","39","Mean","65.7","Range","41-89","62.3","53","Not mentioned",NA,"","","","","",NA,"","","19","48.7","26","49.1","",NA,"","0.974","7","20","11","20.8","",NA,"","0.737","6","15.4","8","15.1","","","","0.969","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","2","5.1","9","17","","","","0.083","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Thrombosis: 4","10.3","1","1.9","","","","0.08","","","","",NA,"","","","Based on the WHO severity scale, patients were classified as mild, moderate and severe.","","53-day Mortality","Based on the WHO severity scale, patients were classified as mild, moderate and severe.","univariate; multivariate","Age; Sex; Comorbidities; Other: hypertension, therapy with ACE-I/ARB, need of oxygen therapy, severity/moderate disease, CRP on admission",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","39","uOR;mOR","3.680;6.652","1.314-10.305;1.868-23.688","0.013;0.003","0.359(14/39);0.359(14/39)","0.132(7/53);0.132(7/53)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"39","uOR;mOR","3.680;6.652","1.314-10.305;1.868-23.688","0.013;0.003","0.359(14/39);0.359(14/39)","0.132(7/53);0.132(7/53)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"4","10.3","","","","","4/14 (0.286)","","","","","","","","","","",NA,"",NA,"","","","","","","","","12","30.8","","","","","4/14 (0.286)","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"Targeted 5; ITK 2; mAb 5; Proteasome inhibitor 7 ","Targeted 12.8; ITK 5.1; mAb 12.8; Proteasome inhibitor 17.9","","","","","Targeted 0.143; ITK 0; mAb 0.714; Proteasome inhibitor 0.143","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","IMIDs 3","7.7","","","","","0.143","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"70002","Lunski 2021","Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana","Consensus","Peer-reviewed","Cancer","Ochsner Health System","2020-10 ","Multivariate Mortality Analyses in COVID-19: Comparing Patients With Cancer and Patients Without Cancer in Louisiana","Lunski MJ","Retrospective","cohort ","Yes","Other: non-specific","US","Louisiana","36 different hospitals and clinics across the state, which ranged from tertiary care centres to primary care office","2020-03-01","2020-04-30","5145","Mortality of patients","hospitalization","Hospitalisation; Mortality","no","""ICD used to identify patients with active cancer or a history of cancer.""","Also from the same population - Ochsners electronic health record system (Epic)","ratio approx 1:15  the study did not explicitly mentioned whether their age, gender and comorbidity were matched. yet, they did p-value analysis for the variables, which aimed to indicate any statistically significant differences in the distribution between the two groups.   From table 1, age, sex, races, and all comorbidities (except obesity) had p-value < 0.05, indicating there are statistically significant differences in the proportions of these variables between the 2 groups, implying that they might not be very well-matched. ",NA,"","","","","45.50%","312","","","","","38.70%","4833","Not mentioned",NA,"","","","","",NA,"","","246","78.90%","1709","35.40%","aOR","0.6","0.47-0.78","","116","37.20%","872","18.00%","aOR","0.92","0.70-1.21","","34","10.90%","192","4.00%","aOR","1.43","0.99-2.08","","","","","","",NA,"",NA,"10","3.20%","20","0.40%","aOR",NA,"","","80","25.60%","902","18.70%","aOR","3.84","2.98-4.93","","35","11.20%","334","6.90%","aOR","1.34","0.96-1.88","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"143 (obesity)","45.80%","2339","48.40%","aOR","1.3","1.03-1.63","","","","","",NA,"","","","","","","","multivariate","Sex; Comorbidities",NA,"26 (lung)","uOR","4.69","2.03-10.86","0.0003","0.308 (8/26)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","70","uOR","1.36","0.65-2.87","0.425","0.114 (8/70)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","32 (GI in general)","uOR","1.96","0.75-5.11","0.174","0.156 (5/32)","0.087 (418/4833)","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"74 (genitourinary)","uOR","3.39","1.98-5.83","1.23E-05","0.243 (18/74)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","13","uOR","0.88","0.11-6.79","1.084","0.077 (1/13)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","uOR","","","","0","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"8","uOR","3.52","0.71-17.50","0.126","0.250 (2/8)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3 (skin and soft tissue)","uOR","5.28","0.48-58.37","0.178","0.333 (1/3)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"251","uOR","2.43","1.74-3.39","2.69E-07","0.187 (47/251)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","61","uOR","4.78","2.75-8.29","5.03E-08","0.311 (19/61)","0.087 (418/4833)","","","","","","","","","","","","","","","","","","","","","23 (endocrine)","uOR (endocrine)","2.22 (endocrine)","0.75-6.57","0.151","0.174 (4/23)","0.087 (418/4833)","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"312","uOR;aOR","2.87;2.03","2.14-3.85;1.44-2.87","P < 0.0001;P < 0.0001","0.212 (66/312);0.212 (66/312)","0.087 (418/4833);0.087 (418/4833)","","","","","","","","","","","","","","uOR","2.34","1.86-2.95","2.07E-12","0.503 (157/312)","0.302 (1460/4833)","no p values reported overall. In uOR it's self calculated",NA,"207","uOR","2","1.36-2.95","0.0004","0.159 (33/207)","0.086 (418/4833)","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"48","uOR","4.8","2.59-8.91","1.02E-06","0.3125 (15/48)","0.086 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","18","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"19","6.1% (19/312)","uOR","6.16","2.41-15.73","0.0002","36.8% (7/19)","0.086 (418/4833)","","","","","","","","","",NA,"",NA,"","","","","","","","","51","16.3% (51/312)","uOR","1.68","0.75-3.75","0.21","13.7% (7/51)","0.086 (418/4833)","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"13","4.2% (13/312)","uOR","4.69","1.44-15.31","0.011","30.8 (4/13)","0.086 (418/4833)","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","2"," 0.6% (2/312)","","","","","0%","0.086 (418/4833)","","","","","","","","","",NA,"","","","","","","","","","","4","1.2% (4/312)","","","","","0%","0.086 (418/4833)","","","","","","","","","",NA,"",NA,NA,"","","","","","","","5","1.6% (5/312)","",NA,"","","0%","0.086 (418/4833)",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"69998","Serraino 2021","Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Consensus","Peer-reviewed","Cancer Medicine","""For the aims of this investigation, the following data sources were used: microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system database; cancer registry; diabetes registry; and municipal registries.""","2021-11","Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Serraino, D","Retrospective","Cohort","Yes","not specified","Italy","Friuli Venezia Giulia (FVG) region (northeastern Italy)","","2020-02-26","2020-12-31","263042","- Odds of positive COVID PCR result in cancer vs non-cancer patients; - Risk of admission to ICU for COVID-positive cancer vs non-cancer patients (all-cause); - Risk of death for COVID-positive cancer vs non-cancer patients (all-cause)","","ICU admission; Mortality","no","""To assess the cancer history, the above data were linked with the regional cancer registry that records incident cancer cases since 1995 and was updated up to December 2017. The cancer registry data includes all malignant neoplasms (International Classification of Diseases 10th version, ICD-10, codes: C00-C96) and benign, in situ, and uncertain behavior neoplasms of bladder (ICD-10: D30.3, D09.0, D41.4). For the years 20182020, information on cancer history was obtained from hospital discharges and the pathological laboratory records. For patients with multiple cancers, the most recent cancer diagnosis was considered, before or up to 30 days from SARS-CoV-2 testing (i.e., concurrent diagnosis).""  NOTE: we are only including patients with cancer diagnosis in the last 13 months.","Controls recruited from the same data sources as cancer patients (microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system database; cancer registry; diabetes registry; and municipal registries).","No matching - but statistical analyses were done adjusted for sex and age group (<40, 40-59, 60-69, 70-79, >=80)",NA,"","","","","1452 (46.9)","3098","","","","","17876(46.7)","38268","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","650","21","3132","8.18","OR","2.98","2.71-3.27","","1405","45.4","7205","18.8","OR","3.58","3.32-3.86","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","425","13.7","1986","5.19","OR","2.9","2.60-3.25","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","""The hospital discharge database (updated on 31 December 2021) was used to assess admissions to ICUs"" - no further information given re defining ICU admission","""Time at risk of death was computed from the date of SARS-CoV-2 test up to the date of death, or 6 February 2021, whichever came first"". Positive PCR tests were identified between 26 February 2020 - 31 December 2020, so all patients were followed up for at least 37 days from date of positive COVID test.","","multivariate","Age; Sex",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","673","mHR","0.92","0.72-1.17","NR","0.104 (70/673)","0.0500 (1914/38268)","mHR","0.98","0.48-2.00","NR","0.0119 (8/673)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"407","mHR","1.34","1.10-1.65","NR","0.241 (98/407)","0.0500 (1914/38268)","mHR","1.4","0.86-2.27","NR","0.0418 (17/407)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"460","mHR","1.04","0.85-1.27","NR","0.235 (108/460)","0.0500 (1914/38268)","mHR","1.15","0.77-1.71","NR","0.0587 (27/460)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"2818","mHR","1.19","1.07-1.31","NR","0.172 (486/2818)","0.0500 (1914/38268)","mHR","1.04","0.82-1.32","NR","0.0291 (82/2818)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","280","mHR","1.79","1.36-2.34","NR","0.193 (54/280)","0.0500 (1914/38268)","mHR","1.5","0.83-2.73","NR","0.0393 (11/280)","0.013 (502/3826)","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"466","mHR","1.93","1.61-2.33","NR","0.255 (119/466)","0.0500 (1914/38268)","mHR","0.9","0.52-1.56","NR","0.0280 (13/466)","0.013 (502/3826)","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"69989","Costa 2021","Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data","Consensus","Peer-reviewed","Cancer","Influenza Epidemiological Surveillance Information System (Sistema de Informao de Vigilncia Epidemiolgica da Gripe [SIVEP-Gripe] in Portuguese) - publicly available online  - retrieved on 2021-01-17","03/08/2021","Higher Severity and Risk of In-Hospital Mortality for COVID-19 Patients With Cancer During the Year 2020 in Brazil: A Countrywide Analysis of Secondary Data","Guilherme Jorge Costa","Retrospective","Cohort","Yes","inpatient","Brazil","N/A","N/A","2020-03-01","2020-12-31","322816","ICU admission  need for respiratory support (noninvasive vs invasive)  time in ICU  in-ICU mortality hospital length of stay in-hospital mortality ","","Severity; Hospitalisation; ICU admission; Mortality","no","History of cancer ","Cancer:control matching = 7406 : 315410   Drawn from same population of hospitalized adult patients w COVID19 diagnosis in Brazil ","Cancer:control = 7406 : 315410   No factors used in matching",NA,"Mean; median","66; 67","SD of mean; range of median","16; NR","52.6","7406","Mean; median","61; 62","SD of mean; range of median","145; NR","56.3","315410","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","1561","33.1","85640","52.7","uOR","0.44","0.42-0.47","<0.001","2405","47.5","116738","67","uOR","0.45","0.42-0.47","<0.001","","","","","",NA,"",NA,"146","3.6","3015","2.3","uOR","1.59","1.340-1.88","<0.001","460","10.8","14456","10.8","uOR","1","0.906-1.10","0.458","521","12.3","13162","9.8","uOR","1.29","1.176-1.42","<0.001","1846","39.6","7723","5.9","uOR","10.46","9.818-11.14","<0.001",NA,NA,NA,NA,"",NA,"",NA,"Obesity 257; neurological disease 320; asthma 129","6.3; 7.6; 3.1","20735;14020; 8833","15.6;10.4; 6.7","uOR; uOR;uOR","0.36; 0.71; 0.45","0.32-0.41; 0.631-0.80; 0.373-0.53","<0.001; <0.001; <0.001","","","","",NA,"","","","need for respiratory support (noninvasive vs invasive)","% admitted to ICU","Hospital mortality","Degree of respiratory support required (none required, noninvasive, invasive) ","univariate; multivariate","Age; Comorbidities; Other: Males also adjusted fo",NA,"","mOR","2.9","NR","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","mOR","1.4","NR","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","mOR","2.9","NR","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","mOR","1.4","NR","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","mOR of bladder; mOR of prostate","1.8; 1.1","NR; NR","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","uOR both sexes; mOR both sexes","2.59;1.83","2.46-2.72;1.72-1.95","<0.01;<0.01","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","uOR both sexes; mOR both sexes","3.27;2.85","2.86-3.80; 2.41-3.38","<0.01;<0.01","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"7406; 7406","uOR both sexes; mOR both sexes","2.66;1.94","2.54-2.80;1.83-2.06","<0.01;<0.01","Total in-hospital: 0.605 (4479/7406); NA","Total in-hospital: 0.365 (115066/315410); NA ","","","","","0.427 (3159/7406)","0.360 (113481/315410)","cOR invasive ventilation; NR noninvasive ventilation","1.33; NR","1.25-1.40; NR","<0.001; NR","0.243 (1802/7406); 0.454 (3360/7406)","0.191 (60197/315410; 0.455 (143446/315410)","invasive resp support; Noninvasive resp support","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7406; 7406","uOR;mOR","2.66;1.94","2.54-2.80;1.83-2.06","<0.01;<0.01","0.605 (4479/7406);0.605 (4479/7406)","0.365 (115066/315410);0.365 (115066/315410)","",NA,"","","0.427 (3159/7406)","0.360 (113481/315410)","% requiring noninvasive; % requiring invasive ventilation","","","","0.454 (3360/7406);0.243 (1802/7406)","0.455 (143446/315410);0.191 (60197/315410)","Noninvasive resp support; invasive resp support","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"7406;7406","100;100","uOR;mOR","2.66;1.94","2.54-2.80;1.83-2.06","<0.01;<0.01","0.605 (4479/7406);0.605 (4479/7406)","0.365 (115066/315410);0.365 (115066/315410)","","","","","0.427 (3159/7406)","0.360 (113481/315410)","% of those requiring noninvasive ventilation; % of those requiring  invasive ventilation","","","","0.454 (3360/7406);0.243 (1802/7406)","0.455 (143446/315410);0.191 (60197/315410)","Noninvasive resp support; invasive resp support","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"69975","Sahin 2021","The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study","Consensus","Peer-reviewed","Clinical Endocrinology","Turkish Ministry of Health National Electronic Database","2021-04","The clinical outcomes of COVID- 19 infection in patients with a history of thyroid cancer: A nationwide study","Sahin M","Retrospective","Cohort","Yes","not specified","Turkey","N/A","Public hospitals University hospitals Private centres","2020-03-11","2020-05-30","776","The primary endpoint was all-cause mortality.","The secondary outcomes were the length of stay in the hospital and admitted to the intensive care unit (ICU) or mechanical ventilation need during hospitalization.","Hospitalisation; ICU admission; Mortality; Other: Intubation","no","Yes, they specifically looked at Thyroid cancer. ""Thyroid cancer was defined based on the International Classification of Disease (ICD-10) codes. Thyroid cancer patients were divided into two groups according to the administration of RAI therapy."" ","Yes, 1:1","The ratio of cancer:non-cancer is 1:1 ""Our study group (total n =776) included thyroid cancer patients (n=388) (C 73) diagnosed with COVID-19 infection and as a control group gender and age-matched patients with COVID-19 without a cancer diagnosis (n=388).""",NA,"Median","53","IQR","19","24","388","Median","53","IQR","19","24","388","Not mentioned",NA,"36","14.4","48","18.2","uOR","0.72","0.46 - 1.14","0.0166","246","63.4","203","52.3","uOR","1.58","1.18 - 2.10","0.00177","182","47.4","104","27.4","uOR","2.41","1.79 - 3.26","6.47 e-9","Heart Failure; CAD; PAD 21; 111; 15","5.4; 28.6; 3.9","21; 72; 11","5.4; 18.6; 2.8","uOR","1; 1.76; 1.38 ","0.54 - 1.86; 1.25 - 2.47; 0.62 - 3.04","1;  0.000974; 0.425","6","1.5","5","1.3","uOR","1.2","0.36 - 3.98","0.761","","","","","",NA,"","","15","9.9","18","11.9","uOR","0.83","0.41 - 1.66","0.594","Asthma/COPD: 133","34.3","116","29.9","uOR","1.22","0.90 - 1.65","0.191","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Dyslipidaemia; Obesity: 125; 24","32.2; 48.0","85; 16","21.9; 36.4","uOR","1.69; 1.53","1.23 - 2.34; 0.80 - 2.93","0.00123; 0.194","","","","",NA,"","","","Intubation","","Mortality was not explicitly defined, however, the primary endpoint was all cause mortality.  The median and range of the followup period for patients with thyroid cancer was calculated as 8 (149) days and for noncancer patients as 8 (137) days.","N/A","univariate; multivariate","Other: Multivariate analysis was only done for hospitalisation. The analysis adjusts for age, sex, pulmonary CT findings of COVID-19, hypertension, dyslipidemia, asthma/COPD, type 2 diabetes mellitus, cardiovascular disease (CVD), and thyroid cancer.",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"388","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ICU; ICU > 4 days  ","0.84; 1.31","0.50 - 1.41; 0.48 - 3.56","0.511; 0.599","0.139 (29/208); 0.552 (16/ 29)","0.119 (34/ 286); 0.485 (16/33)","uOR","1.07","0.52 - 2.19","0.855","0.0770 (16/208)","0.0524 (15/286)","","uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation","0.41; 0.62; 0.38","0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54","5.83e-9; 0.00203; <0.001","0.536 (208/388); 0.495 (103/ 208); NA  ","0.737 (286/388); 0.500 (143/286); NA",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"388","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ICU; ICU > 4 days  ","0.84; 1.31","0.50 - 1.41; 0.48 - 3.56","0.511; 0.599","0.139 (29/208); 0.552 (16/ 29)","0.119 (34/ 286); 0.485 (16/33)","uOR","1.07","0.52 - 2.19","0.855","0.0770 (16/208)","0.0524 (15/286)","","uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation","0.41; 0.62; 0.38","0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54","5.83e-9; 0.00203; <0.001","0.536 (208/388); 0.495 (103/ 208); NA","0.737 (286/388); 0.500 (143/286); NA","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"388","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ICU; ICU > 4 days ","0.84; 1.31","0.50 - 1.41; 0.48 - 3.56","0.511; 0.599","0.139 (29/208); 0.552 (16/ 29)","0.119 (34/ 286); 0.485 (16/33)","uOR","1.07","0.52 - 2.19","0.855","0.0770 (16/208)","0.0524 (15/286)","","uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation","0.41; 0.62; 0.38","0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54","5.83e-9; 0.00203; <0.001","0.536 (208/388); 0.495 (103/ 208); NA","0.737 (286/388); 0.500 (143/286); NA","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","776","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ","0.84","0.50 - 1.41","0.511","0.139 (29/208)","0.119 (34/286)","uOR","1.07","0.52 - 2.19","0.511","0.0770 (16/208)","0.0524 (15/286)","","uOR","0.41","0.30 - 0.56","5.83E-09","0.536 (208/388)","0.737 (286/388)",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","72","18.556","cOR","0.66","0.15-2.95","0.589","0.0278 (2/72) ","0.0412 (16/388)","cOR ICU; ICU> 4 days","1.00; 0.20 ","0.37 - 2.72; 0.02 - 2.05","0.998; 0.146","0.119 (5/42); 0.200 (1/5)","0.119 (34/286); 0.552 (16/29)","cOR","1.39 ","0.38 - 5.02","0.614","0.0714 (3/42)","0.0524 (15/286)","","cOR hospitalisation; hospitalisation > 8 days","0.50; 1.00","0.30 - 0.84; 0.52 -1.91","0.00807; 1.00","0.583 (42/72); 0.500 (21/42)","0.737 (286/388); 0.500 (143/286)","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"776","100","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR","0.84","0.50 - 1.41","0.511","0.139 (29/208)","0.119 (34/286)","uOR","1.07","0.52 - 2.19","0.511","0.0770 (16/208)","0.0524 (15/286)","","uOR","0.41","0.30 - 0.56","5.83E-09","0.536 (208/388)","0.737 (286/388)","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"68513","Udovica 2022","High mortality in patients with active malignancy and severe COVID-19: Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic","Consensus","Peer-reviewed","Magazine of European medical oncology ","","2022-05","High mortality in patients with active malignancy and severe COVID-19","Udovica S ","Retrospective","Cohort","Yes","inpatient","Austria ","Vienna ","245 consecutive patients admitted for severe COVID-19 at four different COVID-19 units in four different oncologic departments in Austria. Non-cancer control from  Department of Medicine I at the Clinic Ottakring in Vienna ","2020-03-01","2021-03-31","245","covid-19 specific in hospital mortality ","","Mortality","no","Pa- tients with active malignancy were defined through one of the following criteria: (1) diagnosis of any histologically proven malignant disease within the last 6 months (excluding basalioma), (2) receiving treatment for a malignant condition within the last 6 months, (3) metastatic or recurrent malignant disease.","Same country but different hospital   This was a 12-month retrospective analysis of 245 consecutive patients admitted for severe COVID-19 at four different COVID-19 units in four different oncologic departments in Austria. The noncancer control group consisted of patients admitted at the Department of Medicine I at the Clinic Ottakring in Vienna for severe COVID-19 but had no history of cancer within the last 5 years","Looking at the data they were roughly age and gender matched   cancer to non-cancer ratio = 89:156",NA,"median ","74","range ","51-95","50.6","89","median ","76","range ","26-97","54.6","156","Other: participants were not tested for strain but paper includes: "" Of note, our study was performed between March 2020 and March 2021. In that period the SARS-CoV-2 back- ground strain and the SARS-CoV-2 alpha variant were the most commonly observed variants and vaccines were not available.""",NA,"","","","","",NA,"","","","","","","",NA,"","","14","15.7","45","28.8","cOR","0.46","0.24-0.9","","47","52.8","71","45.5","cOR","1.34","0.79-2.26","","","","","","",NA,"",NA,"10","11.2","10","6.4","cOR","1.85","0.74-4.63","","10","11.2","16","10.3","cOR","1.11","0.48-2.56","","22","24.7","24","15.4","cOR","1.81","0.94-3.46","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"17; 27; 8","19.1; 19.1; 9.0","49; 37; 35","31.4; 23.7; 22.6","cOR","0.52; 0.76; 0.34","0.28-0.97; 0.40-1.45; 0.15-0.77","","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia",NA,"others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","I calculated crude OR and CI but have left p-values blank for James to calculate as discussed with him ","Severe COVID-19 was defined as COVID-19 associated with hypoxia necessitating conventional oxygen supplementation to keep blood oxygen satura- tion 94%. Critical disease was defined as requiring high-flow oxygen therapy (HFOT) with FiO2 levels of 0.6 or above or requiring treatment in an intensive care unit (ICU) for respiratory or multiorgan failure. HFOT was initiated as per local guidelines (requir- ing oxygen above 6 l/min). ","","OVID-19-spe- cific in-hospital mortality, defined as death during a COVID-19 infection requiring at least supplemental oxygen 6 l/min; or with signs of pulmonary mani- festations of COVID-19 on chest X-ray; or death in an ICU due to respiratory or multiorgan failure. Patients who died from other causes while having COVID-19, including those dying from progressive malignant disease, were excluded from the analysis of the primary endpoint.","The primary study endpoint was COVID-19-spe- cific in-hospital mortality, defined as death during a COVID-19 infection requiring at least supplemental oxygen 6 l/min; or with signs of pulmonary mani- festations of COVID-19 on chest X-ray; or death in an ICU due to respiratory or multiorgan failure.   Severe COVID-19 was defined as COVID-19 asso- ciated with hypoxia necessitating conventional oxy- gen supplementation to keep blood oxygen satura- tion 94%. Critical disease was defined as requiring high-flow oxygen therapy (HFOT) with FiO2 levels of 0.6 or above or requiring treatment in an intensive care unit (ICU) for respiratory or multiorgan failure. HFOT was initiated as per local guidelines (requir- ing oxygen above 6 l/min).","univariate; multivariate","Age; Comorbidities; Other: The multivari- able mortality model for COVID-19-associated mor- tality included age (categorical < 65 or 65 years), di- agnosis of active malignancy, comorbidities (chronic cardiovascular disease [CVD], chronic respiratory dis- ease, moderate or severe liver disease, severe chronic kidney disease (CKD), diabetes, dementia, neurologi- cal diseases, obesity) and ECOG performance status.",NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","15","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"8","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"54","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","35","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"89","uOR; mOR ","2.56; 4.59","1.47-4.47; 2.26-9.30","< 0.001; < 0.001","41/89; 41/89","43/156; 43/156","","","","0.59","0.18","0.147","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"45","50.1","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","5","5.6","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"13","14.6","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","5.6","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","4","4.5","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","9","10.1","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"245","100","","","","","","","","","","","","","","","","","","","","","","","","","","","Of note, our study was performed between March 2020 and March 2021. In that period the SARS-CoV-2 back- ground strain and the SARS-CoV-2 alpha variant were the most commonly observed variants and vaccines were not available","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"","245","100%",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"68304","Korkusuz 2022","Changing characteristics of cancer patients during the COVID-19 pandemic","Consensus","Peer-reviewed","The Journal of Infection in Developing Countries","Bakirkoy Dr. Sadi Konuk Training and Research  Hospital centre database","2021-14","Changing characteristics of cancer patients during the COVID-19 pandemic","Korkusuz RK","Retrospective","Cohort","Yes","not specified","Turkey","N/A","Bakirkoy Dr. Sadi Konuk Training and Research  Hospital Centre","2020-03-15","2021-02-01","1793","The aim of this retrospective study, conducted in the  largest pandemic centre in Istanbul, was to evaluate  how cancer patients were affected by COVID-19  infection in the second wave of the pandemic in Turkey  and to investigate the clinical course and factors  affecting mortality.","ICU Admission and hospital length of stay(days)","Hospitalisation; ICU admission; Mortality","no","Patients with an active diagnosis of cancer - inferred from the fact that all patients have at least Stage 1 cancer and not remission.","Same hospital ","1511 non cancer patients: 216 cancer patients from second wave on table 4 282 Patients in first wave but no malignancy vs non malignant comparison Age, Gender and Comorbidity match",NA,"Median","64","Range","18-97","64.35","216","Median","63","Range","21-103","58.17","1511","Not mentioned",NA,"","","","","",NA,"","","31 (first wave); 71 (second wave); 102 (total)","47 (first wave); 32.9 (second wave); 36.2 (total)","nr (first wave); 726 (second wave); 726 (total)","nr (first wave); 48.04 (second wave); 48.04 (total)","",NA,"","","24 (first wave); 57 (second wave); 81 (total)","36.4 (first wave); 26.4 (second wave); 28.7 (total)","nr (first wave); 503 (second wave); 503 (total)","nr (first wave); 33.28 (second wave); 33.28 (total)","",NA,"","","2 (first wave); 15 (second wave); 17 (total)","3 (first wave); 6.9 (second wave); 6.03 (total)","nr; (first wave) 217 (second wave); 217 (total)","nr (first wave); 14.36 (second wave); 14.36 (total)","","","","","5 (first wave); 9 (second wave); 14 (total)","7.6 (first wave); 4.2 (second wave); 4.96 (total)","nr (first wave); 53 (second wave); 53 (total)","nr (first wave); 3.5 (second wave); 3.5 (total)","",NA,"",NA,"","","","","",NA,"","","7 (first wave); 11 (second wave); 18 (total)","10.6 (first wave); 5.1 (second wave); 6.38 (total)","nr (first wave); 67 (second wave); 67 (total) ","nr (first wave); 4.43 (second wave); 4.43 (total)","",NA,"","","17 (first wave); 34 (second wave); 51 (total)","25.8 (first wave); 15.7 (second wave); 18.1 (total)","nr (first wave); 62 (second wave); 62 (total)","nr (first wave); 4.1 (second wave); 4.1 (total)","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Severity of pneumonia as seen on CT - the cases were divided into 3 groups as  mild involvement (<25% involvement), moderate  involvement  (2674%  involvement)  and  severe  involvement (>75% involvement)","Admission to ICU","No clear definition of mortality","Severity of pneumonia as seen on CT - the cases were divided into 3 groups as  mild involvement (<25% involvement), moderate  involvement  (2674%  involvement)  and  severe  involvement (>75% involvement)   The defintion of severe involvement is given above.","univariate; multivariate","Age; Sex; Comorbidities",NA,"7 (first wave); 41 (second wave); 48 (total)","","","","","NR (first wave); NR (second wave); 0.375 (18/48) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","",NA,"",NA,"","","","","","","","","","","11 (first wave); 21 (second wave); 32 (total)","","","","","nr (first wave); nr (second wave); 0.219 (7/32) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","",NA,"",NA,"","","","","","","","","","","19 (first wave); 58 (second wave); 77 (total)","","","","","NR (first wave); NR (second wave); 0.338 (26/77) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"12 (first wave); 31 (second wave); 43 (total)","","","","","NR (first wave); NR (second wave); 12/43 (0.279) (total)","nr (first wave); 0.0876  (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"57 (first wave); 182 (second wave); 239 (total)","","","","","NR (first wave); NR (second wave); 0.318 (76/239) (total)","nr (first wave); 0.0876  (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","",NA,"",NA,"","","","","","","","","","","9 (first wave); 34 (second wave); 43 (total)","","","","","nr (first wave); nr (second wave); 0.535 (23/43 ) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"66 (first wave); 216 (second wave); 282 (total)","","","","","0.227 (15/66) (first wave); 0.389 (84/216) (second wave); 0.351 (99/282) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","0.242 (16/66) (first wave); 0.361 (78/261) (second wave); 0.333 (94/282) (total)","nr (first wave); 0.108 (164/1511) (second wave); 0.108 (164/1511) (total)","","","","","0.159 (10/66) (first wave); 0.243 (51/216) (second wave); 0.216 (61/282) (total)","nr (first wave); 0.300 (455/1511) (second wave); 0.300 (455/1511) (total)","","","","","","","","",NA,"51 (first wave); 104 (second wave); 155 (total)","","","","","nr (first wave); nr (second wave); 0.245 (38/155) (total)","nr (first wave); 0.0876 (133/1511) (second wave) ; 0.0876 (133/1511) (total) ","","","","","","",NA,NA,NA,NA,"",NA,"first wave; second wave; combined total","","","","","",NA,NA,"15 (first wave); 112 (second wave); 127 (total)","","","","","nr (first wave); nr (second wave); 0.480 (61/127) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","",NA,"",NA,"","","first wave; second wave; combined total","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"22 (first wave); 97 (second wave); 119 (total)","33.3 (first wave); 44.9 (second wave); 42.2 (total)","","","","","nr (first wave); nr (second wave); 0.445 (53/119) (total)","nr (first wave); 0.0876 (133/1511) (second wave); 0.0876 (133/1511) (total)","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"68083","Kim 2022","Characterizing cancer and COVID-19 outcomes using electronic health records","Consensus","Peer-reviewed","PLOS One","Optum de-identified COVID-19 Electronic Health Record (EHR) Optum1s longitudinal EHR repository is derived from more than 700 hospitals and 7000 clinics in the United States","2022-05","Characterizing cancer and COVID-19 outcomes using electronic health records","Kim, YK ","Prospective","Cohort ","Yes","not specified","United States","N/A","N/A","2020-06-01","2020-12-31","271,639","Our primary objective was to determine the effect of cancer on the outcomes of COVID-19, specifically hospitalization, intensive care unit (ICU) admission, ventilator use, and all-cause deaths occurring within 30 days of COVID-19 infection, by comparing these outcomes between COVID-19 patients with and without a cancer diagnosis. ","The secondary objective was to identify factors associated with mortality in COVID-19 patients with recent cancer treatment. Potential predictors included chemotherapy and radiation therapy within 3 months before the COVID-19, age, sex (not included for breast, endometrial, and prostate cancers), race/ethnicity, insurance type, regions, and comorbidity conditions such as chronic conditions identified and known risk factors ","Severity; Hospitalisation; ICU admission; Mortality","no","Included patients with cancer diagnosis over 1 year, however in the baseline characteristics table, they included individual characteristics for the recent cancer group which was input into the DE table.","Yes 253,179 pts Non cancer: 18,460 cancer with 10,246 patients with a diagnosis of cancer within 1 year","253,179 pts Non cancer: 18,460 cancer with 10,426 patients with a diagnosis of cancer within 1 year Age, gender and comorbidity matched",NA,"median","66","IQR","57-76","47.3","10426","median","46","IQR","32-60","42.7","253179","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","3648","35","42542","16.8","",NA,"","","5183","49.7","49725","19.6","","","","","1986","19","15599","6.2","",NA,"",NA,"2338","22.4","18270","7.2","",NA,"","","2675","25.7","18145","7.2","",NA,"","","4402","42.2","62429","24.7","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Peripheral Vascular Disease: 2574","Peripheral Vascular Disease: 24.7","Peripheral Vascular Disease: 14708","Peripheral Vascular Disease: 5.8","","","","","","","","",NA,"","","","Not given but outcomes also include ventilator use which is listed as severe outcome","Admitted to ICU is given as an outcome","30-day all cause mortality","Mortality/Hospitalization/ICU/Ventilator given  Will put ventilator use under the severe disease column 30 day all cause mortality given in mortality column","univariate; multivariate","Age; Sex; Comorbidities",NA,"887","mRR","1.85","1.582.17","<0.001","NR","0.019 (4854/253179)","mRR","1.35","1.121.63","0.002","NR","0.025 (6449/253179)","mRR","1.21","0.891.63","0.22","NR","0.011 (2855/253179)","","mRR","1.31","1.19-1.44","<0.001","NR","0.099 (25092/253179)","","2143","mRR","1.08","0.881.32","0.47","NR","0.019 (4854/253179)","mRR","0.92","0.741.13","0.409  ","NR","0.025 (6449/253179)","mRR","1.06","0.781.45","0.7","NR","0.011 (2855/253179)","","mRR","0.99   ","0.901.09","0.876","NR","0.099 (25092/253179)","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"794","mRR","0.91","0.691.19","0.50  ","NR","0.019 (4854/253179)","mRR","0.81","0.611.07","0.14","NR","0.025 (6449/253179)","mRR","0.9","0.611.35","0.62","NR","0.011 (2855/253179)","","mRR","1.05","0.931.20","0.42","NR","0.099 (25092/253179)","","207 (liver); 121 (pancreas)","mRR (liver); mRR (pancreas)","2.46 (liver); 1.94 (pancreas)","1.803.36 (liver); 1.193.16 (pancreas)","<0.001 (liver); 0.008 (pancreas)","NR (liver); NR (pancreas)","0.019 (4854/253179) (liver); 0.019 (4854/253179) (pancreas)","mRR (liver); mRR (pancreas)","0.96 (liver);0.72 (pancreas)","0.621.49 (liver); 0.351.46 (pancreas)","0.85 (liver); 0.363 (pancreas) ","NR (liver); NR (pancreas)","0.025 (6449/253179) (liver); 0.025 (6449 /253179) (pancreas)","mRR (liver); mRR (pancreas)","1.14 (liver); 0.84 (pancreas)","0.632.05 (liver); 0.332.12 (pancreas)","0.67 (liver); 0.71 (pancreas)","NR (liver); NR (pancreas)","0.011 (2855/253179) (liver); 0.011 (2855/253179) (pancreas)","","mRR (liver); mRR (pancreas)","1.23 (liver); 0.98 (pancreas)","1.001.51 (liver); 0.711.35 (pancreas)","0.05 (liver); 0.91  (pancreas)","NR (liver); NR (pancreas)","0.099 (25092/253179) (liver); 0.099 (25092/253179) (pancreas)",NA,"474","mRR","1.15","0.861.53","0.34","NR","0.019 (4854/253179)","mRR","0.8","0.571.13","0.202","NR","0.025 (6449/253179)","mRR","0.79","0.491.30","0.36","NR","0.011 (2855/253179)","","mRR","1.06","0.911.22","0.46","NR","0.099 (25092/253179)",NA,"1781 ","mRR","0.82","0.700.96","0.015","NR","0.019 (4854/253179)","mRR","0.81","0.680.96","0.017","NR","0.025 (6449/253179)","mRR","0.78","0.601.01","0.055","NR","0.011 (2855/253179)","","mRR","0.95","0.881.02 ","0.177","NR","0.099 (25092/253179)","","291","mRR","1.62","0.962.74","0.07","NR","0.019 (4854/253179)","mRR","1.58","1.032.41","0.04","NR","0.025 (6449/253179)","mRR","1.53","0.812.90","0.19","NR","0.011 (2855/253179)","","mRR","1.15  ","0.901.46","0.27","NR","0.099 (25092/253179)",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"476","mRR","0.83","0.461.51","0.55  ","NR","0.019 (4854/253179)","mRR","0.58","0.301.11","0.10  ","NR","0.025 (6449/253179)","mRR","0.38","0.121.19","0.1","NR","0.011 (2855/253179)","","mRR","0.76","0.590.9","0.035","NR","0.099 (25092/253179)",NA,"409","mRR","0.96","0.671.38","0.82","NR","0.019 (4854/253179)","mRR","0.89","0.571.38","0.61","NR","0.025 (6449/253179)","mRR","0.58","0.271.27","0.177","NR","0.011 (2855/253179)",NA,"mRR","0.86  ","0.691.06","0.163","NR","0.099 (25092/253179)","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"8952","mRR","1.12  ","1.041.22","0.004","NR","0.019 (4854/253179)","mRR","0.97","0.891.06","0.52","NR","0.025 (6449/253179)","mRR","0.95","0.841.08","0.453","NR","0.011 (2855/253179)","","mRR","1.05","1.001.09","0.03","NR","0.099 (25092/253179)","","2224","mRR","1.48"," 1.301.68","<0.001 ","NR","0.019 (4854/253179)","mRR","1.27","1.101.46","0.001","NR","0.025 (6449/253179)","mRR","1.41","1.161.72","0.001","NR","0.011 (2855/253179)","","mRR","1.31","1.221.40"," <0.001 ","NR","0.099 (25092/253179)","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"10426","mRR","1.17","1.08-1.25","<0.001","0.075 (781/10426)","0.019 (4854/253179)","mRR","1.02","0.95-1.11","0.54","0.065 (674/10426)","0.025 (6449/253179)","mRR","1.05","0.93-1.17","0.45","0.032 (332/10426)","0.011 (2855/253179)","","mRR","1.1","1.06-1.14","<0.001","0.24 (2476/10426)","0.099 (25092/253179)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"1580","mRR","2.09","1.822.39","<0.001","NR","0.019 (4854/253179)","mRR","1.33","1.131.56","0.001","NR","0.025 (6449/253179)","mRR","1.32","1.04-1.68","0.021","NR","0.011 (2855/253179)","","mRR","1.26   ","1.161.37","<0.001 ","0.24 (2476/10426)","0.099 (25092/253179)","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"NR","NR","uRR; mRR","1.31; 1.37 ","1.08-1.60; 1.121.69 ","0.006; 0.003","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","NR","NR","uRR; mRR","1.89; 1.83  ","1.44-2.49; 1.372.46","<0.001; <0.001","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"67898","Plais 2022","Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study","Consensus","Peer-reviewed","Frontiers in Oncology ","","2022-03"," Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study","Plais H","Prospective","Cohort","Yes","inpatient","France","17 French ICUs","17 French ICUs","2020-03-12","2021-03-08","409","Mortality at day 60 after ICU admission ","","Mortality","no","Cancer for which treatment (chemo, targeted therapy, immunotherapy, radiotherapy or surgery) within 6 months or with active surveillance within 6 months of ICU admission or haematological cancer that is not in complete remission","Adult patients admitted to participating ICUs without active canceras per above definition. Same cohort/hospitals/country. ","1:3 cancer:non cancer, propensity score matched based on probability of cancer at admission (based on sex, age, BMI, diabetes, chronic respiratory disease, congestive heart failure, organ transplant,immunosuppressive therapy, HIV, antimicrobial treatment, hospitalisation within the last 3 months, SAPS II and SOFA scores, and PaO2 at baseline)",NA,"Mean","69","NR","65-73","68.6","105","Mean","67","NR","59-75","69.4","315","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","24","22.9","107","34","",NA,"","","10","9.5","29","9.2","","","","","","","","","",NA,"",NA,"1","1","8","2.5","",NA,"","","12","11.4","32","10.2","",NA,"","","8","7.6","12","3.8","","","","","26","24.8","17","5.4","","","","",NA,NA,NA,NA,"",NA,"",NA,"3 (HIV); 1 (solid organ transplantation)","2.9 (HIV); 1 (solid organ transplantation)","6 (HIV); 11 (solid organ transplantation)","1.9 (HIV); 3.5 (solid organ transplantation)","","","","","","","","",NA,"","","","","","likelihood of mortality at day 60 after ICU admission ","","univariate; multivariate","Age; Other: Cancer type, norepinephrine use, antimicrobial treatment, treatment with hydroxychloroquine and azithromycin, age at admission, period of admittance based on definition 1st and 2nd waves of SARS-Cov-2 in France",NA,"12","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","Includes hepatobiliary cancers","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","Grouped with upper GI ","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"2","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"54","uOR; mOR","1.88; 2.344","0.82-4.27; 0.87-6.31","0.13; 0.0262","NR; NR","0.274 (86/315); 0.274 (86/315)","","","","","","","",NA,"",NA,"","","","","","","","","","","51","uOR; mOR","3.19; 4.144","1.38-7.37; 1.24-13.83","0.0065; 0.0262","NR; NR","0.274 (86/315); 0.274 (86/315)","","","","","","","","","","","","","","","","","","","","","Endocrine: 2 ","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"105","uOR","2.3","1.24-4.28","0.0082","0.562 (59/105)","0.274 (86/315)","","","","","","","","","","","","","","","","","","","","",NA,"31","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"23","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"420","100","uOR","2.3","1.24-4.28","0.0082","0.562 (59/105)","0.274 (86/315)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"67144","Alpert 2021","Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study","Consensus","Peer-reviewed","JNCI Cancer Spectrum","We used anonymous data from the Mount Sinai Health System (MSHS) COVID-19 registry, which includes all patients with an encounter at a MSHS facility who were diagnosed with, under investigation, or screened for COVID-19","2020-11","Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study","Alpert N","Retrospective","Cohort ","Yes","inpatient and outpatient (no breakdown)","USA ","New York ","Mount Sinai Hospital ","2020-03-01","2020-05-27","5556","sepsis, venous thromboembolism, acute kidney injury, intensive care unit admission, all-cause mortality.","","ICU admission; Mortality; Other: VTE, AKI","no"," Patients were identified as having cancer if they had any International Classification of Diseases (ICD)-10-CM code starting with C that was listed as active in their medical record. This included patients with a newly diagnosed cancer or those on an active course of treatment, but not those with a history of cancer. Leukemia, lymphoma, and myeloma were classified as nonsolid tumors","matched for gender, age, comorbidity  cancer: non-cancer = 421:5135","1:13  gender, age, comorbidity matched multivariate and propensity matched ",NA,"Mean","69.2","SE","0.7","59.4","421","Mean ","63.8","SE","0.2","56.6","5135","Not mentioned",NA,"","","","","",NA,"","","223","53","1677","32.7","cOR","2.32","1.9-2.84","","139","33","1138","22.2","cOR","1.73","1.4-2.14","","177","42","1300","25.3","cOR","2.14","1.75-2.62","","","","","","",NA,"",NA,"26","6.2","107","2.1","cOR","3.09","1.99-4.81","","70","16.6","566","11","cOR","1.61","1.23-2.11","","64","15.2","427","8.3","cOR","1.98","1.49-2.63","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"43","10.2","388","7.6","cOR","1.39","1.00-1.94","","Chronic lung disease = COPD + Asthma  CVD = HF + AF + coronary artery disease   Others = Obesity","Others = Obesity","Others = Obesity","Others = Obesity",NA,"Others = Obesity","Others = Obesity ","Chronic lung disease = COPD + Asthma  CVD = HF + AF + coronary artery disease   Others = Obesity  I calculated crude OR and CI and have left p-values for James as discussed ","paper did not define severity but included data for sepsis, which I have included under severe = Defined as more than 1 of the following: temperature greater than 100.4F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","ICU defined as intensive care unit, no other info given ","no definition of mortality or number of days, but is stated as 'all cause'","paper did not define severity but included data for sepsis, which I have included under severe = Defined as more than 1 of the following: temperature greater than 100.4F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","multivariate; Other: Multivariable analyses were adjusted for age, sex, and number of additional comorbidities and stratified into solid and non- solid cancers. ","Age; Sex; Comorbidities",NA,"19","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","46","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"32","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","32","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"13","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"81","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","20","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"15","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"273","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","96","","","","","","","","","","","","","","","","","","","","","","","","","","","26","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","26","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"421","mOR","1.02","0.81-1.29","0.86","129/421","1272/5135","mOR","1.04","0.80-1.34","1","82/421","913/5135","mOR ","1.31","1.06-1.61","0.05","253/421","2821/5135","the paper did not specify severity, but specified sepsis which I have included in the severity column   unspecified = multiple sites ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","421","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"5556","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"","5556","",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"67122","Rugge 2022","Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy","Consensus","Peer-reviewed","Tumori Journal","Regional Population-Based Cancer Registries","2021-12","Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy","Rugge M","Retrospective","cohort","Yes","inpatient and outpatient (with breakdown)","Italy","Veneto and Friuli Venezia Giulia","","2020-02-22","2020-07-31","22564","patients hospitalization (whatever the clinical setting, other than the intensive care unit [ICU]) and admission to an ICU","Vital status (mortality)","Hospitalisation; ICU admission; Mortality","no","Cancer diagnosed 12 months before testing COV2+ve* and Cancer diagnosed >12 months before testing COV2+ve","the resident population of the Veneto and Friuli Venezia Giulia regions (in northeastern Italy) who tested +ve for SARS-CoV-2 without a history of cancer","None",NA,"Median","73","IQR","62-82.25","53.4","324","Median","51","IQR","36-66","40.1","20777","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","","","","","univariate; multivariate","Age; Sex; Comorbidities",NA,"23 (lung)","uOR","7.19","3.15-16.42","3.99E-06","0.435 (10/23)","0.097 (2008/20777)","uOR","1.24","0.17-9.22","0.845","0.001 (1/23)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","9.18","3.31-25.50","2.66E-05","0.737 (14/19)","0.234 (4685/20047)","Lung","34","uOR","1.61","0.62-4.17","0.333","0.147 (5/34)","0.097 (2008/20777)","","","","","0.000 (0/34)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","1.82","0.84-3.95","0.131","0.357 (10/28)","0.234 (4685/20047)","Breast","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"34 (colorectal)","uOR","5.1","2.52-10.32","8.00E-06","0.353 (12/34)","0.097 (2008/20777)","uOR","4.71","1.82-12.20","0.0015","0.147 (5/34)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","3.53","1.66-7.52","0.0011","0.519 (14/27)","0.234 (4685/20047)","Colorectal","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"63 (prostate, urology)","uOR","3.74","2.16-6.47","3.48E-06","0.286 (18/63)","0.097 (2008/20777)","uOR","1.85","0.67-5.11","0.24","0.063 (4/63)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","3.17","1.90-5.29","1.29E-05","0.492 (29/59)","0.234 (4685/20047)","Urinary Bladder+Prostate","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","41","uOR","8.07","4.36-14.94","9.32E-11","0.463 (19/41)","0.097 (2008/20777)","uOR","1.4","0.34-5.81","0.659","0.049 (2/41)","0.035 (734/20777)","","","","","","","","uOR","8.53","4.11-17.69","1.79E-08","0.722 (26/36)","0.234 (4685/20047)","","129","uOR","4.35","3.00-6.33","7.19E-14","0.318 (41/129)","0.097 (2008/20777)","uOR","1.33","0.59-3.03","0.508","0.047 (6/129)","0.035 (734/20777)","",NA,"",NA,NA,NA,"","uOR","3.92","2.65-5.81","3.30E-11","0.545 (55/101)","0.234 (4685/20047)","Others","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"324","uOR;mOR","4.48;3.013","3.535-5.681;2.290-3.949","<0.001; NR","0.324 (105/324); 0.324 (105/324)","0.097 (2008/20777); 0.097 (2008/20777)","uOR;mOR","1.61;1.049","0.993-2.599;0.621-1.664","0.053; NR","0.056 (18/324); 0.056 (18/324)","0.035 (734/20777); 0.035 (734/20777)","","","","","","","","uOR;mOR","4.22;2.883","3.30-5.40;2.215-3.762","<0.001; NR","0.562 (198/263); 0.562 (198/263)","0.234 (4685/20047); 0.234 (4685/20047)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"66861","Chavez-MacGregor 2022","Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients with or Without Cancer","Consensus","Peer-reviewed","JAMA Oncology","Optum de-identified COVID-19 electronic health record data set, which contains data from more than 700 hospitals and 7000 clinics across the US.","2022-01","Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer","Chavez-MacGregor M","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","United States","N/A","N/A - but included >700 hospitals in the US","2020-01-01","2021-01-28","507307","30-day Mortality, 30-day Mechanical ventilation, 30-day ICU stay, 30-day Hospitalisation","","Severity; Hospitalisation; ICU admission; Mortality","no","Used the following ICD criteria from electronic health records:  ICD-9: 140-165, 170-176, 179-209, 239  ICD-10: C00-C26, C30-C41, C43, C45-C58, C60-C80, C7A, C7B, C81-C96, D37-D47.   Cancer group was split into: (a) patients receiving treatment (radiotherapy or systemic therapy) <3 months before COVID diagnosis, and (b) patients not receiving recent treatment.  Both groups are included in our review given that all cancer patients had to have at least two ICD codes for cancer within 1 year before COVID diagnosis.","Controls drawn from the same data source (Optum COVID-19 electronic health record data set) - so from the same >700 hospitals and the same >7000 clinics across the US.","Did not match controls for all study analyses. However, they do report in Supplemental Table 6 outcomes of matched analysis. For this analysis, they matched in 1:5 ratio by age, sex and comorbidity.",NA,"Median","With recent cancer treatment: 66; Without recent cancer treatment: 68","IQR","With recent cancer treatment: 57-75; Without recent cancer treatment: 59-77","47.9","14287","Median","48","IQR","32-61","44.5","493020","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"1547 (Severe obesity (BMI 40))","10.8 (Severe obesity (BMI 40))","50115 (Severe obesity (BMI 40))","10.2 (Severe obesity (BMI 40))","uOR (Severe obesity (BMI 40))","1.07 (Severe obesity (BMI 40))","1.02-1.13 (Severe obesity (BMI 40))","","","","","",NA,"","","","Mechanical ventilation","ICU admission within 30-days of positive COVID test. Identified from the following electronic health record codes: 0200 - General classification ICU, 0201 - Surgical ICU, 0202 - Medical ICU, 0203 - Pediatric ICU, 0204 - Psychiatric ICU, 0206 - Intermediate ICU, 0207 - Burn care, 0208 - Trauma care, 0209 - Other intensive care, 0210 - General classification cardiac care unit (CCU), 0211 - Myocardial infarction care, 0212 - Pulmonary care, 0213 - Heart transplant, 0214 - Intermediate CCU, 0219 - Other coronary care.","30-day mortality.","30-day Mechanical ventilation. Identified using electronic health record codes.","multivariate","Age; Sex; Comorbidities; Other: race, diagnosis period, skilled nurse facility, insurance, geographical region",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"14287","aOR (No recent treatment);aOR (recent treatment)","0.93 (No recent treatment);1.74 (Recent treatment)","0.84-1.02 (No recent treatment);1.54-1.96 (Recent treatment)","0.12 (No recent treatment);<0.001 (Recent treatment)","0.049 (No recent treatment);0.087 (Recent treatment)","0.016 (7888/493020);0.016 (7888/493020)","aOR (No recent treatment);aOR (recent treatment)","0.98 (No recent treatment);1.69 (Recent treatment)","0.91-1.06 (No recent treatment);1.54-1.87 (Recent treatment)","0.61 (No recent treatment);<0.001 (Recent treatment)","0.075 (749/9991) (No recent treatment);0.137 (589/4296) (Recent treatment)","0.033 (16270/493020);0.033 (16270/493020)","aOR (No recent treatment);aOR (recent treatment)","0.61 (No recent treatment);1.00 (recent treatment)","0.54-0.68 (No recent treatment);0.88-1.13 (recent treatment)","<0.001 (No recent treatment);0.94 (recent treatment)","0.038 (380/9991) (No recent treatment); 0.073 (314/4296) (recent treatment)","0.022 (10846/493020);0.022 (10846/493020)","No recent treatment;Recent treatment","aOR (No recent treatment);aOR (recent treatment)","0.79;1.19","0.75-0.83;1.11-1.27","<0.001;<0.001","0.251 (2508/9991);0.357 (1534/4296)","0.146 (71981/493020);0.016 (7888/493020)","No recent treatment;recent treatment",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"Chemotherapy: 1634; Chemo-immunotherapy: 195","Chemotherapy: 11.4;  Chemo-immunotherapy: 1.4","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","Targeted therapy or endocrine therapy: 1068","Targeted therapy or endocrine therapy: 7.5","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"Targeted therapy or endocrine therapy: 1068","Targeted therapy or endocrine therapy: 7.5","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","592","4.1","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","806","5.6","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"66531","Chai 2021","One-year mortality and consequences of COVID-19 in cancer patients: A cohort study","Consensus","Peer-reviewed","IUBMB Life","","2021-07","One-year mortality and consequences of COVID-19 in cancer patients: A cohort study","Chai C","Prospective","cohort","Yes","inpatient","China","Wuhan, Hubei Province","Union Hospital, Affiliated Dongfeng Hospital, The Central Hospital of Wuhan","2020-01-01","2020-03-18","1162","1-year all-cause mortality rate and sequelae","hospital mortality rate, the length of hospital stay, and the 12-month all-cause post-discharge mortality rate","Severity; Mortality","no","""hospitalized patients with active cancer"" ""Primary tumor sub-types were classified by the WHO Classification of Tumors series""","age and sex, 1:3","age and sex matched",NA,"Median","65","IQR","59-70","49","166","Median","65","IQR","59-70","49","498","Not mentioned",NA,"8","5","14","3","",NA,"","","55","33","171","34","",NA,"","","24","15","104","21","",NA,"","","12","7","40","8","","","","","4","2","18","4","",NA,"",NA,"5","3","7","1","",NA,"","","3","2","11","2","",NA,"","","11","7","25","5","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Hyperlipidemia 33","20","76","15","","","","","Hyperuricemia 16","10","42","8",NA,"","","","COVID-19 disease severity was defined according to World Health Organization (WHO) guidelines","Not gi","1-year all-cause mortality rate ","","Other: needs recalculation - not accounting for comparison and 1-year (meaning not covid-19 deaths as well)","",NA,"25","uOR (lung)","2.07","0.68-6.31","0.205","0.16 (4/25)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","","","","","","","","","19","uOR","1.28","0.28-5.72","0.764","0.105 (2/19)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","","","","","","","","","10","uOR (gastric)","10.86","3.02-39.02","0.0003","0.500 (5/10)","0.084 (42/498)","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"23","uOR (colon, rectal)","3.02","1.07-8.53","0.038","0.217 (5/23)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","","","","","","","","","9","uOR (liver, pancreas)","3.1","0.62-15.41","0.1693","0.222 (2/9)","0.084 (42/498)","","","","","","","","","","","","","","","","","","","",NA,"5","uOR","2.71","0.30-24.84","0.3867","0.200 (1/5)","0.084 (42/498)","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"17","uOR (prostate, bladder, penile, testicular)","1.45","0.32-6.55","0.6467","0.118 (2/17)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","","","","","","","","","16","uOR (cervical, ovary, endometrial)","0.72","0.09-5.62","1.1958","0.063 (1/16)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","uOR (brain)","10.86","0.67-176.73","0.095","0.500 (1/2)","0.084 (42/498)","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"4","uOR (nasopharyngeal)","10.86","1.49-79.05","0.0189","0.500 (2/4)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","nasopharyngeal","","","","","","",NA,"1","","","","","1.000 (1/1)","0.084 (42/498)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","4","","","","","0.000 (0/4)","0.084 (42/498)","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"149","uOR","2.3","1.35-3.89","0.0022","0.174 (26/149)","0.084 (42/498)","","","","","","","",NA,"",NA,"","","","","","","","","","","17","uOR","9.65","3.54-26.32","<0.001","0.471 (8/17)","0.084 (42/498)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"166","uOR","2.8","1.71-4.57","<0.0001","0.204 (34/166)","0.084 (42/498)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"66333","Al 2021","COVID-19 amongst cancer patients: An experience from Oman","Consensus","Peer-reviewed","Journal of the Pakistan Medical Association","For Cancer: Cancer Registry of The Directorate-General of Non-Communicable Diseases, Ministry of Health, Oman. For COVID-19: Coronavirus Registry of Oman.","2021-10","COVID-19 amongst cancer patients: an experience from Oman","Al Bahrani BJ","Prospective","Cohort","Yes","inpatient","Oman","Muscat (and linked tertiary hospitals in Oman)","Royal Hospital, Muscat and its linked tertiary hospitals.","2020-03-24","2020-10-23","522","ICU, Mortality, Hospitalisation*","Septicaemia, intubation (only in controls), WBC, CRP, Renal impairment, Ferritin, Hypocalcaemia, Transaminase, LDH, Troponin, D Dimer, ","Hospitalisation; ICU admission; Mortality","no","All patients with a cancer diagnostic code listed in the registry of the Directorate-General of Non-Communicable Diseases","All tertiary centre inpatients with a positive covid-19 test whom are not on the cancer registry across the whole of Oman.","Significant different between two cohorts in terms of age, gender, ethnicity, T2DM, HTN. Controlled in terms of respiratory disease (6/77: 49/445, p=.4)",NA,"","","","","46.8","77","","","","","","445","Not mentioned",NA,"","","","","",NA,"","","20","26","207","46.5","uOR","0.4","0.23-0.69","7.90E-04","15","19.5","204","45.8","uOR","0.29","0.16-0.52","1.50E-05","9","11.7","82","18.4","uOR","0.59","0.28-1.22","0.15","","","","","",NA,"",NA,"6","7.8","36","8.1","uOR","0.96","0.39-2.36","0.93","15","19.5","407","91.5","uOR","0.02","0.01-0.04","1.00E-49","6","7.8","49","11","uOR","0.68","0.28-1.65","0.4","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Not assessed","Actual ICU admission (not just IMV)","Mortality before study end date","Not assessed","univariate","",NA,"6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","16","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"3","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","6","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"70","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","","","","","","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","3","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"77","uOR","2.89","1.70-4.93","0.0000564","0.351","0.157","uOR","0.03","0.02-0.06","5.00E-40","0.195","0.877","","","","","","","","","","","","","","",NA,"27","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"50","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"26","33.8","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","8","10.4","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"14","18.2","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","6.5","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","3","3.9","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"522","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"66084","Zhou 2021","Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study","Consensus","Peer-reviewed","BMC Infectious Diseases","","2021-08","Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study","Zhou Y","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Taikang Hospital Other temporary hospitals of Wuhan","2020-02-10","2020-04-15","309","Clinical features of COVID-19 patients with cancer and identify death outcome related risk factors","","Severity; Mortality","no","no info on how long had cancer for","Age, gender, and comorbidities matched Cancer:control = 1:2","Cancer to non-cancer: 1:2 Age, gender, and comorbidity matched",NA,"median","66","IQR","24-90","54.4","56","median","66","IQR","20-95","55.8","115","Not mentioned",NA,"","","","","",NA,"","","37","35.9","59","28.6","",NA,"","0.195","14","13.6","23","11.1","",NA,"","0.579","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Heart disease: 11","Heart disease: 10.7","30 (Heart disease)","14.5 (Heart disease)","","","","0.379 (Heart disease)","","","","",NA,"","","","Respiratory rate >30 breaths per minute O2 saturation <93% at rest Oxygenation index is <300mmHg","","no stated","Respiratory rate >30 breaths per minute O2 saturation <93% at rest Oxygenation index is <300mmHg","","",NA,"17 (lung)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","23","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","15","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"4 (colorectal)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"1","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"13 (bladder+prostate)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8 (ovarian+cervical+endometrial)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"103","uOR","2.89","1.17-7.09","0.0211","0.117 (12/103)","0.044 (9/206)","","","","","","","uOR","1.19","0.72-1.97","0.505","0.350 (36/103)","0.311 (64/206)","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"65975","Cai 2021","Immunological alternation in COVID-19 patients with cancer and its implications on mortality","Consensus","Peer-reviewed","OncoImmunology","Health records in two branches of Tongji Hospital","04/01/2021","Immunological alternation in COVID-19 patients with cancer and its implications on mortality","Cai, Guangyao","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Tongji hospital (Optical Valley Branch and Sino-French New City Branch)","2020-02-04","2020-03-31","2425 admitted patients 2052 after loss to follow up (subsequent percentages are of this cohort)","Death  Time from illness onset to death/discharge Survival time: time from COVID onset to death or discharge","Severity of COVID-19  Fever - axillary temp at least 37.3C ","Severity; Mortality","no","No definition, just those with or without cancer   Subgroup analyses with recent anti-cancer treatments within 40 days before COVID-19 onset ","Cancer:non-cancer = 93:1959  Patients from the same hospital ","Propensity score matching system 1 (sex, age, symptoms, comorbidities) - matched 1:10, so total of cancer to non-cancer = 93:930   Propensity score matching system 2 (all of above AND immunological indices) - matched 1:10, so total of cancer to non-cancer = 49:490",NA,"Median of all; Median of propensity score matching 1; median of propensity score matching 2","65; 65; 65","IQR","56-71; 56-71;58-73","47.3; 47.3; 59.2","93; 93; 49","Median of all; Median of propensity score matching 1; median of propensity score matching 2","62; 65; 66","IQR","51-70; 56-71; 57-74","48.7; 47.8; 60.6","1959; 930; 490","Not mentioned",NA,"","","","","",NA,"","","38","40.9","774","39.5","",NA,"","","17","18.3","328","16.7","",NA,"","","12","12.9","189","9.6","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","4","4.3","28","1.4","",NA,"","","0","0","18","0.9","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"3;0","3.2;0.0","50;9","2.6;0.5","","","","","Others: Hepatitis B;Hepatitis C","","","",NA,"","","","The severity of COVID-19 was graded according to the 7th edition of the Diagnosis and Treatment Protocol of COVID-19: moderate, severe, critical ","","Not said, but death or discharge was used as the clinical outcome of the study.","The severity of COVID-19 was graded according to the 7th edition of the Diagnosis and Treatment Protocol of COVID-19: moderate, severe, critical ","univariate; multivariate","Age; Sex; Comorbidities; Other: multivariate logistic regression model 1: symptoms, multivariate logistic regression model 2: symptoms, immune indices including hsCRP, PCT, ferritin, TNF-, IL-1, IL-2 R, IL-6, IL-8, IL-10, lymphocytes",NA,"12","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","0.667 (2/3)","","","","","",NA,NA,"",NA,"",NA,"","","Oesophagus","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"4","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"11","","","","","0.500 (4/8)","","","","","","","","",NA,"",NA,"","","Bladder","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"2","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","0.555 (5/9)","","","","","","","","","","","","","","","","","","","","","","14 thyroid","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","uOR total population;uOR propensity score 1;uOR propensity score 2;mOR  model 1 total population;mOR model 1 propensity score 1;mOR model 1 propensity score 2;mOR  model 2 total population;mOR model 2 propensity score 1;mOR model 2 propensity score 2; uHR total population;uHR propensity score 1;uHR propensity score 2;mHR model 1 total population;mHR model 1 propensity score 1;mHR model 1 propensity score 2;mHR model 2 total population;mHR model 2 propensity score 1;mHR model 2 propensity score 2","2.708;2.907;0.862;2.640;2.468;0.867;1.931;0.716;1.115;1.995;1.648;0.786;2.023;1.965;0.972;0.778;1.442;0.513","1.655-4.429;1.263-3.481; 0.436-1.702;1.498-4.654;1.388-4.388;0.403-1.866; 0.498-7.493;0.127-4.028;0.277-4.485;1.280-3.108;1.044-2.603;0.435-1.423;1.296-3.159;1.239-3.117;0.532-1.779;0.404-1.496;0.724-2.872;0.419-1.545 ","<0.001;0.004;0.668;0.001;0.004;0.715;0.341;0.704;0.878;0.002;0.032;0.427;0.002;0.004;0.928;0.451;0.298;0.804","0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49)","0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490); 0.108 (212/1959); 0.135 (126/930); 0.253 (123/490)","","","","","","","","","","","Moderate 0.0860 (8/93); severe 0.434 (45/93); critical 0.430 (40/93)","Moderate 0.119 (233/1955); Severe 0.702 (1372/1955); critical 0.179 (350/1955)","","","","","","","","",NA,"37 ('early')","NA as used early as reference ","","","","0.189 (7/37)","","","","","","","",NA,NA,NA,NA,"Moderate 0.135 (5/37); severe 0.514 (19/37); critical 0.351 (13/37)",NA,"Moderate;severe;critical","","","","","",NA,NA,"18 ('late')","Using EARLY as reference uOR; HR; mOR model 1; HR","0.536; 0.629;0.975; 2.347","0.099-2.887; 0.131-3.029;0.051-18.495; 0.305-18.053","0.468; 0.563;0.987; 0.412","0.111 (2/18); NA; NA; NA","","","","","","","","",NA,"",NA,"Moderate 0.0556 (1/18); severe 0.556 (10/18); critical 0.389 (7/18)","","","","","","","","","model 1 adjustment of covariates","38","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"9","9.7","uOR; uHR;mOR model 1;mHR model 1","1.400; 1.109;0.876; 0.521","0.253 - 7.759; 0.240 - 5.133;0.115 - 6.646; 0.080 - 3.402","0.700;0.894;0.898;0.496","0.222 (2/9); NA; NA; NA","0.108 (212/1959);0.135 (126/930); NA; NA","","","","","","","","","",NA,"Moderate 0.000 (0/9); severe 0.444 (4/9); critical 0.556 (5/9)",NA,"Note that all these therapies are within 40 days","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"2","2.2","uOR; uHR;mOR model 1;mHR model 1","4.583;3.949;22.027;25.952","0.267 - 78.548;0.498 - 31.280;0.311 - 1558.242;0.771 - 873.562","0.294;0.193;0.155;0.070","0.500 (1/2); NA; NA; NA","0.108 (212/1959);0.135 (126/930); NA; NA","","","","","","","",NA,NA,NA,"Moderate 0.000 (0/2); severe 0.500 (1/2); critical 0.500 (1/2)",NA,"","","","","","","","","4","4.3","uHR","0.513","0.000 - 510.340","0.513","0.000 (0/4)","0.108 (212/1959)","","","","","","","","","",NA,"Moderate 0.000 (0/4); severe 0.500 (2/4); critical 0.500 (2/4)","","","","","","","","","","1","1.1","uHR","0.048","0.000 - 8846600","0.755","0.000 (0/1)","0.108 (212/1959)","","","","","","","","","",NA,"Moderate 0.000 (0/1); severe 0.000 (0/1); critical 1.000 (1/1)",NA,NA,"","","","","","","","2","2.15","uHR","0.045","0.000-5547.994","0.603","0.000 (0/2)","0.108 (212/1959)",NA,NA,NA,NA,NA,NA,"","","",NA,"Moderate 0.000 (0/2); severe 0.000 (0/2); critical 1.000 (2/2)",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"93;93;49;93;93;49;93;93;49;93;93;49;93;93;49;93;93;49","100","uOR total population;uOR propensity score 1;uOR propensity score 2;mOR  model 1 total population;mOR model 1 propensity score 1;mOR model 1 propensity score 2;mOR  model 2 total population;mOR model 2 propensity score 1;mOR model 2 propensity score 2; uHR total population;uHR propensity score 1;uHR propensity score 2;mHR model 1 total population;mHR model 1 propensity score 1;mHR model 1 propensity score 2;mHR model 2 total population;mHR model 2 propensity score 1;mHR model 2 propensity score 2 ","2.708;2.907;0.862;2.640;2.468;0.867;1.931;0.716;1.115;1.995;1.648;0.786;2.023;1.965;0.972;0.778;1.442;0.513","1.655-4.429;1.263-3.481; 0.436-1.702;1.498-4.654;1.388-4.388;0.403-1.866; 0.498-7.493;0.127-4.028;0.277-4.485;1.280-3.108;1.044-2.603;0.435-1.423;1.296-3.159;1.239-3.117;0.532-1.779;0.404-1.496;0.724-2.872;0.419-1.545 ","<0.001;0.004;0.668;0.001;0.004;0.715;0.341;0.704;0.878;0.002;0.032;0.427;0.002;0.004;0.928;0.451;0.298;0.804","0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49)","0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490); 0.108 (212/1959); 0.135 (126/930); 0.253 (123/490)","","","","","","","","","","","Moderate 0.0860 (8/93); severe 0.434 (45/93); critical 0.430 (40/93)","Moderate 0.119 (233/1955); Severe 0.702 (1372/1955); critical 0.179 (350/1955) ","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"65844","Bertuzzi 2021","Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy","Consensus","Peer-reviewed","British Journal of Cancer","Medical records at IRCCS, Rozzano, Italy","2021-05","Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy","Bertuzzi AF","Retrospective","cohort","Yes","inpatient","Italy","Lombardy","IRCCS, Rozzano","2020-02-27","2020-05-20","557","Mortality","ICU Admission","ICU admission; Mortality","no","Evidence in EHRs. Active cancer was defined by the presence of localised or metastatic disease at covid onset.","controls from the same hospital","propensity score matching for age and comorbidities - 1 cancer: 4 control",NA,"Mean","71","95%CI","67-74","67.4","46","Mean","65","95%CI","64-66","67.3","511","Not mentioned",NA,"9","19.6","41","8","uOR","0.28","0.12-0.65","0.002131","21","45.7","263","51.6","uOR","0.79","0.43-1.45","0.442006","12","26.1","125","24.5","uOR","1.09","0.55-2.16","0.81208","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"12; 13","26.7; 28.9","42; 44","23.3; 24.4","uOR","1.45; 1.79","0.74-2.85; 0.92-3.49","0.279626; 0.081512","Dyslipidemia; Coronary Artery Disease","","","",NA,"","","","","","in-hospital fatality rate","","univariate; multivariate","Age",NA,"9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","3","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"33","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","","","","","","","","","","","","","","","all GU = 6; all GI = 10","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"46","uHR; mHR","2.79; 2.26","1.76-4.42; 1.39-3.657","<0.001; <0.001","0.500 (23/46); 0.500 (23/46)","0.202 (103/511); 0.202 (103/511)","","","","","","","","","","","","","","","","","","","","",NA,"17","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"29","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"13","28.3","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","4","8.7","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"1","2.2","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","10.9","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","4","8.7","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","21","45.7","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"557","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"65461","Al-Mozaini 2021","SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer","Consensus","Peer-reviewed","Frontiers In Oncology | Cancer Epidemiology and Prevention","""Medical records books"" of King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and Park View Hospital, Chittagong, Bangladesh","2021-08","SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer","Al-Mozaini M","Retrospective","Cohort","Yes","inpatient","Saudi Arabia and Bangladesh","Riyadh and Chittagong","King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and Park View Hospital, Chittagong, Bangladesh","2020-06-30","2020-08-07","184","Mortality","Mild, moderate, severe cases","Severity; Mortality","no","Having received anticancer treatment with curative, radical, adjuvant, or neoadjuvant therapy or treated in the last 12 months with radiotherapy, surgery, and chemotherapy.","""A total of 120 COVID-19-positive noncancer adult patients admitted by the same hospitals and same time period were included in this study as a control group.""","Not explicitly matched. Chi2 shows sex matched but not age matched.",NA,"Median","55","IQR","10.5","75","64","Median","53","IQR","9","62.5","120","Not mentioned",NA,"","","","","",NA,"","","19","29.69","21","17.5","uOR","1.99","0.98 - 4.06","0.056","13","20.31","31","25.83","uOR","0.73","0.35 - 1.52","0.4","15","23.44","11","9.17","uOR","3.03","1.30 - 7.08","0.008","","","","","",NA,"",NA,"","","","","",NA,"","","3","4.69","9","7.5","uOR","0.61","0.16 - 2.32","0.46","2","3.12","9","7.5","uOR","0.4","0.08 - 1.90","0.23","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","any of the following symptoms: breathing rate of 30 or more breaths/min, the oxygen saturation level below 93%, one or multiple organ failures, requiring intensive care unit (ICU) and invasive mechanical ventilation support (IVS), a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO2:FiO2) of less than 300 mmHg, or infiltrates in more than 50% of the lung field within 24 to 48 h; ","/","Death before study end date","any of the following symptoms: breathing rate of 30 or more breaths/min, the oxygen saturation level below 93%, one or multiple organ failures, requiring intensive care unit (ICU) and invasive mechanical ventilation support (IVS), a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO2:FiO2) of less than 300 mmHg, or infiltrates in more than 50% of the lung field within 24 to 48 h; ","univariate","",NA,"9","uOR","43.17","7.79-239.15","6.90E-10","0.778","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","16","uOR","1.76","0.35-8.99","0.49","0.125","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","4","uOR","12.33","1.55-98.17","0.0033","0.5","0.0917","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"12","uOR","2.47","0.47-13.02","0.27","0.167","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","3","NA (0 value)","","","","0","0.0917","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"6","NA (0 value)","","","","0","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","5","uOR","18.5","2.73-125.41","9.40E-05","0.6","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"6","NA (0 value)","","","","0","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"61","uOR","4.39","1.81-10.65","5.60E-04","0.262","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","3","uOR","6.17","0.51-74.73","0.11","1","0.0917","","","","","","","","","","","","","","","","","","","","","0","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","0","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"64","uOR;aOR (MV regress)","3.66;2.59","1.56-8.57;1.47-5.26","0.0028;0.001","0.2969(19/64);0.2969(19/64)","0.075(9/120),0.075(9/120),","aOR (MV regress)","4.22","3.17-6.26","0.001","0.2031","0.05","aOR (MV regress)","2.26","1.77-4.61","0.01","0.375","","","","","","","","","",NA,"43","uOR","3.74","1.40-9.97","0.0057","0.233","0.0917","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"21","uOR","9.25","3.08-27.77","7.49E-06","0.429","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","0","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"33","51.6","uOR","11.89","4.72-29.96","2.55E-07","0.545 (18/33)","0.0917","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","7.8","NR (0 value)","0","","","0 (0/5)","0.0917","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","10","15.6","NR (0 value)","0","","","0 (0/10)","0.0917",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"64534","Monari 2021","More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study","Consensus","Peer-reviewed","Frontiers in Oncology","","2021-05","More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study","Monari C","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Italy","Campania region (13 cities: Naples, Caserta, Salerno, Benevento, Pozzuoli, Eboli and Vallo della Lucania)","N/A","2020-02-28","2020-05-31","371","COVID-19 severity (requiring mechanical ventilation and/or admission to ICU and/or in case of death).","","Severity; Mortality","no","17 patients active cancer (defined as subjects who had received anti-neoplastic treatment (radio-, chemo- or immuno/target-therapy or surgery) within the last 30 days or the subjects without indication of treatment due to a late stage of disease of without treatment options (off-therapy).  12 inactive cancer (defined as a history of cancer without anticancer treatment in the last 30 days (follow-up))","Not age matched (table 2) Were sex matched (table 2) Not comorbidity matched (table 2)","Ratio of active cancer to non-cancer 17:337 Not age matched (table 2), were sex matched (table 2), not comorbidity matched (table 2)",NA,"Median","72","IQR","61-78","76.5","13","Median","58","IQR","46-69","61.7","208","Not mentioned",NA,"","","","","",NA,"","","11","64.7","138","40.9","",NA,"","0.083","","","","","",NA,"","","11","64.7","71","21.1","","","","<0.001","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","5","29.4","47","13.9","","","","0.17","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","",NA,"","","","Requiring mechanical ventilation and/or admission to ICU and/or in case of death.","","no statement","Mild: asymptomatic or experienced a mild infection with home quarantine and/or did not need oxygen (O2) therapy and/or had a Modified Early Warning Score (MEWS) below 3 points.  Moderate: hospitalized and required low flow O2 therapy or non-invasive O2 therapy and/or had a MEWS equal or above 3 points (3).  Severe: ICU admission and/or mechanical and/or patient died.","multivariate","Age; Sex; Comorbidities; Other: Charlson Index Score indicates comorbidities",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"17","uOR","7.3","2.68-19.90","<0.001","0.529 (9/17)","0.134 (45/337)","","","","","","","mOR","5.33","1.72-16.53","<0.001","0.647","0.217","mORs presented are for severity","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"63774","Rthrich 2021","COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry","Consensus","Peer-reviewed","Annals of Hematology","Lean European Open Survey on SARS-COV-2 (LEOSS) registry ","2020-11","COVID-19 in cancer patients: clinical characteristics and outcomean analysis of the LEOSS registry","Rthrich MM","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Germany","N/A","N/A","2020-03-16","2020-08-31","2833","Death (attributed to COVID-19), clinical manifestation of COVID-19 ","Survival at day 30","Mortality","no","","Same multinational cohort (LEOSS)","active cancer to non-cancer ratio: 197:2636  evident sex matching",NA,"Age ranges ","<18: 5/435; 18-25: 1/435; 26-35: 4/435; 36-45: 13/435; 46-55: 36/435; 56-65: 72/435; 66-75: 108/435; 76-85: 158/435; >85: 8/435","","","59.5","435","Age ranges ","<18: 47/2636; 18-25: 60/2636; 26-35: 197/2636; 36-45: 239/2636; 46-55: 434/2636; 56-65: 527/2636; 66-75: 413/2636; 76-85: 508/2636; >85: 211/2636","","","59.5","2636","Not mentioned",NA,"36/225","16","170/1270 ","14","",NA,"","","259/430","60","1249/2591","48","",NA,"","","63/429; 41/426 ","14.5; 9.5","349/2572; 172/2563  ","13.5; 6.5","",NA,"","","36/424; 52/420; 81/420; 34/421","8.5; 12; 19.5; 8","156/2539; 242/2537; 343/2518; 104/2521","6; 9.5; 13.5; 4","","","","","59/427","14","222/2560","8.5","",NA,"",NA,"5/428; 6/428 ","1; 1.5","53/2558; 22/2561","2; 1","",NA,"","","87/428","20.5","359/2569","14","",NA,"","","39/430; 15/429; 27/422","9; 3.5; 6.5","149/2572; 137/2564; 110/2539","6; 5.5; 4.5","","","","","5/429","1","49/2564","2","","","","",NA,NA,NA,NA,"",NA,"",NA,"69/184; 19/428; 3/429; 48/429; 15/431","24; 4.5; 0.5; 11; 3.5","419/1597; 51/2558; 20/2560; 209/2358; 55/2562","26; 2; 1; 8; 2","","","","","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy  DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia ","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy  DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy  DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia",NA,"","","",NA,NA,"The primary endpoint (death related to COVID-19) was observed in 97 (22.5%) patients, while the majority died within 30 days after diagnosis of SARS-CoV-2 (19.5%)",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"197","cOR","2.22","1.59 - 3.10","0.0000044","52/197","367/2636","","","","","","","","","","","","","I calculated crude OR, CI and p-value for mortality attributed to covid-19 in *active* cancer patients vs. non-cancer patients ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"36/418","8.5","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"96/418","22","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","25/418","5.5","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","39/418","9","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"62340","Westblade 2020","SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19","Consensus","Peer-reviewed","Cancer Cell","EHRs from NewYork-Presbyterian Hospital (NYP), Weill Cornell Medical Center, NYP Lower Manhattan Hospital, and NYP Queens","2020-11","SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19","Westblade LF","Retrospective","Cohort","Yes","inpatient","USA","New York","New York-Presbyterian Hospital (NYP), Weill Cornell Medical Center, NYP Lower Manhattan Hospital, and NYP Queens","2020-03-15","2020-05-14","3014","Intubation, Need for vasopressors, mortality","","ICU admission; Mortality","no","Either under active surveillance at time of admission for COVID-19 OR had active cancer-directed therapy in the six months prior to admission","Inpatients at the same hospitals diagnosed during the same time period","Not explicitly matched but no significant differences in terms of age and sex",NA,"Median","72","IQR","66-80","53","100","Median","65","IQR","53-77","57.8","2914","Not mentioned",NA,"31","31","573","19.7","uOR","1.84","1.19 - 2.83","0.0054","48","48","1232","42.3","uOR","1.26","0.85 - 1.88","0.26","33","33","935","32.1","uOR","1.04","0.68 - 1.59","0.85","39","39","602","20.7","uOR","2.46","1.63 - 3.71","1.00E-05","","","","","",NA,"",NA,"2","2","26","0.9","uOR","2.27","0.53 - 9.69","0.26","8","8","270","9.3","uOR","0.85","0.41 - 1.77","0.67","21","21","450","15.4","uOR","1.46","0.89 - 2.38","0.13","0","0","28","1","NA (0 value)","","","","3","3","101","3.47","uOR","0.86","0.27 - 2.76","0.8","","","","","","","","","","","","",NA,"","","","not defined","intubation","In-hospital mortality","not defined","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"60","cOR","1.294","0.7402-2.2620","0.3658","0.300 (18/60)","0.249 (725/2914)","","","","","","","",NA,"",NA,"","","","","","","","","","","40","cOR","1.294","0.6546-2.5579","0.4585","0.300 (12/40)","0.249 (725/2914)","","","","","","","","","","","","","","","","","","","","","64","","","","","","","","","","","","","",NA,"",NA,NA,NA,"only includes patients with Ct value <30","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"100","cOR","1.294","0.8368-2.0009","0.2465","0.300 (30/100)","0.249 (725/2914)","cOR","0.7688","0.4406-1.3416","0.3547","0.15 (15/100)","0.187 (544/2914)","","","","","","","includes patients with Ct value >30","ICU admission defined as those requiring intubation","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","100","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"100","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"62182","Christopher 2020","Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience","Consensus","Peer-reviewed","Frontiers in Oncology","Electronic health records of the University College London Hospitals NHS Foundation Trust.","2020-11","Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience","Christopher C. T. Sng","Retrospective","Cohort","Yes","inpatient","UK","London","University College London Hospitals NHS Foundation Trust","2020-03-01","2020-05-31","626","All-cause mortality.","","Mortality","no","Any evidence of solid cancer in EHR. Active cancer = cancer diagnosis or anti-cancer treatment within the last 12 months or radiological or biochemical evidence of active or recurrent cancer.","Patients with no evidence of cancer in their EHR recruited from the same hospital.","Age- and sex-matched control patients. Not co-morbidity matched. Cancer : control = 94 : 226",NA,"median","71","iqr","62-80","66","94","median","70.5","iqr","60-80","67","226","Not mentioned",NA,"7","7","13","6","uOR","1.32","0.51-3.42","0.568403","37","39","123","54","uOR","0.54","0.33-0.89","0.014103","24","26","73","32","uOR","0.72","0.42-1.23","0.230143","18","19","59","26","uOR","0.67","0.37-1.21","0.1848","12","13","37","16","uOR","0.75","0.37-1.51","0.414594","3","3","4","2","uOR","1.83","0.40-8.34","0.428448","12","13","26","12","uOR","1.13","0.54 - 2.34","0.75068","14","15","47","21","uOR","0.67","0.35-1.28","0.220784","4","4","13","6","uOR","0.73","0.23-2.29","0.58658",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","immunosuppressed = ongoing corticosteroid use; comorbidities compare control cohort to 98 patients with a history of cancer (of whom 58 had active cancer)","","","",NA,"","","","","","All cause mortality up to and including 12 June 2020.","","multivariate","Age; Comorbidities; Other: Ethnicity.",NA,"15","aHR","0.7","0.28-1.79","0.46","0.333 (5/15)","","","","","","","","",NA,"",NA,"","","","","","","","","","","8","aHR","1.56","0.55-4.38","0.4","0.500 (4/8)","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"24","aHR","1.65","0.85-3.19","0.14","0.542 (13/24)","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","aHR","0.6","0.19-1.96","0.4","0.333 (3/9)","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"58","aHR","1.64","1.03-2.6","0.04","0.448 (26/58)","","","","","","","","","","","","","","","","","","","","","total = active cancer only, subtypes include active and non-active",NA,"58","","","","","0.448 (26/58)","0.341 (77/226)","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"19","uHR","1.13","0.54-2.37","0.75","0.474 (9/19)","0.341 (77/226)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"15","25.9","mHR","2.04","0.84-4.9","0.11","0.467 (7/15)","0.341 (77/226)","","","","","","","","","",NA,"",NA,"","","","","","","","","8","13.8","mHR","1.94","0.74-5.1","0.18","0.625 (5/8)","0.341 (77/226)","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"2","3.45","mHR","3.44","0.44-27.2","0.24","0.500 (1/2)","0.341 (77/226)","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","8.62","mHR","1.94","0.45-8.4","0.38","0.400 (2/5)","0.341 (77/226)","","","","","","","","","",NA,"","","","","","","","","","","4","6.9","mHR","1.7","0.39-7.3","0.48","0.500 (2/4)","0.341 (77/226)","","","","","","","","","",NA,"",NA,NA,"","","","","","","","3","5.17","mHR","1.4","0.18-10.8","0.75","0.333 (1/3)","0.341 (77/226)",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"320","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"62120","Brar 2020","COVID-19 severity and outcomes in patients with cancer: A matched cohort study","Consensus","Peer-reviewed","Journal of Clinical Oncology","Hospital records for Weill Cornell Medicine and Lower Manhattan Hospital","2020-09","COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study","Brar G.","Retrospective","Cohort","Yes","inpatient","USA","New York City","2 New York-Presbyterian hospitals: Weill Cornell Medicine and Lower Manhattan Hospital","2020-03-03","2020-05-15","585","Composite incident outcome of: 1) ICU admission 2) Intubation 3) Death","","Severity; ICU admission; Mortality","no","All consecutively hospitalized patients with an active hematologic or solid tumor malignancy","Patients at the same two hospitals with no cancer diagnostic code","cancer: non-cancer = 1:4 Formally matched for age, gender and comorbiditiies",NA,"Median","72.5","IQR","64.2-79.9","54.70%","117","Median","71.2","IQR","62.1-79.6","54.70%","468","Not mentioned",NA,"39","33.4","129","27.7","uOR","1.31","0.22-0.85","0.22","62","53","269","57.5","uOR","0.83","0.21-0.56","0.38","38","32.5","136","29.1","uOR","1.17","0.22-0.76","0.47","","","","","","","","","","","","","",NA,"",NA,"3","","2","0.4","uOR","6.13","0.92-1.01","0.02","3","2.6","23","4.9","uOR","0.51","0.15-0.62","0.27","","","","","","","","","0","0","3","0.6","uOR","n/a","n/a","n/a",NA,NA,NA,NA,"",NA,"",NA,"22; 13; 9; 6","18.8; 11.1; 7.7; 5.1","78; 32; 33;29","16.7; 6.8; 7.1; 6.2","uOR; uOR; uOR; uOR","1.16; 1.70; 1.10; 0.82","0.27-0.69; 0.35-0.86; 0.39-0.51; 0.33-0.46","0.58; 0.12; 0.81; 0.66","CAD; HF; COPD; Asthma","","","",NA,"","","","Composite outcome: death, intubation, or ICU admission","","in hospital mortality","Composite outcome: death, intubation, or ICU admission","multivariate","Age; Sex; Comorbidities",NA,"1","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","15","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"22","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"75","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","42","","","","","","","","","","","","","","","","","","","","","","","","","","","19","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","Combined lower + upper GI","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"117","uHR; mHR","0.74; 0.98","0.53-1.03; 0.58-1.67",">.05; 0.894","29/117; 0.248","100/468; 0.214","","","","","","","mHR","0.8","0.57-1.13",">.05","","","","","","","","","","",NA,"22","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"26","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","27","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"52","44.4","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","32","27.4","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","14","12","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","21","18","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"585","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"61946","Duarte 2020","Outcomes of covid-19 patients under cytotoxic cancer chemotherapy in brazil","Consensus","Peer-reviewed","Cancers","SIVEP","24/11/2020","Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil","Duarte, Mateus Bringel Oliveira ","Retrospective","Cohort ","Yes","inpatient","Brazil","Brazilian Southeast region ","","2020-01-01","2020-09-28","38899(non-matched);927(pair matched)","Mortality, severity ","","Severity; Mortality","no","Cancer was defined as any oncological disease reported in SIVEP (Brazilian Ministry of Healths electronic registry for epidemiological surveillance of flu-like syndromes)  cancer patients were stratified into active and non-active chemo - numbers and stats provided below only include  1. Non Pair-matched: active chemo patients vs non-cancer controls to ensure previous cancer patients are not included within non-active chemo  2. Pair matched: cancer (active chemo) vs non cancer controls   (pair matched to active and inactive chemo)   n.b. for cancer subtype, only data for the active chemo cohort were available (data for the pair matched active chemo cohort breakdown by cancer types are not available )  data pulled from addition supplementary resources (available here: https://www.mdpi.com/2072-6694/12/12/3490/s1)  ","same multinational cohort ","for matched data == cancer: control = 246: 681 for non-matched data == cancer: control = 431: 38468 matched data was matched for: age, sex, race, Brazilian region, type of presentation, and comorbidities",NA,"age ranges","non-pair matched: <50 (121); 50-64 (172); 65-79 (1220); >80 (16)   pair matched: <50 (49); 50-64 (99); 65-79 (89); >80 (9) ","","","non-pair matched: 43.2%;pair matched: 49.6% ","non-pair matched: 431;pair matched: 246","age ranges","non-pair matched: <50 (10192); 50-64 (11730); 65-79 (11379); >80 (5167)   pair matched: <50 (166); 50-64 (274); 65-79 (216); >80 (25) ","","","non-pair matched: 57.5%;pair matched: 45.2% ","non-pair matched: 38468;pair matched: 681","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","66 (non-pair matched); 38(pair matched)","15.3 (non-pair matched); 15.5 (pair matched)","11333 (non-pair matched); 103 (pair matched)","49 (non-pair matched); 15.1 (pair matched)","",NA,"","","83 (non-pair matched); 60 (pair matched)"," 19.3 (non-pair matched); 24.4(pair matched)","15866 (non-pair matched); 145(pair matched)","41.2 (non-pair matched); 21.3(pair matched)","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","23 (non-pair matched); 15(pair matched)","5.3 %(non-pair matched); 6.1%(pair matched)","2630(non-pair matched); 38(pair matched)","6.8%(non-pair matched); 5.6%(pair matched)","",NA,"","","17(non-pair matched); 11(pair matched)","3.9%(non-pair matched); 4.5%(pair matched)","2152(non-pair matched); 28(pair matched)","5.6%(non-pair matched); 4.1%(pair matched)","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"neurological disease 5(non-pair matched); 5(pair matched)","neurological disease 1.1% (non-pair matched); 2.0%(pair matched)","neurological disease: 2026 (non-pair matched); 13 (pair matched)","neurological disease: 5.3%(non-pair matched); 1.9%(pair matched)","","","","","","","","",NA,"","","","Critical presentation/severity was defined as the use of invasive mechanical ventilation.","","not specified at any point "," Critical presentation/severity was defined as the use of invasive mechanical ventilation.","Other: OR values not what we want as said by James - ""Just record the raw numbers and leave the ORs and p values blank (those reported are not comparable to the ORs we want).""","",NA,"30","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","66","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","39","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"64","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","18","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"0","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","42","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"8","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"11","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"5","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","10","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"320","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","111","","","","","","","","","","","","","","","","","","","","","","","","","","","17","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"431","","","","","(265/431) (non-matched); (162/246) (pair-matched)","14255/38468 (non-matched); 217/681 (pair-matched)","","","","","","","","","","","(97/431) non-matched;  (59/246) pair-matched","(9848/38468) non-matched; (158/681) pair-matched","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","431 (non-matched); 426 (pair-matched)","","","","","265/431 non-matched; 162/246 pair-matched","14255/38468 non-matched;217/ 681 pair-matched ","",NA,"","","","","","","","","97/431 non-matched;59/246 pair-matched ","9848/38468 non-matched; 158/681 pair-matched","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"38899(non-matched);927 (pair matched)","100;100","","","","","265/431 non-matched; 162/246 pair-matched","14255/38468 (non-matched); 217/681 (pair-matched)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","97/431 (non-matched); 59/246 (pair-matched)","9848/38468 (non-matched);158/681(pair-matched)","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"61922","Mehta 2020","Case fatality rate of cancer patients with COVID-19 in a New York Hospital system","Consensus","Peer-reviewed","American Association for Cancer Research","","2020-05","Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System","Mehta V","Retrospective","Cohort","Yes","inpatient","USA","New York City","Montefiore Health System","2020-03-18","2020-04-08","1308","Case fatality in COVID-19 patients with cancer vs. patients without cancer","","ICU admission; Mortality","no","patients with a history of malignancy. Cases identified as having  benign neoplasms were excluded.","Age and sex matched 5:1 ratio","Ratio of cancer to non-cancer: 1:5 Age and sex matched No mention of whether comorbidity matched",NA,"Median","69","Range","Oct-92","58","218","","","","","","1090","Not mentioned",NA,"","","","","",NA,"","","147","67.4","","","",NA,"","","80","36.7","","","",NA,"","","43","19.7","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","54","24.8","","","",NA,"","","62","28.4","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"33 (congestive heart failure, CHF)","15.1","","","","","","","","","","",NA,"","","","","","","","multivariate","Age; Sex",NA,"11 (lung)","aOR","7.58","2.28-25.15","0.001","0.545 (6/11)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","28","aOR","1.05","0.36-3.08","0.933","0.143 (4/28)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","8","aOR","3.79","0.90-16.02","0.071","0.375 (3/8)","0.137 (149/1090)","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"21 (colorectal)","aOR","3.89","1.58-9.54","0.003","0.381 (8/21)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","7","aOR","2.53","0.49-13.14","0.277","0.286 (2/7)","0.137 (149/1090)","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","aOR","3.95","1.27-12.23","0.018","0.385 (5/13)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"8","aOR","0.9","0.11-7.39","1.066","0.125 (1/8)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3","aOR","3.16","0.28-35.04","0.358","0.333 (1/3)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"164","aOR","2.11","1.42-3.12","0.0002","0.250 (41/164)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","54","aOR","3.71","2.08-6.63","1.17E-05","0.370 (20/54)","0.137 (149/1090)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"218","aOR","2.45","1.74-3.46","4.53E-07","0.280 (61/218)","0.137 (149/1090)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"42","19.3","uOR","1.49","0.69-3.27","0.334","0.190 (8/42)","0.137 (149/1090)","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","49","22.5","uOR","1.83","0.91-3.66","0.089","0.224 (11/49)","0.137 (149/1090)","","","","","","","","","",NA,"","","","","","","","","","","5","2.3","uOR","1.58","0.18-14.22","0.7","0.2000 (1/5)","0.137 (149/1090)","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"61478","Zhang 2020","Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19","Consensus","Peer-reviewed","Frontiers in Oncology","Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China.","2020-10","Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19","Zhang B","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China.","2020-01-17","2020-05-18","171","Disease severity, mortality ","","Severity; ICU admission; Mortality","no","breast cancer cohort n=35 and other types of cancer cohort n=81 ","Comparison group drawn from same five tertiary hospitals as cancer groups.  Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China. Thirty-five breast cancer patients with COVID-19, 81 other types of cancer patients with COVID-19, and 55 COVID-19 patients without cancer were recruited between January 17, 2020 and May 18, 2020","ratio of cancer to non-cancer = 116:55 median age in all groups are matched",NA,"median; median","56 (breast cancer); 58 (other cancers)","IQR; IQR","45 - 62 (breast cancers);  49 - 62 (other cancers)","0 (breast cancers); 46.9 (other cancers)","35 (breast cancers); 81 (other cancers)","median","57","IQR","49 - 64","41.8","55","Not mentioned",NA,"","","","","",NA,"","","24","20.7","17","30.9","cOR","0.58","0.28 - 1.21","1.177","16","13.8","10","18.2","cOR","0.72","0.30 - 1.71","1.354","9","7.8","7","12.7","cOR","0.58","0.20 - 1.64","1.346","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","6","5.2","0","0","cOR","undefined","undefined","undefined","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"6 (common pulmonary infections); 9 (anaemia)","5.2 (common pulmonary infections); 7.8 (anaemia)","0 (common pulmonary infections); 0 (anaemia)","0 (common pulmonary infections); 0 (anaemia)","cOR","undefined","undefined","undefined","","","","",NA,"","","","","","","","Other: univariate analysis only available for breast cancer cohort, not all cancer patients so I instead calculated crude OR, CI, p-value for outcomes of interest and all cancer patients","",NA,"12 (lung); 2 (nasopharynx)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","35","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6 (gastric); 1 (oesophageal)","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","","","","","","",NA,NA,"6 (colon); 3 (rectum)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5 (pancreas); 4 (liver)","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"3 (bladder)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7 (cervical); 3 (ovarian)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1 (meningioma)","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","1 (osteosarcoma)","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6 (leukaemia); 6 (myeloma); 4 (lymphoma); 2 (myelodysplastic syndrome)","","","","","","","","","","","","","","","","","","","","","","","","","","","7 (thyroid); 1 (liposarcoma)","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"116","","","","","0.069 (8/116)","0 (0/55)","","","","","0.069 (8/116)","0 (0/55)","cOR","4.59","2.16 - 9.77","0.0001","0.534 (62/116)","0.200 (11/55)","non-cancer data taken from table 5 and cancer data summed across both cohorts from table 6. I calculated crude OR, CI and p-value using this data","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"61253","Shoumariyeh 2020","Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany","Consensus","Peer-reviewed","Cancer Medicine","EHRs from University Hospital Freiburg","2020-08","Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany","Shoumariyeh K","Retrospective","cohort","Yes","inpatient","Germany","Freiburg","University Hospital of Freiburg","2020-02-27","2020-04-10","78","Treatment","Mortality","ICU admission; Mortality","no","active cancer or cancer in remission","controls at the same hospital","age-matched",NA,"Median","73","range","54-95","56.4","39","Median","76","range","45-96","64.1","39","Not mentioned",NA,"6","15.4","9","23.1","",NA,"","0.4998","","","","","",NA,"","","5","12.8","9","23.1","",NA,"","0.3768","30","76.9","34","87.2","","","","0.3768","","","","","",NA,"",NA,"1","2.6","3","7.7","",NA,"","0.6151","5","12.8","15","38.5","",NA,"","0.0183","3","7.7","11","28.2","","","","0.0362","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"3","7.7","3","7.7","","","","1","Others = Rheumatological","","","",NA,"","","","","","","","univariate","",NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","3","","","","","","","","","","",NA,NA,"",NA,"",NA,"","","all GI","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"16","","","","","","","","","","","","","",NA,"",NA,"","","uro-gynec","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"29","uOR","0.47","0.15-1.42","1.218","Jun-29","14/39","uOR","0.8","0.29-2.24","1.25","Sep-29","14/39","",NA,"",NA,"","","","","","","","","","","7","uOR","0.45","0.08-2.40","1.346","02-Oct","14/39","uOR","4.17","0.93-18.72","0.063","07-Oct","14/39","","","","","","","LYMPHOMA/MYELOMA","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","3","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEUKEMIA/PHN",NA,NA,NA,NA,NA,NA,NA,"39","uOR","0.46","0.17-1.27","1.135","Aug-39","14/39","uOR","1.24","0.50-3.10","0.658","16/39","14/39","","","","","","","","","","","","","","",NA,"29","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,"","","",NA,"",NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"","","",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"78","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
=======
=======
"Covidence #","Study ID","Title","Reviewer Name","Peer-reviewed or Preprint","Journal","Database/Study ID","Date of Publication (Month and Year)","Title of paper","First Author (Last name and Initials)","Retrospective/Prospective","Study Design","Does the study primarily compare cancer vs. non-cancer cohorts?","Does the study include inpatients/ outpatients/both/ or non-specific?","Study Country/Countries","Study Regions/Cities","Hospital(s)","Study Start Date","Study End Date","Total study size (number of patients)","Primary Outcomes of Study","Secondary outcomes of study","outcomes described","Explicitly included vaccinated patients","Definition of Cancer patient","Comparison group","Comparator group matching strategy","Baseline characteristics:","Cancer Age (measure of centre) e.g. mean/median","Cancer Age (centre)","Cancer Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance","Cancer Age (spread)","Cancer Sex (% male)","Cancer Total number","Control (non-cancer) Age (measure of centre) e.g. mean/median","Control (non-cancer) Age (centre)","Control (non-cancer) Age (measure of spread) e.g. IQR/ range/ SD/ SE/ 95% CI/ Variance","Control (non-cancer) Age (spread)","Control (non-cancer) Sex (% male)","Control (non-cancer) Total number","Which COVID-19 variant does the study identify?","Co-morbidities:","Smoking Number (cancer)","Smoking Percentage (cancer)","Smoking Number (control)","Smoking Percentage (control)","Smoking Measure of Association","Smoking OR/RR value","Smoking 95% Confidence Interval","Smoking p-value","Hypertension Number (cancer)","Hypertension Percentage (cancer)","Hypertension Number (control)","Hypertension Percentage (control)","Hypertension Measure of Association","Hypertension OR/RR value","Hypertension 95% Confidence Interval","Hypertension p-value","Diabetes Mellitus (DM) Number (cancer)","Diabetes Mellitus (DM) Percentage (cancer)","Diabetes Mellitus (DM) Number (control)","Diabetes Mellitus (DM) Percentage (control)","Diabetes Mellitus (DM) Measure of Association","Diabetes Mellitus (DM) OR/RR value","Diabetes Mellitus (DM) 95% Confidence Interval","Diabetes Mellitus (DM) p-value","Cardiovascular Disease (CVD) Number (cancer)","Cardiovascular Disease (CVD) Percentage (cancer)","Cardiovascular Disease (CVD) Number (control)","Cardiovascular Disease (CVD) Percentage (control)","Cardiovascular Disease (CVD) Measure of Association","Cardiovascular Disease (CVD) OR/RR value","Cardiovascular Disease (CVD) 95% Confidence Interval","Cardiovascular Disease (CVD) p-value","Cerebrovascular Disease Number (cancer)","Cerebrovascular Disease Percentage (cancer)","Cerebrovascular Disease Number (control)","Cerebrovascular Disease Percentage (control)","Cerebrovascular Disease Measure of Association","Cerebrovascular Disease OR/RR value","Cerebrovascular Disease 95% Confidence Interval","Cerebrovascular Disease p-value","Chronic Liver Disease Number (cancer)","Chronic Liver Disease Percentage (cancer)","Chronic Liver Disease Number (control)","Chronic Liver Disease Percentage (control)","Chronic Liver Disease Measure of Association","Chronic Liver Disease OR/RR value","Chronic Liver Disease 95% Confidence Interval","Chronic Liver Disease p-value","Chronic Kidney Disease Number (cancer)","Chronic Kidney Disease Percentage (cancer)","Chronic Kidney Disease Number (control)","Chronic Kidney Disease Percentage (control)","Chronic Kidney Disease Measure of Association","Chronic Kidney Disease OR/RR value","Chronic Kidney Disease 95% Confidence Interval","Chronic Kidney Disease p-value","Chronic Lung Disease Number (cancer)","Chronic Lung Disease Percentage (cancer)","Chronic Lung Disease Number (control)","Chronic Lung Disease Percentage (control)","Chronic Lung Disease Measure of Association","Chronic Lung Disease OR/RR value","Chronic Lung Disease 95% Confidence Interval","Chronic Lung Disease p-value","Immunodeficiency/ Immunosuppression Number (cancer)","Immunodeficiency/ Immunosuppression Percentage (cancer)","Immunodeficiency/ Immunosuppression Number (control)","Immunodeficiency/ Immunosuppression Percentage (control)","Immunodeficiency/ Immunosuppression Measure of Association","Immunodeficiency/ Immunosuppression OR/RR value","Immunodeficiency/ Immunosuppression 95% Confidence Interval","Immunodeficiency/ Immunosuppression p-value","Autoimmune Disease Number (cancer)","Autoimmune Disease Percentage (cancer)","Autoimmune Disease Number (control)","Autoimmune Disease Percentage (control)","Autoimmune Disease Measure of Association","Autoimmune Disease OR/RR value","Autoimmune Disease 95% Confidence Interval","Autoimmune Disease p-value","Others: Please Specify Number (cancer)","Others: Please Specify Percentage (cancer)","Others: Please Specify Number (control)","Others: Please Specify Percentage (control)","Others: Please Specify Measure of Association","Others: Please Specify OR/RR value","Others: Please Specify 95% Confidence Interval","Others: Please Specify p-value","Notes Number (cancer)","Notes Percentage (cancer)","Notes Number (control)","Notes Percentage (control)","Notes Measure of Association","Notes OR/RR value","Notes 95% Confidence Interval","Notes p-value","Definition of severity","Definition of ICU admission/Critical","Definition of mortality","Definition of severe disease","Univariate or multivariate analysis?","Multivariate analysis is adjusted by","Primary Cancer Site:","Thoracic (lung, mesothelioma) Total Number of Patients","Thoracic (lung, mesothelioma) Measure of Association [mortality]","Thoracic (lung, mesothelioma) value [mortality]","Thoracic (lung, mesothelioma) 95% CI [mortality]","Thoracic (lung, mesothelioma) p-value [mortality]","Thoracic (lung, mesothelioma) cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [mortality]","Thoracic (lung, mesothelioma) Measure of Association [ICU]","Thoracic (lung, mesothelioma) value [ICU]","Thoracic (lung, mesothelioma) 95% CI [ICU]","Thoracic (lung, mesothelioma) p-value [ICU]","Thoracic (lung, mesothelioma) cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [ICU]","Thoracic (lung, mesothelioma) Measure of Association [severe disease]","Thoracic (lung, mesothelioma) value [severe disease]","Thoracic (lung, mesothelioma) 95% CI [severe disease]","Thoracic (lung, mesothelioma) p-value [severe disease]","Thoracic (lung, mesothelioma) cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [severe disease]","Thoracic (lung, mesothelioma) Comment","Thoracic (lung, mesothelioma) Measure of Association [hospitalisation]","Thoracic (lung, mesothelioma) value [hospitalisation]","Thoracic (lung, mesothelioma) 95% CI [hospitalisation]","Thoracic (lung, mesothelioma) p-value [hospitalisation]","Thoracic (lung, mesothelioma) cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Non-cancer: Event/Total [hospitalisation]","Thoracic (lung, mesothelioma) Comment.1","Breast Total Number of Patients","Breast Measure of Association [mortality]","Breast value [mortality]","Breast 95% CI [mortality]","Breast p-value [mortality]","Breast cancer: Event/Total [mortality]","Breast Non-cancer: Event/Total [mortality]","Breast Measure of Association [ICU]","Breast value [ICU]","Breast 95% CI [ICU]","Breast p-value [ICU]","Breast cancer: Event/Total [ICU]","Breast Non-cancer: Event/Total [ICU]","Breast Measure of Association [severe disease]","Breast value [severe disease]","Breast 95% CI [severe disease]","Breast p-value [severe disease]","Breast cancer: Event/Total [severe disease]","Breast Non-cancer: Event/Total [severe disease]","Breast Comment","Breast Measure of Association [hospitalisation]","Breast value [hospitalisation]","Breast 95% CI [hospitalisation]","Breast p-value [hospitalisation]","Breast cancer: Event/Total [hospitalisation]","Breast Non-cancer: Event/Total [hospitalisation]","Breast Comment.1","Upper GI (gastric, oesophageal) Total Number of Patients","Upper GI (gastric, oesophageal) Measure of Association [mortality]","Upper GI (gastric, oesophageal) value [mortality]","Upper GI (gastric, oesophageal) 95% CI [mortality]","Upper GI (gastric, oesophageal) p-value [mortality]","Upper GI (gastric, oesophageal) cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [mortality]","Upper GI (gastric, oesophageal) Measure of Association [ICU]","Upper GI (gastric, oesophageal) value [ICU]","Upper GI (gastric, oesophageal) 95% CI [ICU]","Upper GI (gastric, oesophageal) p-value [ICU]","Upper GI (gastric, oesophageal) cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [ICU]","Upper GI (gastric, oesophageal) Measure of Association [severe disease]","Upper GI (gastric, oesophageal) value [severe disease]","Upper GI (gastric, oesophageal) 95% CI [severe disease]","Upper GI (gastric, oesophageal) p-value [severe disease]","Upper GI (gastric, oesophageal) cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [severe disease]","Upper GI (gastric, oesophageal) Comment","Upper GI (gastric, oesophageal) Measure of Association [hospitalisation]","Upper GI (gastric, oesophageal) value [hospitalisation]","Upper GI (gastric, oesophageal) 95% CI [hospitalisation]","Upper GI (gastric, oesophageal) p-value [hospitalisation]","Upper GI (gastric, oesophageal) cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Non-cancer: Event/Total [hospitalisation]","Upper GI (gastric, oesophageal) Comment.1","Lower GI (colorectal, small bowel) Total Number of Patients","Lower GI (colorectal, small bowel) Measure of Association [mortality]","Lower GI (colorectal, small bowel) value [mortality]","Lower GI (colorectal, small bowel) 95% CI [mortality]","Lower GI (colorectal, small bowel) p-value [mortality]","Lower GI (colorectal, small bowel) cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [mortality]","Lower GI (colorectal, small bowel) Measure of Association [ICU]","Lower GI (colorectal, small bowel) value [ICU]","Lower GI (colorectal, small bowel) 95% CI [ICU]","Lower GI (colorectal, small bowel) p-value [ICU]","Lower GI (colorectal, small bowel) cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [ICU]","Lower GI (colorectal, small bowel) Measure of Association [severe disease]","Lower GI (colorectal, small bowel) value [severe disease]","Lower GI (colorectal, small bowel) 95% CI [severe disease]","Lower GI (colorectal, small bowel) p-value [severe disease]","Lower GI (colorectal, small bowel) cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [severe disease]","Lower GI (colorectal, small bowel) Comment","Lower GI (colorectal, small bowel) Measure of Association [hospitalisation]","Lower GI (colorectal, small bowel) value [hospitalisation]","Lower GI (colorectal, small bowel) 95% CI [hospitalisation]","Lower GI (colorectal, small bowel) p-value [hospitalisation]","Lower GI (colorectal, small bowel) cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Non-cancer: Event/Total [hospitalisation]","Lower GI (colorectal, small bowel) Comment.1","Hepatobiliary (liver, pancreas, gall bladder) Total Number of Patients","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [mortality]","Hepatobiliary (liver, pancreas, gall bladder) value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [mortality]","Hepatobiliary (liver, pancreas, gall bladder) p-value [mortality]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [mortality]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [ICU]","Hepatobiliary (liver, pancreas, gall bladder) value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [ICU]","Hepatobiliary (liver, pancreas, gall bladder) p-value [ICU]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [ICU]","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) p-value [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [severe disease]","Hepatobiliary (liver, pancreas, gall bladder) Comment","Hepatobiliary (liver, pancreas, gall bladder) Measure of Association [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) 95% CI [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) p-value [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Non-cancer: Event/Total [hospitalisation]","Hepatobiliary (liver, pancreas, gall bladder) Comment.1","Renal Total Number of Patients","Renal Measure of Association [mortality]","Renal value [mortality]","Renal 95% CI [mortality]","Renal p-value [mortality]","Renal cancer: Event/Total [mortality]","Renal Non-cancer: Event/Total [mortality]","Renal Measure of Association [ICU]","Renal value [ICU]","Renal 95% CI [ICU]","Renal p-value [ICU]","Renal cancer: Event/Total [ICU]","Renal Non-cancer: Event/Total [ICU]","Renal Measure of Association [severe disease]","Renal value [severe disease]","Renal 95% CI [severe disease]","Renal p-value [severe disease]","Renal cancer: Event/Total [severe disease]","Renal Non-cancer: Event/Total [severe disease]","Renal Comment","Renal Measure of Association [hospitalisation]","Renal value [hospitalisation]","Renal 95% CI [hospitalisation]","Renal p-value [hospitalisation]","Renal cancer: Event/Total [hospitalisation]","Renal Non-cancer: Event/Total [hospitalisation]","Renal Comment.1","Urology (ureter, bladder, prostate) Total Number of Patients","Urology (ureter, bladder, prostate) Measure of Association [mortality]","Urology (ureter, bladder, prostate) value [mortality]","Urology (ureter, bladder, prostate) 95% CI [mortality]","Urology (ureter, bladder, prostate) p-value [mortality]","Urology (ureter, bladder, prostate) cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [mortality]","Urology (ureter, bladder, prostate) Measure of Association [ICU]","Urology (ureter, bladder, prostate) value [ICU]","Urology (ureter, bladder, prostate) 95% CI [ICU]","Urology (ureter, bladder, prostate) p-value [ICU]","Urology (ureter, bladder, prostate) cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [ICU]","Urology (ureter, bladder, prostate) Measure of Association [severe disease]","Urology (ureter, bladder, prostate) value [severe disease]","Urology (ureter, bladder, prostate) 95% CI [severe disease]","Urology (ureter, bladder, prostate) p-value [severe disease]","Urology (ureter, bladder, prostate) cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [severe disease]","Urology (ureter, bladder, prostate) Comment","Urology (ureter, bladder, prostate) Measure of Association [hospitalisation]","Urology (ureter, bladder, prostate) value [hospitalisation]","Urology (ureter, bladder, prostate) 95% CI [hospitalisation]","Urology (ureter, bladder, prostate) p-value [hospitalisation]","Urology (ureter, bladder, prostate) cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Non-cancer: Event/Total [hospitalisation]","Urology (ureter, bladder, prostate) Comment.1","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Total Number of Patients","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [mortality]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [ICU]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [severe disease]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Measure of Association [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) 95% CI [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) p-value [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Non-cancer: Event/Total [hospitalisation]","Gynecological (vaginal, uterine, cervical, ovarian, vulval, endometrial, leiomyosarcoma etc) Comment.1","CNS Total Number of Patients","CNS Measure of Association [mortality]","CNS value [mortality]","CNS 95% CI [mortality]","CNS p-value [mortality]","CNS cancer: Event/Total [mortality]","CNS Non-cancer: Event/Total [mortality]","CNS Measure of Association [ICU]","CNS value [ICU]","CNS 95% CI [ICU]","CNS p-value [ICU]","CNS cancer: Event/Total [ICU]","CNS Non-cancer: Event/Total [ICU]","CNS Measure of Association [severe disease]","CNS value [severe disease]","CNS 95% CI [severe disease]","CNS p-value [severe disease]","CNS cancer: Event/Total [severe disease]","CNS Non-cancer: Event/Total [severe disease]","CNS Comment","CNS Measure of Association [hospitalisation]","CNS value [hospitalisation]","CNS 95% CI [hospitalisation]","CNS p-value [hospitalisation]","CNS cancer: Event/Total [hospitalisation]","CNS Non-cancer: Event/Total [hospitalisation]","CNS Comment.1","Head and neck Total Number of Patients","Head and neck Measure of Association [mortality]","Head and neck value [mortality]","Head and neck 95% CI [mortality]","Head and neck p-value [mortality]","Head and neck cancer: Event/Total [mortality]","Head and neck Non-cancer: Event/Total [mortality]","Head and neck Measure of Association [ICU]","Head and neck value [ICU]","Head and neck 95% CI [ICU]","Head and neck p-value [ICU]","Head and neck cancer: Event/Total [ICU]","Head and neck Non-cancer: Event/Total [ICU]","Head and neck Measure of Association [severe disease]","Head and neck value [severe disease]","Head and neck 95% CI [severe disease]","Head and neck p-value [severe disease]","Head and neck cancer: Event/Total [severe disease]","Head and neck Non-cancer: Event/Total [severe disease]","Head and neck Comment","Head and neck Measure of Association [hospitalisation]","Head and neck value [hospitalisation]","Head and neck 95% CI [hospitalisation]","Head and neck p-value [hospitalisation]","Head and neck cancer: Event/Total [hospitalisation]","Head and neck Non-cancer: Event/Total [hospitalisation]","Head and neck Comment.1","Skin (including melanoma) Total Number of Patients","Skin (including melanoma) Measure of Association [mortality]","Skin (including melanoma) value [mortality]","Skin (including melanoma) 95% CI [mortality]","Skin (including melanoma) p-value [mortality]","Skin (including melanoma) cancer: Event/Total [mortality]","Skin (including melanoma) Non-cancer: Event/Total [mortality]","Skin (including melanoma) Measure of Association [ICU]","Skin (including melanoma) value [ICU]","Skin (including melanoma) 95% CI [ICU]","Skin (including melanoma) p-value [ICU]","Skin (including melanoma) cancer: Event/Total [ICU]","Skin (including melanoma) Non-cancer: Event/Total [ICU]","Skin (including melanoma) Measure of Association [severe disease]","Skin (including melanoma) value [severe disease]","Skin (including melanoma) 95% CI [severe disease]","Skin (including melanoma) p-value [severe disease]","Skin (including melanoma) cancer: Event/Total [severe disease]","Skin (including melanoma) Non-cancer: Event/Total [severe disease]","Skin (including melanoma) Comment","Skin (including melanoma) Measure of Association [hospitalisation]","Skin (including melanoma) value [hospitalisation]","Skin (including melanoma) 95% CI [hospitalisation]","Skin (including melanoma) p-value [hospitalisation]","Skin (including melanoma) cancer: Event/Total [hospitalisation]","Skin (including melanoma) Non-cancer: Event/Total [hospitalisation]","Skin (including melanoma) Comment.1","Sarcoma (including Musculo skeletal) Total Number of Patients","Sarcoma (including Musculo skeletal) Measure of Association [mortality]","Sarcoma (including Musculo skeletal) value [mortality]","Sarcoma (including Musculo skeletal) 95% CI [mortality]","Sarcoma (including Musculo skeletal) p-value [mortality]","Sarcoma (including Musculo skeletal) cancer: Event/Total [mortality]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [mortality]","Sarcoma (including Musculo skeletal) Measure of Association [ICU]","Sarcoma (including Musculo skeletal) value [ICU]","Sarcoma (including Musculo skeletal) 95% CI [ICU]","Sarcoma (including Musculo skeletal) p-value [ICU]","Sarcoma (including Musculo skeletal) cancer: Event/Total [ICU]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [ICU]","Sarcoma (including Musculo skeletal) Measure of Association [severe disease]","Sarcoma (including Musculo skeletal) value [severe disease]","Sarcoma (including Musculo skeletal) 95% CI [severe disease]","Sarcoma (including Musculo skeletal) p-value [severe disease]","Sarcoma (including Musculo skeletal) cancer: Event/Total [severe disease]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [severe disease]","Sarcoma (including Musculo skeletal) Comment","Sarcoma (including Musculo skeletal) Measure of Association [hospitalisation]","Sarcoma (including Musculo skeletal) value [hospitalisation]","Sarcoma (including Musculo skeletal) 95% CI [hospitalisation]","Sarcoma (including Musculo skeletal) p-value [hospitalisation]","Sarcoma (including Musculo skeletal) cancer: Event/Total [hospitalisation]","Sarcoma (including Musculo skeletal) Non-cancer: Event/Total [hospitalisation]","Sarcoma (including Musculo skeletal) Comment.1","SOLID AGGREGATED [add all solid values] Total Number of Patients","SOLID AGGREGATED [add all solid values] Measure of Association [mortality]","SOLID AGGREGATED [add all solid values] value [mortality]","SOLID AGGREGATED [add all solid values] 95% CI [mortality]","SOLID AGGREGATED [add all solid values] p-value [mortality]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [mortality]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [mortality]","SOLID AGGREGATED [add all solid values] Measure of Association [ICU]","SOLID AGGREGATED [add all solid values] value [ICU]","SOLID AGGREGATED [add all solid values] 95% CI [ICU]","SOLID AGGREGATED [add all solid values] p-value [ICU]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [ICU]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [ICU]","SOLID AGGREGATED [add all solid values] Measure of Association [severe disease]","SOLID AGGREGATED [add all solid values] value [severe disease]","SOLID AGGREGATED [add all solid values] 95% CI [severe disease]","SOLID AGGREGATED [add all solid values] p-value [severe disease]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [severe disease]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [severe disease]","SOLID AGGREGATED [add all solid values] Comment","SOLID AGGREGATED [add all solid values] Measure of Association [hospitalisation]","SOLID AGGREGATED [add all solid values] value [hospitalisation]","SOLID AGGREGATED [add all solid values] 95% CI [hospitalisation]","SOLID AGGREGATED [add all solid values] p-value [hospitalisation]","SOLID AGGREGATED [add all solid values] cancer: Event/Total [hospitalisation]","SOLID AGGREGATED [add all solid values] Non-cancer: Event/Total [hospitalisation]","SOLID AGGREGATED [add all solid values] Comment.1","Haematological Total Number of Patients","Haematological Measure of Association [mortality]","Haematological value [mortality]","Haematological 95% CI [mortality]","Haematological p-value [mortality]","Haematological cancer: Event/Total [mortality]","Haematological Non-cancer: Event/Total [mortality]","Haematological Measure of Association [ICU]","Haematological value [ICU]","Haematological 95% CI [ICU]","Haematological p-value [ICU]","Haematological cancer: Event/Total [ICU]","Haematological Non-cancer: Event/Total [ICU]","Haematological Measure of Association [severe disease]","Haematological value [severe disease]","Haematological 95% CI [severe disease]","Haematological p-value [severe disease]","Haematological cancer: Event/Total [severe disease]","Haematological Non-cancer: Event/Total [severe disease]","Haematological Comment","Haematological Measure of Association [hospitalisation]","Haematological value [hospitalisation]","Haematological 95% CI [hospitalisation]","Haematological p-value [hospitalisation]","Haematological cancer: Event/Total [hospitalisation]","Haematological Non-cancer: Event/Total [hospitalisation]","Haematological Comment.1","Other Total Number of Patients","Other Measure of Association [mortality]","Other value [mortality]","Other 95% CI [mortality]","Other p-value [mortality]","Other cancer: Event/Total [mortality]","Other Non-cancer: Event/Total [mortality]","Other Measure of Association [ICU]","Other value [ICU]","Other 95% CI [ICU]","Other p-value [ICU]","Other cancer: Event/Total [ICU]","Other Non-cancer: Event/Total [ICU]","Other Measure of Association [severe disease]","Other value [severe disease]","Other 95% CI [severe disease]","Other p-value [severe disease]","Other cancer: Event/Total [severe disease]","Other Non-cancer: Event/Total [severe disease]","Other Comment","Other Measure of Association [hospitalisation]","Other value [hospitalisation]","Other 95% CI [hospitalisation]","Other p-value [hospitalisation]","Other cancer: Event/Total [hospitalisation]","Other Non-cancer: Event/Total [hospitalisation]","Other Comment.1","Unspecified Total Number of Patients","Unspecified Measure of Association [mortality]","Unspecified value [mortality]","Unspecified 95% CI [mortality]","Unspecified p-value [mortality]","Unspecified cancer: Event/Total [mortality]","Unspecified Non-cancer: Event/Total [mortality]","Unspecified Measure of Association [ICU]","Unspecified value [ICU]","Unspecified 95% CI [ICU]","Unspecified p-value [ICU]","Unspecified cancer: Event/Total [ICU]","Unspecified Non-cancer: Event/Total [ICU]","Unspecified Measure of Association [severe disease]","Unspecified value [severe disease]","Unspecified 95% CI [severe disease]","Unspecified p-value [severe disease]","Unspecified cancer: Event/Total [severe disease]","Unspecified Non-cancer: Event/Total [severe disease]","Unspecified Comment","Unspecified Measure of Association [hospitalisation]","Unspecified value [hospitalisation]","Unspecified 95% CI [hospitalisation]","Unspecified p-value [hospitalisation]","Unspecified cancer: Event/Total [hospitalisation]","Unspecified Non-cancer: Event/Total [hospitalisation]","Unspecified Comment.1","Total (OF ALL CANCERS) Total Number of Patients","Total (OF ALL CANCERS) Measure of Association [mortality]","Total (OF ALL CANCERS) value [mortality]","Total (OF ALL CANCERS) 95% CI [mortality]","Total (OF ALL CANCERS) p-value [mortality]","Total (OF ALL CANCERS) cancer: Event/Total [mortality]","Total (OF ALL CANCERS) Non-cancer: Event/Total [mortality]","Total (OF ALL CANCERS) Measure of Association [ICU]","Total (OF ALL CANCERS) value [ICU]","Total (OF ALL CANCERS) 95% CI [ICU]","Total (OF ALL CANCERS) p-value [ICU]","Total (OF ALL CANCERS) cancer: Event/Total [ICU]","Total (OF ALL CANCERS) Non-cancer: Event/Total [ICU]","Total (OF ALL CANCERS) Measure of Association [severe disease]","Total (OF ALL CANCERS) value [severe disease]","Total (OF ALL CANCERS) 95% CI [severe disease]","Total (OF ALL CANCERS) p-value [severe disease]","Total (OF ALL CANCERS) cancer: Event/Total [severe disease]","Total (OF ALL CANCERS) Non-cancer: Event/Total [severe disease]","Total (OF ALL CANCERS) Comment","Total (OF ALL CANCERS) Measure of Association [hospitalisation]","Total (OF ALL CANCERS) value [hospitalisation]","Total (OF ALL CANCERS) 95% CI [hospitalisation]","Total (OF ALL CANCERS) p-value [hospitalisation]","Total (OF ALL CANCERS) cancer: Event/Total [hospitalisation]","Total (OF ALL CANCERS) Non-cancer: Event/Total [hospitalisation]","Total (OF ALL CANCERS) Comment.1","Metastasis status:","M0/Stage I-III: No metastasis Total number of Patients","M0/Stage I-III: No metastasis Measure of Association [mortality]","M0/Stage I-III: No metastasis value [mortality]","M0/Stage I-III: No metastasis 95% CI [mortality]","M0/Stage I-III: No metastasis p-value [mortality]","M0/Stage I-III: No metastasis cancer: Event/Total [mortality]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [mortality]","M0/Stage I-III: No metastasis Measure of Association [ICU]","M0/Stage I-III: No metastasis value [ICU]","M0/Stage I-III: No metastasis 95% CI [ICU]","M0/Stage I-III: No metastasis p-value [ICU]","M0/Stage I-III: No metastasis cancer: Event/Total [ICU]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [ICU]","M0/Stage I-III: No metastasis Measure of Association [severe]","M0/Stage I-III: No metastasis value [severe]","M0/Stage I-III: No metastasis 95% CI [severe]","M0/Stage I-III: No metastasis p-value [severe]","M0/Stage I-III: No metastasis cancer: Event/Total [severe]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [severe]","M0/Stage I-III: No metastasis Comment","M0/Stage I-III: No metastasis Measure of Association [hospitalisation]","M0/Stage I-III: No metastasis value [hospitalisation]","M0/Stage I-III: No metastasis 95% CI [hospitalisation]","M0/Stage I-III: No metastasis p-value [hospitalisation]","M0/Stage I-III: No metastasis cancer: Event/Total [hospitalisation]","M0/Stage I-III: No metastasis Non-cancer: Event/Total [hospitalisation]","M0/Stage I-III: No metastasis Comment.1","M1/Stage IV: metastatic disease Total number of Patients","M1/Stage IV: metastatic disease Measure of Association [mortality]","M1/Stage IV: metastatic disease value [mortality]","M1/Stage IV: metastatic disease 95% CI [mortality]","M1/Stage IV: metastatic disease p-value [mortality]","M1/Stage IV: metastatic disease cancer: Event/Total [mortality]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [mortality]","M1/Stage IV: metastatic disease Measure of Association [ICU]","M1/Stage IV: metastatic disease value [ICU]","M1/Stage IV: metastatic disease 95% CI [ICU]","M1/Stage IV: metastatic disease p-value [ICU]","M1/Stage IV: metastatic disease cancer: Event/Total [ICU]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [ICU]","M1/Stage IV: metastatic disease Measure of Association [severe]","M1/Stage IV: metastatic disease value [severe]","M1/Stage IV: metastatic disease 95% CI [severe]","M1/Stage IV: metastatic disease p-value [severe]","M1/Stage IV: metastatic disease cancer: Event/Total [severe]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [severe]","M1/Stage IV: metastatic disease Comment","M1/Stage IV: metastatic disease Measure of Association [hospitalisation]","M1/Stage IV: metastatic disease value [hospitalisation]","M1/Stage IV: metastatic disease 95% CI [hospitalisation]","M1/Stage IV: metastatic disease p-value [hospitalisation]","M1/Stage IV: metastatic disease cancer: Event/Total [hospitalisation]","M1/Stage IV: metastatic disease Non-cancer: Event/Total [hospitalisation]","M1/Stage IV: metastatic disease Comment.1","Unknown Total number of Patients","Unknown Measure of Association [mortality]","Unknown value [mortality]","Unknown 95% CI [mortality]","Unknown p-value [mortality]","Unknown cancer: Event/Total [mortality]","Unknown Non-cancer: Event/Total [mortality]","Unknown Measure of Association [ICU]","Unknown value [ICU]","Unknown 95% CI [ICU]","Unknown p-value [ICU]","Unknown cancer: Event/Total [ICU]","Unknown Non-cancer: Event/Total [ICU]","Unknown Measure of Association [severe]","Unknown value [severe]","Unknown 95% CI [severe]","Unknown p-value [severe]","Unknown cancer: Event/Total [severe]","Unknown Non-cancer: Event/Total [severe]","Unknown Comment","Unknown Measure of Association [hospitalisation]","Unknown value [hospitalisation]","Unknown 95% CI [hospitalisation]","Unknown p-value [hospitalisation]","Unknown cancer: Event/Total [hospitalisation]","Unknown Non-cancer: Event/Total [hospitalisation]","Unknown Comment.1","Treatment type:","Chemotherapy Total number of patients","Chemotherapy percentage","Chemotherapy measurement of association (OR/RR) [mortality]","Chemotherapy value [mortality]","Chemotherapy 95% CI [mortality]","Chemotherapy p-value [mortality]","Chemotherapy cancer: Event/Total [mortality]","Chemotherapy Non-cancer: Event/Total [mortality]","Chemotherapy measurement of association (OR/RR) [ICU]","Chemotherapy value [ICU]","Chemotherapy 95% CI [ICU]","Chemotherapy p-value [ICU]","Chemotherapy cancer: Event/Total [ICU]","Chemotherapy Non-cancer: Event/Total [ICU]","Chemotherapy measurement of association (OR/RR) [severe]","Chemotherapy value [severe]","Chemotherapy 95% CI [severe]","Chemotherapy p-value [severe]","Chemotherapy cancer: Event/Total [severe]","Chemotherapy Non-cancer: Event/Total [severe]","Chemotherapy Comment [incl. name of targeted/immunotherapy]","Chemotherapy Measure of Association [hospitalisation]","Chemotherapy value [hospitalisation]","Chemotherapy 95% CI [hospitalisation]","Chemotherapy p-value [hospitalisation]","Chemotherapy cancer: Event/Total [hospitalisation]","Chemotherapy Non-cancer: Event/Total [hospitalisation]","Chemotherapy Comment","Hormonal therapy Total number of patients","Hormonal therapy percentage","Hormonal therapy measurement of association (OR/RR) [mortality]","Hormonal therapy value [mortality]","Hormonal therapy 95% CI [mortality]","Hormonal therapy p-value [mortality]","Hormonal therapy cancer: Event/Total [mortality]","Hormonal therapy Non-cancer: Event/Total [mortality]","Hormonal therapy measurement of association (OR/RR) [ICU]","Hormonal therapy value [ICU]","Hormonal therapy 95% CI [ICU]","Hormonal therapy p-value [ICU]","Hormonal therapy cancer: Event/Total [ICU]","Hormonal therapy Non-cancer: Event/Total [ICU]","Hormonal therapy measurement of association (OR/RR) [severe]","Hormonal therapy value [severe]","Hormonal therapy 95% CI [severe]","Hormonal therapy p-value [severe]","Hormonal therapy cancer: Event/Total [severe]","Hormonal therapy Non-cancer: Event/Total [severe]","Hormonal therapy Comment [incl. name of targeted/immunotherapy]","Hormonal therapy Measure of Association [hospitalisation]","Hormonal therapy value [hospitalisation]","Hormonal therapy 95% CI [hospitalisation]","Hormonal therapy p-value [hospitalisation]","Hormonal therapy cancer: Event/Total [hospitalisation]","Hormonal therapy Non-cancer: Event/Total [hospitalisation]","Hormonal therapy Comment","Targeted therapy (RTK inhibitor/mAb against receptors) Total number of patients","Targeted therapy (RTK inhibitor/mAb against receptors) percentage","Targeted therapy (RTK inhibitor/mAb against receptors) measurement of association (OR/RR) [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) value [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [mortality]","Targeted therapy (RTK inhibitor/mAb against receptors) measurement of association (OR/RR) [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) value [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [ICU]","Targeted therapy (RTK inhibitor/mAb against receptors) measurement of association (OR/RR) [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) value [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [severe]","Targeted therapy (RTK inhibitor/mAb against receptors) Comment [incl. name of targeted/immunotherapy]","Targeted therapy (RTK inhibitor/mAb against receptors) Measure of Association [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) value [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) 95% CI [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) p-value [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) cancer: Event/Total [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) Non-cancer: Event/Total [hospitalisation]","Targeted therapy (RTK inhibitor/mAb against receptors) Comment","radiotherapy Total number of patients","radiotherapy percentage","radiotherapy measurement of association (OR/RR) [mortality]","radiotherapy value [mortality]","radiotherapy 95% CI [mortality]","radiotherapy p-value [mortality]","radiotherapy cancer: Event/Total [mortality]","radiotherapy Non-cancer: Event/Total [mortality]","radiotherapy measurement of association (OR/RR) [ICU]","radiotherapy value [ICU]","radiotherapy 95% CI [ICU]","radiotherapy p-value [ICU]","radiotherapy cancer: Event/Total [ICU]","radiotherapy Non-cancer: Event/Total [ICU]","radiotherapy measurement of association (OR/RR) [severe]","radiotherapy value [severe]","radiotherapy 95% CI [severe]","radiotherapy p-value [severe]","radiotherapy cancer: Event/Total [severe]","radiotherapy Non-cancer: Event/Total [severe]","radiotherapy Comment [incl. name of targeted/immunotherapy]","radiotherapy Measure of Association [hospitalisation]","radiotherapy value [hospitalisation]","radiotherapy 95% CI [hospitalisation]","radiotherapy p-value [hospitalisation]","radiotherapy cancer: Event/Total [hospitalisation]","radiotherapy Non-cancer: Event/Total [hospitalisation]","radiotherapy Comment","immunotherapy (immune checkpoint inhibitors/CAR-T) Total number of patients","immunotherapy (immune checkpoint inhibitors/CAR-T) percentage","immunotherapy (immune checkpoint inhibitors/CAR-T) measurement of association (OR/RR) [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [mortality]","immunotherapy (immune checkpoint inhibitors/CAR-T) measurement of association (OR/RR) [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [ICU]","immunotherapy (immune checkpoint inhibitors/CAR-T) measurement of association (OR/RR) [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [severe]","immunotherapy (immune checkpoint inhibitors/CAR-T) Comment [incl. name of targeted/immunotherapy]","immunotherapy (immune checkpoint inhibitors/CAR-T) Measure of Association [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) value [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) 95% CI [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) p-value [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) cancer: Event/Total [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) Non-cancer: Event/Total [hospitalisation]","immunotherapy (immune checkpoint inhibitors/CAR-T) Comment","surgery Total number of patients","surgery percentage","surgery measurement of association (OR/RR) [mortality]","surgery value [mortality]","surgery 95% CI [mortality]","surgery p-value [mortality]","surgery cancer: Event/Total [mortality]","surgery Non-cancer: Event/Total [mortality]","surgery measurement of association (OR/RR) [ICU]","surgery value [ICU]","surgery 95% CI [ICU]","surgery p-value [ICU]","surgery cancer: Event/Total [ICU]","surgery Non-cancer: Event/Total [ICU]","surgery measurement of association (OR/RR) [severe]","surgery value [severe]","surgery 95% CI [severe]","surgery p-value [severe]","surgery cancer: Event/Total [severe]","surgery Non-cancer: Event/Total [severe]","surgery Comment [incl. name of targeted/immunotherapy]","surgery Measure of Association [hospitalisation]","surgery value [hospitalisation]","surgery 95% CI [hospitalisation]","surgery p-value [hospitalisation]","surgery cancer: Event/Total [hospitalisation]","surgery Non-cancer: Event/Total [hospitalisation]","surgery Comment","COVID variants:","WT/Wu-1 Total Number of patients","WT/Wu-1 Percentage","WT/Wu-1 Measure of Association [mortality]","WT/Wu-1 value [mortality]","WT/Wu-1 95% CI [mortality]","WT/Wu-1 p-value [mortality]","WT/Wu-1 cancer: Event/Total [mortality]","WT/Wu-1 Non-cancer: Event/Total [mortality]","WT/Wu-1 Measure of Association [ICU]","WT/Wu-1 value [ICU]","WT/Wu-1 95% CI [ICU]","WT/Wu-1 p-value [ICU]","WT/Wu-1 cancer: Event/Total [ICU]","WT/Wu-1 Non-cancer: Event/Total [ICU]","WT/Wu-1 Measure of Association {severe]","WT/Wu-1 value [severe]","WT/Wu-1 95% CI [severe]","WT/Wu-1 p-value [severe]","WT/Wu-1 cancer: Event/Total [severe]","WT/Wu-1 Non-cancer: Event/Total [severe]","WT/Wu-1 Comment","WT/Wu-1 Measure of Association [hospitalisation]","WT/Wu-1 value [hospitalisation]","WT/Wu-1 95% CI [hospitalisation]","WT/Wu-1 p-value [hospitalisation]","WT/Wu-1 cancer: Event/Total [hospitalisation]","WT/Wu-1 Non-cancer: Event/Total [hospitalisation]","WT/Wu-1 Comment.1","Beta Total Number of patients","Beta Percentage","Beta Measure of Association [mortality]","Beta value [mortality]","Beta 95% CI [mortality]","Beta p-value [mortality]","Beta cancer: Event/Total [mortality]","Beta Non-cancer: Event/Total [mortality]","Beta Measure of Association [ICU]","Beta value [ICU]","Beta 95% CI [ICU]","Beta p-value [ICU]","Beta cancer: Event/Total [ICU]","Beta Non-cancer: Event/Total [ICU]","Beta Measure of Association {severe]","Beta value [severe]","Beta 95% CI [severe]","Beta p-value [severe]","Beta cancer: Event/Total [severe]","Beta Non-cancer: Event/Total [severe]","Beta Comment","Beta Measure of Association [hospitalisation]","Beta value [hospitalisation]","Beta 95% CI [hospitalisation]","Beta p-value [hospitalisation]","Beta cancer: Event/Total [hospitalisation]","Beta Non-cancer: Event/Total [hospitalisation]","Beta Comment.1","Gamma Total Number of patients","Gamma Percentage","Gamma Measure of Association [mortality]","Gamma value [mortality]","Gamma 95% CI [mortality]","Gamma p-value [mortality]","Gamma cancer: Event/Total [mortality]","Gamma Non-cancer: Event/Total [mortality]","Gamma Measure of Association [ICU]","Gamma value [ICU]","Gamma 95% CI [ICU]","Gamma p-value [ICU]","Gamma cancer: Event/Total [ICU]","Gamma Non-cancer: Event/Total [ICU]","Gamma Measure of Association {severe]","Gamma value [severe]","Gamma 95% CI [severe]","Gamma p-value [severe]","Gamma cancer: Event/Total [severe]","Gamma Non-cancer: Event/Total [severe]","Gamma Comment","Gamma Measure of Association [hospitalisation]","Gamma value [hospitalisation]","Gamma 95% CI [hospitalisation]","Gamma p-value [hospitalisation]","Gamma cancer: Event/Total [hospitalisation]","Gamma Non-cancer: Event/Total [hospitalisation]","Gamma Comment.1","Delta Total Number of patients","Delta Percentage","Delta Measure of Association [mortality]","Delta value [mortality]","Delta 95% CI [mortality]","Delta p-value [mortality]","Delta cancer: Event/Total [mortality]","Delta Non-cancer: Event/Total [mortality]","Delta Measure of Association [ICU]","Delta value [ICU]","Delta 95% CI [ICU]","Delta p-value [ICU]","Delta cancer: Event/Total [ICU]","Delta Non-cancer: Event/Total [ICU]","Delta Measure of Association {severe]","Delta value [severe]","Delta 95% CI [severe]","Delta p-value [severe]","Delta cancer: Event/Total [severe]","Delta Non-cancer: Event/Total [severe]","Delta Comment","Delta Measure of Association [hospitalisation]","Delta value [hospitalisation]","Delta 95% CI [hospitalisation]","Delta p-value [hospitalisation]","Delta cancer: Event/Total [hospitalisation]","Delta Non-cancer: Event/Total [hospitalisation]","Delta Comment.1","Omicron Total Number of patients","Omicron Percentage","Omicron Measure of Association [mortality]","Omicron value [mortality]","Omicron 95% CI [mortality]","Omicron p-value [mortality]","Omicron cancer: Event/Total [mortality]","Omicron Non-cancer: Event/Total [mortality]","Omicron Measure of Association [ICU]","Omicron value [ICU]","Omicron 95% CI [ICU]","Omicron p-value [ICU]","Omicron cancer: Event/Total [ICU]","Omicron Non-cancer: Event/Total [ICU]","Omicron Measure of Association {severe]","Omicron value [severe]","Omicron 95% CI [severe]","Omicron p-value [severe]","Omicron cancer: Event/Total [severe]","Omicron Non-cancer: Event/Total [severe]","Omicron Comment","Omicron Measure of Association [hospitalisation]","Omicron value [hospitalisation]","Omicron 95% CI [hospitalisation]","Omicron p-value [hospitalisation]","Omicron cancer: Event/Total [hospitalisation]","Omicron Non-cancer: Event/Total [hospitalisation]","Omicron Comment.1","Unspecified/Total Total Number of patients","Unspecified/Total Percentage","Unspecified/Total Measure of Association [mortality]","Unspecified/Total value [mortality]","Unspecified/Total 95% CI [mortality]","Unspecified/Total p-value [mortality]","Unspecified/Total cancer: Event/Total [mortality]","Unspecified/Total Non-cancer: Event/Total [mortality]","Unspecified/Total Measure of Association [ICU]","Unspecified/Total value [ICU]","Unspecified/Total 95% CI [ICU]","Unspecified/Total p-value [ICU]","Unspecified/Total cancer: Event/Total [ICU]","Unspecified/Total Non-cancer: Event/Total [ICU]","Unspecified/Total Measure of Association {severe]","Unspecified/Total value [severe]","Unspecified/Total 95% CI [severe]","Unspecified/Total p-value [severe]","Unspecified/Total cancer: Event/Total [severe]","Unspecified/Total Non-cancer: Event/Total [severe]","Unspecified/Total Comment","Unspecified/Total Measure of Association [hospitalisation]","Unspecified/Total value [hospitalisation]","Unspecified/Total 95% CI [hospitalisation]","Unspecified/Total p-value [hospitalisation]","Unspecified/Total cancer: Event/Total [hospitalisation]","Unspecified/Total Non-cancer: Event/Total [hospitalisation]","Unspecified/Total Comment.1","Other Total Number of patients","Other Percentage","Other Measure of Association [mortality].1","Other value [mortality].1","Other 95% CI [mortality].1","Other p-value [mortality].1","Other cancer: Event/Total [mortality].1","Other Non-cancer: Event/Total [mortality].1","Other Measure of Association [ICU].1","Other value [ICU].1","Other 95% CI [ICU].1","Other p-value [ICU].1","Other cancer: Event/Total [ICU].1","Other Non-cancer: Event/Total [ICU].1","Other Measure of Association {severe]","Other value [severe]","Other 95% CI [severe]","Other p-value [severe]","Other cancer: Event/Total [severe]","Other Non-cancer: Event/Total [severe]","Other Comment.2","Other Measure of Association [hospitalisation].1","Other value [hospitalisation].1","Other 95% CI [hospitalisation].1","Other p-value [hospitalisation].1","Other cancer: Event/Total [hospitalisation].1","Other Non-cancer: Event/Total [hospitalisation].1","Other Comment.3","COVID vaccination status:","vaccinated Total number of patients","vaccinated Percentage","vaccinated Measure of Association [mortality]","vaccinated value [mortality]","vaccinated 95% CI [mortality]","vaccinated p-value [mortality]","vaccinated cancer: Event/Total [mortality]","vaccinated Non-cancer: Event/Total [mortality]","vaccinated Measure of Association [ICU]","vaccinated value [ICU]","vaccinated 95% CI [ICU]","vaccinated p-value [ICU]","vaccinated cancer: Event/Total [ICU]","vaccinated Non-cancer: Event/Total [ICU]","vaccinated Measure of Association [severe]","vaccinated value [severe]","vaccinated 95% CI [severe]","vaccinated p-value [severe]","vaccinated cancer: Event/Total [severe]","vaccinated Non-cancer: Event/Total [severe]","vaccinated Measure of Association [hospitalisation]","vaccinated value [hospitalisation]","vaccinated 95% CI [hospitalisation]","vaccinated p-value [hospitalisation]","vaccinated cancer: Event/Total [hospitalisation]","vaccinated Non-cancer: Event/Total [hospitalisation]","vaccinated Comment","unvaccinated Total number of patients","unvaccinated Percentage","unvaccinated Measure of Association [mortality]","unvaccinated value [mortality]","unvaccinated 95% CI [mortality]","unvaccinated p-value [mortality]","unvaccinated cancer: Event/Total [mortality]","unvaccinated Non-cancer: Event/Total [mortality]","unvaccinated Measure of Association [ICU]","unvaccinated value [ICU]","unvaccinated 95% CI [ICU]","unvaccinated p-value [ICU]","unvaccinated cancer: Event/Total [ICU]","unvaccinated Non-cancer: Event/Total [ICU]","unvaccinated Measure of Association [severe]","unvaccinated value [severe]","unvaccinated 95% CI [severe]","unvaccinated p-value [severe]","unvaccinated cancer: Event/Total [severe]","unvaccinated Non-cancer: Event/Total [severe]","unvaccinated Measure of Association [hospitalisation]","unvaccinated value [hospitalisation]","unvaccinated 95% CI [hospitalisation]","unvaccinated p-value [hospitalisation]","unvaccinated cancer: Event/Total [hospitalisation]","unvaccinated Non-cancer: Event/Total [hospitalisation]","unvaccinated Comment","Is individual patient data available?"
>>>>>>> e9e7a88f1f39e2789ac070cc3e50eaf314fbb06b
"137597","Yienolu 2020","The outcome of COVID-19 in patients with hematological malignancy.","Consensus","Peer-reviewed","Journal of Medical Virology","Republic of Turkey, Ministry of Health Database","2020-08","The outcome of COVID19 in patients with hematological malignancy","Tugce N","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Republic of Turkey","N/A","","2020-03-11","2020-06-22","1480","Comparison of COVID-19 severity and mortality between cancer patient and control ","","Severity; Hospitalisation; ICU admission; Mortality","no"," All COVID19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbiditymatched COVID19 patients without cancer (n = 740) at 1:1 ratio was used for comparison.","All COVID19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbidity-matched COVID19 patients without cancer (n = 740) at 1:1 ratio was used for comparison","All COVID19 patients with hematological malignancy (n = 740) were included in the study and age, sex, and comorbidity-matched COVID19 patients without cancer (n = 740) at 1:1 ratio was used for comparison",NA,"median","56","range","18-94","53.6","740","median","56","range","18-87","54.1","740","Not mentioned",NA,"","","","","",NA,"","","379","51.2","378","51.1","",NA,"","1","198","26.8","198","26.8","",NA,"","1","156","21.1","135","18.2","","","","0.2","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","175","23.6","164","22.2","","","","0.5","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Severe COVID-19 was defined as the existence of dyspnea, blood oxygen saturation less than or equal to 93% PaO2/FiO2 <300 greater than 50% in lung infiltration within 24 hours to 48hours. Critical COVID-19 was described as the existence of respiratory failure septic shock and/or multiple organ failure. ","physical admission to ICU","case-fatality rate: follow up not specified","Combined Severe + Criticial cohorts: Severe COVID19 was defined as the existence of dyspnea, blood oxygen saturation less than or equal to 93%, PaO2/FiO2 < 300 and greater than 50% progression in lung infiltrates within 24 to 48 hours. Critical COVID19 was defined as the existence of respiratory failure, septic shock, and/or multiple organ dysfunctions.","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","740","Crude OR","0.45","0.32-0.65","8.48e-6","0.138 (102/740)","0.0676 (50/740)","Crude OR","1.80","1.34-2.41","6.84E-05","0.189 (140/740)","0.115 (85/740)","Crude OR","1.66","1.30-2.11","3.67E-05","0.288 (213/740)","0.196 (145/740)","Crude ORs - calculated by extractor","","","","","0.611 (452/740)","0.553 (409/740)","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"740","Crude OR","0.45","0.32-0.65","8.48e-6","0.138 (102/740)","0.0676 (50/740)","Crude OR","1.80","1.34-2.41","6.84E-05","0.189 (140/740)","0.115 (85/740)","Crude OR","1.66","1.30-2.11","3.67E-05","0.288 (213/740)","0.196 (145/740)","Crude ORs - calculated by extractor","","","","","0.611 (452/740)","0.553 (409/740)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"1480","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"131660","Muge 2021","Comparison of Systemic Immune-Inflammation Index (SII), Early Warning Score (ANDC) and Prognostic Nutritional Index (PNI) in Hospitalized Patients with Malignancy, and Their Influence on Mortality from COVID-19 (preprint)","Consensus","Other: Peer-reviewed","Infectious Agents and Cancer","","2021-09-15","Comparison of Systemic Immune-Inflammation Index (SII), Early Warning Score (ANDC) and Prognostic Nutritional Index (PNI) in Hospitalized Patients with Malignancy, and Their Influence on Mortality from COVID-19","Bilge M","Retrospective","Cohort","Yes","Other: Inpatient","Turkey","Istanbul","Prof. Dr. Murat Dilmener Emergency Hospital","2020-09-01","2020-12-31","186","Mortaility","ICU admission","Severity; ICU admission; Mortality","Other: No","No limits on type of malignancy, simple stated as ""various malignancies""","No malignancy","75:111; age matched; comorbidity matched",NA,"Mean","64.69 ","Variance","12.98  ","62.7","75","Mean","64.81","Variance","6.35 ","63.0","111","Not mentioned",NA,"","","","","",NA,"","","33","44%","50","45%","",NA,"","Not significant","20","26.7%","21","18.9%","",NA,"","Not significant","8","10.7%","24","21.6%","","","","Not significant","","","","","",NA,"",NA,"","","","","",NA,"","","4","5.3%","6","5.4%","",NA,"","Not significant","7","9.3%","5","4.5%","","","","Not significant","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","Not specified; simply categorised into moderate and severe categories","univariate","Age; Sex; Comorbidities",NA,"15","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"7","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"14","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","","","","","","","","","","","","","","","14","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"75","uOR","2.39","1.803.16","","17.3%","2.7%","cRR","0","","","0/75=0.00%","0/111=0.00%","cRR for moderate disease; cRR for severe disease","Moderate: 41.3/51.4=0.804; Severe: 58.7/48.6=1.21","","Not significant; not significant","41.3%; 58.7%","51.4%; 48.6%","No p-value stated; simply reported ""not significant"" for disease status between cancer and non-cancer groups","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"128789","Joaquin 2020","Multiple Myeloma and SARS-CoV-2 Infection: Clinical Characteristics and Prognostic Factors of Inpatient Mortality (preprint)","Consensus","Peer-reviewed","Blood Cancer Journal ","This retrospective case series investigated 167 patients reported from 73 hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes were compared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admitted at six participating hospitals. A modified version of a questionnaire proposed by the International Myeloma Society was used for data extraction. A common set of demographic, clinical, laboratory, treatment, and outcome variables were collected for the MM and noncancer cohorts of hospitalized COVID-19 patients. Specific disease status and treatment data were obtained for MM patients. Data extraction was performed locally by hematology departments in participating hospitals and centrally processed by the PETHEMA/GEM data-monitoring unit","2020-10","Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality","Martnez-Lpez J","Retrospective","Cohort","Yes","inpatient","Spain","N/A","","2020-03-01","2020-04-30","210","mortality, severity ","","Severity; Mortality","no","patients diagnosed with multiple myeloma  active cancer n=43  *active cancer*","167 MM patients reported from 73 hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes were compared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admitted at six participating hospitals.  matched for age and sex 1:1","ratio of cancer to non-cancer = 1:1 age and sex matched = 1:1",NA,"median","71","IQR","62 - 78","57","167","median","71","IQR","63 - 78","57","167","Not mentioned",NA,"","","","","",NA,"","","67","40","79","47","",NA,"","","28","17","36","22","",NA,"","","35","21","32","19","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","32","19","13","8","",NA,"","","23","14","34","20","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","inpatient mortality ","","Other: crude OR/CI/p-values calculated as univariate/multivariate analysis not provided for outcomes of interest","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","Multiple Myeloma 43","cOR","3.24","1.61 - 6.52","0.00103","0.488 (21/43)","0.228 (38/167)","","","","","","","","","","","","","I calculated crude OR, CI and p-value for mortality and active MM (n=43) vs. non-cancer (n=167). Raw mortality data taken from table 1 and 2","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"124497","Brijesh 2023","Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2 (preprint)","Consensus","Peer-reviewed","Cardio-Oncology","National COVID Cohort Collaborative (N3C) supported by NIH","2023-10","Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2","Brijesh Patel","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","United States","N/A","N/A","2020-01-01","2022-07-22","418306","1) Major adverse cardiac events: acute heart failure, stroke, myocardial infarction, death as all-cause mortality   2) Death all-cause mortality ","Survival probability for COVID-19 strains ","Severity; Mortality","no","Cancer cohort: Active oncologic condition - received chemotherapy within 30 days before or after index admission + Cardiovascular disease + Covid positive   Cancers that were excluded included non-melanoma skin cancers, benign tumors, or unknown types: to avoid uncertainties related to unknown cancer types, and to prevent the incorporation of relatively benign cancers that may not reflect the serious implications typically associated with malignancies. ","Non-cancer cohort: Cardiovascular disease + NO cancer + Covid positive, drawn from patients from the same N3C database from hospitals across the US  Cancer (cardioonc +): control (CVD +) = 1414: 41985","All patients had cardiovascular disease  Cancer (cardioonc +): control (CVD +) = 1414: 41985 Not matched ",NA,"% of those >65 = 63.3%","","","","50.7","1414","% of those >65 = 62.9%","","","","56.6","41985","Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"","","","","",NA,"","","1190","84.2","31978","76.2","",NA,"","","649","45.9","22283","53.1","",NA,"","","All patients have but specific ones - Atrial fibrillation/flutter; chronic heart failure; chronic ischaemic heart disease; history of CABG; pacemaker ICD; peripheral vascular disease; prior heart transplant; prior heart valve; valvular heart disease: 488; 623; 853; 40; 24; 945; 24; 62; 797","34.5; 44.1; 60.3; 20.8; 1.7; 66.8; 1.7; 4.4; 56.4","14086; 19785; 28195; 1319; 409; 29209; 350; 1940; 16802","33.6; 47.1; 67.2; 3.1; 1; 69.6; 0.8; 4.6; 40","","","","","245","17.3","6852","16.3","",NA,"",NA,"","","","","",NA,"","","650","46","17063","40.6","",NA,"","","COPD  204","14.4","3506","8.4","","","","","Prior heart transplant 24","1.7","350","0.8","","","","",NA,NA,NA,NA,"",NA,"",NA,"Alcohol abuse; asthma; dyslipidemia: 103; 81; 998 ","7.3; 5.7; 70.6","2815; 1636; 28779","6.7; 3.9; 68.5","","","","","","","","","","","","","MACE (major adverse cardiac events) = acute heart failure, stroke, myocardial infarction, death as all-cause mortality ","","All-cause mortality ","MACE (major adverse cardiac events) = acute heart failure, stroke, myocardial infarction, death as all-cause mortality between January 1, 2020 and July 21, 2022  But MACE was adjusted: the cumulative incidences from each component in MACE including stroke, acute heart failure and MI were estimated and compared between different disease groups using competing risk analysis adjusting for the death  the terminal event.","multivariate","Age; Sex; Comorbidities; Other: BMI and other available patient characteristics  the cumulative incidences from each component in MACE including stroke, acute heart failure and MI were estimated and compared between different disease groups using competing risk analysis adjusting for the death  the terminal event.",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1391","cOR","1.8620 ","1.6599-2.0887","P < 0.0001 ","0.324 (450/1391)","0.204 (8310/40666)","","","","","","","cOR","1.3037 ","1.1715-1.4508","P < 0.0001 ","0.498 (693/1391)","0.432 (17581/40666)","CardioOnc+WRTCardioOnc-_CalculatedRatio: Cardio onc + / CVD+","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","1391","cOR","1.8620","1.6599-2.0887","P < 0.0001","0.324 (450/1391)","0.204 (8310/40666)","",NA,"","","","","cOR","1.3037","1.1715-1.4508","P < 0.0001","0.498 (693/1391)","0.432 (17581/40666)","","",NA,"","","","",NA,NA,"791","55.9","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","537","38","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"382","27","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","297","21","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"737","52.1% of all cancer covid patients ","cOR","2.0391","1.7509-2.3746","P < 0.0001","0.376 (277/737)","0.228 (5047/22137)","",NA,"",NA,"","","cOR","1.3806","1.1914-1.5998","P < 0.0001","0.545 (402/737)","0.465 (10294/22137)","","",NA,"",NA,"","","Early strain",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"262","18.5% of all cancer covid patients","cOR","1.1457","0.8569-1.5318","P = 0.3586","0.225 (59/262)","0.167 (1075/6440) ",NA,NA,NA,NA,NA,NA,"cOR","1.1753","0.9139-1.5113","P = 0.2082","0.408 (107/262)","0.370 (2383/6440)","",NA,NA,NA,NA,NA,NA,NA,"68","4.81% of all cancer covid patients","cOR","1.5941","0.8746-2.9052","P = 0.1279","0.206 (14/68)","0.140 (303/2166)",NA,NA,NA,NA,NA,NA,"cOR","1.0173","0.6139-1.6859","P = 0.9469","0.353 (24/68)","0.349 (756/2166)","",NA,NA,NA,NA,NA,NA,NA,"1391","100%","cOR","1.8620","1.6599-2.0887","P < 0.0001","0.324 (450/1391)","0.204 (8310/40666)","","","","","","","cOR","1.3037","1.1715-1.4508","P < 0.0001","0.498 (693/1391)","0.432 (17581/40666)","","","","","","","","1391 is not the same as the total number of cardioonc patients (1414) reported in table 1","324 Alpha","22.9% of all cancer covid patients","cOR","1.9037","1.4960-2.4224","P < 0.0001","0.309 (100/324)","0.190 (1885/9923)","",NA,"",NA,"","","cOR","1.3583","1.0885 to 1.6949","P = 0.0067","0.494 (160/324)","0.418 (4148/9923)","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"124006","Bazgir 2022","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Consensus","Peer-reviewed","International Journal of Cancer Management","Ilam COVID-19 monitoring and evaluation project (Ilam-CEMP)","2022-10","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy"," Bazgir N.","Retrospective","Cohort","Yes","inpatient","Iran","Ilam","N/A","2020-03-05","2021-03-21","320","in-hospital mortality ","intensive care unit (ICU) admission mechanical ventilation median survival ","ICU admission; Mortality","no","Active cancer - i.e., receiving treatments in the past 2 months. ","Same hospital","64:256 Age and gender matched Multivariate analysis adjusted for comorbidities. ",NA,"mean","63.9 "," SE","2.5","53.1","64","mean","62.1"," SE","0.8","52.7","256","Not mentioned",NA,"0","0","7","2.7","",NA,"","","21","32.8","97","37.9","",NA,""," ","11","17.2","64","25","",NA," ","","14","21.9","76","29.7","",""," ","","8","3.1","2","3.1","",NA,"",NA,"","","","","",NA,"","","14","5.5","5","7.8","",NA,"","","20","7.8","5","7.8","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Requiring mechanical ventilation ","Admission to ICU during follow up (hospital stay) ","12 month mortality","Requiring mechanical ventilation ","univariate; multivariate","Age; Sex",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"64","uHR; mHR","2.79; 2.27","1.70 - 4.59; 1.25 - 4.13","<0.001; 0.007","0.45 (29/64); 0.45 (29/64)","0.136 (35/256); 0.136 (35/256)","","","","","0.56 (36/64)","0.266 (68/256)","","","","","0.37 (24/64)","NR","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"28","44","","","","","0.57 (16/28)","0.136 (35/256)","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"122739","Adrian 2021","Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): A Sub-Study of the Philippine CORONA Study (preprint)","Consensus","Peer-reviewed","Frontiers in Oncology","Database from previous clinical trial, The Philippine CORONA study (NCT04386083)","2022-04","Outcomes and Risk Factors of Patients With COVID-19 and Cancer (ONCORONA): Findings from The Philippine CORONA Study","Espiritu A. I.","Retrospective","Cohort","Yes","not specified","The Philippines","Nationwide","Asian Hospital and Medical Center, Muntinlupa City; Baguio General Hospital and Medical Center, Baguio City; Cagayan Valley Medical Center, Tuguegarao City; Capitol Medical Center, Quezon City; Cardinal Santos Medical Center, San Juan City; Chong Hua Hospital, Cebu City; De La Salle University Medical and Health Sciences Institute, Dasmarias City; East Avenue Medical Center, Quezon City; Jose B. Lingad Memorial Regional Hospital, City of San Fernando, Pampanga; Dr. Jose N. Rodriguez Memorial and Sanitarium Hospital, Caloocan City; Jose R. Reyes Memorial Medical Center, Manila; Lung Center of the Philippines, Quezon City; Manila Doctors Hospital, Manila; Medical Center Manila, Manila; Makati Medical Center, Makati City; New Era General Hospital, Quezon City; Northern Mindanao Medical Center, Cagayan de Oro City; Quirino Memorial Medical Center, Quezon City; Ospital ng Makati, Makati City; Perpetual Succour Hospital, Cebu City; Dr. Pablo O. Torre Memorial Hospital (Riverside Medical Center, Inc.), Bacolod City; University of the PhilippinesPhilippine General Hospital, Manila; Philippine Heart Center, Quezon City; Research Institute for Tropical Medicine, Muntinlupa City; San Lazaro Hospital, Manila; San Juan De Dios Educational Foundation Inc.Hospital, Pasay City; Southern Isabela Medical Center, Santiago City; St. Lukes Medical Center, Quezon City; St. Lukes Medical Center, Bonifacio Global City, Taguig City; Southern Philippines Medical Center, Davao City; The Medical City, Pasig City; University of the East Ramon Magsaysay Memorial Medical Center, Inc., Quezon City; University of Santo Tomas Hospital, Manila; Veterans Memorial Medical Center, Quezon City; Vicente Sotto Memorial Medical Center, Cebu City; Western Visayas Medical Center, Iloilo City; Zamboanga City Medical Center, Zamboanga City","2020-02","2020-12","10881","Mortality, respiratory failures, duration of ventilator dependence, intensive care unit (ICU) admission, length of ICU and hospital stay","","Severity; Hospitalisation; ICU admission; Mortality","no"," 19 years old with cancer in hospital record (ambiguous timecourse)","Controls from the same 37 hospitals","Ratio of cancer:non-cancer: 244:10637 Cancer cohort significantly more likely to be female and  60 years old (James chi2)",NA,"","","","","48.90%","244","","","","","53.5%","10637","Not mentioned",NA,"31","12.7%","995","9.4%","",NA,"","<0.001","113","46.3%","3534","33.2%","",NA,"","<0.001","64","26.2%","2127","20.0%","",NA,"","0.016","20","8.2%","492","4.6%","","","","0.009","14","5.7%","307","2.9%","",NA,"","0.009","1","0.4%","59","0.6%","",NA,"","1.000","24","9.8%","587","5.5%","",NA,"","0.004","12","4.9%","604","5.7%","","","","0.611","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Did not specify","ICU admission evidenced on EPIC","in hospital mortality (before discharge/ transfer)","COVID-19 severity at nadir: mild/moderate, severe/critical","univariate; multivariate","Age; Sex; Comorbidities; Other: y adjusted for age group, sex, smoking history, hypertension, diabetes, chronic cardiac disease, chronic kidney disease, chronic respiratory disease, and chronic neurologic disease",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"244","uOR; uHR; mHR","2.71; 2.07; 1.72","2.06-3.56; 1.65-2.59; 1.37-2.16","8.87E-14; nr; nr","0.328 (80/244)","0.152 (1622/10637)","uOR; uHR; mHR","2.54; 2.25; 1.57","1.93-3.34; 1.79-2.83; 1.24-1.97","5.73E-12; nr; nr","0.320 (78/244)","0.156 (1662/10637)","uOR; aOR","1.79; 1.75","1.39-2.31; 1.32-2.33","5.55E-06; nr","0.521 (125/244); 0.521 (125/244)","0.374 (3936/10637); 0.374 (3936/10637)","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"10881","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"81620","Johannesen 2021","COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway.","Consensus","Peer-reviewed","Frontiers in Oncology"," Norwegian Surveillance System for Communicable Diseases  Data on cancer and treatment was available from the Cancer Registry of Norway, the Norwegian Patient Registry and the Norwegian Prescription Database","2021-03","COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway","Johannesen T.B","Retrospective","Cohort study","Yes","inpatient and outpatient (no breakdown)","Norway","N/A","N/A","2020-01-01","2020-05-31","8410","Death due to Covid-19 ","Combined outcome: Death and/or admitted to hospital due to COVID-19","Hospitalisation; Mortality; Other: Combined outcome: Death and/or admitted to hospital due to COVID-19","no","Any cancer diagnosis before the confirmed diagnosis of Covid-19. Cancer group split by treatment recency <1 year, 1-5 years, >5 years since cancer diagnosis. Only data on <1 year since cancer diagnosis included below. ","Same cohort without history of cancer","No matching",NA,"","","","","","53","","","","","","7841","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Death and/or admission to hospital due to Covid19","","Norwegian Cause of Death Registry all deaths up to May 31, 2020 were included. The registry follows the WHO guidelines for certifying COVID-19 as a cause of death and the ICD-10 code U07.1 was used for defining COVID-19 as the underlying cause of death. The definition of the causal sequence leading to death due to COVID-19 was followed and 19 patients with COVID-19 as contributing but not underlying cause of death were excluded","Death and/or admission to hospital due to Covid19","univariate; multivariate","Age; Sex; Other: Multivariate model adjusted for age and gender.  Unclear about any other additional variables - potentially all variables in table 5  (all cancer, solid tumour, non solid tumour, localised/ regional disease, distant disease, unknown stage, chemo therapy, immunotherapy, steroids, radiotherapy, surgery).",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"53","","","","","","","","","","","","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53);0.400 (21/53)","0.110 (854/7841);0.110 (854/7841)","table5:Non cancer mortality and/or hospitalisation due to covid not given but stated as comparison group","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53;53","","","","","","","",NA,"","","","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53);0.400 (21/53)","0.110 (854/7841);0.110 (854/7841)","Non cancer mortality and /or hospitalisation due covid not given but stated as comparison group ","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","53","","",NA,"","","","","",NA,"",NA,"","","uOR; mOR","5.37; 2.08","3.08-9.35; 1.14-3.80","","0.400 (21/53)","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"81415","Mohamed 2021","COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes.","Consensus","Peer-reviewed","Journal of Cancer Biology","Mount Sinai Health System EHRs (NYC)","2021-03","COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes","Mohamed NE","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","USA","New York, USA","8 Hospitals comprising the Mount Sinai Health System (Mount Sinai Beth Israel, Mount Sinai Brooklyn, Mount Sinai Hospital, Mount Sinai Queens, Mount Sinai Morningside, Mount Sinai West, New York Eye and Ear Infirmary of Mount Sinai, Mount Sinai South Nassau).","2020-03-28","2020-04-26","4641","Mortality","Hospitalisation","Hospitalisation; Mortality","no","""cancer status (yes, no).""","All patients who tested positive for covid-19 across the same hospital group over the same period whom were not included in the cancer cohort","Table 1 shows gender matched but mismatch in terms of age and ethnicity.",NA,"Median","69","IQR","61-78","55.35","236","Median","57","IQR","40-70","55.20","4405","Not mentioned",NA,"94","39.8","797","18.1","OR (univariate)","1.55","1.20 - 1.56",">.1","118","50.0","929","21.1","aOR","1.32","1.00 - 1.74",".1","73","30.9","672","15.3","aOR","1.27","0.95 - 1.70",".1","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","32","13.6","256","5.81","","","","","11","4.6","60","1.4","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Not assessed","/","Does not specify beyond "" during the observation period"" - unclear if this has the same cut-off dates as the inclusion period","Not given","univariate; multivariate","Age; Sex; Comorbidities; Other: Age, sex, smoking status, COPD, HTN, DM, Obesity, Cancer",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"236","aOR","1.58,0.85","1.05-2.36,0.56-1.29","NA,NA","0.123","0.081","","","","","","","","","","","","","p value not given for MV - included in MV regression so had to have a significance of p0.1 on univariate to be included.","Crude OR","1.07","0.67-1.71","0.779","0.915","0.910","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","236","","","","","0.123","0.081","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"4641","100","","","","","0.123","0.081","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"79599","Noh 2023","Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.","Consensus","Peer-reviewed","Cancer Medicine","Cancer pts: The University of Texas MD Anderson Cancer Center Controls: The University of Texas Health Science Center at Houston, UTH","2023-07","Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study","Noh S","Prospective","Cohort","Yes","inpatient","USA","Texas USA","The University of Texas MD Anderson Cancer Center and The University of Texas Health Science Center at Houston, UTH.","2020-03","2021-06","139","WHO Clinical Progression Scale","Radiographic data","Severity; ICU admission","no","Patients recruited from a cancer centre (University of Texas MD Anderson Cancer Centre MDACC)","Patients without cancer at a tertiary referral centre (University of Texas Health Science Center at Houston UTH) both in the same city.","Not formally controlled. Chi2 confirms matched for sex.",NA,"Mean","60","Range","50-69","53","94","Mean","54","Range","45-65","49","45","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","WHO scale 6, 7, 8 or 9","World Health Organization (WHO) clinical progression scale of 7, 8 or 9","not reported","WHO scale 6, 7, 8, 9","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"94","","","","","","","uOR","0.46","0.11 - 1.91","0.27","0.0426","0.0889","uOR","0.58","0.28 - 1.21","0.15","0.298","0.422","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","94","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"94","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"78588","Dai 2020","Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China","Consensus","Peer-reviewed","Cancer Control","","2020-09","Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China","Dai MY","Retrospective","Cohort","Yes","inpatient","China","Wuhan","6 hospitals in Wuhan, China: Zhongnan  Hospital  of  Wuhan  University,  The  Leishenshan  Hospital,  Hubei  Cancer  Hospital,  Union Hospital affiliated to Tongji Medical College, The Central Hospital of Wuhan, Wuhan Seventh hospital","2020-01-01","2020-03-01","217","Severe event, ICU, IMV, Death","Restricted mean survival time for each of the primary outcomes","Severity; ICU admission; Mortality","no","*Pre-existing diagnostic code of lung cancer* active rx within last 3 months presented for MV regression giving aOR of death for several different chemotherapy methods in table s3.","A matched cohort of inpatients from the same six hospitals whom did not have a pre-existing diagnostic code for cancer","Matched for age, sex, region and time period with 1:6 cancer: control",NA,"Mean","67.26","SD","8.40","80.6","31","","","","","","186","Not mentioned",NA,"15","48.39","","","",NA,"","","9","29.03","","","",NA,"","","4","12.90","","","",NA,"","","4","12.90","","","","","","","2","6.45","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","3","9.68","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Severe symptoms according to the 5th edition of 2019 novel coronavirus disease diagnostic criteria published by the national health commission in China. Definition is as follows. Adults who meet any one of the following:1.Shortness of breath, RR>30 breaths/minute; 2.Oxygen saturation<93% at rest;3.Arterial oxygen partial pressure (PaO2)/ fraction of inspired oxygen (FiO2)<300mmHg(1mmHg=0.133kPa);4.The patient should be managed as a severe case if lung imaging shows a substantial progression of lesions (greater than 50%) within 24-48 hours.","Physical ICU admission (not just IMV)","Death before end date of the study","Severe symptoms according to the 5th edition of 2019 novel coronavirus disease diagnostic criteria published by the national health commission in China. Definition is as follows. Adults who meet any one of the following:1.Shortness of breath, RR>30 breaths/minute; 2.Oxygen saturation<93% at rest;3.Arterial oxygen partial pressure (PaO2)/ fraction of inspired oxygen (FiO2)<300mmHg(1mmHg=0.133kPa);4.The patient should be managed as a severe case if lung imaging shows a substantial progression of lesions (greater than 50%) within 24-48 hours.","multivariate","Age; Sex; Other: Smoking hx, smoking, surgey,   Radiotherapy, Chemotherapy, Targeted therapy, Immunotherapy), IL-6 (not cancer vs no controls)",NA,"31","mHR","3.87","1.02 - 14.71","0.047","0.258 (8/31)","","mHR","4.72","1.19 - 18.72","0.027","0.322 (10/31)","","mHR","4.28","1.44 - 12.71","0.009","0.548 (17/31)","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"31","mHR","3.87","1.02 - 14.71","0.047","0.258 (8/31)","","mHR","4.72","1.19 - 18.72","0.027","0.322 (10/31)","","mHR","4.28","1.44 - 12.71","0.009","0.548 (17/31)","","","","","","","","","",NA,"15","","","","","0.267 (4/15)","","","","","","0.267 (4/15)","",NA,NA,NA,NA,"0.467 (7/15)",NA,"","","","","","",NA,NA,"12","","","","","0.250 (3/12)","","","","","","0.333 (4/12)","","",NA,"",NA,"0.583 (7/12)","","","","","","","","","","4","","","","","0.250 (1/12)","","",NA,"","","0.500 (2/4)","","","","","","0.500 (2/4)","","","",NA,"","","","",NA,NA,"10","32.3","aOR (MV reg)","0.190","0.014 - 2.537","0.209","","","","","","","","","aOR (MV reg)","0.295","0.033 - 2.635","0.275","",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"3","9.68","aOR (MV reg)",NA,NA,NA,"","","","","","","","","aOR (MV reg)",NA,NA,NA,"",NA,"","","","","","","","","8","25.8","aOR (MV reg)","5.150","0.332 - 79.969","0.241","","","","","","","","","aOR (MV reg)","1.555","0.137 - 17.705","0.722","","","","","","","","","","","4","12.9","aOR (MV reg)","0.983","0.047 - 20.494","0.991","","","","","","","","","aOR (MV reg)","0.368","0.025 - 5.415","0.466","",NA,NA,"","","","","","","","7","22.6","aOR (MV reg)","1.255","1.019 - 4.287","0.030","","",NA,NA,NA,NA,NA,NA,"aOR (MV reg)","1.342","0.049 - 2.366","0.027","",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"31","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"75567","Bazgir 2022","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Consensus","Peer-reviewed","International Journal of Cancer Management","all patients with COVID-19 who were admitted to the hospital were eligible for enrolment into the Ilam COVID-19 monitoring and evaluation project (Ilam-CEMP). The Ilam-CEMP is one of the first registries in the country (Iran) that enables near real-time monitoring of essential data and trends about the effect of COVID-19 on patients","2022-10","Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy","Bazgir N","Retrospective","Cohort","Yes","inpatient","Iran","Ilam","urban primary and secondary academic hospital in Ilam.","2020-03-05","2021-03-21","2350","This studys primary outcome was in-hospital mortality or discharge from the hospital.","","ICU admission; Mortality; Other: Survival probability","no","Patients with active cancer were defined as those receiving treatments for cancer such as adjuvant, radical, cura-tve, neo-adjuvant settings, or chemotherapy within the past two months. ","At the same time, 256 controls matched cases by age, gender, and without a history of cancer were randomly selected from the same registry dataset.","We analyzed 64 (2.7%) patients diagnosed with cancer and symptomatic COVID-19. In this study, 64 patients with cancer were compared to 256 patients (by age and gender) without cancer at Irans urban academic hospital.",NA,"Mean","63.9","SD","2.5","53.1","64","Mean","62.1","SD","0.8","52.7","256","",NA,"0","0","7","2.7","",NA,"","","21","32.8","97","37.9","",NA,"","0.45","11","17.2","64","25","",NA,"","0.19","14","21.9","76","29.7","","","","0.21","8","3.1","2","3.1","",NA,"","1","","","","","",NA,"","","14","5.5","5","7.8","",NA,"","0.48","20","7.8","5","7.8","","","","1.00","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","univariate; multivariate","Age; Sex",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"64","uHR; aHR","2.79; 2.27","1.70-4.59; 1.25-4.13","<0.001; 0.007","0.453 (29/64); 0.453 (29/64)","0.137 (35/256); 0.137 (35/256)","uHR; aHR","10.8; 6.68","5.11-22.72; 2.97--15.01","<0.001; <0.001","0.563 (36/64); 0.563 (36/64)","0.266 (68/256); 0.266 (68/256)","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"28","44","uHR; aHR","3.14; 1.65","1.77-5.57; 0.60-4.56","<0.001; 0.33","0.571 (16/27); 0.571 (16/27)","0.137 (35/256); 0.137 (35/256)","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"75065","Zhou 2023","Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study","Consensus","Peer-reviewed","Cancer Medicine","population based study on patients who presented to Hong Kong public hospitals and outpatient clinics using CDARS, a territory-wide database that centralizes patient information from 43 local hospitals and their associated ambulatory and outpatient facilities","2022-01","Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study","Zhou J","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","China","Hong Kong","43 local hospitals and their associated ambulatory and outpatient facilities","2020-01-01","2020-12-08","6089","composite endpoint of requirement for intubation, ICU admission and 30-day mortality. Details regarding the individual components that constitute this composite endpoint were extracted from CDARS","","Severity; ICU admission; Mortality","no","The inclusion criteria for this study were as follows: patients who had a positive RT-PCR for COVID-19, had pre-existing active malignancy diagnosed by clinical, radiological and pathological investigations and were admitted to the public hospital within the stated time period. The exclusion criteria included malignancy diagnosed after COVID-19 infection and patients in complete remission from cancer.","Same hospitals   The following study consisted of 6089 COVID-19 patients (median age: 45.9 [27.8.162.7] years; 50% male), of which 142 were cancer subjects","ratio of cancer to non-cancer = 142:5947  no matching mentioned or evident ",NA,"Median","63.82","IQR","51.0178.62","45.07","142","Median","45.22","IQR","27.6262.33","49.87","5947","Not mentioned",NA,"","","","","",NA,"","","54","38.02","845","14.2","cOR","3.71","2.62 - 5.24","0","11","7.74","132","2.21","cOR","3.7","1.95 - 7.01","0.00007","","","","","","","","","9","6.33","112","1.88","cOR","3.53","1.75 - 7.10","5e-04","3","2.11","29","0.48","cOR","4.4","1.33 - 14.63","0.0154","1","0.7","15","0.25","cOR","2.8","0.37 - 21.38","0.3245","6","4.22","75","1.26","cOR","3.45","1.48 - 8.07","0.0042","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"systemic embolism 1, gastrointestinal bleeding 12, obesity 1, dementia and alzheimer's 3, heart failure 1, atrial fibrillation 5, ventricular tachycardia/fibrillation 3, acute MI 6, ischaemic heart disease 16, peripheral vascular disease 2","systemic embolism 0.7, gastrointestinal bleeding 8.45, obesity 0.7, dementia and alzheimer's 2,11, heart failure 0.70, atrial fibrillation 3.52, ventricular tachycardia/fibrillation 2.11, acute MI 4.22, ischaemic heart disease 11.26, peripheral vascular disease 1.4","systemic embolism 16, gastrointestinal bleeding 103, obesity 23, dementia and alzheimer's 22, heart failure 31, atrial fibrillation 84, ventricular tachycardia/fibrillation 28, acute MI 68, ischaemic heart disease 180, peripheral vascular disease 25","systemic embolism 0.26, gastrointestinal bleeding 1.73, obesity 0.38, dementia and alzheimer's 0.36, heart failure 0.52, atrial fibrillation 1.41, ventricular tachycardia/fibrillation 0.47, acute MI 1.14, ischaemic heart disease 3.02, peripheral vascular disease 0.42","","","","","CVD has been separated out in ""others""  Chronic lung disease = COPD  Cerebrovascular disease = stroke/TIA","","","","","Self-calculated","Self-calculated","Self-calculated","","The primary outcome was a composite endpoint  of patients who required intubation, required intensive care unit (ICU) admission and/or suffered 30-day mortality.","30 day mortality ","""patients with malignancy more frequently progress to severe complications, ranging from liver injury  and acute respiratory distress syndrome"". In this paper they present outcomes as severe COVID-19 composite outcome. The primary outcome was a composite endpoint of requirement for intubation, ICU admission and 30-day mortality","univariate; multivariate","Age; Sex; Comorbidities; Other: multivariate analysis is also adjusted for medication treatments ",NA,"lung 9","","","","","","","","","","","","","aHR","3.19","0.88 - 11.54","0.0766","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","27","","","","","","","","","","","","","aHR","2.73","0.76 - 9.79","0.1222","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","gastrointestinal 14","","","","","","","","","","",NA,NA,"aHR","3.79","1.12 - 12.88","0.0325",NA,NA,"outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","",NA,NA,"colorectal 11","","","","","","","","","","","","","aHR","5.07","1.5 - 17.17 ","0.0091","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"genitourinary 8","","","","","","","","","","","","","aHR","2.63","0.67 - 10.31","0.1659","","","outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","85","","","","","","","","","","","","","aHR","1.34","0.58 - 3.11","0.4897",NA,NA,"outcome = severe COVID-19 composite outcome in hospitalized patients","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"154","","","","","","","","","","","","","aHR","3.77","1.63 - 8.72 ","0.0019","","","outcome = severe COVID-19 composite outcome in hospitalized patients; Composite outcome of intubation ICU admission and/or 30-day mortality","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"74954","Kodde 2023","Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network","Consensus","Peer-reviewed","Infection","QlikView","2022-06-03","Mortality in cancer patients with SARSCoV2 or seasonal influenza:  an observational cohort study from a Germanwide hospital network","Kodde C","Retrospective","Cohort","Yes","inpatient","Germany","","Helios group hospitals (85)","2020-01","2021-08","36726","Mortality, mechanical ventilation","","Severity; Mortality","no","The cancer cohort was defined by the presence of any of the three related Elixhauser comorbidities (lymphoma, meta- static cancer, solid tumor).","Same hospital group","1625:27659",NA,"Mean","72.2","SD","11.8","58.2","1625","Mean","68.0","SD","17.6","52.1","27659","Not mentioned",NA,"","","","","",NA,"","","Uncomplicated: 733 Complicated: 219","Uncomplicated: 45.1% Complicated: 13.5%","","","",NA,"","","Uncomplicated: 301 Complicated: 186","Uncomplicated: 18.5% Complicated: 11.4%","","","",NA,"","","CHF: 402","CHF: 24.7%","","","","","","","","","","","",NA,"",NA,"116","7.1%","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Need for mechanical ventilation","Not specified","In-hospital mortality","","univariate; multivariate","Age; Sex; Comorbidities; Other: comorbidities: Elixhauser index",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1625","mOR","2.10","1.88-2.35","<0.01","0.349 (530/1519)","0.203 (5483/27015)","","","","","0.294 (477/1625)","0.276 (8076/29284)","mOR","0.82","0.72-0.94","<0.01","","","","","","","","","","",NA,"1391","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"629","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73804","Starkey 2023","A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","Consensus","Peer-reviewed","Nature Scientific Reports","National Cancer Registry UK and National Immunisation Management Service (NIMS)","2023-07","A populationscale temporal casecontrol evaluation of COVID19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","Thomas Starkey","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","England","Population Scale (England)","Population Scale (England)","2020-11-01","2022-08-31","15928326","Hospitalisation, ICU, COVID-19 mortality","Hospital assessment","Hospitalisation; ICU admission; Mortality","yes","On the National Cancer Registry UK","Same National Cohort (National Immunisation Management Service (NIMS) of the UK)","No matching specified. Have assessed manually and cohorts match neither in terms of sex nor in terms of age. Approx 1:124.1 cancer: control.Multivariate aORs are adjusted for age, sex, ethnicity and deprivation however.",NA,"","","","","50.48","127322","","","","","43.05","15801004","Other: ORs and base rates are given for each of the four outcomes for each two month period so could be used to generate these figures",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Any of: hospital assessment, inpatient hospitalisation, intensive care  admission, COVID-19 mortality","physical ICU admission (not just IMV)","""Case-mortality rate"" unclear follow up"," Any of: hospital assessment, inpatient hospitalisation, intensive care  admission, COVID-19 mortality","multivariate","Age; Sex; Other: age, sex, ethnicity and deprivation.",NA,"","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","12.13;4.43;18.55;4.97","8.62-17.08;3.04-6.44;16.75-20.55;4.45-5.56","<0.00001;<0.00001;<0.00001;<0.00001","","","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","13.5;6.47;5.58;2.53","6.40-28.45;2.88-14.51;3.70-8.42;1.64-3.89","<0.00001;<0.00001;<0.00001;0.00003","","","",NA,"",NA,"","","","uOR;mOR of respiratory and intrathoracic organs; uOR;mOR of lungs ","9.55;3.60;7.28;3.39","8.83-10.33;3.32-3.92;5.71-9.28;2.60-4.41","<0.00001;<0.00001;<0.00001;<0.00001","","","","","uOR;mOR","2.53;1.66","2.23-2.88;1.45-1.91","<0.00001;<0.00001","","","uOR;mOR","0.56;0.58","0.29-1.07;0.29-1.16","0.07973;0.12508","","","",NA,"",NA,"","","","uOR;mOR","1.78;1.14","1.64-1.93;1.05-1.24","<0.00001;0.00308","","","","","uOR;mOR (includes small bowel and hepatobiliary)","17.34;5.85","15.22-19.76;5.08-6.74","<0.00001;<0.00001","","","uOR;mOR (includes small bowel and hepatobiliary)","1.51;0.78","0.56-4.02;0.29-2.09","0.41298;0.62780",NA,NA,"",NA,"",NA,NA,NA,"","uOR;mOR (including small bowel and hepatobiliary)","7.48;3.17","6.72-8.33;2.83-3.55","<0.00001;<0.00001","",NA,NA,"","uOR;mOR (colorectal only)","8.11;2.36","7.31-9.00;2.10-2.64","<0.00001;<0.00001","","","uOR;mOR (colorectal only)","4.91;2.76","3.60-6.71;2.01-3.79","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR (colorectal only)","4.49;2.01","4.17-4.84;1.86-2.18","<0.00001;<0.00001","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract","2.19;2.76;4.76;1.08; 8.99;1.86","1.27-3.78;1.54-4.95;4.30-5.28;0.97-1.20;7.89-10.23;1.62-2.15","0.00502;0.00069;<0.00001;0.18331;<0.00001;<0.00001","","","uOR;mOR of male urological; uOR;mOR of prostate; uOR;mOR of urinary tract","1.95;2.13;2.38;0.89;4.18;1.80","0.49-7.80;0.53-8.53;1.69-3.36;0.61-1.28;2.69-6.49;1.13-2.86","0.34593;0.28740;<0.00001;0.52082;<0.00001;0.01341","","","",NA,"",NA,"","","","uOR;mOR of male urological;uOR;mOR of prostate; uOR;mOR of urinary tract","1.65;2.04;3.19;1.25;4.93;1.78","1.19-2.29;1.43-2.90;2.98-3.41;1.16-1.34;4.49-5.41;1.61-1.97","0.00271;0.00007;<0.00001;<0.00001;<0.00001;<0.00001","","","","","uOR;mOR","4.32;2.80","3.61-5.18;2.30-3.41","<0.00001;<0.00001","","","uOR;mOR","2.06;1.78","1.11-3.84;0.96-3.31","0.02220;0.06927","","","",NA,"",NA,"","","","uOR;mOR","2.64;1.77","2.34-2.98;1.56-2.02","<0.00001;<0.00001","","",NA,"","uOR;mOR","9.94;11.35","7.26-13.61;7.93-16.23","<0.00001;<0.00001","","","uOR;mOR","4.05;4.37","1.30-12.60;1.40-13.60","0.01554;0.01098",NA,NA,NA,NA,NA,NA,NA,NA,"","uOR;mOR","4.64;4.02","3.64-5.92;3.07-5.28","<0.00001;<0.00001","",NA,NA,"","uOR;mOR","5.32;2.79","4.03-7.03;2.08-3.74","<0.00001;<0.00001","","","uOR;mOR","7.77;5.24","4.50-13.41;3.03-9.06","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","3.86;2.24","3.24-4.60;1.86-2.70","<0.00001;<0.00001","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"uOR;mOR","10.43;4.08","8.08-13.47;3.09-5.39","<0.00001;<0.00001","","","uOR;mOR","2.80;1.78","0.90-8.71;0.57-5.52","0.07451;0.32148",NA,NA,NA,NA,NA,NA,NA,NA,"","uOR;mOR","5.02;2.51","4.12-6.11;2.03-3.11","<0.00001;<0.00001",NA,NA,NA,"","uOR;mOR","6.42;2.27","6.15-6.71;2.17-2.38","<0.00001;<0.00001","","","uOR;mOR","2.77;1.64","2.38-3.23;1.39-1.92","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","3.67;1.80","3.56-3.78;1.74-1.86","<0.00001;<0.00001","","","","","uOR;mOR","11.46;4.27","10.57-12.42;3.91-4.66","<0.00001;<0.00001","","","uOR;mOR","13.05;7.70","10.96-15.54;6.43-9.22","<0.00001;<0.00001","","","","","","","","","","uOR;mOR","7.82;4.12","7.41-8.25;3.89-4.37","<0.00001;<0.00001","","","","","uOR;mOR of endocrine glands","1.92;2.29","1.15-3.19;1.30-4.04","","","","uOR;mOR of endocrine glands","1.48;0.00","0.37-5.93;0.00-5.11E+46","0.57912;0.87726","","","",NA,"",NA,NA,NA,"","uOR;mOR of endocrine glands","1.91;2.00","1.46-2.49;1.50-2.66","<0.00001;<0.00001","","","","","uOR;mOR",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"127322","uOR;mOR","7.12;2.54","6.85-7.40;2.44-2.65","<0.00001;<0.00001","0.0752; 0.0752","0.00715; 0.00715","uOR;mOR","4.22;2.53","3.76-4.74;2.24 - 2.86","<0.00001;<0.00001","0.00892;0.00892","0.00229;0.00229","","","","","","","","uOR;mOR","4.22;2.10","4.11-4.33;2.04 - 2.16","<0.00001;<0.00001","0.128;0.128","0.0261;0.0261","",NA,"","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","3.68;1.38;4.55;1.75;8.22;2.66","3.31-4.09;1.23-1.54;4.03-5.14;1.54-1.99;7.44-9.08;2.39-2.95","<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001","","","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","1.89;1.12;3.32;2.11;1.70;0.86","1.33-2.69;0.77-1.63;2.37-4.65;1.48-3.01;1.02-2.82;0.51-1.46","0.00042;0.53783;<0.00001;0.00004;0.04105;0.58374","","",NA,NA,NA,NA,"",NA,"","uOR;mOR stage I; uOR;mOR stage II; uOR;mOR stage III","2.62;1.29;3.12;1.57;4.46;2.01","2.46-2.80;1.21-1.39;2.88-3.37;1.44-1.70;4.15-4.79;1.86-2.16","<0.00001;<0.00001;<0.00001;<0.00001;<0.00001;<0.00001","",NA,NA,"","uOR;mOR","19.71;6.66","17.69-21.97;5.90-7.52","<0.00001;<0.00001","","","uOR;mOR","8.36;3.98","5.79-12.05;2.70-5.87","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR ","7.66;3.57","6.98-8.40;3.24-3.94","<0.00001;<0.00001","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","uOR;mOR","11.58;7.69","10.81-12.40;7.13-8.29","<0.00001;<0.00001","","","uOR;mOR","7.53;5.51","6.20-9.15;4.50-6.74","<0.00001;<0.00001","","","",NA,"",NA,"",NA,"","uOR;mOR","6.29;4.14","5.98-6.61;3.92-4.36","<0.00001;<0.00001","","","","","","uOR;mOR","11.32;3.17","7.36-17.40;2.03-4.95","<0.00001;<0.00001","","","uOR;mOR","2.85;1.21","0.40-20.25;0.17-8.63","0.29636;0.84867",NA,NA,NA,NA,NA,NA,NA,NA,NA,"uOR;mOR","9.18;4.07","6.86-12.27;3.00-5.53","<0.00001;<0.00001",NA,NA,NA,"","","uOR;mOR","20.61;14.12","16.38-25.93;10.93-18.25","<0.00001;<0.00001","","","uOR;mOR","28.91;21.97","18.73-44.62;14.17-34.05","<0.00001;<0.00001","","","",NA,NA,NA,"",NA,"B/T-cell antibody therapy","uOR;mOR","13.03;9.38","11.02-15.41;7.83-11.24","<0.00001;<0.00001","","","","","","uOR;mOR","8.12;4.29","7.38-8.93;3.88-4.76","<0.00001;<0.00001","","","uOR;mOR","3.68;2.53","2.65-5.10;1.81-3.56","<0.00001;<0.00001","","","",NA,"",NA,"","","","uOR;mOR","4.17;2.39","3.88-4.47;2.21-2.57","<0.00001;<0.00001","","","","","","uOR;mOR","11.10;3.76","6.99-17.63;2.32-6.10","<0.00001;<0.00001","","","uOR;mOR","0.00;0.00","0.00-1.95E+37;0.00-1.37E+36","0.87403;0.86020","","","",NA,"",NA,"",NA,NA,"uOR;mOR","7.56;3.06","5.64-10.12;2.26-4.15","<0.00001;<0.00001","","","","","","",NA,"","<0.00001;<0.00001","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"15928326","100","uOR;mOR","7.12;2.54","6.85-7.40;2.44-2.65","<0.00001;<0.00001","","","uOR;mOR","4.22;2.53","3.76-4.74;2.24-2.86","<0.00001;<0.00001","","","","","","","","","","uOR;mOR","4.22;2.53","3.76-4.74;2.24-2.86","<0.00001;<0.00001","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73512","Johansson 2023","Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era","Consensus","Peer-reviewed","The Lancet","National health registry data from Norway, Denmark, and Iceland","2023-07","Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era","Johansson A. L. V","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Norway, Denmark, Iceland","N/A","N/A","2020-03-01","2020-12-31","9,222,321","COVID-19 hospitalisation COVID-19 ICU admission COVID-19 ICU mechanical ventilation COVID-19 death","","Hospitalisation; ICU admission; Mortality; Other: ICU mechanical ventilation","no","*Cancer diagnosed <1 year before testing positive for SARS-CoV-2* Cancer diagnosed <5 years before testing positive for SARS-CoV-2","Same country, general population","Cancer diagnosed <1yr : general population = 949:9222321 No matching",NA,"Median (Norway); Median (Denmark); Median (Iceland)","60-64; 65-69; 18-69","25th centile (Norway); 75th centile (Norway); 25th centile (Denmark); 75th centile (Denmark); 25th centile (Iceland); 75th centile (Iceland)","50-54; 75-79; 50-54; 75-79; 18-69; >70","52.1","495","","","","","","","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Severe COVID-19 outcomes: COVID-19 hospitalisation, COVID-19 ICU admission, COVID-19 ICU mechanical ventilation, COVID-19 death","""Intensive care admission due to COVID-19 was defined as admission to an ICU with a primary discharge diagnosis of COVID-19""","""Death related to COVID-19 was defined as a) death with COVID-19 as underlying cause of death, or b) death within 30 days after admission to hospital with COVID-19 as primary discharge diagnosis.""","Severe COVID-19 outcomes: COVID-19 hospitalisation, COVID-19 ICU admission, COVID-19 ICU mechanical ventilation, COVID-19 death","","Comorbidities",NA,"11; 63","SIR","4.07; 5.42","0.84-11.90; 2.71-9.70","NR; NR","(<5/11); (11/63)","(407/41468); (1019/166522)","SIR","0; 1.29","N/A; 0.16-4.65","NR; NR","(0/11); (<5/63)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR","1.94; 2.25","0.63-4.53; 1.47-3.30","NR; NR","(5/11); (26/63)","(2361/41468); (8230/166522)","Norway (lung); Denmark (lung)","28; 100","SIR","3.29; 0.62","0.40-11.87; 0.02-3.44","NR; NR","(<5/28); (<5/100)","(407/41468); (1019/166522)","SIR","0; 2.12","N/A; 0.26-7.66","NR; NR","(0/28); (<5/100)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR","2.49; 1.46","0.91-5.41; 0.84-2.38","NR; NR","(6/28); (16/100)","(2361/41468); (8230/166522)","Norway; Denmark","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"24; 92","SIR","0.64; 1.30","0.02-3.58; 0.35-3.33","NR; NR","(<5/24); (<5/92)","(407/41468); (1019/166522)","SIR","4.03; 3.87","0.83-11.79; 1.55-7.97","NR; NR","(<5/24); (7/92)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR","1.93; 2.13","0.83-3.80; 1.45-3.00","NR; NR","(8/24); (32/92)","(2361/41468); (8230/166522)","Norway (colorectal); Denmark (colorectal)","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"35; 76","SIR","0.69; 1.19","0.02-3.87; 0.33-3.06","NR; NR","(<5/35); (<5/76)","(407/41468); (1019/166522)","SIR","2.18; 0.35","0.45-6.37; 0.01-1.94","NR; NR","(<5/35); (<5/76)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR","2.16; 1.18","1.11-3.77; 0.73-1.81","NR; NR","(12/35); (21/76)","(2361/41468); (8230/166522)","Norway (prostate); Denmark (prostate)","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"21; 59","SIR","N/A; 0.79","N/A; 0.02-4.42","NR; NR","(0/21); (<5/59)","(407/41468); (1019/166522)","SIR","N/A; 3.33","N/A; 0.69-9.74","NR; NR","(0/21); (<5/59)","(379/41468); (911/166522)","",NA,"",NA,"","",NA,"SIR","1.73; 1.35","0.47-4.44; 0.65-2.49","NR; NR","(4/21); (10/59)","(2361/41468); (8230/166522)","Norway (melanoma); Denmark (melanoma)",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","28; 123","SIR","5.64; 4.15","1.83-13.16; 2.32-6.85","NR; NR","(5/28); (15/123)","(407/41468); (1019/166522)","SIR","7.64; 5.93","2.08-19.56; 3.24-9.94","NR; NR","(<5/28); (14/123)","(379/41468); (911/166522)","","","","","","","","SIR","4.37; 3.96","2.26-7.63; 3.10-4.98","NR; NR","(12/28); (73/123)","(2361/41468); (8230/166522)","Norway; Denmark","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"203; 727; 19","SIR","2.18; 2.29; NR","1.29-3.45; 1.66-3.07; NR","NR; NR; NR","(18/203); (44/727); NR","(407/41468); (1019/166522); NR","SIR","3.19; 2.52; NR","1.86-5.11; 1.75-3.50; NR","NR; NR; NR","(17/203); (35/727); NR","(379/41468); (911/166522); NR","","","","","","","","SIR","2.43; 2.23; NR","1.89-3.09; 1.96-2.54; NR","NR; NR; NR","(67/203); (241/727); NR","(2361/41468); (8230/166522); NR","Norway; Denmark; Iceland",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"56; 35; 176; 167","27.6; 17.2; 24.2; 23.0","SIR","2.74; 2.49; 6.30; 6.61","0.56-8.00; 0.30-9.01; 3.73-9.96; 3.92-10.44","","(<5/56); (<5/35); (18/176); (18/167)","(407/41468); (1019/166522)","SIR","5.35; 6.61; 7.27; 6.94","1.96-11.64; 2.15-15.42; 4.44-11.24; 4.11-10.97","","(6/56); (5/35); (20/176);  (18/167)","(379/41468); (911/166522)","",NA,"",NA,"",NA,"","SIR","4.10; 4.75; 4.92; 4.89","2.60-6.15; 2.81-7.50; 3.99-5.99; 3.94-5.99","","(23/56); (18/35); (98/176); (92/167)","(2361/41468); (8230/166522)","Norway ""CT any""; Norway ""CT only""; Denmark ""CT any"";  Denmark ""CT only""  (For non-cancer column, just Norway; Denmark)","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"79","10.9","SIR","5.73","2.47-11.29","","(8/79)","(1019/166522)","SIR","9.55","4.77-17.08","","(11/79)","(911/166522)","",NA,NA,NA,"",NA,"","SIR","5.70","4.23-7.52","","(50/79)","(8230/166522)","Denmark","24; 77","11.8; 10.6%","SIR","1.50; 5.95","0.04-8.38; 2.72-11.30","","(<5/24); (9/77)","(407/41468); (1019/166522)","SIR","1.86; 2.26","0.05-10.36; 0.47-6.60","","(<5/24); (<5/77)","(379/41468); (911/166522)","",NA,"",NA,"","","","SIR","3.27; 2.97","1.49-6.21; 1.99-4.26","","(9/24); (29/77)","(2361/41468); (8230/166522)","Norway ""RT any"";  Denmark ""RT any""  (For non-cancer column, just Norway; Denmark)","51","7.0","SIR","8.26","3.32-17.03","","(7/51)","(1019/166522)","SIR","5.79","1.58-14.82","","(<5/51)","(911/166522)","",NA,"",NA,"",NA,NA,"SIR","4.59","2.97-6.78","","(25/51)","(8230/166522)","Denmark","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73383","Hosseini-Moghaddam 2023","SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer","Consensus","Peer-reviewed","JAMA Network Open","COVID-19 Integrated Testing Database; Ontario Registered Persons Database; Canadian Institute for Health Information's Discharge Abstract Database.","2023-08","SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer","Hosseini-Moghaddam, S M","Retrospective","Cohort","Yes","outpatient","Canada","Ontario","","2020-01-01","2021-12-31","464574","COVID-19 infection positivity.","Hospitalisation, ICU admission and mortality.","Hospitalisation; ICU admission; Mortality","yes","Not specified.","Drawn from same national cohort. ","Age, gender and co-morbidities were not matched.  Cancer : control =8378 : 456196",NA,"Mean","59.61","SD","18.05","40.6","8378","Mean","45.95","SD","18.24","48.96","456196","Not mentioned",NA,"","","","","",NA,"","","4219","50.4","108968","23.9","cOR","3.23","3.10-3.38 ","","2475","29.5","69480","15.2","cOR","2.33","2.23-2.45","","1499","17.9","26250","5.8","cOR","3.57","3.37-3.78","","207","2.5","4248","0.9","cOR","2.7","2.34-3.10",NA,"124","1.5","1102","0.2","cOR","6.2","5.15-7.48","","779","9.3","11959","2.6","cOR","3.81","3.53-4.11","","2035","24.3","83958","18.4","cOR","1.42","1.35-1.50","","128","1.5","1715","0.4","cOR","","","",NA,NA,NA,NA,"",NA,"",NA,"88; 647","1.1; 7.7","2797; 16094","0.6; 3.5","cOR","1.72; 2.29","1.39-2.13; 2.11-2.48","","IBD; Dementia  taken from eTable4 in supps","IBD; Dementia   taken from eTable4 in supps","IBD; Dementia  data taken from eTable2 and cancer data from eTable4 has been subtracted to get non-cancer cohort data","IBD; Dementia","","IBD; Dementia","IBD; Dementia","I calculated crude OR and CI and have left p-values for James as discussed","","21-day ICU admission","28-day mortality.","","multivariate","Age; Sex; Comorbidities; Other: Past healthcare utilisation, income, rurality, PHU region, Ontario Marginalisation Index, 2016 Canada census variables.",NA,"321","","","","","0.178 (57/321)","","","","","","","","",NA,"",NA,"","","","","","","","0.312 (100/321)","","","1272","","","","","0.061 (78/1272)","","","","","","","","",NA,"",NA,"","","","","","","","0.134 (171/1272)","","","132","","","","","0.106 (14/132)","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","0.257 (34/132)",NA,NA,"676","","","","","0.095 (64/676)","","","","","","","","",NA,"",NA,"","","","","","","","0.204 (138/676)","","","71","","","","","0.113 (8/71)","","",NA,"","","","","","","","","","","","","","","","0.225 (16/71)","","","271","","","","","0.077 (21/271)","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"0.155 (42/271)","",NA,"1336","","","","","0.099 (132/1336)","","","","","","","","",NA,"",NA,"","","","","","","","0.208 (278/1336)","","","1797","","","","","0.015 (27/1797)","","","","","","","","",NA,"",NA,"","","","","","","","0.0573 (103/1797)","",NA,"47","","","","","0.128 (6/47)","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","0.255 (12/47)",NA,NA,"698","","","","","0.016 (11/698)","","","","","","","","",NA,"",NA,"","","","","","","","0.113 (79/698)","",NA,"125","","","","","0.080 (10/125)","","","","","","","","",NA,"",NA,"","",NA,"","","","","0.096 (12/125)","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"7185","aHR","1.31","1.19-1.44","","0.066 (475/7185)","","aHR","0.93","0.82-1.05","","0.366 (388/1060)","","",NA,"",NA,"","","","aHR","1.11","1.05-1.18","","0.148 (1061/7185)","","adjusted HRs taken from eTable10 in supps","1193","aHR","2.04","1.74-2.38","","0.137 (163/1193)","","aHR","1.14","0.93-1.40","","0.405 (130/321)","","","","","","","","","aHR","1.75","1.57-1.96","","0.269 (321/1193)","","adjusted HRs taken from eTable10 in supps","439; 357","","","","","0.107 (47/439); 0.151 (54/357)","","","","","","","","",NA,"",NA,NA,NA,"","","","","","0.173 (76/439); 0.303 (108/357)","","other solid tumour; other haematological malignancy ","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"8378","","","","","","0.0466 (21267/456188)","","","","","","0.345 (10207/29582)","","","","","","","non-cancer EVENT/TOTAL taken from graphs in figure 1. We have subtracted number survived at end of period from number survived at start of period to get number who died.   cancer EVENT/TOTAL taken from eTable11 in supps","","","","","","0.094 (42886/456034)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,"43046","9.3","aHR","0.57; 0.50","0.51-0.63; 0.45-0.57",NA,"","","aHR","0.76; 0.74","0.68-0.85; 0.63-0.87",NA,"","",NA,NA,NA,NA,NA,NA,"aHR","0.68; 0.42","0.64-0.71; 0.39-0.46",NA,NA,NA,"raw data taken from supps eTable2. Vaccinated is sum of dose 1, dose 2 and dose 3. Data taken for covid-19 positive cohort   HRs taken from eTable10 (1dose; >2 dose). Note: it is not comparing cancer to non-cancer but vaccinated to unvaccinated so data may not be relevant ","421528","90.7",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"73036","Mirgh 2021","Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India(rerun)","Consensus","Peer-reviewed","Cancer Medicine","Records from Tata Memorial Centre","2021-11-16","Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India","Mirgh S. P.","Retrospective","Cohort","Yes","inpatient","India","Navi Mumbai","Tata Memorial Centre","2020-05-22","2020-12-01","202 - 2 excluded due to indeterminate PCR   200 included ","Overall mortality","Duration of hospitalisation  Factors affecting mortality  Baseline covid-19 severity","Severity; Mortality","no","*Patients with cancer (cancer cohort)*: Patients with both haematological and solid organ malignancies comprised the cancer cohort   *Active anti-cancer treatment cohort*: any chemotherapy or radiotherapy or major surgery within 4 weeks of SARS-CoV-2 positiv- ity  Remission of the malignant disease was defined as ab- sence of disease at last follow-up before contracting SARS- CoV-2 infection","Cancer:control = 109:91  Not matched ","Cancer:control = 109:91  Not matched ",NA,"Median","51","IQR","33-62","58.7","109","Median","38","IQR","32-49","68.1","91","Not mentioned",NA,"","","","","",NA,"","","19","17.1","21","23.6","",NA,"","","9","8.1","13","14.6","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Baseline COVID-19 severity ON ADMISSION was graded as per 7-point ordinal scale published by Goldman et al  Whether oxygen support was subsequently required during hospitalization ","","Overall mortality = calculated from first date of SARS-CoV-2 RT-PCR positivity until date of death during hospital stay","Baseline covid19 severity per ordinal scale by Goldman et al AT ADMISSION   Also whether COVID-19 infection required oxygen support during hospitalization","univariate; multivariate","Other: Unclear ",NA,"4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","18","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8 (AL GI)","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"11 (ALL GENITOURINARY)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"12","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","7","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","48","","","","","","","","","","","","","","","","","","","","","","","","","","","Unknown primary 1","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"109","uOR","7.04","1.25-39.54","0.027","0.101 (11/109)","0.0110 (1/91)","","","","","","","","","","","0.110 (12/109); 0.312 (34/109)","0.0220 (2/91); 0.147 (16/109)","Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","109","uOR","7.04","1.25-39.54","0.027","0.101 (11/109)","0.0110 (1/91)","",NA,"","","","","","","","","0.110 (12/109); 0.312 (34/109)","0.0220 (2/91); 0.147 (16/109)","Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","",NA,"","","","",NA,NA,"82","75.2","uOR","11.10","1.37-89.62","","9/82","1/109","","","","","","","",NA,"",NA,"",NA,"In preceding one month","","","","","","","They have a discrepancy btw in-text number of chemo patients (79) and the table 4 (82), we used table 4 value to calculated crude OR ","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"9","8.26","","","","","","","","","","","","","",NA,NA,NA,"",NA,"Rituximab within 6mo of infection ","","","","","","","","7","6.4","","","","","","","","","","","","","",NA,"",NA,"","","In preceiding 1 month of coid infection ","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","9","8.2","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"In preceiding 1 month of coid infection ",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"109","100","uOR","7.04","1.25-39.54","0.027","0.101 (11/109)","0.0110 (1/91)","","","","","","","","","","","0.110 (12/109), 0.312 (34/109)","0.0220 (2/91); 0.147 (16/109)","Baseline covid-19 severity (severe = score of 2 or 3), Oxygen support during hospitalization ","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72989","Li 2020","Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission(rerun)","Consensus","Peer-reviewed","Leukemia - Nature","","2020-07-20","Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission","Li Q","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Union Hospital, Wuhan Central Hospital, General Hospital of Central Theater Command, PLA, Wuhan Jinyintan Hospital","2020-01-20","2020-04-04","1859","Death COVID-19 severity","Time from illness onset to ICU admission Time from illness onset to repeated negative SARSCOV2 tests Time from illness onset to admission, progression, or outcome (discharged alive or died) Time from diagnosis to outcome (discharged alive or died) Time from admission to outcome (discharged alive or died)","Severity; ICU admission; Mortality","no","*Non-remission* Remission defined as complete remission for >= 1year","Not explicitly matched","Cancer:non-cancer = 18:1794 Not age, gender, or comorbidity matched",NA,"Median","54","IQR","27-66","61","11","Median","59","IQR","45-68","50","903","Not mentioned",NA,"3","17","105","6","",NA,"","","3","17","559","31","",NA,"","","0","0","250","14","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Severity of COVID-19 was graded as follows: (1) mild; mild clinical symptoms, no pneumonia on lung CT; (2) common: fever, cough and lung CT with pneumonia; (3) severe: respiratory distress (respiratory rate>30min1, oxygen saturation (O2Sat)93% at rest and/or ratio of arterial oxygen partial pressure to fractional inspired oxygen300mmHg (PaO2/FIO2); and (4) critical: aforementioned criteria of respiratory failure receiving mechanical ventilation, shock and/or organ failure other than lung and/or intensive care unit (ICU) hospitalisation.","Critical: aforementioned criteria of respiratory failure receiving mechanical ventilation; shock; and/or organ failure other than lung; and/or intensive care unit (ICU) hospitalisation.","not stated","Severe: respiratory distress (respiratory rate>30min1, oxygen saturation (O2Sat)93% at rest and/or ratio of arterial oxygen partial pressure to fractional inspired oxygen300mmHg (PaO2/FIO2)","multivariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"18","NR","NR","NR","NR","0.500 (9/18)","0.106 (191/1794)","NR","NR","NR","NR","0.056 (1/18)","NR ","NR","NR","NR","NR","0.444 (8/18)","NR","NB: 'critical' disease is also a category in this paper. Data pulled from suppl table 7 (limited data available).","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72919","Cook 2022","Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19(rerun)","Consensus","Peer-reviewed","Clinical Lymphoma, Myeloma and Leukemia","MedStar electronic health record at MedStar Georgetown University Hospital and/or Washington Hospital Center","2022-07","Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19","Cook MR","Retrospective","Cohort","Yes","inpatient","USA","Washington D.C.","MedStar Georgetown University Hospital and Washington Hospital Center","2020-03","2020-05","762","VTE and Cerebrovascular accident","VTE + CVA composite, ICU admission, COVID-related mortality","ICU admission; Mortality","no","Doesn't specify beyond: haematological malignancy and control cohorts extracted from the REDCap database","Non-haematological malignancy patients who had a positive COVID-19 test at ED or as an inpatient at the same hospital group.","Not matched for age",NA,"Mean","69.40","SD","14.80","52.4","124*","Mean","53.95","SD","16.81","48.8","709","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","none","physical ICU admission (which was presented as a different outcome to respiratory support)","heterogenous follow up: "" date of last clinical follow-up or date of death.""","none","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"0","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53","uOR","uOR == 4.37","2.38-8.03","3.20E-07","0.358","0.113","uOR","mOR ==1.32","0.68-2.59","0.414","0.226","0.181","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"53","uOR","uOR == 4.37","2.38-8.03","3.20E-07","0.358","0.113","uOR"," mOR == 1.32","0.68-2.59","0.414","0.226","0.181","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","53","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"762","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72884","Mohamed 2021","Cancer and COVID-19: Analysis of patient outcomes(rerun)","Consensus","Peer-reviewed","Future Oncology ","REDCap electronic data capture tools hosted at Tulane Medical Center","2021-07","Cancer and COVID-19: analysis of patient outcomes","Mohamed A","Retrospective","Cohort","Yes","inpatient","USA","Louisiana, New Orleans","Tulane Medical Center","2020-02-27","2020-04-27","214","in-hospital mortality ","risk of ICU admission, risk of endotracheal intubation, duration of mechanical ventilation and length of hospital stay ","Severity; ICU admission; Mortality","no","Cancer patients were divided into patients receiving treatment as active cancer and patients in remission with nonactive cancer   *active cancer*","same hospitals   This cohort of COVID-19 patients is representative of the patient population at two university hospitals in New Orleans, Louisiana","active cancer to non-cancer ratio = 11:203",NA,"mean","60.7","SD","9.3","54.5","11","mean","58.7","SD","14.6","45.5","203","Not mentioned",NA,"","","44","22.9","",NA,"","","9","81.8","152","74.9","uOR","1.51","0.32 - 7.22","0.603447","1","9.1","84","41.4","uOR","0.14","0.02 - 1.13","0.330","1","9.1","22","10.8","uOR","0.82","0.10 - 6.74","0.855459","","","25","12.3","",NA,"",NA,"","","","","",NA,"","","2","18.2","27","13.3","uOR","1.45","0.30 - 7.07","0.645025","","","48","23.6","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"4","36.4","125","63.8","uOR","0.36","0.10 - 1.26","0.096026","Other = obesity, Chronic lung disease = COPD + Asthma ","","","","","","","","Two scoring systems were used for severity assessment: 1) the CURB-65 score and 2) the Quick Sequential Organ Failure Assessment (qSOFA) score  - unclear if severe was when either or both were positive or if all patients even had both","/","in hospital mortality. No mention of how long patients were followed up for","Two scoring systems were used for severity assessment: 1) the CURB-65 score and 2) the Quick Sequential Organ Failure Assessment (qSOFA) score ","univariate; Other: no relevant analysis provided so calculated crude OR, CI and p-values from the data","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"11","uOR","1.93","0.49 - 7.67","0.355","0.273 (3/11)","0.163 (33/203)","uOR","5.0","1.43 - 17.45","0.012","0.455 (5/11)","0.143 (29/203)","","","","","","","I calculated crude OR, CI and p-values for mortality and ICU admission using data in table 1 for non-cancer patients and table 3 for active cancer patients ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"214","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72854","Konermann 2023","High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.(rerun)","Consensus","Peer-reviewed","Oncology Research and Treatment","ClinicalTrials.gov, NCT04659187","2023-02","High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study","Konermann F M","Prospective","Cohort","Yes","inpatient","Germany","N/A","The hospital network Asklepios","2020-03-11 (WT to Delta); 2022-01-01 (Omicron)","2022-01-01 (WT to Delta); 2022-07-20 (Omicron)","27,490","""Survival status at discharge from hospital is the primary end-point of the investigation."" ","""Additionally, we differentiated patients with solid and hematological malignancies with regard to the primary endpoint.""","Mortality","no","*Active cancer*, history of cancer","Same country, but involved multiple centers across Germany","2,578:24,912",NA,"Active Cancer/ WT-D; Active Cancer/Omicron  Median","75; 74","IQR","65 - 82; 64 - 81","58; 62","777; 736","No Cancer/WT-D; No Cancer/Omicron  Median","70; 72","IQR","54 - 82; 53 - 83","52; 49","14,998; 9,914","Wild Type (Ancestral/Wu-1); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"","","","","",NA,"","","","","","","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  166; 138","21; 19","No Cancer/WT-D; No Cancer/Omicron  3,644; 1,890","24; 19","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  120; 103   CAD Active Cancer/ WT-D; Active Cancer/Omicron  119; 117","Heart Failure 15; 14   CAD 15; 16","Heart Failure No Cancer/WT-D; No Cancer/Omicron 1,962; 1,342  CAD No Cancer/WT-D; No Cancer/Omicron 2,020; 1339","Heart Failure 13; 14  CAD 13; 14","","","","","Active Cancer/ WT-D; Active Cancer/Omicron  45; 33","5.8; 4.5","No Cancer/WT-D; No Cancer/Omicron  997; 676","6.6; 6.8","",NA,"",NA,"Active Cancer/ WT-D; Active Cancer/Omicron  11;15","1.4; 2.0","No Cancer/WT-D; No Cancer/Omicron  94; 85","0.6; 0.9","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  136; 110  ","18; 15","No Cancer/WT-D; No Cancer/Omicron  2, 332; 1,334","16; 13","",NA,"","","Active Cancer/ WT-D; Active Cancer/Omicron  99; 73","13; 9.9","No Cancer/WT-D; No Cancer/Omicron  1,396; 842","9.3; 8.5","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Dyslipidemia Active Cancer/ WT-D; Active Cancer/Omicron  127; 95  Obesity Active Cancer/ WT-D; Active Cancer/Omicron 29; 19","Dyslipidemia 16; 13   Obesity 3.7; 2.6","Dyslipidemia No Cancer/WT-D; No Cancer/Omicron  2,334; 1,521  Obesity No Cancer/WT-D; No Cancer/Omicron  992; 382","Dyslipidemia 16; 15  Obesity 6.6; 3.9","","","","","","","","","","","","","Mechanical ventilation (intubation)","","Survival status at discharge from hospital is the primary endpoint of the investigation.","","multivariate","Sex; Comorbidities",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"1172","cOR","NR","NR","NR","0.234 (274/1172)","0.220 (2000/9089)","","","","","","","",NA,"",NA,"","","","","","","","","","","341","cOR","NR","NR","NR","0.237 (81/341)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1513","mOR","1.685","1.686 - 2.064","NR","0.235 (355/1513)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"WT/D cancer patients 777","51.4 of cancer patients","mOR","1.94","1.646 - 2.285","NR","0.272 (211/777)","0.161 (2418/14998)","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"736 cancer patients","48.6 of cancer patients","mOR","2.864","2.354 - 3.486","NR","0.196 (144/736)","0.0783 (776/9914)",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"1513","100","cOR","","","","0.235 (355/1513)","0.220 (2000/9089)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72749","Passamonti 2020","Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(rerun)","Consensus","Peer-reviewed","Lancet Haematology","","2020-08","Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","Passamonti F","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Italy","","","2020-02-25","2020-06-22","536","Mortality among patients with haematological malignancies and COVID-19 and evaluation of potential predictive parameters of mortality including biochemical parameters, haematological malignancy characteristics (disease type, disease status, and therapy status), and COVID-19 severity.","Epidemiology of patients with haematological malignancies infected by SARS-CoV-2 (ie, type of haematological malignancy, ICU admission  rate, laboratory abnormalities, and haematological malignancy-specific treatments) Evolution of haematological malignancies Dynamics of viral load","Severity; ICU admission; Mortality","no","Haematological malignancies Median time since haematological malignancy diagnosis (years) is 2 (IQR: 0-6). Table 1.","general Italian population","no",NA,"Mean;Median","66.8;68","SD for mean;IQR for median","13.3;58-77","63","340","","","","","","","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","72","13","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"34","6","","","",NA,"","","42","8","","","",NA,"","","43","8","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Heart disease: 82 Vascular disease: 91 Connective tissue diseases: 13","Heart disease: 15 Vascular disease: 17 Connective tissue diseases: 2","","","","","","","","","","","","","","","Severe = dyspnoea, respiratory frequency 30 breaths per min, SpO2 93%, PaO2/FiO2 <300, or lung infiltrates >50%.","Critical = respiratory failure, septic shock, or multiple organ disfunction or failure.","not stated","Severe = dyspnoea, respiratory frequency 30 breaths per min, SpO2 93%, PaO2/FiO2 <300, or lung infiltrates >50%.","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","536","Standardised mortality ratio","2.04","1.77-2.34","","0.369","","","","","","0.153","","","","","","0.362","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"See haematological row","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72735","Altuntas 2021","COVID-19 in hematopoietic cell transplant recipients(rerun)","Consensus","Peer-reviewed","Bone Marrow Transplantation","","2020-10-28","COVID-19 in hematopoietic cell transplant recipients","Altuntas F","Retrospective","Cohort","Yes","inpatient","Turkey","N/A ","N/A ","2020-03-11","2020-05-29","994","Hospital stay duration  ICU stay duration  ICU admission  Mechanical ventilation  COVID-19 severity  Case fatality rate","","Severity; Hospitalisation; ICU admission; Mortality","no","*Haematological cancer + hematopoietic cell transplant*, *Haematological cancer*  No definition of timeline of diagnosis/treatment allowed ","Total cancer group (recipients of haematological cell transplant, or no transplant) : non-cancer = 32 or 465 : 497  Patients that were also diagnosed and included in the Republic of Turkey Ministry of Health database ","Total cancer group (recipients of haematological cell transplant, or no transplant) : non-cancer = 32 or 465 : 497  Age and comorbid disease matched ",NA,"Median (Haematological cell transplant recipients w cancer); Median (non-HCT recipients with cancer)","56.5; 57","Range (Haematological cell transplant recipients w cancer); Range (non-HCT recipients with cancer)","19-74; 18-93","78.1; 53.8","32; 465","Median","55","Range","19-87","54.1","497","Not mentioned",NA,"","","","","",NA,"","","18; 201","56.3; 43.2","200","40.2","",NA,"","0.2","7; 111","21.9; 23.9","114","22.9","",NA,"","0.9","5; 69","15.6; 14.8","63","12.7","","","","0.6","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","10; 86","31.3; 18.5","86","17.3","","","","0.1","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","Haematological cell transplant recipients w cancer; non-HCT recipients with cancer","Severity classified as ""severe"" or ""critical"" but how these were defined was not explained   Also whether or not mechanical ventilation was required","Rate of ICU admission","Case fatality rate, duration of follow up not defined. ","Severity classified as ""severe"" or ""critical"" but how these were defined was not explained  HENCE THIS WILL NOT BE INCLUDED IN DATA EXTRACTION ","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","32; 465","OR (calculated from crude CFR data, the groups are age and comorbid matched) of 1) Haematological cell transplant recipients w cancer,  2) non-HCT recipients with cancer, OR of mechanical ","3.10; 2.25","1.11-8.67; 1.40-3.61","0.0308; 0.0008","0.156 (5/32); 0.118 (55/465)","0.0563 (28/497); 0.0563 (28/497)","OR (calculated from crude % of ICU admission data, the groups are age and comorbid matched) of 1) Haematological cell transplant recipients w cancer,  2) non-HCT recipients with cancer, OR of mechanical ","2.21; 25.69","0.912-5.33; 15.25-43.27","0.0792; <0.0001","0.219 (7/32); 0.211 (98/465)","0.113 (56/497); 0.113 (56/497)","DO NOT EXTRACT - OR of combined severe and critical illness (calculated from crude % of severe/critical illness, the groups are age and comorbid matched)  of 1) Haematological cell transplant recipients w cancer,  2) non-HCT recipients with cancer, OR of mechanical ventilation (calculated from crude % of those requiring mechanical ventilation, the groups are age and comorbid matched) of 1) Haematological cell transplant recipients w cancer,  2) non-HCT recipients with cancer,","2.13; 1.81; 2.37; 2.269","0.995-4.570; 1.345-2.431; 0.861-6.529; 1.485-3.467","0.0515; 0.0001; 0.0947; 0.0002","0.344 (11/32); 0.308 (143/465); 0.156 (5/32); 0.151 (70/465)","0.197 (98/497); 0.197 (98/497); 0.0724 (36/497); 0.0724 (36/497)","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72612","Mariniello 2021","Descriptive Comparative Analysis of Patients with Cancer Referring to the Emergency Department of an Italian University Hospital across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves(rerun)","Consensus","Peer-reviewed","JCO Oncology Practice","Electronic Database of the San Luigi Gonzaga University Hospital (Orbassano-Turin, Italy) in a 3-week time frame during the first and second COVID-19 waves. We considered ED admissions from March 9 to March 29, 2020, for the first wave. From October 24 to November 13, 2020, for the second wave.","2021-07","Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the SARS-CoV-2 Waves","Mariniello, AM","Retrospective","Cohort","Yes","not specified","Italy","Turin, Italy","San Luigi Gonzaga University Hospital","2020-03-09 (1st wave); 2020-10-24 (2nd wave) ","2020-03-29 (1st wave);  2020-11-13 (2nd wave)","739","Symptoms at ED - None, Fever, Respiratory, GI, Respiratory Failure","Whether patients were discharged, ICU, HDU or deceased ","Severity; Hospitalisation; ICU admission; Mortality","no","histologically confirmed active solid or hematologic mal ignancies, including all patients with cancer at advanced disease stage, and those at early stages who underwent treatment with radical intent up to 12 months before ED admission. Patients with cancer who were radically treated and disease-free for at least 12 months were excluded.","Yes","Number of cancer to non-cancer patients broken up into two distinct time periods -""first wave and second wave"".  First wave - 155 Non-cancer and 8 Oncological Patients Second wave - 537 Non-cancer and 39 Oncological patients. Age matched, gender matched. Comorbidity matched. ",NA,"Median","73(first wave), 68(2nd wave)","IQR","63-80(first wave); 45-75(2nd wave)","87% male(first wave);  56% male(2nd wave)","8 pts in first wave 39 pts in second wave","Median","59(first wave); 63(2nd wave)","IQR","49-73(first wave); 45-75(second wave)","61% male(1st wave);  58% male(2nd wave)","155 pts in first wave 537 pts in second wave","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","metabolic defined(includes obesity and diabetes) 3 in first wave;  7 in second wave","27.5% first wave;  17.9% in second wave","42 in first wave;  105 in second wave","27% first wave;  19.6% second wave","",NA,"","0.9","CCV - Cardiocerebrovascular defined as  5 in first wave;  25 in second wave","62.5% first wave;  64% in second wave","69 in first wave;  215 in second wave","44.5% in first wave;  40% in second wave","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","2(first wave);  6(second wave)","25%(first wave);  15.4%(second wave)","17(1st wave);  49(2nd wave)","11%(first wave);  9.1%(second wave)","","","","","2(1st wave) 4(2nd wave)","25%(1st wave);  10.3%(2nd wave)","6(1st wave);  16(2nd wave)","3.9%(1st wave);  3%(1st wave)","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Respiratory failure","Admitted to ICU ","Deceased at Emergency Department","Respiratory failure ","univariate","",NA,"4(1st wave);  7(2nd wave)","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"3(1st wave);   6(2nd wave) ","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","1(1st wave);  13(2nd wave) ","","","","","","","","","","","","","","","","","","","","","","","","","","","6 (2nd wave) ","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"First Wave - 8;  Second Wave - 39","NR","NR","NR","NR","0/ 8 (1st wave);   3/39(2nd wave) ","1/155(1st wave); 0/537 (2nd wave) ","NR","NR","No statistical significance (no further information given)","0.5 - No statistical signifance in ICU admission between cohorts for 1st and 2nd wave together ","3/8 (1st wave); 6/39 (2nd wave) ","33/155 (1st wave); 41/537 (2nd wave) ","NR","NR","NR","0.049 (1st and 2nd wave) also says this but not sure what it means ""However, the higher frequency of respiratory fai lure in C19-CP was significant even when stratifying for pandemic wave (Mantel-Haenszel test P 5 .045).""","6/8 (1st wave), 23/39 (2nd wave) ","90/155 (1st wave), 231/537 (2nd wave) ","dates = start: 2020-03-09 (1st wave): 2020-10-24 (2nd wave);  end: 2020-11-13 (1st wave); 2020-11-13 ","NR"," NR","","0.0004 (overall across 1st and 2nd wave) ","7/8 (1st wave);  30/39 (2nd wave) ","118/155 (wave 1);  246/537 (wave 2)  ","dates = start: 2020-03-09 (1st wave): 2020-10-24 (2nd wave);  end: 2020-11-13 (1st wave); 2020-11-13 ",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"Stage 3 and 4 - Advanced disease 5/8 in first wave;  28/39 in second wave","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"1(1st wave) 18(2nd wave)","16%(1st wave) 66.7%(2nd wave)","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","1(1st wave) 4(2nd wave)","16%(1st wave) 14.8%(2nd wave)","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"TK Inhibitors 1(1st wave) 2(2nd wave)","TK Inhibitors 16%(1st) 7.4%(2nd wave)","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2(1st wave) 2(2nd wave)","33%(1st) 7.4%(2nd)","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"72593","Anantharaman 2021","SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California(rerun)","Consensus","Peer-reviewed","The Oncologist ","","2020-12","SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California","Anantharaman, A","Retrospective","Cohort Study","Yes","inpatient and outpatient (no breakdown)","USA","Northern California ","n/a","2020-02-25","2020-06-08","4627","Emergency department visit, inpatient hospitalisation, ICU stay, mechanical ventilation, non invasive ventilation and mortality between Covid-19 diagnosis and first 45 days of diagnosis or end of study","Distinct primary and secondary outcomes not stated","Hospitalisation; ICU admission; Mortality; Other: ED visit, non invasive ventilation ","no","*Active cancer: Patients having active treatment for cancer (including infusion or oral chemo or radiation) in 180 days prior to covid-19 diagnosis* History of cancer but no active treatment  - this group was not included below  ","Adults with positive lab test for Covid-19 with no cancer history. Adults with positive lab test for Covid-19 with history of cancer in Kaiser Permanente Northern California (KPNC) cancer registry but no active treatment cancer in 180 days prior to Covid-19 diagnosis and no history of cancer.   N.b.Adjusted ORs calculated adjusting for demographic and clinical characteristics (cancer history, age, sex, race/ethnicity, body mass index, charlson comorbidity index, hypertension, diabetes, smoking status, neighbourhood deprivation index) and week of Covid-19 diagnosis to account for changing testing and treatment guidelines. ","33 patients with active cancer treatment within 180 days,  4380 no active cancer treatment or history. No age/gender/comorbidity matching. Adjusted ORs calculated adjusting for demographic and clinical characteristics (cancer history, age, sex, race/ethnicity, body mass index, charlson comorbidity index, hypertension, diabetes, smoking status, neighbourhood deprivation index) and week of Covid-19 diagnosis to account for changing testing and treatment guidelines. ",NA,"","","Age groups","18-59: 39%; 60-69: 24%; 70+: 36%","45%","33","","","Age groups","18-59: 77%; 60-69: 13%; 70+: 10%","48%","4380","Not mentioned",NA,"","39","","25","",NA,"","","","42","","13","",NA,"","","","18","","13","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Invasive mechanical Ventilation ","","45 days (or end of study) ","Severe disease not explicitly stated but patients requiring invasive ventilation investigated and recorded below","multivariate","Age; Sex; Comorbidities; Other: cancer history, age, sex, race/ethnicity, body mass ass index, Charlson comorbidity index, hypertension, diabetes, smoking status, and neighborhood deprivation index and week of COVID-19 diagnosis",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"33","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.30","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","Severity = invasive ventilator ","mOR","1.55","0.67-3.59","NR","NR","NR","No p values or absolute numbers stated. Also have pooled outcomes, ED visit, non invasive ventilation cancer vs non cancer if relevant.",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","33","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.3","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","","mOR","1.55","0.67-3.59","NR","NR","NR",NA,NA,"12","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","11","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"14","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"4413","100","mOR","2.78","0.92-8.43","NR","NR","NR","mOR","1.30","0.41-4.08","NR","NR","NR","mOR","0.81","0.18-3.75","NR","NR","NR","","mOR","1.55","0.67-3.59","NR","NR","NR","NR","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"71781","Martin 2023","SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation.","Consensus","Peer-reviewed","Oncology","Research Electronic Data Capture (REDCap) electronic data capture tools hosted at IRYCIS","2022-09","SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation","Martin M.","Retrospective","Cohort","Yes","inpatient","Spain","Madrid","Hospital Universitario Ramn y Cajal","2020-03","2020-09","2772","Mortality","","Mortality","no","Only patients with a diagnosis of SARS-CoV-2 infection confirmed by PCR in nasopharyngeal exudate and with available data for status, current oncological treatment, and follow-up of the oncological disease were included. ","81 (active cancer treatment) vs 164 (cancer survival) vs 2527 (control)","2527 (control) vs 81 (active cancer treatment) vs 164 (with history of cancer). Not matched.",NA,"Median","71","IQR","62-79","60.5","81","Median","69","IQR","55-81","58.8","2527","Not mentioned",NA,"","","","","",NA,"","","39","48.1","1093","43.3","",NA,"","0.01","21","25.9","466","18.5","",NA,"","0.04","14","17.3","458","18.1","","","","0.01","","","","","",NA,"",NA,"","","","","",NA,"","","4","4.9","197","7.8","",NA,"","0.01","10","12.3","282","11.2","","","","0.01","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","N/A","N/A","Not specified.","N/A","univariate; multivariate","Age; Comorbidities; Other: Active cancer treatment",NA,"10","uOR","9.6","2.4-37.3","N/A","0.7 (7/10)","0.4 (4/10)","","","","","","","",NA,"",NA,"","","","","","","","","","","19","uOR","0.7","0.2-2.6","N/A","0.158 (3/19)","0.125 (2/16)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2","uOR","N/A","","N/A","0.5 (1/2)","0 (0/3)","",NA,"","","","","","","","","","","","","","","","","","","3","uOR","N/A","","N/A","0","0.333 (4/12)","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"16","uOR","2.4","0.8-6.8","N/A","0.375 (6/16)","0.313 (10/32)","","","","","","","",NA,"",NA,"","","Bladder cancer has no death, and is classified in another group in the paper","","","","","","","","1","uOR","N/A","","N/A","0","0 (0/2)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1","uOR","N/A","","N/A","0","0/0","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"4","uOR","N/A","","N/A","0","0.6 (3/5)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1","uOR","N/A","","N/A","1 (1/1)","0.286 (4/14)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","2","uOR","N/A","","N/A","0.5 (1/2)","0.333 (1/3)","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8","uOR","2.4","0.5-10.3","N/A","0.375 (3/8)","0.286 (4/14)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"81","uOR","2.259","1.35-3.77","0.002","0.333 (27/81)","0.268 (44/164 )","","","","","","","","","","","","","multivariate analysis of risk of death in patients under active oncological treatment","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"30","37.0% (30/81)","OR","3.15 (univariate)  3.624","1.52-6.53  1.17-11.17","0.002  0.025","0.467 (14/30)","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","Chemotherapy treatment versus other treatment","25","","","","","","0.32 (8/25)","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"7","","","","","","0","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","11","","","","","","0.364 (4/11)","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","6","","",NA,"","","0.167 (1/6)","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"71633","Raad 2023","International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.","Consensus","Peer-reviewed","eLife","","2023-01","International multicenter study  comparing COVID-19 in patients with  cancer to patients without cancer: Impact  of risk factors and treatment modalities  on survivorship","Raad I. I.","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","USA, Australia, Brazil, France, Japan, Lebanon, Singapore, South Korea, Spain","","","2020-01-04","2020-11-15","3966","30 day mortality","Hospital readmissions within 30 days after  COVID-19 diagnosis, mechanical ventilation, progression to lower respiratory tract infection, co-infection","Hospitalisation; ICU admission; Mortality","Other: No","Cancer diagnosed or treated within a year  before the diagnosis of COVID-19","Same multinational cohort","1115:2851 = 1:2.56 country adjusted, age/gender/comorbidity matching not mentioned",NA,"Median","61","Range","18-100","45","1115","Median","50","Range","18-100","47","2851","Not mentioned",NA,"409","38","348","17","",NA,"","<0.0001","546","49","1020","36","",NA,"","<0.0001","299","27","6599","23","",NA,"","<0.0001","History of ischemic heart disease: 94; history of heart failure: 85","History of ischemic heart disease: 9; history of heart failure: 12","History of ischemic heart disease: 226; history of heart failure: 240","History of ischemic heart disease: 8; history of heart failure: 12","","","","History of ischemic heart disease: 0.57; history of heart failure: <0.001","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","COPD/bronchiolitis obliterans: 75; asthma: 106","COPD/bronchiolitis obliterans: 7; asthma: 10","COPD/bronchiolitis obliterans: 175; asthma: 178","COPD/bronchiolitis obliterans: 9; asthma: 6","","","","COPD/bronchiolitis obliterans: 0.07; asthma: <0.001","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","multivariate","Other: Country, tocilizumab treatment, convalescent plasma treatment",NA,"64","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"632","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","283","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"1115","mOR (multiple imputations)","1.23","0.87-1.75","0.24","","","cRR","(141/1100)/(225/1846)=1.05","","0.62","141/1100","225/1846","","","","0.98","135/1096=12.3%","130/1052=12.4%","","cRR","(63/481)/(60/806)=1.76","","<0.0001","63/481=13.1%","60/806=7.44%","Hospitalisation referred to hospital re-admission within 30 days of COVID-19 diagnosis",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"71628","Turtle 2023","Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.","Consensus","Peer-reviewed","PLOS Medicine"," ISARIC WHO Clinical Characterisation Protocol UK prospective observational cohort study (ISARIC4C)","2023-01","Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study","Lance Turtle","Prospective","Cohort","Yes","inpatient","United Kingdom","N/A","N/A","2020-01-17","2022-02-28","156552","In-hospital mortality ","4C mortality score - illness severity at presentation until 28 days after admission   In-hospital interventions: Use of oxygen  Noninvasive ventilation  Invasive mechanical ventilation  Admission to critical care ","Severity; ICU admission; Mortality","yes","Cancer patients who are immunocompromised ","Drawn from the same multinational cohort  Includes patients with a 'history of malignant neoplasm'","Cancer immunocompromised to immunocompetent (assumed non-cancer) = 5116:134598  Not matched ",NA,"median","72.0","IQR","62.0-79.7","58.1","5116","median","69.5","IQR","53.4-82.0","55.3","134598","Wild Type (Ancestral/Wu-1); Alpha (B.1.1.7); Delta (B.1.617.2); Omicron (B.1.1.529/BA.1)",NA,"1621","31.7","33798","25.1","",NA,"","","2049","40.1","57117","42.4","",NA,"","","1188","23.2","36322","27.0","",NA,"","","1318","25.8","35597","26.4","","","","","","","","","",NA,"",NA,"229","4.5","3800","2.8","",NA,"","","790","15.4","18901","14.0","",NA,"","","946","18.5","18495","13.7","","","","","5116","100","0","0","","","","",NA,NA,NA,NA,"",NA,"",NA,"Asthma;chronic neurological disorder;chronic haematologic disease;dementia;malnutrition;Rheumatologic disease 511;385;1132;160;559","10;7.5;22.1;5.6;3.1;10.9","17720;13957;3665;15328;2417;12901","13.2;10.4;2.7;11.4;1.8;9.6","","","","","","","","","","","","","Invasive ventilation required   Note that paper states ""Disease severity as measured using 4C mortality score (respiratory rate (breaths per min), Glasgow Coma Scale, oxygen saturation (%), blood urea (mmol/L), blood C-reactive protein (CRP, mg/L)"" but this data is not avilable for individual immunocompromised subtypes (cancer) ","Critical care admission ","28 days","Noninvasive or Invasive ventilation required ","multivariate","Age; Sex; Comorbidities; Other: Ethnicity, deprivation index, vaccination, ",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"5116","mOR","2.00","1.87-2.15","<0.001","0.355 (1818/5116)","0.213 (28608/134598)","mOR","0.77","0.70-0.85","<0.001","0.867 (4437/5116)","0.154 (20710/134598)","mOR;mOR","0.93;0.65","0.86-1.01;0.56-0.76","0.095;<0.001","0.179 (918/5116);0.0461(236/5116)","0.182 (24445/134598);0.0644 (8665/134598)","Noninvasive;invasive","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5116","mOR","2.00","1.87-2.15","<0.01","0.365 (1818/5116)","0.219 (28608/134598)","mOR","0.77","0.70-0.85","<0.001","0.873 (4437/5116)","0.155 (20710/134598)","mOR;mOR","0.93;0.65","0.86-1.01;0.56-0.76","0.095;<0.001","0.182 (918/5116);0.047(236/5116)","0.185 (24445/134598);0.066 (8665/134598)","Noninvasive;invasive","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","mOR","1.28","1.20-1.36","<0.001","","","",NA,"",NA,"","","",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","mOR","0.83","0.76-0.91","<0.001","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,NA,NA,"","","mOR","0.66","0.54-0.80","<0.001","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","Compared to immunocompetent wave 1 hence may not be useful",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","Alpha","","mOR","1.19","1.12-1.26","<0.001","","","",NA,"",NA,"","","","","","","","","Compared to immunocompetent wave 1 hence may not be useful","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"71512","Nolan 2023","Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.","Consensus","Peer-reviewed","CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION","COVID EHR Cohort","2023-01","Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin","Nolan, M. B.","Retrospective","Cohort","Yes","inpatient","US","","Duke University, Hackensack Meridian Health, Mayo Clinic (3 locations: Phoenix, AZ, Jacksonville, FL, Rochester, MN), Memorial Sloan Kettering Cancer Center, Mount Sinai, New York University, Northwestern University, University of California-Davis, University of California-San Francisco, University of Chicago, University of Illinois at Chicago, University of Kansas, University of Maryland, University of Michigan, University of North Carolina, University of Utah, University of Wisoconsin, Vanderbilt University, Virginia Commonweatlth University, Washington University, Yale University","2020-02-01","2021-09-30","104590","in-hospital mortality and ICU admission","","ICU admission; Mortality","yes","Current cancer (not extracted data on past history of cancer as timeline not specified) ","same databases","No matching of patients and controls.",NA,"","","","","55.0","7141","","","","","49.2","90700","Not mentioned",NA,"3616","50.6","33647","36.9","",NA,"","0.079","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","icu admission","in hospital mortality","","multivariate","Age; Sex; Comorbidities; Other: BMI",NA,"732","uOr; mOR","2.47; 1.93","2.04-2.99; 1.59-2.36","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","611","uOr; mOR","1.47; 1.57","1.14-1.88; 1.21-2.03","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"1062","uOr; mOR","1.70; 1.40","1.42-2.04; 1.17-1.69","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","""Digestive system"" cancer.","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"628","uOr; mOR","1.88; 1.05","1.49-2.36; 0.83-1.33","<0.001; 0.66","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"2012; 2012; 4337; 4337","uOr; mOR; uOR; mOR","2.28; 1.94; 1.82; 1.48","2.01-2.58; 1.71-2.21; 1.66-1.99; 1.35-1.62","<0.001; <0.001; <0.001; <0.001","nr; nr; nr; nr","0.092 (8384/90700); 0.092 (8384/90700); 0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","",NA,"",NA,"","","metastatic; metastatic; solid tumour without metastasis; solid tumour without metastasis","","","","","","","","2482","uOr; mOR","2.02; 1.71","1.80-2.26; 1.52-1.92","<0.001; <0.001","nr; nr","0.092 (8384/90700); 0.092 (8384/90700)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"7141","uOr; mOR","1.91; 1.58","1.78-2.06; 1.46-1.70","<0.001; <0.001","0.146 (1040/7141); 0.146(1040/7141)","0.092 (8384/90700); 0.092 (8384/90700)","uOR; mOR","1.31; 1.24","1.24-1.39; 1.17-1.32","<0.001; <0.001","0.247 (1763/7141); 0.247(1763/7141)","0.199 (18063/90700); 0.199 (18063/90700)","","","","","","","","","","","","","","",NA,"4337","uOR; mOR","1.82; 1.48","1.66-1.99; 1.35-1.62","<0.001; <0.001","nr; nr","0.92 (8384/90700); 0.92 (8384/90700)","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"2012","uOR; mOR","2.28; 1.94","2.01-2.58; 1.71-2.21","<0.001; <0.001","nr; nr","0.92 (8384/90700); 0.92 (8384/90700)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,"6344","11.5","","","",NA,"0.104 (76/733)","0.052 (252/4848)","","","",NA,"0.205 (150/733)","0.163 (790/4848)",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"","48639","88.5",NA,NA,NA,NA,"0.131 (403/3074)","0.076 (3237/42593)",NA,NA,NA,NA,"0.241 (741/3074)","0.182 (7752/42593)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"70896","Abuhelwa 2022","In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States.","Consensus","Peer-reviewed","Cancers","the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) 2020 database","2022-12"," In-Hospital Mortality and Morbidity in Cancer Patients with COVID-19: A Nationwide Analysis from the United States ","Abuhelwa Z","Retrospective","Cohort","Yes","inpatient","United States","N/A","N/A","2020-01-01","2020-12-31","1050045","All-cause in-hospital mortality","(i) morbidity as measured by the rates of septic shock, acute respiratory failure, acute respiratory distress syndrome, and mechanical ventilation (ii) resource utilization as measured by length of hospital stay and total hospitalization charges.","ICU admission; Mortality; Other: Morbidity (ARDS, Mechanical ventilation), resource utilization","no","Patients with a principal diagnosis of COVID-19 who have underlying cancer as secondary diagnosis were included in the analyses. The included cancers were lung, breast, colorectal, prostate, leukemia, lymphoma, and multiple myeloma. Patients were excluded if they were less than 18 years of age. The ICD-10-CM diagnosis codes were used to extract data (Supplementary Table S1).","Patient with a COVID-19 diagnosis without a cancer diagnosis","No matching - all non-cancer patients used in multivariable regression model.",NA,"mean","70.92","95% CI","70.52-71.32","56.57","27760","mean","64.57","95% CI","64.41-64.74","52.7","1022285","Not mentioned",NA,"10110","36.42","273260","26.73","",NA,"","<0.001","19380","69.81","692565","67.75","",NA,"","<0.001","9585","34.53","419910","41.08","",NA,"","","6175","22.24","186725","18.27","","","","<0.001","","","","","",NA,"",NA,"1320","4.76","44360","4.34","",NA,"","0.151","4790","17.26","150100","14.68","",NA,"","<0.001","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","No mention of CVD. I put in numbers of coronary artery disease.","","","","","","","","N/A","Mechanical ventilation","all-cause in-hospital mortality","N/A","multivariate","Age; Sex; Comorbidities; Other: age, sex, race, admission type, admission day, hospital bed size, hospital teaching status, hospital region, insurance status, median annual income, and comorbidities.",NA,"4400","mOR","1.57","1.31-1.88","<0.001","0.209 (920/4400)","","","","","","","","",NA,"",NA,"","","lung","","","","","","","","3340","mOR","0.96","0.73-1.27","0.763","0.103 (345/3340)","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"1675","mOR","1.45","1.07-1.96","0.015","0.191 (320/1675)","","","","","","","","",NA,"",NA,"","","colorectal","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"4080","mOR","0.94","0.77-1.14","0.533","0.190 (775/4080)","","","","","","","","",NA,"",NA,"","","prostate","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"13495","","","","","0.175 (2360/13495)","","","","","","","","",NA,"",NA,"","","","","","","","","","","13550","mOR;mOR;mOR","1.22;1.30;1.20","1.02-1.45;1.05-1.61;0.94-1.52","0.028;0.016;0.137","0.174 (2351/13550)","","","","","","","","","","","","","","leukemia;lymphoma;multiple myeloma","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"27760","mOR","1.21","1.12-1.31","<0.001","0.224;0.156;0.108","0.120 (122451/1022285)","mOR(mechanical_ventilation)","0.98","0.88-1.09","0.767","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"70028","Sanchez-Pina 2020","Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies","Consensus","Peer-reviewed","European Journal of Haematology","","2020-07-20","Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies","Sanchez-Pina JM","Retrospective","Cohort","Yes","inpatient and outpatient (no breakdown)","Spain","Madrid","Universitario 12 de Octubre, Instituto de Investigacin Sanitaria Hospital ","2020-03-07","2020-04-07","92","Mortality","","Severity; Hospitalisation; ICU admission; Mortality","no","The objective of the present study was to describe infection in a consecutive series of patients with haematological malignancies who were diagnosed with COVID-19 in the greater Madrid area.","We also compared the outcome of this cohort of patients with a contemporaneous control population of patients with COVID-19 and similar characteristics but without haematological malignancies at our hospital","We selected a control group of 53 patients without haematological malignancies from the overall COVID-19 patients who were admitted or attended to in the emergency room at our hospital during the study period. These selected patients were similar to the haematological cases with respect to age and severity index values at admission, but they did not have any history of cancer.",NA,"Mean","64.7","Range","36-88","59","39","Mean","65.7","Range","41-89","62.3","53","Not mentioned",NA,"","","","","",NA,"","","19","48.7","26","49.1","",NA,"","0.974","7","20","11","20.8","",NA,"","0.737","6","15.4","8","15.1","","","","0.969","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","2","5.1","9","17","","","","0.083","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Thrombosis: 4","10.3","1","1.9","","","","0.080","","","","","","","","","Based on the WHO severity scale, patients were classified as mild, moderate and severe.","","53-day Mortality","Based on the WHO severity scale, patients were classified as mild, moderate and severe.","univariate; multivariate","Age; Sex; Comorbidities; Other: hypertension, therapy with ACE-I/ARB, need of oxygen therapy, severity/moderate disease, CRP on admission",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","39","uOR;mOR","3.680;6.652","1.314-10.305;1.868-23.688","0.013;0.003","0.359(14/39);0.359(14/39)","0.132(7/53);0.132(7/53)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"39","uOR;mOR","3.680;6.652","1.314-10.305;1.868-23.688","0.013;0.003","0.359(14/39);0.359(14/39)","0.132(7/53);0.132(7/53)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"4","10.3","","","","","4/14 (0.286)","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","12","30.8","","","","","4/14 (0.286)","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"Targeted 5; ITK 2; mAb 5; Proteasome inhibitor 7 ","Targeted 12.8; ITK 5.1; mAb 12.8; Proteasome inhibitor 17.9","","","","","Targeted 0.143; ITK 0; mAb 0.714; Proteasome inhibitor 0.143","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","IMIDs 3","7.7","","","","","0.143","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"70002","Lunski 2021","Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana","Consensus","Peer-reviewed","Cancer","Ochsner Health System","2020-10 ","Multivariate Mortality Analyses in COVID-19: Comparing Patients With Cancer and Patients Without Cancer in Louisiana","Lunski MJ","Retrospective","cohort ","Yes","Other: non-specific","US","Louisiana","36 different hospitals and clinics across the state, which ranged from tertiary care centres to primary care office","2020-03-01","2020-04-30","5145","Mortality of patients","hospitalization","Hospitalisation; Mortality","no","""ICD used to identify patients with active cancer or a history of cancer.""","Also from the same population - Ochsners electronic health record system (Epic)","ratio approx 1:15  the study did not explicitly mentioned whether their age, gender and comorbidity were matched. yet, they did p-value analysis for the variables, which aimed to indicate any statistically significant differences in the distribution between the two groups.   From table 1, age, sex, races, and all comorbidities (except obesity) had p-value < 0.05, indicating there are statistically significant differences in the proportions of these variables between the 2 groups, implying that they might not be very well-matched. ",NA,"","","","","45.5%","312","","","","","38.7%","4833","Not mentioned",NA,"","","","","",NA,"","","246","78.9%","1709","35.4%","aOR","0.6","0.47-0.78","","116","37.2%","872","18.0%","aOR","0.92","0.70-1.21","","34","10.9%","192","4.0%","aOR","1.43","0.99-2.08","","","","","","",NA,"",NA,"10","3.2%","20","0.4%","aOR",NA,"","","80","25.6%","902","18.7%","aOR","3.84","2.98-4.93","","35","11.2%","334","6.9%","aOR","1.34","0.96-1.88","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"143 (obesity)","45.8%","2339","48.4%","aOR"," 1.30","1.03-1.63","","","","","","","","","","","","","","multivariate","Sex; Comorbidities",NA,"26","uOR","4.69","2.03-10.86","0.0003","0.308 (8/26)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","70 ","uOR","1.36","0.65-2.87","0.425","0.114 (8/70)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","32 (GI in general)","uOR","1.96","0.75-5.11","0.174","0.156 (5/32)","0.087 (418/4833)","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"74","uOR","3.39","1.98-5.83","1.227E-05","0.243 (18/74)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","13","uOR","0.88","0.11-6.79","1.084","0.077 (1/13)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","uOR","","","","0","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"8","uOR","3.52","0.71-17.50","0.126","0.250 (2/8)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3","uOR","5.28","0.48-58.37","0.178","0.333 (1/3)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"251","uOR","2.43","1.74-3.39","2.687E-07","0.187 (47/251)","0.087 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","61","uOR","4.78","2.75-8.29","5.034E-08","0.311 (19/61)","0.087 (418/4833)","","","","","","","","","","","","","","","","","","","","","23 (endocrine)","uOR","2.22","0.75-6.57","0.151","0.174 (4/23)","0.087 (418/4833)","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"312","uOR;aOR","2.87;2.03","2.14-3.85;1.44-2.87","","0.212 (66/312)","0.087 (418/4833)","","","","","","","","","","","","","","uOR","2.34","1.86-2.95","2.073E-12","0.503 (157/312)","0.302 (1460/4833)","",NA,"207","uOR","2.00","1.36-2.95","0.0004","0.159 (33/207)","0.086 (418/4833)","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"48","uOR","4.80","2.59-8.91","1.020E-06","0.3125 (15/48)","0.086 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","18","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"19","6.1% (19/312)","uOR","6.16","2.41-15.73","0.0002","36.8% (7/19)","0.086 (418/4833)","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","51","16.3% (51/312)","uOR","1.68","0.75-3.75","0.210","13.7% (7/51)","0.086 (418/4833)","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"13","4.2% (13/312)","uOR","4.69","1.44-15.31","0.011","30.8 (4/13)","0.086 (418/4833)","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","2"," 0.6% (2/312)","","","","","0%","0.086 (418/4833)","","","","","","","",NA,"",NA,"","","","","","","","","","","4","1.2% (4/312)","","","","","0%","0.086 (418/4833)","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","5","1.6% (5/312)","",NA,"","","0%","0.086 (418/4833)",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"69998","Serraino 2021","Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Consensus","Peer-reviewed","Cancer Medicine","""For the aims of this investigation, the following data sources were used: microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system database; cancer registry; diabetes registry; and municipal registries.""","2021-11","Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy","Serraino, D","Retrospective","Cohort","Yes","not specified","Italy","Friuli Venezia Giulia (FVG) region (northeastern Italy)","","2020-02-26","2020-12-31","263042","- Odds of positive COVID PCR result in cancer vs non-cancer patients; - Risk of admission to ICU for COVID-positive cancer vs non-cancer patients (all-cause); - Risk of death for COVID-positive cancer vs non-cancer patients (all-cause)","","ICU admission; Mortality","no","""To assess the cancer history, the above data were linked with the regional cancer registry that records incident cancer cases since 1995 and was updated up to December 2017. The cancer registry data includes all malignant neoplasms (International Classification of Diseases 10th version, ICD-10, codes: C00-C96) and benign, in situ, and uncertain behavior neoplasms of bladder (ICD-10: D30.3, D09.0, D41.4). For the years 20182020, information on cancer history was obtained from hospital discharges and the pathological laboratory records. For patients with multiple cancers, the most recent cancer diagnosis was considered, before or up to 30 days from SARS-CoV-2 testing (i.e., concurrent diagnosis).""  NOTE: we are only including patients with cancer diagnosis in the last 13 months.","Controls recruited from the same data sources as cancer patients (microbiological laboratory records; hospital discharge database; Johns Hopkins Adjusted Clinical Group (ACG) system database; cancer registry; diabetes registry; and municipal registries).","No matching - but statistical analyses were done adjusted for sex and age group (<40, 40-59, 60-69, 70-79, >=80)",NA,"","","","","1452 (46.9)","3098","","","","","17876(46.7)","38268","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","650","21.0","3132","8.18","OR","2.98","2.71-3.27","","1405","45.4","7205","18.8","OR","3.58","3.32-3.86","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","425","13.7","1986","5.19","OR","2.90","2.60-3.25","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","""The hospital discharge database (updated on 31 December 2021) was used to assess admissions to ICUs"" - no further information given re defining ICU admission","""Time at risk of death was computed from the date of SARS-CoV-2 test up to the date of death, or 6 February 2021, whichever came first"". Positive PCR tests were identified between 26 February 2020 - 31 December 2020, so all patients were followed up for at least 37 days from date of positive COVID test.","","multivariate","Age; Sex",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","673","mHR","0.92","0.72-1.17","NR","0.104 (70/673)","0.0500 (1914/38268)","mHR","0.98","0.48-2.00","NR","0.0119 (8/673)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"407","mHR","1.34","1.10-1.65","NR","0.241 (98/407)","0.0500 (1914/38268)","mHR","1.40","0.86-2.27","NR","0.0418 (17/407)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"460","mHR","1.04","0.85-1.27","NR","0.235 (108/460)","0.0500 (1914/38268)","mHR","1.15","0.77-1.71","NR","0.0587 (27/460)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"2818","mHR","1.19","1.07-1.31","NR","0.172 (486/2818)","0.0500 (1914/38268)","mHR","1.04","0.82-1.32","NR","0.0291 (82/2818)","0.013 (502/3826)","",NA,"",NA,"","","","","","","","","","","280","mHR","1.79","1.36-2.34","NR","0.193 (54/280)","0.0500 (1914/38268)","mHR","1.50","0.83-2.73","NR","0.0393 (11/280)","0.013 (502/3826)","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"466","mHR","1.93","1.61-2.33","NR","0.255 (119/466)","0.0500 (1914/38268)","mHR","0.90","0.52-1.56","NR","0.0280 (13/466)","0.013 (502/3826)","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"69989","Costa 2021","Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data","Consensus","Peer-reviewed","Cancer","Influenza Epidemiological Surveillance Information System (Sistema de Informao de Vigilncia Epidemiolgica da Gripe [SIVEP-Gripe] in Portuguese) - publicly available online  - retrieved on 2021-01-17","2021-08-03","Higher Severity and Risk of In-Hospital Mortality for COVID-19 Patients With Cancer During the Year 2020 in Brazil: A Countrywide Analysis of Secondary Data","Guilherme Jorge Costa","Retrospective","Cohort","Yes","inpatient","Brazil","N/A","N/A","2020-03-01","2020-12-31","322816","ICU admission  need for respiratory support (noninvasive vs invasive)  time in ICU  in-ICU mortality hospital length of stay in-hospital mortality ","","Severity; Hospitalisation; ICU admission; Mortality","no","History of cancer ","Cancer:control matching = 7406 : 315410   Drawn from same population of hospitalized adult patients w COVID19 diagnosis in Brazil ","Cancer:control = 7406 : 315410   No factors used in matching",NA,"Mean; median","66; 67","SD of mean","16","52.6","7406","Mean; median","61; 62","SD of mean","145","56.3","315410","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","1561","33.1","85640","52.7","uOR","0.44","0.42-0.47","<0.001","2405","47.5","116738","67","uOR","0.45","0.42-0.47","<0.001","","","","","",NA,"",NA,"146","3.6","3015","2.3","uOR","1.59","1.340-1.88","<0.001","460","10.8","14456","10.8","uOR","1","0.906-1.10","0.458","521","12.3","13162","9.8","uOR","1.29","1.176-1.42","<0.001","1846","39.6","7723","5.9","uOR","10.46","9.818-11.14","<0.001",NA,NA,NA,NA,"",NA,"",NA,"Obesity 257; neurological disease 320; asthma 129","6.3; 7.6; 3.1","20735;14020; 8833","15.6;10.4; 6.7","uOR; uOR;uOR","0.36; 0.71; 0.45","0.32-0.41; 0.631-0.80; 0.373-0.53","<0.001; <0.001; <0.001","","","","","","","","","need for respiratory support (noninvasive vs invasive)","% admitted to ICU","Hospital mortality","Degree of respiratory support required (none required, noninvasive, invasive) ","univariate; multivariate","Age; Comorbidities; Other: Males also adjusted fo",NA,"","mOR","2.9","Stated available in the bar chart but not available? ","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","mOR","1.4","Stated available in the bar chart but not available? ","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","mOR","2.9","Stated available in the bar chart but not available? ","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","mOR","1.4","Stated available in the bar chart but not available? ","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","mOR of bladder; mOR of prostate","1.8; 1.1","Stated available in the bar chart but not available? ","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","uOR both sexes; mOR both sexes","2.59;1.83","2.46-2.72;1.72-1.95","<0.01;<0.01","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","uOR both sexes; mOR both sexes","3.27;2.85","2.86-3.80; 2.41-3.38","<0.01;<0.01","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"7406; 7406","uOR both sexes; mOR both sexes","2.66;1.94","2.54-2.80;1.83-2.06","<0.01;<0.01","Total in-hospital: 0.605 (4479/7406)","Total in-hospital: 0.365 (115066/315410)","","","","","0.427 (3159/7406)","0.360 (113481/315410)","uOR","1.33","1.25-1.40","<0.001","0.243 (1802/7406); 0.454 (3360/7406)","0.191 (60197/315410); 0.455 (143446/315410)","invasive resp support; Noninvasive resp support","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7406; 7406","uOR;mOR","2.66;1.94","2.54-2.80;1.83-2.06","<0.01;<0.01","0.605 (4479/7406);0.605 (4479/7406)","0.365 (115066/315410);0.365 (115066/315410)","",NA,"","","0.427 (3159/7406)","0.360 (113481/315410)","% requiring noninvasive; % requiring invasive ventilation","","","","0.454 (3360/7406);0.243 (1802/7406)","0.455 (143446/315410);0.191 (60197/315410)","Noninvasive resp support; invasive resp support","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"7406;7406","100;100","uOR;mOR","2.66;1.94","2.54-2.80;1.83-2.06","<0.01","0.605 (4479/7406);0.605 (4479/7406)","0.365 (115066/315410);0.365 (115066/315410)","","","","","0.427 (3159/7406)","0.360 (113481/315410)","% of those requiring noninvasive ventilation; % of those requiring  invasive ventilation","","","","0.454 (3360/7406);0.243 (1802/7406)","0.455 (143446/315410);0.191 (60197/315410)","Noninvasive resp support; invasive resp support","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"69975","Sahin 2021","The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study","Consensus","Peer-reviewed","Clinical Endocrinology","Turkish Ministry of Health National Electronic Database","2021-04","The clinical outcomes of COVID- 19 infection in patients with a history of thyroid cancer: A nationwide study","Sahin M","Retrospective","Cohort","Yes","not specified","Turkey","N/A","Public hospitals University hospitals Private centres","2020-03-11","2020-05-30","776","The primary endpoint was all-cause mortality.","The secondary outcomes were the length of stay in the hospital and admitted to the intensive care unit (ICU) or mechanical ventilation need during hospitalization.","Hospitalisation; ICU admission; Mortality; Other: Intubation","no","Yes, they specifically looked at Thyroid cancer. ""Thyroid cancer was defined based on the International Classification of Disease (ICD-10) codes. Thyroid cancer patients were divided into two groups according to the administration of RAI therapy."" ","Yes, 1:1","The ratio of cancer:non-cancer is 1:1 ""Our study group (total n =776) included thyroid cancer patients (n=388) (C 73) diagnosed with COVID-19 infection and as a control group gender and age-matched patients with COVID-19 without a cancer diagnosis (n=388).""",NA,"Median","53","IQR","19","24","388","Median","53","IQR","19","24","388","Not mentioned",NA,"36","14.4","48","18.2","uOR","0.72","0.46 - 1.14","0.0166","246","63.4","203","52.3","uOR","1.58","1.18 - 2.10","0.00177","182","47.4","104","27.4","uOR","2.41","1.79 - 3.26","6.47 e-9","Heart Failure; CAD; PAD 21; 111; 15","5.4; 28.6; 3.9","21; 72; 11","5.4; 18.6; 2.8","uOR","1; 1.76; 1.38 ","0.54 - 1.86; 1.25 - 2.47; 0.62 - 3.04","1;  0.000974; 0.425","6","1.5","5","1.3","uOR","1.2","0.36 - 3.98","0.761","","","","","",NA,"","","15","9.9","18","11.9","uOR","0.83","0.41 - 1.66","0.594","Asthma/COPD: 133","34.3","116","29.9","uOR","1.22","0.90 - 1.65","0.191","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Dyslipidaemia; Obesity: 125; 24","32.2; 48.0","85; 16","21.9; 36.4","uOR","1.69; 1.53","1.23 - 2.34; 0.80 - 2.93","0.00123; 0.194","","","","","","","","","Intubation","","Mortality was not explicitly defined, however, the primary endpoint was all cause mortality.  The median and range of the followup period for patients with thyroid cancer was calculated as 8 (149) days and for noncancer patients as 8 (137) days.","N/A","univariate; multivariate","Other: Multivariate analysis was only done for hospitalisation. The analysis adjusts for age, sex, pulmonary CT findings of COVID-19, hypertension, dyslipidemia, asthma/COPD, type 2 diabetes mellitus, cardiovascular disease (CVD), and thyroid cancer.",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"388","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ICU; ICU > 4 days  ","0.84; 1.31","0.50 - 1.41; 0.48 - 3.56","0.511; 0.599","0.139 (29/208); 0.552 (16/ 29)","0.119 (34/ 286); 0.485 (16/33)","uOR","1.07","0.52 - 2.19","0.855","0.0770 (16/208)","0.0524 (15/286)","","uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation","0.41; 0.62; 0.38","0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54","5.83e-9; 0.00203; <0.001","0.536 (208/388); 0.495 (103/ 208)   ","0.737 (286/388); 0.500 (143/286)",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"388","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ICU; ICU > 4 days  ","0.84; 1.31","0.50 - 1.41; 0.48 - 3.56","0.511; 0.599","0.139 (29/208); 0.552 (16/ 29)","0.119 (34/ 286); 0.485 (16/33)","uOR","1.07","0.52 - 2.19","0.855","0.0770 (16/208)","0.0524 (15/286)","","uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation","0.41; 0.62; 0.38","0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54","5.83e-9; 0.00203; <0.001","0.536 (208/388); 0.495 (103/ 208)","0.737 (286/388); 0.500 (143/286)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"388","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ICU; ICU > 4 days ","0.84; 1.31","0.50 - 1.41; 0.48 - 3.56","0.511; 0.599","0.139 (29/208); 0.552 (16/ 29)","0.119 (34/ 286); 0.485 (16/33)","uOR","1.07","0.52 - 2.19","0.855","0.0770 (16/208)","0.0524 (15/286)","","uOR Hospitalisation; uOR Hospitalisation > 8 days; mOR Hospitalisation","0.41; 0.62; 0.38","0.30 - 0.56; 0.46 - 0.84; 0.27 - 0.54","5.83e-9; 0.00203; <0.001","0.536 (208/388); 0.495 (103/ 208)","0.737 (286/388); 0.500 (143/286)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","776","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR ","0.84","0.50 - 1.41","0.511","0.139 (29/208)","0.119 (34/286)","uOR","1.07","0.52 - 2.19","0.511","0.0770 (16/208)","0.0524 (15/286)","","uOR","0.41","0.30 - 0.56","5.83e-9","0.536 (208/388)","0.737 (286/388)",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","72","18.556","cOR","0.66","0.15-2.95","0.589","0.0278 (2/72) ","0.0412 (16/388)","cOR ICU; ICU> 4 days","1.00; 0.20 ","0.37 - 2.72; 0.02 - 2.05","0.998; 0.146","0.119 (5/42); 0.200 (1/5)","0.119 (34/286); 0.552 (16/29)","cOR","1.39","0.38 - 5.02","0.614","0.0714 (3/42)","0.0524 (15/286)","","cOR hospitalisation; hospitalisation > 8 days","0.50; 1.00","0.30 - 0.84; 0.52 -1.91","0.00807; 1.00","0.583 (42/72); 0.500 (21/42)","0.737 (286/388); 0.500 (143/286)","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"776","100","uOR","0.93","0.46 - 1.92","0.855","0.0387 (15/388)","0.0412 (16/388)","uOR","0.84","0.50 - 1.41","0.511","0.139 (29/208)","0.119 (34/286)","uOR","1.07","0.52 - 2.19","0.511","0.0770 (16/208)","0.0524 (15/286)","","uOR","0.41","0.30 - 0.56","5.83e-9","0.536 (208/388)","0.737 (286/388)","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"68513","Udovica 2022","High mortality in patients with active malignancy and severe COVID-19: Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic","Consensus","Peer-reviewed","Magazine of European medical oncology ","","2022-05","High mortality in patients with active malignancy and severe COVID-19","Udovica S ","Retrospective","Cohort","Yes","inpatient","Austria ","Vienna ","245 consecutive patients admitted for severe COVID-19 at four different COVID-19 units in four different oncologic departments in Austria. Non-cancer control from  Department of Medicine I at the Clinic Ottakring in Vienna ","2020/03/01","2021/03/31","245","covid-19 specific in hospital mortality ","","Mortality","no","Pa- tients with active malignancy were defined through one of the following criteria: (1) diagnosis of any histologically proven malignant disease within the last 6 months (excluding basalioma), (2) receiving treatment for a malignant condition within the last 6 months, (3) metastatic or recurrent malignant disease.","Same country but different hospital   This was a 12-month retrospective analysis of 245 consecutive patients admitted for severe COVID-19 at four different COVID-19 units in four different oncologic departments in Austria. The noncancer control group consisted of patients admitted at the Department of Medicine I at the Clinic Ottakring in Vienna for severe COVID-19 but had no history of cancer within the last 5 years","Looking at the data they were roughly age and gender matched   cancer to non-cancer ratio = 89:156",NA,"median ","74","range ","51-95","50.6","89","median ","76","range ","26-97","54.6","156","Other: participants were not tested for strain but paper includes: "" Of note, our study was performed between March 2020 and March 2021. In that period the SARS-CoV-2 back- ground strain and the SARS-CoV-2 alpha variant were the most commonly observed variants and vaccines were not available.""",NA,"","","","","",NA,"","","","","","","",NA,"","","14","15.7","45","28.8","cOR","0.46","0.24-0.9","","47","52.8","71","45.5","cOR","1.34","0.79-2.26","","","","","","",NA,"",NA,"10","11.2","10","6.4","cOR","1.85","0.74-4.63","","10","11.2","16","10.3","cOR","1.11","0.48-2.56","","22","24.7","24","15.4","cOR","1.81","0.94-3.46","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"17; 27; 8","19.1; 19.1; 9.0","49; 37; 35","31.4; 23.7; 22.6","cOR","0.52; 0.76; 0.34","0.28-0.97; 0.40-1.45; 0.15-0.77","","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","","others = obesity; neurological disease; dementia","others = obesity; neurological disease; dementia","I calculated crude OR and CI but have left p-values blank for James to calculate as discussed with him ","Severe COVID-19 was defined as COVID-19 associated with hypoxia necessitating conventional oxygen supplementation to keep blood oxygen satura- tion 94%. Critical disease was defined as requiring high-flow oxygen therapy (HFOT) with FiO2 levels of 0.6 or above or requiring treatment in an intensive care unit (ICU) for respiratory or multiorgan failure. HFOT was initiated as per local guidelines (requir- ing oxygen above 6 l/min). ","","OVID-19-spe- cific in-hospital mortality, defined as death during a COVID-19 infection requiring at least supplemental oxygen 6 l/min; or with signs of pulmonary mani- festations of COVID-19 on chest X-ray; or death in an ICU due to respiratory or multiorgan failure. Patients who died from other causes while having COVID-19, including those dying from progressive malignant disease, were excluded from the analysis of the primary endpoint.","The primary study endpoint was COVID-19-spe- cific in-hospital mortality, defined as death during a COVID-19 infection requiring at least supplemental oxygen 6 l/min; or with signs of pulmonary mani- festations of COVID-19 on chest X-ray; or death in an ICU due to respiratory or multiorgan failure.   Severe COVID-19 was defined as COVID-19 asso- ciated with hypoxia necessitating conventional oxy- gen supplementation to keep blood oxygen satura- tion 94%. Critical disease was defined as requiring high-flow oxygen therapy (HFOT) with FiO2 levels of 0.6 or above or requiring treatment in an intensive care unit (ICU) for respiratory or multiorgan failure. HFOT was initiated as per local guidelines (requir- ing oxygen above 6 l/min).","univariate; multivariate","Age; Comorbidities; Other: The multivari- able mortality model for COVID-19-associated mor- tality included age (categorical < 65 or 65 years), di- agnosis of active malignancy, comorbidities (chronic cardiovascular disease [CVD], chronic respiratory dis- ease, moderate or severe liver disease, severe chronic kidney disease (CKD), diabetes, dementia, neurologi- cal diseases, obesity) and ECOG performance status.",NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","15","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"8","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"54","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","35","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"89","uOR; mOR ","2.56; 4.59","1.47-4.47; 2.26-9.30","< 0.001; < 0.001","41/89","43/156","","","","0.59","0.18","0.147","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"45","50.1","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","5","5.6","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"13","14.6","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","5.6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","4.5","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","9","10.1","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"245","100","","","","","","","","","","","","","","","","","","","","","","","","","","","Of note, our study was performed between March 2020 and March 2021. In that period the SARS-CoV-2 back- ground strain and the SARS-CoV-2 alpha variant were the most commonly observed variants and vaccines were not available","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"","245","100%",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"68304","Korkusuz 2022","Changing characteristics of cancer patients during the COVID-19 pandemic","Consensus","Peer-reviewed","The Journal of Infection in Developing Countries","Bakirkoy Dr. Sadi Konuk Training and Research  Hospital centre database","2021-14","Changing characteristics of cancer patients during the COVID-19 pandemic","Korkusuz RK","Retrospective","Cohort","Yes","not specified","Turkey","N/A","Bakirkoy Dr. Sadi Konuk Training and Research  Hospital Centre","2020-03-15 ","2021-02-01","1793","The aim of this retrospective study, conducted in the  largest pandemic centre in Istanbul, was to evaluate  how cancer patients were affected by COVID-19  infection in the second wave of the pandemic in Turkey  and to investigate the clinical course and factors  affecting mortality.","ICU Admission and hospital length of stay(days)","Hospitalisation; ICU admission; Mortality","no","Patients with an active diagnosis of cancer - inferred from the fact that all patients have at least Stage 1 cancer and not remission.","Same hospital ","1511 non cancer patients: 216 cancer patients from second wave on table 4 282 Patients in first wave but no malignancy vs non malignant comparison Age, Gender and Comorbidity match",NA,"Median","64","Range","18-97","64.35","216","Median","63","Range","21-103","58.17","1511","Not mentioned",NA,"","","","","",NA,"","","31; 71; 102","47; 32.9; 36.2","nr; 726; 726","nr; 48.04; 48.04","",NA,"","","24; 57; 81","36.4; 26.4; 28.7","nr; 503; 503","nr; 33.28; 33.28","",NA,"","","2; 15; 17","3; 6.9; 6.03","nr; 217; 217","nr; 14.36; 14.36","","","","","5; 9; 14","07.6; 4.2; 4.96","nr; 53; 53","nr; 3.5; 3.5","",NA,"",NA,"","","","","",NA,"","","7; 11; 18","10.6; 5.1; 6.38","nr; 67; 67 ","nr; 4.43; 4.43","",NA,"","","17; 34; 51","25.8; 15.7; 18.1","nr; 62; 62","nr; 4.1; 4.1","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","first wave; second wave; combined total","first wave; second wave; combined total","first wave; second wave; combined total","first wave; second wave; combined total","","","","","Severity of pneumonia as seen on CT - the cases were divided into 3 groups as  mild involvement (<25% involvement), moderate  involvement  (2674%  involvement)  and  severe  involvement (>75% involvement)","Admission to ICU","No clear definition of mortality","Severity of pneumonia as seen on CT - the cases were divided into 3 groups as  mild involvement (<25% involvement), moderate  involvement  (2674%  involvement)  and  severe  involvement (>75% involvement)   The defintion of severe involvement is given above.","univariate; multivariate","Age; Sex; Comorbidities",NA,"7; 41; 48","","","","","NR; NR; 0.375 (18/48)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","",NA,"",NA,"","","first wave; second wave; combined total","","","","","","","","11; 21; 32","","","","","nr; nr; 0.219 (7/32)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","",NA,"",NA,"","","first wave; second wave; combined total","","","","","","","","19; 58; 77","","","","","NR; NR; 0.338 (26/77)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","",NA,NA,"",NA,"",NA,NA,NA,"first wave; second wave; combined total","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"12; 31; 43","","","","","NR; NR; 12/43 (0.279)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","",NA,"",NA,"","","first wave; second wave; combined total","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"57; 182; 239","","","","","NR; NR; 0.318 (76/239)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","",NA,"",NA,"","","first wave; second wave; combined total","","","","","","","","9; 34; 43","","","","","nr; nr; 0.535 (23/43 )","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","","","","","","","first wave; second wave; combined total","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"66; 216; 282","","","","","0.227 (15/66); 0.389 (84/216); 0.351 (99/282)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","0.242 (16/66); 0.361 (78/261); 0.333 (94/282)","nr; 0.108 (164/1511); 0.108 (164/1511)","","","","","0.159 (10/66); 0.243 (51/216); 0.216 (61/282)","nr; 0.300 (455/1511); 0.300 (455/1511)","first wave; second wave; combined total","","","","","","","",NA,"51; 104; 155","","","","","nr; nr; 0.245 (38/155)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","",NA,NA,NA,NA,"",NA,"first wave; second wave; combined total","","","","","",NA,NA,"15; 112; 127","","","","","nr; nr; 0.480 (61/127)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","",NA,"",NA,"","","first wave; second wave; combined total","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"22; 97; 119","33.3; 44.9; 42.2","","","","","nr; nr; 0.445 (53/119)","nr; 0.0876 (133/1511); 0.0876 (133/1511)","","","","","","","",NA,"",NA,"",NA,"first wave; second wave; combined total","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"68083","Kim 2022","Characterizing cancer and COVID-19 outcomes using electronic health records","Consensus","Peer-reviewed","PLOS One","Optum de-identified COVID-19 Electronic Health Record (EHR) Optum1s longitudinal EHR repository is derived from more than 700 hospitals and 7000 clinics in the United States","2022-05","Characterizing cancer and COVID-19 outcomes using electronic health records","Kim, YK ","Prospective","Cohort ","Yes","not specified","United States","N/A","N/A","2020-06-01","2020-12-31","271,639","Our primary objective was to determine the effect of cancer on the outcomes of COVID-19, specifically hospitalization, intensive care unit (ICU) admission, ventilator use, and all-cause deaths occurring within 30 days of COVID-19 infection, by comparing these outcomes between COVID-19 patients with and without a cancer diagnosis. ","The secondary objective was to identify factors associated with mortality in COVID-19 patients with recent cancer treatment. Potential predictors included chemotherapy and radiation therapy within 3 months before the COVID-19, age, sex (not included for breast, endometrial, and prostate cancers), race/ethnicity, insurance type, regions, and comorbidity conditions such as chronic conditions identified and known risk factors ","Severity; Hospitalisation; ICU admission; Mortality","no","Included patients with cancer diagnosis over 1 year, however in the baseline characteristics table, they included individual characteristics for the recent cancer group which was input into the DE table.","Yes 253,179 pts Non cancer: 18,460 cancer with 10,246 patients with a diagnosis of cancer within 1 year","253,179 pts Non cancer: 18,460 cancer with 10,426 patients with a diagnosis of cancer within 1 year Age, gender and comorbidity matched",NA,"median","66","IQR","57-76","47.3","10426","median","46","IQR","32-60","42.7","253179","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","3648","35.0","42542","16.8","",NA,"","","5183","49.7","49725","19.6","","","","","1986","19.0","15599","6.2","",NA,"",NA,"2338","22.4","18270","7.2","",NA,"","","2675","25.7","18145","7.2","",NA,"","","4402","42.2","62429","24.7","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Peripheral Vascular Disease: 2574","Peripheral Vascular Disease: 24.7","Peripheral Vascular Disease: 14708","Peripheral Vascular Disease: 5.8","","","","","","","","","","","","","Not given but outcomes also include ventilator use which is listed as severe outcome","Admitted to ICU is given as an outcome","30-day all cause mortality","Mortality/Hospitalization/ICU/Ventilator given  Will put ventilator use under the severe disease column 30 day all cause mortality given in mortality column","univariate; multivariate","Age; Sex; Comorbidities",NA,"887","mRR","1.85","1.582.17","<0.001","NR","0.019 (4854/253179)","mRR","1.35","1.121.63","0.002","NR","0.025 (6449/253179)","mRR","1.21","0.891.63","0.22","NR","0.011 (2855/253179)","","mRR","1.31","1.19-1.44","<0.001","NR","0.099 (25092/253179)","","2143","mRR","1.08","0.881.32","0.47","NR","0.019 (4854/253179)","mRR","0.92","0.741.13","0.409  ","NR","0.025 (6449/253179)","mRR","1.06","0.781.45","0.7","NR","0.011 (2855/253179)","","mRR","0.99   ","0.901.09","0.876 ","NR","0.099 (25092/253179)","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"794","mRR","0.91","0.691.19","0.50  ","NR","0.019 (4854/253179)","mRR","0.81; 0.72","0.611.07","0.14","NR","0.025 (6449/253179)","mRR","0.9","0.611.35","0.62","NR","0.011 (2855/253179)","","mRR","1.05  ","0.931.20","0.42","NR","0.099 (25092/253179)","","207; 121","mRR; mRR","2.46; 1.94","1.803.36; 1.193.16","<0.001; 0.008","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","mRR; mRR","0.96","0.621.49; 0.351.46","0.85; 0.363 ","NR; NR","0.025 (6449/253179); 0.025 (6449/253179)","mRR; mRR","1.14; 0.84","0.632.05; 0.332.12","0.67; 0.71","NR; NR","0.011 (2855/253179); 0.011 (2855/253179)","liver; pancreas","mRR; mRR","1.23; 0.98","1.001.51; 0.711.35","0.05; 0.91 ","NR; NR","0.099 (25092/253179); 0.099 (25092/253179)","liver; pancreas","474","mRR","1.15","0.861.53","0.34","NR","0.019 (4854/253179)","mRR","0.8","0.571.13","0.202","NR","0.025 (6449/253179)","mRR","0.79","0.491.30","0.36","NR","0.011 (2855/253179)","","mRR","1.06","0.911.22","0.46","NR","0.099 (25092/253179)",NA,"1781 ","mRR","0.82","0.700.96","0.015","NR","0.019 (4854/253179)","mRR","0.81","0.680.96","0.017","NR","0.025 (6449/253179)","mRR","0.78","0.601.01","0.055","NR","0.011 (2855/253179)","","mRR","0.95","0.881.02 ","0.177","NR","0.099 (25092/253179)","","291","mRR","1.62","0.962.74","0.07","NR","0.019 (4854/253179)","mRR","1.58","1.032.41","0.04","NR","0.025 (6449/253179)","mRR","1.53","0.812.90","0.19","NR","0.011 (2855/253179)","","mRR","1.15  ","0.901.46","0.27","NR","0.099 (25092/253179)",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"476","mRR","0.83","0.461.51","0.55  ","NR","0.019 (4854/253179)","mRR","0.58","0.301.11","0.10  ","NR","0.025 (6449/253179)","mRR","0.38","0.121.19)","0.1","NR","0.011 (2855/253179)","","mRR","0.76   ","0.590.9","0.035","NR","0.099 (25092/253179)",NA,"409","mRR","0.96","0.671.38","0.82","NR","0.019 (4854/253179)","mRR","0.89","0.571.38","0.61","NR","0.025 (6449/253179)","mRR","0.58","0.271.27","0.177","NR","0.011 (2855/253179)",NA,"mRR","0.86  ","0.691.06","0.163","NR","0.099 (25092/253179)","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"8952","mRR","1.12  ","1.041.22","0.004","NR","0.019 (4854/253179)","mRR","0.97","0.891.06","0.52","NR","0.025 (6449/253179)","mRR","0.95","0.841.08","0.453","NR","0.011 (2855/253179)","","mRR","1.05","1.001.09","0.03","NR","0.099 (25092/253179)","","2224","mRR","1.48 "," 1.301.68","<0.001 ","NR","0.019 (4854/253179)","mRR","1.27","1.101.46","0.001","NR","0.025 (6449/253179)","mRR","1.41","1.161.72","0.001","NR","0.011 (2855/253179)","","mRR","1.31 ","1.221.40"," <0.001 ","NR","0.099 (25092/253179)","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"10426","mRR","1.17","1.08-1.25","<0.001","0.075 (781/10426)","0.019 (4854/253179)","mRR","1.02","0.95-1.11","0.54","0.065 (674/10426)","0.025 (6449/253179)","mRR","1.05","0.93-1.17","0.45","0.032 (332/10426)","0.011 (2855/253179)","","mRR","1.10","1.06-1.14","<0.001","0.24 (2476/10426)","0.099 (25092/253179)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"1580","mRR","2.09","1.822.39","<0.001","NR","0.019 (4854/253179)","mRR","1.33","1.131.56","0.001","NR","0.025 (6449/253179)","mRR","1.32","1.04-1.68","0.021","NR","0.011 (2855/253179)","","mRR","1.26   ","1.161.37","<0.001 ","0.24 (2476/10426)","0.099 (25092/253179)","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"NR","NR","uRR; mRR","1.31; 1.37 ","1.08-1.60; 1.121.69 ","0.006; 0.003","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","NR","NR","uRR; mRR","1.89; 1.83  ","1.44-2.49; 1.372.46","<0.001; <0.001","NR; NR","0.019 (4854/253179); 0.019 (4854/253179)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"67898","Plais 2022","Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study","Consensus","Peer-reviewed","Frontiers in Oncology ","","2022-03"," Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study","Plais H","Prospective","Cohort","Yes","inpatient","France","17 French ICUs","17 French ICUs","2020-03-12","2021-03-08","409","Mortality at day 60 after ICU admission ","","Mortality","no","Cancer for which treatment (chemo, targeted therapy, immunotherapy, radiotherapy or surgery) within 6 months or with active surveillance within 6 months of ICU admission or haematological cancer that is not in complete remission","Adult patients admitted to participating ICUs without active canceras per above definition. Same cohort/hospitals/country. ","1:3 cancer:non cancer, propensity score matched based on probability of cancer at admission (based on sex, age, BMI, diabetes, chronic respiratory disease, congestive heart failure, organ transplant,immunosuppressive therapy, HIV, antimicrobial treatment, hospitalisation within the last 3 months, SAPS II and SOFA scores, and PaO2 at baseline)",NA,"Mean","69","NR","65-73","68.6","105","Mean","67","NR","59-75","69.4","315","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","24","22.9","107","34","",NA,"","","10","9.5","29","9.2","","","","","","","","","",NA,"",NA,"1","1","8","2.5","",NA,"","","12","11.4","32","10.2","",NA,"","","8","7.6","12","3.8","","","","","26","24.8","17","5.4","","","","",NA,NA,NA,NA,"",NA,"",NA,"3; 1","2.9; 1","6; 11","1.9; 3.5","","","","","Others: HIV; Solid organ transplant","Others: HIV; Solid organ transplant","Others: HIV; Solid organ transplant","Others: HIV; Solid organ transplant","","","","","","","likelihood of mortality at day 60 after ICU admission ","","univariate; multivariate","Age; Other: Cancer type, norepinephrine use, antimicrobial treatment, treatment with hydroxychloroquine and azithromycin, age at admission, period of admittance based on definition 1st and 2nd waves of SARS-Cov-2 in France",NA,"12","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","8","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"Includes hepatobiliary cancers","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","Grouped with upper GI ","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"2","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","2","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"54","uOR; mOR","1.88; 2.344","0.82-4.27; 0.87-6.31","0.13; 0.0262","NR; NR","0.274 (86/315); 0.274 (86/315)","","","","","","","",NA,"",NA,"","","","","","","","","","","51","uOR; mOR","3.19; 4.144","1.38-7.37; 1.24-13.83","0.0065; 0.0262","NR; NR","0.274 (86/315); 0.274 (86/315)","","","","","","","","","","","","","","","","","","","","","Endocrine: 2 ","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"105","uOR","2.3","1.24-4.28","0.0082","0.562 (59/105)","0.274 (86/315)","","","","","","","","","","","","","","","","","","","","",NA,"31","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"23","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"420","100","uOR","2.3","1.24-4.28","0.0082","0.562 (59/105)","0.274 (86/315)","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"67144","Alpert 2021","Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study","Consensus","Peer-reviewed","JNCI Cancer Spectrum","We used anonymous data from the Mount Sinai Health System (MSHS) COVID-19 registry, which includes all patients with an encounter at a MSHS facility who were diagnosed with, under investigation, or screened for COVID-19","2020-11","Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study","Alpert N","Retrospective","Cohort ","Yes","inpatient and outpatient (no breakdown)","USA ","New York ","Mount Sinai Hospital ","2020/03/01 ","2020/05/27","5556","sepsis, venous thromboembolism, acute kidney injury, intensive care unit admission, all-cause mortality.","","ICU admission; Mortality; Other: VTE, AKI","no"," Patients were identified as having cancer if they had any International Classification of Diseases (ICD)-10-CM code starting with C that was listed as active in their medical record. This included patients with a newly diagnosed cancer or those on an active course of treatment, but not those with a history of cancer. Leukemia, lymphoma, and myeloma were classified as nonsolid tumors","matched for gender, age, comorbidity  cancer: non-cancer = 421:5135","1:13  gender, age, comorbidity matched multivariate and propensity matched ",NA,"Mean","69.2","SE","0.7","59.4","421","Mean ","63.8","SE","0.2","56.6","5135","Not mentioned",NA,"","","","","",NA,"","","223","53","1677","32.7","cOR","2.32","1.9-2.84","","139","33","1138","22.2","cOR","1.73","1.4-2.14","","177","42","1300","25.3","cOR","2.14","1.75-2.62","","","","","","",NA,"",NA,"26","6.2","107","2.1","cOR","3.09","1.99-4.81","","70","16.6","566","11","cOR","1.61","1.23-2.11","","64","15.2","427","8.3","cOR","1.98","1.49-2.63","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"43","10.2","388","7.6","cOR","1.39","1.00-1.94","","Chronic lung disease = COPD + Asthma  CVD = HF + AF + coronary artery disease   Others = Obesity","Others = Obesity","Others = Obesity","Others = Obesity","","Others = Obesity","Others = Obesity ","Chronic lung disease = COPD + Asthma  CVD = HF + AF + coronary artery disease   Others = Obesity  I calculated crude OR and CI and have left p-values for James as discussed ","paper did not define severity but included data for sepsis, which I have included under severe = Defined as more than 1 of the following: temperature greater than 100.4F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","ICU defined as intensive care unit, no other info given ","no definition of mortality or number of days, but is stated as 'all cause'","paper did not define severity but included data for sepsis, which I have included under severe = Defined as more than 1 of the following: temperature greater than 100.4F; heart rate greater than 90 beats per minute; respiratory rate greater than 20 breaths per minute; white blood cell count less than 4000 or greater than 12 000 cells/lL","multivariate; Other: Multivariable analyses were adjusted for age, sex, and number of additional comorbidities and stratified into solid and non- solid cancers. ","Age; Sex; Comorbidities",NA,"19","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","46","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"32","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","32","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","13","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"81","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","20","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"15","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"273","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","96","","","","","","","","","","","","","","","","","","","","","","","","","","","26","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","26","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"421","mOR","1.02 ","0.81-1.29","0.86","129/421","1272/5135","mOR","1.04","0.80-1.34","1.0","82/421","913/5135","mOR ","1.31","1.06-1.61","0.05","253/421","2821/5135","the paper did not specify severity, but specified sepsis which I have included in the severity column   unspecified = multiple sites ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","421","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"5556","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"","5556","",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"67122","Rugge 2022","Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy","Consensus","Peer-reviewed","Tumori Journal","Regional Population-Based Cancer Registries","2021-12","Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy","Rugge M","Retrospective","cohort","Yes","inpatient and outpatient (with breakdown)","Italy","Veneto and Friuli Venezia Giulia","","2020-02-22","2020-07-31","22564","patients hospitalization (whatever the clinical setting, other than the intensive care unit [ICU]) and admission to an ICU","Vital status (mortality)","Hospitalisation; ICU admission; Mortality","no","Cancer diagnosed 12 months before testing COV2+ve* and Cancer diagnosed >12 months before testing COV2+ve","the resident population of the Veneto and Friuli Venezia Giulia regions (in northeastern Italy) who tested +ve for SARS-CoV-2 without a history of cancer","None",NA,"Median","73","IQR","62-82.25","53.4","324","Median","51","IQR","36-66","40.1","20777","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","univariate; multivariate","Age; Sex; Comorbidities",NA,"23","uOR","7.19","3.15-16.42","3.987E-06","0.435 (10/23)","0.097 (2008/20777)","uOR","1.24","0.17-9.22","0.845","0.001 (1/23)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","9.18","3.31-25.50","2.663E-05","0.737 (14/19)","0.234 (4685/20047)","Lung","34","uOR","1.61","0.62-4.17","0.333","0.147 (5/34)","0.097 (2008/20777)","","","","","0.000 (0/34)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","1.82","0.84-3.95","0.131","0.357 (10/28)","0.234 (4685/20047)","Breast","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"34","uOR","5.10","2.52-10.32","7.996E-06","0.353 (12/34)","0.097 (2008/20777)","uOR","4.71","1.82-12.20","0.0015","0.147 (5/34)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","3.53","1.66-7.52","0.0011","0.519 (14/27)","0.234 (4685/20047)","Colorectal","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"63","uOR","3.74","2.16-6.47","3.482E-06","0.286 (18/63)","0.097 (2008/20777)","uOR","1.85","0.67-5.11","0.240","0.063 (4/63)","0.035 (734/20777)","",NA,"",NA,"","","","uOR","3.17","1.90-5.29","1.293E-05","0.492 (29/59)","0.234 (4685/20047)","Urinary Bladder+Prostate","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","41","uOR","8.07","4.36-14.94","9.317E-11","0.463 (19/41)","0.097 (2008/20777)","uOR","1.40","0.34-5.81","0.659","0.049 (2/41)","0.035 (734/20777)","","","","","","","","uOR","8.53","4.11-17.69","1.790E-08","0.722 (26/36)","0.234 (4685/20047)","","129","uOR","4.35","3.00-6.33","7.188E-14","0.318 (41/129)","0.097 (2008/20777)","uOR","1.33","0.59-3.03","0.508","0.047 (6/129)","0.035 (734/20777)","",NA,"",NA,NA,NA,"","uOR","3.92","2.65-5.81","3.303E-11","0.545 (55/101)","0.234 (4685/20047)","Others","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"324","uOR;mOR","4.48;3.013","3.535-5.681;2.290-3.949","<0.001; NR","0.324 (105/324); 0.324 (105/324)","0.097 (2008/20777); 0.097 (2008/20777)","uOR;mOR","1.61;1.049","0.993-2.599;0.621-1.664","0.053; NR","0.056 (18/324); 0.056 (18/324)","0.035 (734/20777); 0.035 (734/20777)","","","","","","","","uOR;mOR","4.22;2.883","3.30-5.40;2.215-3.762","<0.001; NR","0.562 (198/263); 0.562 (198/263)","0.234 (4685/20047); 0.234 (4685/20047)","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"66861","Chavez-MacGregor 2022","Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients with or Without Cancer","Consensus","Peer-reviewed","JAMA Oncology","Optum de-identified COVID-19 electronic health record data set, which contains data from more than 700 hospitals and 7000 clinics across the US.","2022-01","Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer","Chavez-MacGregor M","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","United States","N/A","N/A - but included >700 hospitals in the US","2020-01-01","2021-01-28","507307","30-day Mortality, 30-day Mechanical ventilation, 30-day ICU stay, 30-day Hospitalisation","","Severity; Hospitalisation; ICU admission; Mortality","no","Used the following ICD criteria from electronic health records:  ICD-9: 140-165, 170-176, 179-209, 239  ICD-10: C00-C26, C30-C41, C43, C45-C58, C60-C80, C7A, C7B, C81-C96, D37-D47.   Cancer group was split into: (a) patients receiving treatment (radiotherapy or systemic therapy) <3 months before COVID diagnosis, and (b) patients not receiving recent treatment.  Both groups are included in our review given that all cancer patients had to have at least two ICD codes for cancer within 1 year before COVID diagnosis.","Controls drawn from the same data source (Optum COVID-19 electronic health record data set) - so from the same >700 hospitals and the same >7000 clinics across the US.","Did not match controls for all study analyses. However, they do report in Supplemental Table 6 outcomes of matched analysis. For this analysis, they matched in 1:5 ratio by age, sex and comorbidity.",NA,"Median","With recent cancer treatment: 66; Without recent cancer treatment: 68","IQR","With recent cancer treatment: 57-75; Without recent cancer treatment: 59-77","47.9","14287","Median","48","IQR","32-61","44.5","493020","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"1547","10.8","50115","10.2","uOR","1.07","1.02-1.13","","Severe obesity (BMI 40)","Severe obesity (BMI 40)","Severe obesity (BMI 40)","Severe obesity (BMI 40)","Severe obesity (BMI 40)","Severe obesity (BMI 40)","Severe obesity (BMI 40)","","Mechanical ventilation","ICU admission within 30-days of positive COVID test. Identified from the following electronic health record codes: 0200 - General classification ICU, 0201 - Surgical ICU, 0202 - Medical ICU, 0203 - Pediatric ICU, 0204 - Psychiatric ICU, 0206 - Intermediate ICU, 0207 - Burn care, 0208 - Trauma care, 0209 - Other intensive care, 0210 - General classification cardiac care unit (CCU), 0211 - Myocardial infarction care, 0212 - Pulmonary care, 0213 - Heart transplant, 0214 - Intermediate CCU, 0219 - Other coronary care.","30-day mortality.","30-day Mechanical ventilation. Identified using electronic health record codes.","multivariate","Age; Sex; Comorbidities; Other: race, diagnosis period, skilled nurse facility, insurance, geographical region",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"14287","aOR (No recent treatment);aOR (recent treatment)","0.93;1.74","0.84-1.02;1.54-1.96","0.12;<0.001","0.049;0.087","0.016 (7888/493020);0.016 (7888/493020)","aOR (No recent treatment);aOR (recent treatment)","0.98;1.69","0.91-1.06;1.54-1.87","0.61;<0.001","0.075 (749/9991);0.137 (589/4296)","0.033 (16270/493020);0.033 (16270/493020)","aOR (No recent treatment);aOR (recent treatment)","0.61;1.00","0.54-0.68;0.88-1.13","<0.001;0.94","0.038 (380/9991); 0.073 (314/4296)","0.022 (10846/493020);0.022 (10846/493020)","No recent treatment;recent treatment","aOR (No recent treatment);aOR (recent treatment)","0.79;1.19","0.75-0.83;1.11-1.27","<0.001;<0.001","0.251 (2508/9991);0.357 (1534/4296)","0.146 (71981/493020);0.016 (7888/493020)","No recent treatment;recent treatment",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"Chemotherapy: 1634; Chemo-immunotherapy: 195","Chemotherapy: 11.4;  Chemo-immunotherapy: 1.4","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","Targeted therapy or endocrine therapy: 1068","Targeted therapy or endocrine therapy: 7.5","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"Targeted therapy or endocrine therapy: 1068","Targeted therapy or endocrine therapy: 7.5","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","592","4.1","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","806","5.6","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"66531","Chai 2021","One-year mortality and consequences of COVID-19 in cancer patients: A cohort study","Consensus","Peer-reviewed","IUBMB Life","","2021-07","One-year mortality and consequences of COVID-19 in cancer patients: A cohort study","Chai C","Prospective","cohort","Yes","inpatient","China","Wuhan, Hubei Province","Union Hospital, Affiliated Dongfeng Hospital, The Central Hospital of Wuhan","2020-01-01","2020-03-18","1162","1-year all-cause mortality rate and sequelae","hospital mortality rate, the length of hospital stay, and the 12-month all-cause post-discharge mortality rate","Severity; Mortality","no","""hospitalized patients with active cancer"" ""Primary tumor sub-types were classified by the WHO Classification of Tumors series""","age and sex, 1:3","age and sex matched",NA,"Median","65","IQR","59-70","49","166","Median","65","IQR","59-70","49","498","Not mentioned",NA,"8","5","14","3","",NA,"","","55","33","171","34","",NA,"","","24","15","104","21","",NA,"","","12","7","40","8","","","","","4","2","18","4","",NA,"",NA,"5","3","7","1","",NA,"","","3","2","11","2","",NA,"","","11","7","25","5","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Hyperlipidemia 33","20","76","15","","","","","Hyperuricemia 16","10","42","8","","","","","COVID-19 disease severity was defined according to World Health Organization (WHO) guidelines","Not gi","1-year all-cause mortality rate ","","Other: needs recalculation - not accounting for comparison and 1-year (meaning not covid-19 deaths as well)","",NA,"25","OR","2.07","0.68-6.31","0.205","0.16","0.084","","","","","","","",NA,"",NA,"","","","","","","","","","","19","OR","1.28","0.28-5.72","0.764","0.105","0.084","","","","","","","",NA,"",NA,"","","","","","","","","","","10","OR","10.86","3.02-39.02","0.0003","0.500","0.084","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"23","OR","3.02","1.07-8.53","0.038","0.217","0.084","","","","","","","",NA,"",NA,"","","","","","","","","","","9","OR","3.10","0.62-15.41","0.1693","0.222","0.084","",NA,"","","","","","","","","","","","","","","","","","","5","OR","2.71","0.30-24.84","0.3867","0.200","0.084","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"17","OR","1.45","0.32-6.55","0.6467","0.118","0.084","","","","","","","",NA,"",NA,"","","","","","","","","","","16","OR","0.72","0.09-5.62","1.1958","0.063","0.084","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","OR","10.86","0.67-176.73","0.095","0.500","0.084","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"4","OR","10.86","1.49-79.05","0.0189","0.500","0.084","","","","","","","",NA,"",NA,"","","nasopharyngeal","","","","","","",NA,"1","","","","","1.000","0.084","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","4","","","","","0.000","0.084","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"149","OR","2.30","1.35-3.89","0.0022","0.174","0.084","","","","","","","",NA,"",NA,"","","","","","","","","","","17","OR","9.65","3.54-26.32","<0.001","0.471","0.084","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"166","OR","2.80","1.71-4.57","<0.0001","0.204","0.084","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"66333","Al 2021","COVID-19 amongst cancer patients: An experience from Oman","Consensus","Peer-reviewed","Journal of the Pakistan Medical Association","For Cancer: Cancer Registry of The Directorate-General of Non-Communicable Diseases, Ministry of Health, Oman. For COVID-19: Coronavirus Registry of Oman.","2021-10","COVID-19 amongst cancer patients: an experience from Oman","Al Bahrani BJ","Prospective","Cohort","Yes","inpatient","Oman","Muscat (and linked tertiary hospitals in Oman)","Royal Hospital, Muscat and its linked tertiary hospitals.","2020-03-24","2020-10-23","522","ICU, Mortality, Hospitalisation*","Septicaemia, intubation (only in controls), WBC, CRP, Renal impairment, Ferritin, Hypocalcaemia, Transaminase, LDH, Troponin, D Dimer, ","Hospitalisation; ICU admission; Mortality","no","All patients with a cancer diagnostic code listed in the registry of the Directorate-General of Non-Communicable Diseases","All tertiary centre inpatients with a positive covid-19 test whom are not on the cancer registry across the whole of Oman.","Significant different between two cohorts in terms of age, gender, ethnicity, T2DM, HTN. Controlled in terms of respiratory disease (6/77: 49/445, p=.4)",NA,"","","","","46.8","77","","","","","","445","Not mentioned",NA,"","","","","",NA,"","","20","26","207","46.5","uOR","0.4","0.23-0.69","7.9e-4","15","19.5","204","45.8","uOR","0.29","0.16-0.52","1.5e-5","9","11.7","82","18.4","uOR","0.59","0.28-1.22","0.15","","","","","",NA,"",NA,"6","7.8","36","8.1","uOR","0.96","0.39-2.36","0.93","15","19.5","407","91.5","uOR","0.02","0.01-0.04","1e-49","6","7.8","49","11.0","uOR","0.68","0.28-1.65","0.40","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Not assessed","Actual ICU admission (not just IMV)","Mortality before study end date","Not assessed","univariate","",NA,"6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","16","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"2","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"3","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","6","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"70","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","","","","","","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","3","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"77","uOR","2.89","1.70-4.93","0.0000564","0.351","0.157","uOR","0.03","0.02-0.06","5e-40","0.195","0.877","","","","","","","","","","","","","","",NA,"27","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"50","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"26","33.8","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","8","10.4","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"14","18.2","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","6.5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","3","3.9","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"522","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"66084","Zhou 2021","Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study","Consensus","Peer-reviewed","BMC Infectious Diseases","","2021-08","Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study","Zhou Y","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Taikang Hospital Other temporary hospitals of Wuhan","2020-02-10","2020-04-15","309","Clinical features of COVID-19 patients with cancer and identify death outcome related risk factors","","Severity; Mortality","no","no info on how long had cancer for","Age, gender, and comorbidities matched Cancer:control = 1:2","Cancer to non-cancer: 1:2 Age, gender, and comorbidity matched",NA,"median","66","IQR","24-90","54.4","56","median","66","IQR","20-95","55.8","115","Not mentioned",NA,"","","","","",NA,"","","37","35.9","59","28.6","",NA,"","0.195","14","13.6","23","11.1","",NA,"","0.579","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"Heart disease: 11","Heart disease: 10.7","Heart disease: 30","Heart disease: 14.5","","","","Heart disease: 0.379","","","","","","","","","Respiratory rate >30 breaths per minute O2 saturation <93% at rest Oxygenation index is <300mmHg","","no stated","Respiratory rate >30 breaths per minute O2 saturation <93% at rest Oxygenation index is <300mmHg","","",NA,"17","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","23","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","15","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","1","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"103","uOR","2.89","1.17-7.09","0.0211","0.117 (12/103)","0.044 (9/206)","","","","","","","uOR","1.19","0.72-1.97","0.505","0.350 (36/103)","0.311 (64/206)","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"65975","Cai 2021","Immunological alternation in COVID-19 patients with cancer and its implications on mortality","Consensus","Peer-reviewed","OncoImmunology","Health records in two branches of Tongji Hospital","2021-01-04","Immunological alternation in COVID-19 patients with cancer and its implications on mortality","Cai, Guangyao","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Tongji hospital (Optical Valley Branch and Sino-French New City Branch)","2020-02-04","2020-03-31","2425 admitted patients 2052 after loss to follow up (subsequent percentages are of this cohort)","Death  Time from illness onset to death/discharge Survival time: time from COVID onset to death or discharge","Severity of COVID-19  Fever - axillary temp at least 37.3C ","Severity; Mortality","no","No definition, just those with or without cancer   Subgroup analyses with recent anti-cancer treatments within 40 days before COVID-19 onset ","Cancer:non-cancer = 93:1959  Patients from the same hospital ","Propensity score matching system 1 (sex, age, symptoms, comorbidities) - matched 1:10, so total of cancer to non-cancer = 93:930   Propensity score matching system 2 (all of above AND immunological indices) - matched 1:10, so total of cancer to non-cancer = 49:490",NA,"Median of all, Median of propensity score matching 1, of propensity score matching 2","65, 65, 65","IQR","56-71, 56-71, 58-73","47.3, 47.3, 59.2","93, 93, 49","Median of all, Median of propensity score matching 1, of propensity score matching 2","62, 65, 66","IQR","51-70, 56-71, 57-74","48.7, 47.8, 60.6","1959, 930, 490","Not mentioned",NA,"","","","","",NA,"","","38","40.9","774","39.5","",NA,"","","17","18.3","328","16.7","",NA,"","","12","12.9","189","9.6","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","4","4.3","28","1.4","",NA,"","","0","0","18","0.9","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"3;0","3.2;0.0","50;9","2.6;0.5","","","","","Others: Hepatitis B;Hepatitis C","","","","","","","","The severity of COVID-19 was graded according to the 7th edition of the Diagnosis and Treatment Protocol of COVID-19: moderate, severe, critical ","","Not said, but death or discharge was used as the clinical outcome of the study.","The severity of COVID-19 was graded according to the 7th edition of the Diagnosis and Treatment Protocol of COVID-19: moderate, severe, critical ","univariate; multivariate","Age; Sex; Comorbidities; Other: multivariate logistic regression model 1: symptoms, multivariate logistic regression model 2: symptoms, immune indices including hsCRP, PCT, ferritin, TNF-, IL-1, IL-2 R, IL-6, IL-8, IL-10, lymphocytes",NA,"12","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","7","","","","","0.667 (2/3)","","","","","",NA,NA,"",NA,"",NA,NA,NA,"Oesophagus","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","5","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","4","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"11","","","","","0.500 (4/8)","","","","","","","","",NA,"",NA,"","","Bladder","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"2","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","","","","","0.555 (5/9)","","","","","","","","","","","","","","","","","","","","","","14 thyroid","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"","uOR total population;uOR propensity score 1;uOR propensity score 2;mOR  model 1 total population;mOR model 1 propensity score 1;mOR model 1 propensity score 2;mOR  model 2 total population;mOR model 2 propensity score 1;mOR model 2 propensity score 2; uHR total population;uHR propensity score 1;uHR propensity score 2;mHR model 1 total population;mHR model 1 propensity score 1;mHR model 1 propensity score 2;mHR model 2 total population;mHR model 2 propensity score 1;mHR model 2 propensity score 2","2.708;2.907;0.862;2.640;2.468;0.867;1.931;0.716;1.115;1.995;1.648;0.786;2.023;1.965;0.972;0.778;1.442;0.513","1.655-4.429;1.263-3.481; 0.436-1.702;1.498-4.654;1.388-4.388;0.403-1.866; 0.498-7.493;0.127-4.028;0.277-4.485;1.280-3.108;1.044-2.603;0.435-1.423;1.296-3.159;1.239-3.117;0.532-1.779;0.404-1.496;0.724-2.872;0.419-1.545 ","<0.001;0.004;0.668;0.001;0.004;0.715;0.341;0.704;0.878;0.002;0.032;0.427;0.002;0.004;0.928;0.451;0.298;0.804","0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49)","0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490;0.108 (212/1959);0.135 (126/930);0.253 (124/490;0.108 (212/1959);0.135 (126/930);0.253 (124/490;0.108 (212/1959);0.135 (126/930);0.253 (124/490); 0.108 (212/1959); 0.135 (126/930); 0.253 (123/490)","","","","","","","","","","","Moderate 0.0860 (8/93); severe 0.434 (45/93); critical 0.430 (40/93)","Moderate 0.119 (233/1955); Severe 0.702 (1372/1955); critical 0.179 (350/1955)","","","","","","","","",NA,"37 ('early')","NA as used early as reference ","","","","0.189 (7/37)","","","","","","","",NA,NA,NA,NA,"Moderate 0.135 (5/37); severe 0.514 (19/37); critical 0.351 (13/37)",NA,"Moderate;severe;critical","","","","","",NA,NA,"18 ('late')","Using EARLY as reference uOR; HR; mOR model 1; HR","0.536; 0.629;0.975; 2.347","0.099-2.887; 0.131-3.029;0.051-18.495; 0.305-18.053","0.468; 0.563;0.987; 0.412","0.111 (2/18)","","","","","","","","",NA,"",NA,"Moderate 0.0556 (1/18); severe 0.556 (10/18); critical 0.389 (7/18)","","","","","","","","","model 1 adjustment of covariates","38 ","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"9","9.7","uOR; uHR;mOR model 1;mHR model 1","1.400; 1.109;0.876; 0.521","0.253 - 7.759; 0.240 - 5.133;0.115 - 6.646; 0.080 - 3.402","0.700;0.894;0.898;0.496","0.222 (2/9)","0.108 (212/1959);0.135 (126/930)","","","","","","","",NA,"",NA,"Moderate 0.000 (0/9), severe 0.444 (4/9), critical 0.556 (5/9)",NA,"Note that all these therapies are within 40 days","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"2","2.2","uOR; uHR;mOR model 1;mHR model 1","4.583;3.949;22.027;25.952","0.267 - 78.548;0.498 - 31.280;0.311 - 1558.242;0.771 - 873.562","0.294;0.193;0.155;0.070","0.500 (1/2)","0.108 (212/1959);0.135 (126/930)","","","","","","","",NA,NA,NA,"Moderate 0.000 (0/2), severe 0.500 (1/2), critical 0.500 (1/2)",NA,"","","","","","","","","4","4.3","uHR","0.513","0.000 - 510.340","0.513","0.000 (0/4)","0.108 (212/1959)","","","","","","","",NA,"",NA,"Moderate 0.000 (0/4), severe 0.500 (2/4), critical 0.500 (2/4)","","","","","","","","","","1","1.1","uHR","0.048","0.000 - 8846600","0.755","0.000 (0/1)","0.108 (212/1959)","","","","","","","",NA,"",NA,"Moderate 0.000 (0/1), severe 0.000 (0/1), critical 1.000 (1/1)",NA,NA,"","","","","","","","2","2.15","uHR","0.045","0.000-5547.994","0.603","0.000 (0/2)","0.108 (212/1959)",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"Moderate 0.000 (0/2), severe 0.000 (0/2), critical 1.000 (2/2)",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"93;93;49;93;93;49;93;93;49;93;93;49;93;93;49;93;93;49","100","uOR total population;uOR propensity score 1;uOR propensity score 2;mOR  model 1 total population;mOR model 1 propensity score 1;mOR model 1 propensity score 2;mOR  model 2 total population;mOR model 2 propensity score 1;mOR model 2 propensity score 2; uHR total population;uHR propensity score 1;uHR propensity score 2;mHR model 1 total population;mHR model 1 propensity score 1;mHR model 1 propensity score 2;mHR model 2 total population;mHR model 2 propensity score 1;mHR model 2 propensity score 2 ","2.708;2.907;0.862;2.640;2.468;0.867;1.931;0.716;1.115;1.995;1.648;0.786;2.023;1.965;0.972;0.778;1.442;0.513","1.655-4.429;1.263-3.481; 0.436-1.702;1.498-4.654;1.388-4.388;0.403-1.866; 0.498-7.493;0.127-4.028;0.277-4.485;1.280-3.108;1.044-2.603;0.435-1.423;1.296-3.159;1.239-3.117;0.532-1.779;0.404-1.496;0.724-2.872;0.419-1.545 ","<0.001;0.004;0.668;0.001;0.004;0.715;0.341;0.704;0.878;0.002;0.032;0.427;0.002;0.004;0.928;0.451;0.298;0.804","0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49);0.247 (23/93);0.247 (23/93);0.245 (12/49)","0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490;0.108 (212/1959);0.135 (126/930);0.253 (124/490;0.108 (212/1959);0.135 (126/930);0.253 (124/490);0.108 (212/1959);0.135 (126/930);0.253 (124/490)","","","","","","","","","","","Moderate 0.0860 (8/93); severe 0.434 (45/93); critical 0.430 (40/93)","Moderate 0.119 (233/1955); Severe 0.702 (1372/1955); critical 0.179 (350/1955) ","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"65844","Bertuzzi 2021","Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy","Consensus","Peer-reviewed","British Journal of Cancer","Medical records at IRCCS, Rozzano, Italy","2021-05","Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy","Bertuzzi AF","Retrospective","cohort","Yes","inpatient","Italy","Lombardy","IRCCS, Rozzano","2020-02-27","2020-05-20","557","Mortality","ICU Admission","ICU admission; Mortality","no","Evidence in EHRs. Active cancer was defined by the presence of localised or metastatic disease at covid onset.","controls from the same hospital","propensity score matching for age and comorbidities - 1 cancer: 4 control",NA,"Mean","71","95%CI","67-74","67.4","46","Mean","65","95%CI","64-66","67.3","511","Not mentioned",NA,"9","19.6","41","8.0","uOR","0.28","0.12-0.65","0.002131","21","45.7","263","51.6","uOR","0.79","0.43-1.45","0.442006","12","26.1","125","24.5","uOR","1.09","0.55-2.16","0.812080","","","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"12; 13","26.7; 28.9","42; 44","23.3; 24.4","uOR","1.45; 1.79","0.74-2.85; 0.92-3.49","0.279626; 0.081512","Dyslipidemia; Coronary Artery Disease","","","","","","","","","","in-hospital fatality rate","","univariate; multivariate","Age",NA,"9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","3","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"33","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","","","","","","","","","","","","","","","all GU = 6; all GI = 10","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"46","uHR; mHR","2.79; 2.26","1.76-4.42; 1.39-3.657","<0.001; <0.001","0.500 (23/46); 0.500 (23/46)","0.202 (103/511); 0.202 (103/511)","","","","","","","","","","","","","","","","","","","","",NA,"17","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"29","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"13","28.3","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","4","8.7","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"1","2.2","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","10.9","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","4","8.7","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","21","45.7","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"557","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"65461","Al-Mozaini 2021","SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer","Consensus","Peer-reviewed","Frontiers In Oncology | Cancer Epidemiology and Prevention","""Medical records books"" of King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and Park View Hospital, Chittagong, Bangladesh","2021-08","SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer","Al-Mozaini M","Retrospective","Cohort","Yes","inpatient","Saudi Arabia and Bangladesh","Riyadh and Chittagong","King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and Park View Hospital, Chittagong, Bangladesh","2020-06-30","2020-08-07","184","Mortality","Mild, moderate, severe cases","Severity; Mortality","no","Having received anticancer treatment with curative, radical, adjuvant, or neoadjuvant therapy or treated in the last 12 months with radiotherapy, surgery, and chemotherapy.","""A total of 120 COVID-19-positive noncancer adult patients admitted by the same hospitals and same time period were included in this study as a control group.""","Not explicitly matched. Chi2 shows sex matched but not age matched.",NA,"Median","55","IQR","10.5","75.0","64","Median","53","IQR","9.0","62.5","120","Not mentioned",NA,"","","","","",NA,"","","19","29.69","21","17.5","OR","1.99","0.98 - 4.06","0.056","13","20.31","31","25.83","OR","0.73","0.35 - 1.52","0.40","15","23.44","11","9.17","OR","3.03","1.30 - 7.08","0.008","","","","","",NA,"",NA,"","","","","",NA,"","","3","4.69","9","7.5","OR","0.61","0.16 - 2.32","0.46","2","3.12","9","7.5","OR","0.40","0.08 - 1.90","0.23","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","any of the following symptoms: breathing rate of 30 or more breaths/min, the oxygen saturation level below 93%, one or multiple organ failures, requiring intensive care unit (ICU) and invasive mechanical ventilation support (IVS), a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO2:FiO2) of less than 300 mmHg, or infiltrates in more than 50% of the lung field within 24 to 48 h; ","/","Death before study end date","any of the following symptoms: breathing rate of 30 or more breaths/min, the oxygen saturation level below 93%, one or multiple organ failures, requiring intensive care unit (ICU) and invasive mechanical ventilation support (IVS), a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO2:FiO2) of less than 300 mmHg, or infiltrates in more than 50% of the lung field within 24 to 48 h; ","univariate","",NA,"9","OR","43.17","7.79 - 239.15","6.9e-10","0.778","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","16","OR","1.76","0.35 - 8.99","0.49","0.125","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","4","OR","12.33","1.55 - 98.17","0.0033","0.500","0.0917","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"12","OR","2.47","0.47 - 13.02","0.27","0.167","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","3","NA (0 value)","","","","0","0.0917","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"6","NA (0 value)","","","","0","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","5","OR","18.50","2.73 - 125.41","9.4e-5","0.600","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"6","NA (0 value)","","","","0","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"61","OR","4.39","1.81 - 10.65","5.6e-4","0.262","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","3","OR","6.17","0.51 - 74.73","0.11","1","0.0917","","","","","","","","","","","","","","","","","","","","","0","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","0","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"64","OR,aOR (MV regress)","3.73,2.59","1.45-9.59,1.47-5.26",".006,.001","0.2969","0.0917","aOR (MV regress)","4.22","3.17-6.26",".001","0.2031","0.050","aOR (MV regress)","2.26*","1.77-4.61",".01","0.375","","","","","","","","","",NA,"43","OR","3.74","1.40 - 9.97","0.0057","0.233","0.0917","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"21","OR","9.25","3.08 - 27.77","7.49e-6","0.429","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","0","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"33","51.6","","","","","","0.0917","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","7.8","","","","","","0.0917","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","10","15.6","",NA,"","","","0.0917",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"186","100","","","","","0.2969","0.0917","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"64534","Monari 2021","More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study","Consensus","Peer-reviewed","Frontiers in Oncology","","2021-05","More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study","Monari C","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Italy","Campania region (13 cities: Naples, Caserta, Salerno, Benevento, Pozzuoli, Eboli and Vallo della Lucania)","N/A","2020-02-28","2020-05-31","371","COVID-19 severity (requiring mechanical ventilation and/or admission to ICU and/or in case of death).","","Severity; Mortality","no","17 patients active cancer (defined as subjects who had received anti-neoplastic treatment (radio-, chemo- or immuno/target-therapy or surgery) within the last 30 days or the subjects without indication of treatment due to a late stage of disease of without treatment options (off-therapy).  12 inactive cancer (defined as a history of cancer without anticancer treatment in the last 30 days (follow-up))","Not age matched (table 2) Were sex matched (table 2) Not comorbidity matched (table 2)","Ratio of active cancer to non-cancer 17:337 Not age matched (table 2), were sex matched (table 2), not comorbidity matched (table 2)",NA,"Median","72.0","IQR","61-78","76.5","13","Median","58.0","IQR","46-69","61.7","208","Not mentioned",NA,"","","","","",NA,"","","11","64.7","138","40.9","",NA,"","0.083","","","","","",NA,"","","11","64.7","71","21.1","","","","<0.001","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","5","29.4","47","13.9","","","","0.17","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","Requiring mechanical ventilation and/or admission to ICU and/or in case of death.","","no statement","Mild: asymptomatic or experienced a mild infection with home quarantine and/or did not need oxygen (O2) therapy and/or had a Modified Early Warning Score (MEWS) below 3 points.  Moderate: hospitalized and required low flow O2 therapy or non-invasive O2 therapy and/or had a MEWS equal or above 3 points (3).  Severe: ICU admission and/or mechanical and/or patient died.","multivariate","Age; Sex; Comorbidities; Other: Charlson Index Score indicates comorbidities",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"17","uOR","7.30","2.68-19.90","<0.001","0.529 (9/17)","0.134 (45/337)","","","","","","","mOR","5.33","1.72-16.53","<0.001","0.647","0.217","mORs presented are for severity","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"63774","Rthrich 2021","COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry","Consensus","Peer-reviewed","Annals of Hematology","Lean European Open Survey on SARS-COV-2 (LEOSS) registry ","2020-11","COVID-19 in cancer patients: clinical characteristics and outcomean analysis of the LEOSS registry","Rthrich MM","Retrospective","Cohort","Yes","inpatient and outpatient (with breakdown)","Germany","N/A","N/A","2020-03-16","2020-08-31","2833 ","Death (attributed to COVID-19), clinical manifestation of COVID-19 ","Survival at day 30","Mortality","no","","Same multinational cohort (LEOSS)","active cancer to non-cancer ratio: 197:2636  evident sex matching",NA,"Age ranges ","<18: 5/435; 18-25: 1/435; 26-35: 4/435; 36-45: 13/435; 46-55: 36/435; 56-65: 72/435; 66-75: 108/435; 76-85: 158/435; >85: 8/435","","","59.5","435","Age ranges ","<18: 47/2636; 18-25: 60/2636; 26-35: 197/2636; 36-45: 239/2636; 46-55: 434/2636; 56-65: 527/2636; 66-75: 413/2636; 76-85: 508/2636; >85: 211/2636","","","59.5","2636","Not mentioned",NA,"36/225","16","170/1270 ","14","",NA,"","","259/430","60","1249/2591","48","",NA,"","","63/429; 41/426 ","14.5; 9.5","349/2572; 172/2563  ","13.5; 6.5","",NA,"","","36/424; 52/420; 81/420; 34/421","8.5; 12; 19.5; 8","156/2539; 242/2537; 343/2518; 104/2521","6; 9.5; 13.5; 4","","","","","59/427","14","222/2560","8.5","",NA,"",NA,"5/428; 6/428 ","1; 1.5","53/2558; 22/2561","2; 1","",NA,"","","87/428","20.5","359/2569","14","",NA,"","","39/430; 15/429; 27/422","9; 3.5; 6.5","149/2572; 137/2564; 110/2539","6; 5.5; 4.5","","","","","5/429","1","49/2564","2","","","","",NA,NA,NA,NA,"",NA,"",NA,"69/184; 19/428; 3/429; 48/429; 15/431","24; 4.5; 0.5; 11; 3.5","419/1597; 51/2558; 20/2560; 209/2358; 55/2562","26; 2; 1; 8; 2","","","","","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy  DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia ","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy  DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","these comorbidities are recorded for the total cancer cohort which consisted of 54% with active malignancy  DM = with end organ damage; without end organ damage  CVD = myocardial infarction; chronic heart failure; coronary artery disease; peripheral  vascular disease  Chronic liver disease = chronic liver disease; liver cirrhosis   Chronic lung disease = COPD; asthma; other chronic pulmonary disease   Immunodeficiency = organ transplantation   Others = obesity; peptic ulcer disease; connective tissue disease; dementia; hemiplegia","","","","",NA,NA,"The primary endpoint (death related to COVID-19) was observed in 97 (22.5%) patients, while the majority died within 30 days after diagnosis of SARS-CoV-2 (19.5%)",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"197","cOR","2.22","1.59 - 3.10","0.0000044","52/197","367/2636","","","","","","","","","","","","","I calculated crude OR, CI and p-value for mortality attributed to covid-19 in *active* cancer patients vs. non-cancer patients ","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"36/418","8.5","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"96/418","22.0","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","25/418","5.5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","39/418","9.0","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"62340","Westblade 2020","SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19","Consensus","Peer-reviewed","Cancer Cell","EHRs from NewYork-Presbyterian Hospital (NYP), Weill Cornell Medical Center, NYP Lower Manhattan Hospital, and NYP Queens","2020-11","SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19","Westblade LF","Retrospective","Cohort","Yes","inpatient","USA","New York","New York-Presbyterian Hospital (NYP), Weill Cornell Medical Center, NYP Lower Manhattan Hospital, and NYP Queens","2020-03-15","2020-05-14","3014","Intubation, Need for vasopressors, mortality","","ICU admission; Mortality","no","Either under active surveillance at time of admission for COVID-19 OR had active cancer-directed therapy in the six months prior to admission","Inpatients at the same hospitals diagnosed during the same time period","Not explicitly matched but no significant differences in terms of age and sex",NA,"Median","72","IQR","66-80","53","100","Median","65","IQR","53-77","57.8","2914","Not mentioned",NA,"31","31","573","19.7","OR","1.84","1.19 - 2.83","0.0054","48","48","1232","42.3","OR","1.26","0.85 - 1.88","0.26","33","33","935","32.1","OR","1.04","0.68 - 1.59","0.85","39","39","602","20.7","OR","2.46","1.63 - 3.71","1e-5","","","","","",NA,"",NA,"2","2","26","0.9","OR","2.27","0.53 - 9.69","0.26","8","8","270","9.3","OR","0.85","0.41 - 1.77","0.67","21","21","450","15.4","OR","1.46","0.89 - 2.38","0.13","0","0","28","1.0","NA (0 value)","","","","3","3","101","3.47","OR","0.86","0.27 - 2.76","0.8","","","","","","","","","","","","","","","","","not defined","","","not defined","univariate","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"60","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","40","","","","","","","","","","","","","","","","","","","","","","","","","","","64","OR","1.34","0.80 - 2.24","0.257","0.391","0.323","","","","","","","",NA,"",NA,NA,NA,"See comments IMPORTANT - Crude OR from scratch","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"100","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","100","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"100","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"62182","Christopher 2020","Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience","Consensus","Peer-reviewed","Frontiers in Oncology","Electronic health records of the University College London Hospitals NHS Foundation Trust.","2020-11","Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience","Christopher C. T. Sng","Retrospective","Cohort","Yes","inpatient","UK","London","University College London Hospitals NHS Foundation Trust","2020-03-01","2020-05-31","626","All-cause mortality.","","Mortality","no","Any evidence of solid cancer in EHR. Active cancer = cancer diagnosis or anti-cancer treatment within the last 12 months or radiological or biochemical evidence of active or recurrent cancer.","Patients with no evidence of cancer in their EHR recruited from the same hospital.","Age- and sex-matched control patients. Not co-morbidity matched. Cancer : control = 94 : 226",NA,"median","71","iqr","62-80","66","94","median","70.5","iqr","60-80","67","226","Not mentioned",NA,"7","7","13","6","uOR","1.32","0.51-3.42","0.568403","37","39","123","54","uOR","0.54","0.33-0.89","0.014103","24","26","73","32","uOR","0.72","0.42-1.23","0.230143","18","19","59","26","uOR","0.67","0.37-1.21","0.184800","12","13","37","16","uOR","0.75","0.37-1.51","0.414594","3","3","4","2","uOR","1.83","0.40-8.34","0.428448","12","13","26","12","uOR","1.13","0.54 - 2.34","0.750680","14","15","47","21","uOR","0.67","0.35-1.28","0.220784","4","4","13","6","uOR","0.73","0.23-2.29","0.586580",NA,NA,NA,NA,"",NA,"",NA,"","","","","","","","","immunosuppressed = ongoing corticosteroid use; comorbidities compare control cohort to 98 patients with a history of cancer (of whom 58 had active cancer)","","","","","","","","","","All cause mortality up to and including 12 June 2020.","","multivariate","Age; Comorbidities; Other: Ethnicity.",NA,"15","aHR","0.70","0.28-1.79","0.46","0.333 (5/15)","","","","","","","","",NA,"",NA,"","","","","","","","","","","8","aHR","1.56","0.55-4.38","0.40","0.500 (4/8)","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"24","aHR","1.65","0.85-3.19","0.14","0.542 (13/24)","","","","","","","","",NA,"",NA,"","","","","","","","","","","9","aHR","0.60","0.19-1.96","0.40","0.333 (3/9)","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"58","aHR","1.64","1.03-2.6","0.04","0.448 (26/58)","","","","","","","","","","","","","","","","","","","","","total = active cancer only, subtypes include active and non-active",NA,"58","","","","","0.448 (26/58)","0.341 (77/226)","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"19","uHR","1.13","0.54-2.37","0.75","0.474 (9/19)","0.341 (77/226)","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"15","25.9","mHR","2.04","0.84-4.9","0.11","0.467 (7/15)","0.341 (77/226)","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","8","13.8","mHR","1.94","0.74-5.1","0.18","0.625 (5/8)","0.341 (77/226)","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"2","3.45","mHR","3.44","0.44-27.2","0.24","0.500 (1/2)","0.341 (77/226)","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","5","8.62","mHR","1.94","0.45-8.4","0.38","0.400 (2/5)","0.341 (77/226)","","","","","","","",NA,"",NA,"","","","","","","","","","","4","6.90","mHR","1.70","0.39-7.3","0.48","0.500 (2/4)","0.341 (77/226)","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","3","5.17","mHR","1.4","0.18-10.8","0.75","0.333 (1/3)","0.341 (77/226)",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"320","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"62120","Brar 2020","COVID-19 severity and outcomes in patients with cancer: A matched cohort study","Consensus","Peer-reviewed","Journal of Clinical Oncology","Hospital records for Weill Cornell Medicine and Lower Manhattan Hospital","2020-09","COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study","Brar G.","Retrospective","Cohort","Yes","inpatient","USA","New York City","2 New York-Presbyterian hospitals: Weill Cornell Medicine and Lower Manhattan Hospital","2020-03-03","2020-05-15","585","Composite incident outcome of: 1) ICU admission 2) Intubation 3) Death","","Severity; ICU admission; Mortality","no","All consecutively hospitalized patients with an active hematologic or solid tumor malignancy","Patients at the same two hospitals with no cancer diagnostic code","cancer: non-cancer = 1:4 Formally matched for age, gender and comorbiditiies",NA,"Median","72.5","IQR","64.2-79.9","54.7%","117","Median","71.2","IQR","62.1-79.6","54.7%","468","Not mentioned",NA,"39","33.4","129","27.7","uOR","1.31","0.22-0.85","0.22","62","53.0","269","57.5","uOR","0.83","0.21-0.56","0.38","38","32.5","136","29.1","uOR","1.17","0.22-0.76","0.47","","","","","","","","","","","","","",NA,"",NA,"3","","2","0.4","uOR","6.13","0.92-1.01","0.02","3","2.6","23","4.9","uOR","0.51","0.15-0.62","0.27","","","","","","","","","0","0","3","0.6","uOR","n/a","n/a","n/a",NA,NA,NA,NA,"",NA,"",NA,"22; 13; 9; 6","18.8; 11.1; 7.7; 5.1","78; 32; 33;29","16.7; 6.8; 7.1; 6.2","uOR; uOR; uOR; uOR","1.16; 1.70; 1.10; 0.82","0.27-0.69; 0.35-0.86; 0.39-0.51; 0.33-0.46","0.58; 0.12; 0.81; 0.66","CAD; HF; COPD; Asthma","","","","","","","","Composite outcome: death, intubation, or ICU admission","","in hospital mortality","Composite outcome: death, intubation, or ICU admission","multivariate","Age; Sex; Comorbidities",NA,"1","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","15","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"22","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"75","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","42","","","","","","","","","","","","","","","","","","","","","","","","","","","19","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","Combined lower + upper GI","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"117","uHR; mHR","0.74; 0.98","0.53-1.03; 0.58-1.67",">.05; 0.894","29/117; 0.248","100/468; 0.214","","","","","","","mHR","0.80","0.57-1.13",">.05","","","","","","","","","","",NA,"22","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"26","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","27","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"52","44.4","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","32","27.4","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","14","12.0","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","21","18.0","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"585","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"61946","Duarte 2020","Outcomes of covid-19 patients under cytotoxic cancer chemotherapy in brazil","Consensus","Peer-reviewed","Cancers","SIVEP","2020-11/24","Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil","Duarte, Mateus Bringel Oliveira ","Retrospective","Cohort ","Yes","inpatient","Brazil","Brazilian Southeast region ","","2020-01-01","2020-09-28","non-matched:38899;pair matched: 927","Mortality, severity ","","Severity; Mortality","no","Cancer was defined as any oncological disease reported in SIVEP (Brazilian Ministry of Healths electronic registry for epidemiological surveillance of flu-like syndromes)  cancer patients were stratified into active and non-active chemo - numbers and stats provided below only include  1. Non Pair-matched: active chemo patients vs non-cancer controls to ensure previous cancer patients are not included within non-active chemo  2. Pair matched: cancer (active chemo) vs non cancer controls   (pair matched to active and inactive chemo)   n.b. for cancer subtype, only data for the active chemo cohort were available (data for the pair matched active chemo cohort breakdown by cancer types are not available )  data pulled from addition supplementary resources (available here: https://www.mdpi.com/2072-6694/12/12/3490/s1)  ","same multinational cohort ","for matched data == cancer: control = 246: 681 for non-matched data == cancer: control = 431: 38468 matched data was matched for: age, sex, race, Brazilian region, type of presentation, and comorbidities",NA,"age ranges","non-pair matched: <50 (121); 50-64 (172); 65-79 (1220); >80 (16)   pair matched: <50 (49); 50-64 (99); 65-79 (89); >80 (9) ","","","non-pair matched: 43.2%;pair matched: 49.6% ","non-pair matched: 431;pair matched: 246","age ranges","non-pair matched: <50 (10192); 50-64 (11730); 65-79 (11379); >80 (5167)   pair matched: <50 (166); 50-64 (274); 65-79 (216); >80 (25) ","","","non-pair matched: 57.5%;pair matched: 45.2% ","non-pair matched: 38468;pair matched: 681","Not mentioned",NA,"","","","","",NA,"","","","","","","",NA,"","","non-pair matched; pair matched: 66; 38","non-pair matched; pair matched: 15.3; 15.5","non-pair matched; pair matched: 11333, 103","non-pair matched; pair matched: 49; 15.1","",NA,"","","non-pair matched; pair matched: 83; 60","non-pair matched; pair matched: 19.3; 24.4","non-pair matched; pair matched: 15866; 145","non-pair matched; pair matched: 41.2; 21.3","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","non-pair matched; pair matched: 23; 15 ","non-pair matched; pair matched: 5.3%; 6.1%","non-pair matched; pair matched: 2630; 38 ","non-pair matched; pair matched: 6.8%; 5.6%","",NA,"","","non-pair matched; pair matched: 17; 11","non-pair matched; pair matched: 3.9%; 4.5%","non-pair matched; pair matched: 2152; 28 ","non-pair matched; pair matched: 5.6%; 4.1%","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"neurological disease:  non-pair matched; pair matched: 5; 5 ","neurological disease:  non-pair matched; pair matched: 1.1%; 2.0%","neurological disease: non-pair matched; pair matched: 2026; 13","neurological disease: non-pair matched; pair matched: 5.3%; 1.9%","","","","","","","","","","","","","Critical presentation/severity was defined as the use of invasive mechanical ventilation.","","not specified at any point "," Critical presentation/severity was defined as the use of invasive mechanical ventilation.","Other: OR values not what we want as said by James - ""Just record the raw numbers and leave the ORs and p values blank (those reported are not comparable to the ORs we want).""","",NA,"30","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","66","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","39","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"64","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","18","","","","","","","",NA,"","","","","","","","","","","","","","","","","","","0","","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","42","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"8","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"11","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"5","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","10","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"320","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","111","","","","","","","","","","","","","","","","","","","","","","","","","","","17","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"431","","","","","non-matched; pair-matched: 265/431; 162/ 246","non-matched; pair-matched: 14255/38468; 217/ 681","","","","","","","","","","","non-matched; pair-matched: 97/431; 59/ 246","non-matched; pair-matched: 9848/38468; 158/ 681","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","non-matched; pair-matched: 431; 246 ","","","","","non-matched; pair-matched: 265/431; 162/ 246","non-matched; pair-matched: 14255/38468; 217/ 681","",NA,"","","","","","","","","non-matched; pair-matched: 97/431; 59/ 246","non-matched; pair-matched: 9848/38468; 158/ 681","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA," non-matched;38899 pair matched: 927","100","","","","","non-matched; pair-matched: 265/431; 162/ 246","non-matched; pair-matched: 14255/38468; 217/ 681","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","non-matched; pair-matched: 97/431; 59/ 246","non-matched; pair-matched: 9848/38468; 158/ 681","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"61922","Mehta 2020","Case fatality rate of cancer patients with COVID-19 in a New York Hospital system","Consensus","Peer-reviewed","American Association for Cancer Research","","2020-05","Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System","Mehta V","Retrospective","Cohort","Yes","inpatient","USA","New York City","Montefiore Health System","2020-03-18","2020-04-08","1308","Case fatality in COVID-19 patients with cancer vs. patients without cancer","","ICU admission; Mortality","no","patients with a history of malignancy. Cases identified as having  benign neoplasms were excluded.","Age and sex matched 5:1 ratio","Ratio of cancer to non-cancer: 1:5 Age and sex matched No mention of whether comorbidity matched",NA,"Median","69","Range","10-92","58","218","","","","","","1090","Not mentioned",NA,"","","","","",NA,"","","147","67.4","","","",NA,"","","80","36.7","","","",NA,"","","43","19.7","","","","","","","","","","","",NA,"",NA,"","","","","",NA,"","","54","24.8","","","",NA,"","","62","28.4","","","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"33 (congestive heart failure, CHF)","15.1","","","","","","","","","","","","","","","","","","","multivariate","Age; Sex",NA,"11","aOR","7.58","2.28-25.15","0.001","0.545 (6/11)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","28","aOR","1.05","0.36-3.08","0.933","0.143 (4/28)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","8","aOR","3.79","0.90-16.02","0.071","0.375 (3/8)","0.137 (149/1090)","","","","",NA,NA,"",NA,"",NA,NA,NA,"","","","","","",NA,NA,"21","aOR","3.89","1.58-9.54","0.003","0.381 (8/21)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","7","aOR","2.53","0.49-13.14","0.277","0.286 (2/7)","0.137 (149/1090)","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","13","aOR","3.95","1.27-12.23","0.018","0.385 (5/13)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"8","aOR","0.90","0.11-7.39","1.066","0.125 (1/8)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"3","aOR","3.16","0.28-35.04","0.358","0.333 (1/3)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"164","aOR","2.11","1.42-3.12","0.0002","0.250 (41/164)","0.137 (149/1090)","","","","","","","",NA,"",NA,"","","","","","","","","","","54","aOR","3.71","2.08-6.63","1.165E-05","0.370 (20/54)","0.137 (149/1090)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"218","aOR","2.45","1.74-3.46","4.527E-7","0.280 (61/218)","0.137 (149/1090)","","","","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"42","19.3","","","","0.2","0.235","0.137","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","49","22.5","","","","0.33","0.224","0.137","","","","","","","",NA,"",NA,"","","","","","","","","","","5","2.3","","","","1","0.200","0.137","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"yes"
"61478","Zhang 2020","Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19","Consensus","Peer-reviewed","Frontiers in Oncology","Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China.","2020-10","Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19","Zhang B","Retrospective","Cohort","Yes","inpatient","China","Wuhan","Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China.","2020-01-17","2020-05-18","171","Disease severity, mortality ","","Severity; ICU admission; Mortality","no","breast cancer cohort n=35 and other types of cancer cohort n=81 ","Comparison group drawn from same five tertiary hospitals as cancer groups.  Our study was performed in five designated tertiary hospitals for the treatment of COVID-19 in Wuhan, China. Thirty-five breast cancer patients with COVID-19, 81 other types of cancer patients with COVID-19, and 55 COVID-19 patients without cancer were recruited between January 17, 2020 and May 18, 2020","ratio of cancer to non-cancer = 116:55 median age in all groups are matched",NA,"median","56; 58","IQR","45 - 62; 49 - 62","0; 46.9","116","median","57","IQR","49 - 64","41.8","55","Not mentioned",NA,"","","","","",NA,"","","24","20.7","17","30.9","cOR","0.58","0.28 - 1.21","1.177","16","13.8","10","18.2","cOR","0.72","0.30 - 1.71","1.354","9","7.8","7","12.7","cOR","0.58","0.20 - 1.64","1.346","","","","","",NA,"",NA,"","","","","",NA,"","","","","","","",NA,"","","6","5.2","0","0","cOR","undefined","undefined","undefined","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"6; 9","5.2; 7.8","0; 0","0; 0","cOR","undefined","undefined","undefined","Others = common pulmonary infection; anemia ","","","","","","","","","","","","Other: univariate analysis only available for breast cancer cohort, not all cancer patients so I instead calculated crude OR, CI, p-value for outcomes of interest and all cancer patients","",NA,"12; 2","","","","","","","","","","","","","",NA,"",NA,"","","lung; nasopharynx","","","","","","","","35","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6; 1","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"gastric; oesophageal","","","","","",NA,NA,"6; 3","","","","","","","","","","","","","",NA,"",NA,"","","colon; rectum","","","","","","","","5; 4","","","","","","","",NA,"","","","","","","","","","","pancreas; liver","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"3","","","","","","","","","","","","","",NA,"",NA,"","","bladder","","","","","","","","7; 3","","","","","","","","","","","","","",NA,"",NA,"","","cervical; ovarian","","","","","","",NA,"1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"meningioma","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","","1","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"osteosarcoma","","","","",NA,NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","6; 6; 4; 2","","","","","","","","","","","","","","","","","","","leukemia; myeloma; lymphoma; myelodysplastic syndrome","","","","","","","","7; 1","","","","","","","","","","","","","",NA,"",NA,NA,NA,"thyroid; liposarcoma","","","","","","","","","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"",NA,NA,NA,NA,NA,NA,NA,"116","cOR","-","-","-","0.069 (8/116)","0 (0/55)","cOR","-","-","-","0.069 (8/116)","0 (0/55)","cOR","4.59","2.16 - 9.77","0.0001","0.534 (62/116)","0.200 (11/55)","non-cancer data taken from table 5 and cancer data summed across both cohorts from table 6. I calculated crude OR, CI and p-value using this data","","","","","","","",NA,"","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
"61253","Shoumariyeh 2020","Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany","Consensus","Peer-reviewed","Cancer Medicine","EHRs from University Hospital Freiburg","2020-08","Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany","Shoumariyeh K","Retrospective","cohort","Yes","inpatient","Germany","Freiburg","University Hospital of Freiburg","2020-02-27","2020-04-10","78","Treatment","Mortality","ICU admission; Mortality","no","active cancer or cancer in remission","controls at the same hospital","age-matched",NA,"Median","73","range","54-95","56.4","39","Median","76","range","45-96","64.1","39","Not mentioned",NA,"6","15.4","9","23.1","",NA,"","0.4998","","","","","",NA,"","","5","12.8","9","23.1","",NA,"","0.3768","30","76.9","34","87.2","","","","0.3768","","","","","",NA,"",NA,"1","2.6","3","7.7","",NA,"","0.6151","5","12.8","15","38.5","",NA,"","0.0183","3","7.7","11","28.2","","","","0.0362","","","","","","","","",NA,NA,NA,NA,"",NA,"",NA,"3","7.7","3","7.7","","","","1.000","Others = Rheumatological","","","","","","","","","","","","univariate","",NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","3","","","","","","","","","","",NA,NA,"",NA,"",NA,NA,NA,"all GI","","","","","",NA,NA,"","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","",NA,"",NA,"","","",NA,"",NA,"","","","",NA,"",NA,"","",NA,"16","","","","","","","","","","","","","",NA,"",NA,"","","uro-gynec","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","","",NA,NA,"5","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","",NA,"","","","","","","","","","","","","","",NA,"",NA,"","",NA,"","","","","","","",NA,"","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,"","","","","",NA,NA,NA,"29","uOR","0.47","0.15-1.42","1.218","6/29","14/39","uOR","0.80","0.29-2.24","1.250","9/29","14/39","",NA,"",NA,"","","","","","","","","","","7","uOR","0.45","0.08-2.40","1.346","2/10","14/39","uOR","4.17","0.93-18.72","0.063","7/10","14/39","","","","","","","LYMPHOMA/MYELOMA","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,NA,NA,"","","","","","","","","3","",NA,"",NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEUKEMIA/PHN",NA,NA,NA,NA,NA,NA,NA,"39","uOR","0.46","0.17-1.27","1.135","8/39","14/39","uOR","1.24","0.50-3.10","0.658","16/39","14/39","","","","","","","","","","","","","","",NA,"29","","","","","","","","","","","","",NA,NA,NA,NA,"",NA,"","","","","","",NA,NA,"10","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","",NA,"","","","","","","","","","","","",NA,"","","","",NA,NA,"","","","","","","","","","","","","","","",NA,"",NA,"",NA,"","","","","","","","","","","","","","","","","","","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,"","","","",NA,NA,NA,"","","","","","","","","","","","","","","",NA,NA,NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"","","","","","","","","","","","","","","","","","","","","","","","","",NA,"",NA,"",NA,NA,"","","","","","","","","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"",NA,"",NA,"",NA,NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","","",NA,"",NA,"","","",NA,"","","","","","",NA,"",NA,"","","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"","","",NA,"","","","",NA,NA,NA,NA,NA,NA,"",NA,"","","","","",NA,NA,NA,NA,NA,NA,NA,"78","100","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",NA,"","","","","",NA,"",NA,"","","","","","","","","","",NA,"",NA,"","","",NA,NA,NA,"","","",NA,"","","","","",NA,"","",NA,NA,NA,NA,NA,NA,"","","",NA,NA,NA,"",NA,"",NA,NA,NA,NA,"","",NA,NA,NA,NA,"","",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"no"
>>>>>>> f4b822a (header unification):data/review_241469_20240110223959_DE_knownDx_peerReviewed.csv
